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SUMMARY 
IV 
SUMMARY 
The DNA in the eukaryotic genome is packaged into chromatin whose basic repeating unit is 
the nucleosome consisting of 147bp of DNA wrapped around an octameric histone core. The 
histone octamer is composed of two copies of each of the four histone proteins H2A, H2B, 
H3 and H4. 
DNA methylation is an epigenetic mechanism that is involved in various important processes 
in the cell such as differentiation and proliferation, transcriptional regulation, genomic 
imprinting, X-chromosome inactivation, silencing of repetitive elements, maintenance of 
genomic stability and DNA repair. In the mammalian genome, DNA methylation occurs 
almost exclusively in the context of CpG di-nucleotides and is brought about by three DNA 
cytosine-5-methyltransferases that use S’adenosyl-methionine (SAM) as methyl-group 
donor. Due to Dnmt1’s preferential activity towards hemi-methylated DNA and the fact that it 
restores methylation patterns on the newly synthesized daughter strand during replication, it 
is referred to as the maintenance DNA methyltransferase, whereas the de novo DNA 
methyltransferases Dnmt3a and Dnmt3b introduce new methylation marks in the genome. 
Dnmt3L is structurally related but catalytically inactive and serves as a cofactor for Dnmt3a 
and Dnmt3b. 
Importantly, DNA methylation is indispensible for mammalian embryogenesis and aberrant 
DNA methylation is often found concomitant with cancer. Dnmt1 was shown to be implicated 
in the formation of tumors, however the underlying mechanisms especially the question of 
Dnmt1 targeting remain largely unknown.  
The goal of this thesis was to identify new Dnmt1 complexes from native tissues that would 
allow comparison of complex composition in tumors. ICBP90 (UHRF1) and USP7 were 
identified as interacting proteins from co-immunoprecipitation experiments. During the course 
of this study, UHRF1 was described not only to interact with Dnmt1 but to recruit Dnmt1 to 
replication foci during late S-phase. In vivo and in vitro immunoprecipitations revealed 
different possible complexes, namely Dnmt1/ICBP90, Dnmt1/USP7 and ICBP90/USP7. 
Furthermore, a possible trimeric complex of USP7 binding with two different domains to both 
Dnmt1 and ICBP90 was established. Notably, chromatin immunoprecipitation demonstrated 
the existence of different Dnmt1/ICBP90/USP7 complexes at four different loci in vivo, 
however the function in chromatin related processes awaits further investigation. 
Interestingly, ICBP90 and USP7 are endowed with antagonistic enzymatic activities. ICBP90 
exhibits autoubiquitinylation and ubiquitinylation activity towards histone H3, and USP7 in 
vitro. On the contrary, USP7 was able to target ICBP90 and histones H2A, H2B and H3 for 
deubiquitination in vitro whereas global levels of ubiquitinylated H2A and H2B were not 
changed upon knockdown or over-expression of USP7. Binding of ICBP90 and Dnmt1 to 
USP7 did not influence the in vitro activity of USP7. Moreover, Dnmt1 was ubiquitinylated by 
ICBP90 in vitro, but Dnmt1 protein or ubiquitinylation levels were not affected by USP7 over-
expression or knockdown in vivo.  
Future research will focus on the role of histone ubiquitinylation/deubiquitination in 
transcriptional repression and silencing of repetitive elements in heterochromatin. 
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In another project, the properties of Dnmt binding to DNA and mono-nucleosomes and the 
principle mechanisms of DNA methylation in chromatin by the de novo DNA 
methyltransferases were in focus. It could be shown that Dnmt3a and Dnmt3b2 stably 
associated with DNA >35bp in length, albeit longer DNA fragments were preferred indicative 
of a cooperative binding process. Furthermore, binding to DNA or mono-nucleosomes was 
highly dynamic and the interaction of mono-nucleosomes with the de novo DNA 
methyltransferases did not disrupt mono-nucleosomes. Dnmt3a generally bound comparably 
well to DNA and mono-nucleosomes with different DNA linker length whereas Dnmt3b2 
preferentially bound to free DNA and mono-nucleosomes with long linker DNA. 
In vitro DNA methylation assays, either performed with radioactive SAM or non-radioactive 
one, but following single-molecule analysis with bisulfite treatment clearly demonstrated that 
Dnmt3a and Dnmt3b2 could not methylate DNA within the nucleosome but only linker DNA. 
This indicated that the DNA strand facing opposite the histone octamer did not represent a 
target for methylation and that nucleosomes constitute a major restriction for DNA 
methylation. Further experiments will address the role of chromatin remodeling enzymes in 
this process. 
Dnmt3L, a stimulatory factor for Dnmt3a and Dnmt3b, was shown to bind to non-methylated 
H3K4. Therefore, the effect of Dnmt3L on binding to DNA and nucleosomes by Dnmt3a and 
Dnmt3b was analyzed. Dnmt3L itself neither bound to DNA nor to mono-nucleosomes in 
EMSA experiments. Addition of Dnmt3L to Dnmt3a and Dnmt3b enhanced DNA binding and 
modified the binding behavior towards nucleosomes.  
Interestingly, recombinant Dnmt3L was tightly associated with nucleosomes when purified 
from Sf21 insect cells. Sucrose density gradient analysis confirmed this observation as 
Dnmt3L was distributed over the whole gradient with nucleosomal species of different weight. 
However, when endogenous nucleosomes were substituted for nucleosomal templates of 
various sizes or ‘naked’ DNA Dnmt3L entered the gradient by 1/3rd, although the peak 
fractions migrated at higher densities.  
To unravel the reasons for the stable association of Dnmt3L with endogenous nucleosomes, 
future work will concentrate on the identification of possible loading factors, specific 
posttranslational histone modifications and nucleosomal architecture.  
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A INTRODUCTION 
A.1 DNA and chromatin 
The enormous length and complexity of eukaryotic genomes confronts the cells with several 
constraints. On the one hand, genomic DNA has to be compacted to fit into the nuclear sub-
cellular compartment and on the other hand, genetic information has to be readily accessible.  
Furthermore, multi-cellular organisms require functional specialization of individual cells in 
united cell structures and thus differential gene expression. Cells meet these requirements 
by assembling the genome into a highly compact but dynamic structure termed chromatin, 
consisting of DNA and associated proteins (histones and non-histone proteins)(Olins and 
Olins 2003). The term chromatin (from the greek word ‘chroma’ for coloring) was first 
proposed in the 1880s when Walter Flemming observed a stainable substance in the cell 
nucleus. Noteworthy, there is evidence that besides proteins, RNA constitutes an integral 
component of chromatin regarding structure and stability (Rodríguez-Campos and Azorín 
2007). 
Chromatin presents the natural substrate for all kinds of DNA-dependent processes such as 
the control of gene expression as well as DNA replication, recombination and repair 
(Felsenfeld and Groudine 2003; Khorasanizadeh 2004). Changes to this highly organized 
structure are allowed through various related mechanisms such as post-translational 
modifications of histones (Vaquero et al. 2003; Fischle 2008), the exchange of canonical 
histones by histone variants (Bernstein and Hake 2006) and by energy-dependent alterations 
of the chromatin structure, a process called ATP-dependent nucleosome remodeling (Varga-
Weisz and Becker 2006). These modulations influence the chromatin structure and therefore 
play a role in the regulation of gene accessibility and expression. 
 
A.1.1 Chromatin structure 
A.1.1.1 The nucleosome is the basic unit of chromatin 
By different levels of compaction, the DNA of the human cell with 2m length is compacted to 
10µm to fit into the nucleus. DNA compaction into chromatin is realized by several layers of 
structural hierarchy.  
The nucleosome core particle (NCP) is the universal repeating unit in chromatin with a 
molecular weight of 210kDa (Kornberg 1974). The high-resolution crystal structure revealed 
an octameric histone core with 147bp of DNA wrapped around in 1.65 helical turns of a flat 
left-handed superhelix (Luger et al. 1997) (Figure 1). The histone octamer itself is composed 
of two copies of each of the four histone proteins H2A, H2B, H3 and H4 (Luger et al. 1997). 
The massive distortion of the DNA is brought about the tight interaction between the rigid 
framework of the histone proteins with the DNA at 14 independent DNA-binding locations 
(Luger and Richmond 1998). Noteworthy, the nucleosome exhibits a modular assembly in 
which the H2A-H2B dimers can be removed while interaction with the DNA and the (H3-H4)2 
tetramer is maintained (Luger 2003), reflecting assembly and disassembly pathways.  
INTRODUCTION 
2 
The four core histones are small basic proteins (11 - 16kDa), which are highly conserved 
throughout evolution. Structurally eukaryotic histones are bipartite proteins composed of a 
carboxy-terminal three-helix ‘histone fold’ domain and less structured N-terminal domains. 
These structural components organize the nucleosomal DNA and mediate intra-nucleosomal 
and secondary inter-nucleosomal interactions (Richmond and Davey 2003; Luger 2006). 
The highly basic amino-terminal domains (‘tails’) extending from the surface of the 
nucleosome are thought to be mainly unstructured. These histone tails that exhibit numerous 
lysine, arginine and serine residues are targets for post-translational modifications (A.1.2). 
Furthermore, nucleosomes not only contain the four canonical histones but also variants that 
either slightly differ in sequence or contain an additional domain or both. Histone variants are 
assumed to be involved in transcriptional regulation, development and tissue specific gene 
expression, thus adding another element of epigenetic regulation to chromatin (Bernstein 
and Hake 2006). 
 
Figure 1  Structure of the nucleosome core particle and posttranslational modifications 
A.) 147 bp of DNA (colored in light blue) are wrapped around the histone octamer in 1.7 turns. The histone 
octamer is composed of two copies of each histone H2A (yellow), H2B (red), H3 (blue) and H4 (green) and forms 
the nucleosome core particle. Histone tails protrude from the nucleosome core particle (white). The red star 
indicates the site of ubiquitination in yeast (taken from (Luger 2003). B.) The histone octamer of the nucleosome 
core particle is shown. H2A (red), H2B (brown), H3 (green), H4 (yellow) and the respective histone tails with the 
sites of modification are depicted. The covalent modifications of the amino acids are shown. Taken from 
(Khorasanizadeh 2004). 
 
A.1.1.2 Structural organization of chromatin 
DNA packaging into chromatin can be dissected into a structural hierarchy with several levels 
of organization (Woodcock and Dimitrov 2001; Horn and Peterson 2002; Woodcock 2006). 
The succession of nucleosomes linked by short stretches of DNA (15-60bp) into a flexible 
chain, also referred to as ‘pearls on a string’, builds up the 10nm fiber of chromatin.  
A fifth histone protein called linker histone H1/H5 is attached to the DNA situated at the 
entry/exit sites of the nucleosome. H1 was shown to control the nucleosomal repeat length 
(Woodcock et al. 2006) thereby facilitating and stabilizing inter-nucleosomal interactions and 
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establishing the second level of organization, the so-called ‘30nm fiber’. The structure of the 
30nm fiber remains elusive despite of intensive work on the topic. Currently two architectural 
concepts on how nucleosomes are arranged within this fiber are under discussion. In the 
‘solenoid model’ nucleosomes are spiraled into a one-start helix (Robinson and Rhodes 
2006; Routh et al. 2008), wherein the nucleosomes are gradually coiled around a central axis 
(6-8 nucleosomes per turn) with the nucleosomes that are adjacent in the 10nm fiber are also 
situated next to one another in the helix. The other model proposed a ‘zig-zag’ packaging 
that features a two-start helix in which the 10nm fiber criss-crossed between two helical turns 
(Dorigo et al. 2004; Khorasanizadeh 2004; Schalch et al. 2005).  
 
Figure 2  Model of hierarchical levels of DNA compaction 
A linear DNA molecule (1) is compacted into a nucleosomal array (2). This 10nm fiber is believed to be wound 
into the 30nm fiber (3) that is depicted according to the solenoid model. Higher order chromatin structures (4 and 
5) contribute to the formation of the highly organized structure of mitotic chromsomes. (modified from (Felsenfeld 
et al. 2004). 
 
Very little is known about levels of organization above the 30nm fiber, i.e. higher order 
tertiary structures although there is accumulating evidence suggesting that chromatin fibers 
are organized into large domains potentially through interaction with a ‘nuclear matrix’ or 
‘scaffold’ (Hancock and pm026 2000; Baxter et al. 2002; Cremer et al. 2004). Furthermore, 
these condensed sections appear to be even more organized and reach their highest level of 
compaction as visible chromosomes during metaphase in mitosis.  
The spatial restricted structural elements are distinguishable by characteristic hallmarks like 
the incorporation of non-canonical histone variants, particular histone posttranslational 
modifications, chromatin compaction status and locally restricted non-histone protein 
components. 
 
A.1.2 Histone posttranslational modifications and cross talk 
Posttranslational modifications (PTM) of histones and other proteins are recognized as 
important regulators of protein function and stability, protein-protein interactions or sub-
cellular localizations (Yang 2005). Histone proteins are subjected to a multitude of different 
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PTMs, also referred to as histone ‘hall marks’, including lysine acetylation, methylation, 
ubiquitinylation and SUMOylation, arginine methylation, serine and threonine 
phosphorylation, glutamate ADP-ribosylation and proline isomerization (Gelato and Fischle 
2008). In addition, methylated lysines can exist in a mono-, di-, or tri-methyl state, whereas 
targeted arginine residues can be modified into symmetric or asymmetric di-methylated or a 
mono-methylated state. 
Conventionally, chromatin can be categorized into two main classes, euchromatin and 
heterochromatin. The first one is characterized by a low condensation state and a more 
nuclease-sensitive configuration, making it poised for gene expression, although not 
necessarily transcriptionally active. In contrast, heterochromatic structures comprise highly 
condensed regions that are in general gene-poor and form mainly on repetitive sequences, 
such as satellite centromeric and pericentromeric repeats as well as telomers (Baxter et al. 
2002; Grewal and Elgin 2002). These structures replicate late in S-phase and are 
accompanied by H3K9me3 and H4K20me3, whereas H3K9ac and H3K16ac and methylated 
H3K4 are often found within euchromatic sites. 
The inactive X-chromosome contains several hallmark histone modifications such as 
H3K9me2, H3K27me3, H4K20me, H3K4 demethylation, general deacetylation, as well as 
the histone variant macroH2A and high level of DNA methylation (Brinkman et al. 2006).  
Many covalent modifications alter the electrostatic charge of histones, thereby changing the 
structural properties of the histones or the chromatin environment. Some histone tail 
modifications serve as target sites for protein recognition modules. (A.1.2.1, A.1.2.2). 
The temporal overlap of various PTMs on histone N-terminal tails discloses the possibility of 
combinatorial effects. Accordingly, the proposed ‘histone code’ postulates that a certain set 
of histone modifications dictates the recruitment of particular transacting factors to 
accomplish specific functions (Strahl and Allis 2000; Jenuwein and Allis 2001; Turner 2007). 
Several experimental data demonstrate indeed combinatorial effects of histone modifications, 
however the evidence for a ‘universal code’ still lacks. It rather seems that the 
interdependency of multiple histone PTMs refer to a ‘cross-talk’ promoting or antagonizing 
one another (Fischle 2008). Importantly, at present it is not clear which PTMs effectively lead 
to the establishment of a chromatin element, or whether an element with certain architectural 
features or protein composition enhance the addition or removal of certain marks 
(Khorasanizadeh 2004; Gelato and Fischle 2008).  
In general, the inter-relationship between posttranslational histone modifications, special 
histone variants, chromatin remodeling (A.1.4), DNA methylation (A.3) and the RNAi 
machinery seem to be important for the establishment or maintenance of certain chromatin 
states (Narlikar et al. 2002; Robertson 2002; Hake et al. 2004; Vos et al. 2006). 
 
A.1.2.1 Histone acetylation 
Histone acetylation is set by histone acetyltransferases (HATs), which catalyze the transfer 
of acetyl groups from acetyl-CoA to the ε-amino terminal groups of specific lysine residues 
on all four core histones. This reaction is reversed by specific factors, the histone 
deacetylases (HDACs), which remove acetyl groups from lysines. Alterations of the histone 
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acetylation state appear to play an important role in chromatin assembly and gene 
regulation. Increased histone acetylation often correlates with transcriptional activity, 
whereas decreased acetylation correlates with a transcriptionally repressed state (Fischle et 
al. 2003a) (Gelato and Fischle 2008). The bromodomain, found in chromatin-associated 
proteins and HATs, functions as the sole protein module known to bind acetyl-lysine motifs 
(Mujtaba et al. 2007).  
The first HAT identified was isolated from macronuclei from Tetrahymena (Brownell et al. 
1996), and showed strong homology to Gcn5, a transcriptional co-activator in S. cerevisiae. 
Gcn5 as the catalytic subunit of the ‘SAGA’ transcriptional co-activator complex (Grant et al. 
1997) clearly linked histone acetylation to gene regulation. In the past years, many HATs 
have been identified, often in multi-protein complexes and with different histone tail 
specificities (Glozak et al. 2005). 
Histone acetylation is believed to primarily neutralize the positive charge of histones, thus 
decreasing their affinity for the DNA and altering nucleosome-nucleosome interactions 
(Vaquero et al. 2003). In fact, eviction of linker histone and H4K16 acetylation resulted in 
decompaction of the 30nm fiber in vitro (Robinson et al. 2008). The resulting permissive 
structure facilitates binding of proteins such as those of the transcriptional machinery 
(Khorasanizadeh 2004). In addition, acetylated tails can directly recruit components of 
chromatin associated factors via the bromodomain (Mujtaba et al. 2007), including the TBP 
associated factor TAFII250 and the human SWI/SNF chromatin remodeling enzyme BrgI 
(A.1.4). 
In general, histone acetylation plays an important role in nuclear processes like chromatin 
assembly, DNA repair and apoptosis, VDJ recombination and dosage compensation in 
Drosophila ((Iizuka and Smith 2003) and references therein).  
 
Histone deacetylases, the enzymes that remove the acetyl groups, are generally suggested 
to play an important role in gene inactivation. Indeed, the first identified histone deacetylase 
(HDAC1), was shown to be a homolog of the yeast Rpd3p transcriptional regulator (Taunton 
et al. 1996). Several classes of HDACs were defined, according to their expression pattern, 
homology and their sensitivity against specific inhibitors. Very often, HDACs are found within 
large multi-subunit complexes, components of which serve to target enzymes to genes, 
leading to transcriptional repression. In agreement, many transcriptional repressors were 
found to be associated with histone deacetylases, and their activity was necessary for gene 
silencing (Vaquero et al. 2003). In particular, class I HDACs form complexes with the 
transcriptional co-repressor Sin3 (David et al. 2008), the ATP-dependent remodeling 
complex NuRD (Zhang et al. 1999), DNA methyltransferases Dnmt1, Dnmt3a/b (Fuks et al. 
2000; Rountree et al. 2000; Fuks et al. 2001; Geiman et al. 2004b) and the histone 
methyltransferase Suvar39H1 (Czermin et al. 2001). Hence, HDACs are involved in multiple 
functions such as transcriptional and epigenetic silencing, development, cell differentiation, 
X-chromosome inactivation in mammalian females, and position effect variegation in 
Drosophila. 
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A.1.2.2 Histone methylation 
Histone methylation occurs on both lysine and arginine residues on several histone tails, 
although it is best described for histone H3 and H4 (Lachner and Jenuwein 2002; Fischle 
2008). Histone methyltransferases (HMT) catalyze the transfer of up to three methyl-groups 
form S-adenosyl-methtionine (SAM) to the ε-amino group of a single lysine residue. The 
protein arginine methyltransferase (PRMT) generates both mono- or di-methylated arginine 
residues, either symmetrically or asymmetrically by transferring methyl-groups to the 
guanidine-group. 
Of the many known lysines residues methylated, six have been well characterized to date: 
five on H3 (K4, K9, K27, K36, K79) and one on H4 (K20) (Lachner and Jenuwein 2002). 
Although histone methylation has been largely associated with transcriptional repression and 
epigenetic regulation, it is also involved in transcriptional activation, dependent on the 
interplay with other histone modifications (Turner 2002). Methylation of K4, K36 and K79 of 
histone H3 are examples of transcriptional activation (Beisel et al. 2002; Fischle et al. 2003a; 
Santos-Rosa et al. 2003), whereas H3K9me3 and H3K27me3 are characteristic marks for 
silenced regions (Bannister et al. 2001; Lachner and Jenuwein 2002). In addition, H3K79me 
and H4K20me have been implicated in the process of DNA repair.  
Probably one of the best-studied modifications, namely H3K9me2/3, functions as a ‘docking 
site’ for HP1 (heterochromatin protein 1), which is characteristic of inactive heterochromatic 
regions (Bannister et al. 2001). Similar, H3K27me3 is bound by the Polycomb group protein 
(PRC1 complex) (Cao et al. 2005), involved in maintaining the silenced state of homeotic 
genes during development and of the X-chromosome. Both proteins bind to the methylated 
lysines through a specific recognition module, the chromodomains (Fischle et al. 2003b). The 
PHD domain (Plant Homeodomain) is another prominent protein fold, found to specifically 
recognize H3K4me2/3 (Bienz 2005), thus reading part of the histone code (Jenuwein and 
Allis 2001; Wysocka et al. 2006). PHD fingers tend to be found in nuclear proteins that have 
a role in chromatin regulation and are involved in both gene activation and repression (Mellor 
2006). In addition other protein domains such the Tudor domain (H3K79me, H4K20me), 
WD40-Repeat domain (H3K4me) are capable of specific interactions with methylated lysine 
residues (Martin and Zhang 2005). 
In relation, Suvar3-9 and E(z) of PRC2 were the first SET domain (Suvar3-9, Enhancer-of-
zeste, Trithorax domain) containing histone methyltransferases (HMT) described (Rea et al. 
2000), specifically methylating H3K9 and H3K27 respectively. Subsequently, by homology 
search to the SET domain and functional assays other HMTs were identified (Vaquero et al. 
2003).  
 
Until recently, it was unclear whether histone lysine demethylation would take place in the 
cell, primarily through the observation, that methyl groups seemed to be very stable on 
heterochromatic regions. The discovery of the LSD1 protein, the first demethylase specific 
for methylated H3K4, dramatically changed the view on the dynamics of histone methylation 
(Shi et al. 2004). LSD1 is present in different repressor complexes and its substrate 
specificity was modulated from H3K4me to H3K9me when binding to the androgen receptor 
(Shi et al. 2005; Metzger et al. 2006), thus exerting a function in gene activation. Recently, 
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five new demethylases were identified that possess the JmjC-domain which is different from 
the LSD1 protein. Interestingly, these demethylases were found to demethylate specific 
methyl states (Culhane and Cole 2007; Swigut and Wysocka 2007). Of Importance are UTX 
(ubiquitously transcribed tetratricopeptide repeat, X chromosome) and JMJD3 (jumonji 
domain containing 3) that were found to specifically remove di- and tri-methyl marks on 
H3K27 in vivo (Hong et al. 2007; Lee et al. 2007b). Furthermore, UTX occupies promoters of 
Hox gene clusters and associates with MLL2/3 during retinoic acid signaling, resulting in 
H3K27 demethylation and H3K4 methylation respectively (Lee et al. 2007b).  
 
A.1.2.3 Other histone modifications 
All histones including H1 have been shown to be substrates for phosphorylation in vivo. In 
particular phosphorylation of H1 and H3 (S10, S28) have been associated with chromosome 
condensation and segregation (Wei et al. 1999; Vaquero et al. 2003). H3S10 
phosphorylation appears early in G2 of the cell cycle, first in pericentromeric heterochromatin 
and then spreading, by metaphase to the rest of the chromosome (Hendzel et al. 1997). A 
‘methyl-phospho binary switch’ has been proposed in that H3S10ph leads to ejection of HP1 
from H3K9me3 (Fischle et al. 2005). Importantly, H3K10ph is regulated by Aurora-B a 
member of the Aurora/AIK kinase family that participates in mitotic regulation. 
ADP-ribosylation implies the transfer of ADP-ribose molecules to either glutamic acids in a 
poly-glutamate stretch or single arginine residues with NAD+ as the source for ADP-ribose. 
Thus, ADP-ribosylation is linked to the metabolic state of the cell. Although H1 and H2B are 
the most highly modified, all histones seem to be ADP-ribosylated (Golderer and Gröbner 
1991). Interestingly, preferentially hyper-acetylated histones, especially H4, are found to be 
ADP-ribosylated. Due to its fast turn-over in the cells, it has been proposed to play a role in 
adaptation of the cell to environmental changes (Pieper et al. 1999). 
 
A.1.3 Polycomb silencing 
Polycomb group proteins (PcG) are epigenetic regulators that silence specific sets of genes 
through chromatin modifications. The most prominent function that can be assigned to PcGs 
is the involvement in X-chromosome inactivation (Xi) in female mammals, but also in 
germline development, stem cell identity, cell-cycle regulation and cancer (Schuettengruber 
et al. 2007). PcG proteins were originally identified in Drosophila as repressors of Hox genes 
based on mutant phenotypes involving posterior transformation of body segments. In 
vertebrates, this function is essentially conserved with several Polycomb mutants exhibiting 
skeletal malformations ((Sparmann and Van Lohuizen 2006) and references therein).  
PcG proteins are classified into two groups on the basis of their association with distinct 
classes of multimeric complexes, termed Polycomb repressive complexes (PRCs) (classes 
of multimeric complexes, termed Polycomb repressive complexes (PRC). The PRC2 core 
complex consists of the mammalian homologs of the Drosophila proteins Enhancer of zeste 
(E(Z)), Suppressor of zeste12 (SU(Z)12), extra sex combs (ESC) and Nurf-55 (RbAp46/48 in 
human) and is involved in initiation of gene repression (Schuettengruber et al. 2007). E(Z) is 
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a SET containing HMT targeting H3K27 and to a lesser extent H3K9 for tri-methylation 
(Müller et al. 2002). PRC1 constitutes a more divers complex with the core components 
Polycomb (PC), Polyhomeotic (PH), Posterior sex combs (PSC) and Sex combs extra 
(SCE/RING). Importantly, PRC1 possess an E3 ubiquitin ligase activity towards H2AK119 
and this modification is associated with gene repression and X-chromosome inactivation (de 
Napoles et al. 2004; Cao et al. 2005; Wu et al. 2008).  
Studies in Drosophila have led to the identification of specific cis-regulatory sequences in 
Hox genes, termed Polycomb response elements (PREs) (Sengupta et al. 2004; Ringrose 
and Paro 2007). PREs are typically several hundred base pairs in length, function as potent 
transcriptional silencer elements and are bound, either directly or indirectly, by PcG proteins. 
The majority of PcG target genes hold extensive H3K27me3 that extends well beyond 
promoter regions (Schwartz et al. 2006). PRC1 was believed to be recruited to appropriate 
genomic loci, due to the recognition of H3K27me3 by Polycomb through its chromodomain 
(Min et al. 2003; Wang et al. 2004b; Fischle et al. 2005).  
 
Figure 3  PRE - Polycomb regulation  
A.) PRC2-mediated H3K27me3 might directly interfere 
with transcriptional activation and/or inhibit H2BK123ub1 
or H3K4me3. Transcription of noncoding RNAs may 
mediate repression of a downstream gene by 
transcriptional interference. TAFs, TBP-associated factors. 
B.) H3K27me3 and PRC1 complexes spread from the 
PRE to a promoter located close to the PRE, interfering 
with ATP-dependent nucleosome remodeling activities 
(SWI/SNF) and RNA Pol II recruitment. The E3 ligase 
activity of dRing leads to H2A ubiquitinylation, contributing 
to silencing. C.) RNA Pol II can be recruited to a subset of 
PcG-silenced genes, suggesting a role for PRC1 in gene 
silencing downstream of RNA Pol II assembly at the 
promoter region. For promoters located far away from 
PRE sequences, PRC2 complexes bound at PREs may 
loop out and contact neighboring nucleosomes. (taken 
from (Schuettengruber et al. 2007)) 
 
 
Recently, a third PRC complex, namely Pleiohomeotic (PHO) repressive complex (PhoRC) 
was purified from Drosophila embryos (Klymenko et al. 2006). Interestingly, PHO bears DNA 
binding capability and therefore combines sequence specific DNA binding with a unique 
binding to mono- and di-methylated H3K9 and H4K20 through the dSfmbt subunit. Neither 
PRC1 nor PRC2 core complexes contain sequence specific DNA binding proteins, but Pho 
has been shown to bind to PRC2 subunits and to induce PRC2 recruitment at the PRE of the 
ubx gene in Drosophila (Schuettengruber et al. 2007). 
The precise molecular mechanisms of PRC-mediated repression are still poorly understood, 
but it has been suggested that the complex can inhibit transcription by preventing ATP-
dependent nucleosome remodeling by the SWI/SNF complex (Shao et al. 1999), as well as 
by directly blocking the transcription initiation machinery (Dellino et al. 2004). PRC2 
mediated H3K27me3 and H1K26me3 serves as binding platform for PRC1 and HP1 
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respectively  (Müller et al. 2002; Kuzmichev et al. 2004). In addition, EZH2 was shown to 
recruit the maintenance methyltransferase Dnmt1 to target genes (Viré et al. 2005) thereby 
setting another repressive mark. Furthermore, ubiquitinylation of H2AK119 by PRC1 together 
with H3K27me3 lead to gene repression by opposing histone marks associated with active 
transcription. USP7, a histone H2B deubiquitinase, was found to be associated with 
Polycomb protein on the ubx PRE and co-localized with homeotic genes in salivary gland 
polytene chromosomes in Drosophila (van der Knaap et al. 2005). Hence, one could envision 
a contribution to silencing through recruitment of USP7 by PRCs, since deubiquitination of 
H2BK120ub1 leads to low levels of active transcription marks H3K4 and H3K79 methylation 
(Sun and Allis 2002). 
 
A.1.4 Chromatin remodeling 
The packaging of chromosomal DNA by nucleosomes condenses and organizes the 
genome, but occludes many regulatory DNA elements. However, this constraint also 
constitutes a level of regulation by allowing accessibility to certain DNA sequences. In order 
to enable dynamic access to packaged DNA and to tailor nucleosome composition in 
chromosomal regions, cells have evolved a set of specialized ATP-dependent chromatin 
remodeling complexes (also referred to as remodelers) that use the energy of ATP hydrolysis 
to move, destabilize, eject or restructure nucleosomes (Becker and Hörz 2002). Remodelers 
were found to be involved in a wide range of processes that include the regulation of 
transcription, chromosome segregation, DNA replication and DNA repair (Clapier and Cairns 
2009). 
 
Figure 4  Snf2-like family of ATPases 
A. Classification of ATPases in three different superfamilies. The Snf2-like family belongs to the DEAD/H 
superfamily of nucleic acid stimulated ATPases and can be further subdivided into subfamilies (Lusser and 
Kadonaga 2003). B. The four most prominent subfamily members of the Snf2-like family are depicted. Although 
they share an ATPase domain that is split into two parts: DExx and HELICc domain, they differ in unique domains 
residing adjacent to the ATPase domain. Bromo (bromodomaims recognize acetylated lysines) and HAS 
(helicase-SANT) domain for SWI/SNF family, SANT-SLIDE (SANT-like ISWI domain) module for ISWI family, 
tandem chromo domain (chromodomains recognize H3K4me2/3) for the CHD family and the HAS domain for the 
INO80 family (Clapier and Cairns 2009). 
 
All ATP-dependent chromatin remodeling factors identified so far are multiprotein complexes 
consisting of 2-12 subunits, and contain a related motor protein subunit that belongs to the 
Snf2-like family of ATPases. The Snf2-like family belongs to the DEAD/H superfamily of 
nucleic acid stimulated ATPases and can be further subdivided into several subfamilies 
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according to the presence of protein motifs outside of the ATPase region (Figure 4) (Eisen et 
al. 1995; Flaus et al. 2006b). At least four major classes of catalytic subunits of chromatin 
remodeling complexes are distinguished: The Swi/Snf family, the Mi-2 / CHD family, the ISWI 
class and the Ino80 group (Figure 4). Several other Snf2-like proteins have been found or 
suggested to possess ATP-dependent chromatin-remodeling activity, such as Rad54, ATRX, 
CSB (Cockayne Syndrome protein B) and the plant protein DDM1 ((Lusser and Kadonaga 
2003) and references therein). 
In addition to their ATPase subunit and unique protein motifs, the particular function and the 
biological context of chromatin remodelers are selectively influenced by a great variety of 
associated subunits (Tsukiyama 2002; Lusser and Kadonaga 2003). 
 
A.2 Ubiquitin and ubiquitin modifying enzymes 
A.2.1 Modification of proteins by ubiquitin and ubiquitin-like proteins (ubl) 
Ubiquitin (ub) is a polypeptide consisting of 76 amino acids and is highly conserved among 
eukaryotes but is absent from bacterial and archea. Among many functions of ubiquitin, the 
best understood is the targeting of proteins for degradation by the proteasome. Ubiquitin is 
attached to a substrate lysine side chain through an isopeptide bond via its C-terminal 
glycine residue in dependency of ATP consumption (Ciechanover et al. 1980; Wilkinson et al. 
1980). Ubiquitinylation occurs through the sequential action of activating (E1), conjugation 
(E2), and ligase (E3) enzymes (Hershko et al. 1983). In detail, E1 activates ubiquitin by using 
ATP to synthesize a high-energy ubiquitin C-terminal adenylate that is needed for the 
formation of an E1-ubiqutin thiol-ester. The latter ubiquitin is passed to an E2 cysteine 
residue and from there, in an E3-dependent manner to the ε-amino group of a lysine in the 
substrate.  
There are two main types of E3s for ubiquitin, the RING class and the HECT class. The 
RING E3’s contain a subunit or domain with a zinc finger domain (RING domain, or the 
structurally related but zinc-free U-box E3’s) and function as adaptors (Figure 5). They bind 
the ubiquitin thiol-ester-linked E2 and substrate proteins simultaneously and position the 
substrate lysine nucleophile in close proximity to the reactive E2-ub thiol-ester bond, 
facilitating the transfer of ubiquitin. Catalysis of ubiquitin-substrate modification by the HECT 
E3’s follows a mechanism distinct from that of the RING E3s. The activated ubiquitin moiety 
is first transferred from the E2 conjugating enzyme to an active-site cysteine in the conserved 
HECT domain of the E3. The thio-ester – linked ubiquitin is subsequently transferred to the 
substrate (Kerscher et al. 2006). 
Proteins can be modified on a single or on multiple residues by a single ubiquitin or by 
ubiquitin oligomers. The fate of an ubiquitin-protein conjugate depends in part of the length of 
the ubiquitin chain and on the configuration of the ubiquitin-ubiquitin linkages in the ubiquitin 
chain. In yeast, potentially all seven conserved lysines of ubiquitin itself (K6, 11, 27, 29, 33, 
48, 63) are used as branching sites for the generation of ubiquitin polymers. K48-linked oligo-
ubiquitin chains efficiently promote binding of the protein to the 26S proteasome, with 
subsequent degradation of the substrate but recycling of ubiquitins ((Amerik and 
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Hochstrasser 2004) and references therein). In contrast, mono-ubiquitinylation or attachment 
of short K63-linked ubiquitin marks target proteins not for proteasomal degradation, but for 
endocytosis, transcriptional control (histone mono-ubiquitinylation), vesicular trafficking and 
DNA repair respectively (Dupré et al. 2001; Hicke 2001; Clague and Urbé 2006; Huang and 
D'Andrea 2006; Osley 2006). 
 
Figure 5  Generalized ubiquitin/ ubiquitin-like conjugation pathway 
Ubiquitin (ub) or ubiquitin-like (ubl) precursors are processed to expose the C-terminal glycine in the mature ubl 
which can be activated with ATP by E1 to form a high-energy ubl-adenylate which is transferred to the catalytic 
cysteine of the E1. The ubl is then transferred via a transthiolation reaction to the E2 conjugating enzyme. The ubl 
can be ligated to a substrate with the aid of an E3 ligase enzyme. The adaptor-like RING E3s catalyze 
modification by binding simultaneously the ubl-E2 thio-ester complex and the substrate thereby bringing the 
substrate lysine and the thio-ester ubiquitin bond in close proximity for transfer. In contrast, the HECT E3s 
catalyze the substrate ligation in two steps. First, the ubl is transferred to a catalytic cysteine of the HECT E3 then 
the E3-ubl thio-ester complex transfers the ubl to the substrate. The DUBs (deubiquitinating enzyme) and the ULP 
(ubl specific protease) can remove ubls from substrates (Kerscher et al. 2006). 
 
Since the discovery of ubiquitin, an entire family of small proteins related to ubiquitin 
(referred to as ubiquitin-like proteins; ubl) has been defined. Although not necessarily sharing 
high sequence similarity, the ubls all possess essentially the same three-dimensional 
structure, the ubiquitin or β-grasp fold (Hochstrasser 2000). Furthermore, all ubls are 
covalently attached via their C-terminal glycine residue to lysine target sites on substrate 
proteins resulting in an isopeptide bond between the ubl and substrate (Welchman et al. 
2005; Kerscher et al. 2006). 
INTRODUCTION 
12 
Considering the large amount of ubls and the fact that ubl modifications are reversible, it was 
not a surprise that there has evolved a great variety of specific E1, E2 and E3 ubl ligases 
(Hochstrasser 2000; Welchman et al. 2005; Kerscher et al. 2006), as well as deubiquitinating 
enzymes (DUB) and ULPs (ubl specific protease) that remove ubls from substrates (Amerik 
and Hochstrasser 2004; Nijman et al. 2005; Kerscher et al. 2006). 
 
A.2.2 UHRF1 – member of the ubiquitin PHD Ring Finger family 
The first two members of the Ubiquitin PHD Ring Finger family that have been identified are 
ICBP90 in human (inverted CCAAT box binding protein of 90kDA) and NP95 in mouse 
(nuclear protein of 95kDa). ICBP90 was found by using the second inverted CCAAT Box 
(ICB2) of the human topoisomerase IIα gene as the DNA target sequence in a yeast 1-hybrid 
screen (Hopfner et al. 2000) whereas NP95 was discovered by engineering antibodies 
against murine thymic lymphoma (Fujimori et al. 1998). ICBP90 and NP95 are encoded by 
the UHRF1 gene (Unoki et al. 2008) and NIRF and NP97 are encoded by the UHRF2 gene 
(Bronner et al. 2007). 
In addition, there is a third member encoded by the UHRF3 gene, namely ICBP55 in human 
and NP55 in mouse, lacking the first N-terminal ubiquitin-like domain (also referred to as 
NIRF_N-domain) and a fourth member encoded by the UHRF4 gene, namely ICBP87, 
lacking the C-terminal RING domain. 
Phylogenetic studies showed that UHRF1 is highly conserved but restricted to vertebrates 
since UHRF1 equivalents were neither found in the fly- or worm-database nor in the S. 
cerevisiae database (Bronner et al. 2007). The author hypotheses that UHRF1 as an E3 
ligase for histones and mono-ubiquitinylation of histones (at least for histone H3) have 
evolved phylogenetically with vertebrates. 
In contrast, in Arabidopsis thaliana a protein that resembles hUHRF1 was found (Woo et al. 
2007) but it differs from the former by the fact that it lacks the NIRF_N domain and by the 
location of the RING domain between the PHD and SRA domain. VIM1 (variant in 
methlyation 1) is able to bind in vitro to methylated DNA and recombinant histones, and 
associates in vivo with methylated genomic loci and chromocenters (Woo et al. 2007) - 
features that are shared by both human and mouse UHRF1 (Citterio et al. 2004; Unoki et al. 
2004; Bostick et al. 2007; Sharif et al. 2007; Karagianni et al. 2008). 
As depicted in Figure 6 UHRF1 consists of four conserved domains. Situated on the far N-
terminus of UHRF1, the NIRF_N domain (also referred to as ubiquitin-like domain; ubl) 
exhibits a typical alpha/beta ubiquitin fold. It is 35% identical to ubiquitin (A.2.1) and the 
lysines K33 and K52 are structurally conserved with K29 and K48 of ubiquitin with poly-
ubiquitinylation of the latter being the key signal for proteasomal degradation (Kerscher et al. 
2006). Nevertheless, the role of the NIRF_N domain is less clear but recent data indicate 
protein-protein interactions. The ubiquitin-like domain (NIRF_N) of PLIC-1 (protein linking 
IAP to the cytoskeleton) is able to bind to the ubiquitin-interacting motif (UIM) of S5a, a 
proteasomal 19S cap subunit (Heir et al. 2006) 
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Figure 6  Domain structure of UHRF1 
The domain structure of human UHRF1 (ICBP90) and the function of the distinct domains are depicted. NIRF_N 
domain (ubiquitin-like domain), PHD domain (Plant Homeodomain), SRA domain (SET and RING Finger 
associated), RING domain (Really interesting new gene). 
 
The PHD domain of ICBP90 was found to confer H3K9me3 specific binding, whereas the 
SRA domain bound equally well to methylated and non-methylated H3K9 (Karagianni et al. 
2008).  
The SRA domain (SET and RING finger associated domain) is a 170 amino acid long 
domain characterized by the conservation of up to 13 evenly spaced glycine residues and 
the VRV(I/V)RG motif (Baumbusch et al. 2001). Due to its YDG motif it is also referred to as 
YDG domain.  
The SRA domain accounts for the high binding affinity of UHRF1 for methyl-CpG di-
nucleotides (Unoki et al. 2004) and its preference for hemi-methylated DNA in vitro (Bostick 
et al. 2007). The structural basis for the recognition of hemi-methylated DNA via the SRA 
domain was recently elucidated revealing a base flipping mechanism of the 5-methyl-
cytosine out of the double helix into a binding pocket of the SRA domain (Arita et al. 2008; 
Avvakumov et al. 2008; Hashimoto et al. 2008). In agreement, ICBP90 is associated with 
methylated promoter regions of various tumor suppressor genes, including p16INK4A and 
p14ARF, in cancer cells (Unoki et al. 2004) and the localization of mUHRF1 on replicating 
heterochromatin is dependent on the presence of hm DNA (Sharif et al. 2007) (see below).  
Besides methylated DNA binding properties, the SRA-domain was also found to interact with 
HDAC1 (Unoki et al. 2004) and Dnmt1 (Achour et al. 2007) (Bostick et al. 2007). By means 
of deletion studies and yeast-2-hybrid experiments, the TS domain of Dnmt1 could be 
identified as the region in Dnmt1 mediating this interaction. 
UHRF1 with its RING Finger domain (Really interesting new gene) located at the C-terminus 
belongs to the class of Ring finger type E3 ubiquitin ligases (Chen et al. 2006; Kerscher et al. 
2006). UHRF1 family members, like other Ring finger containing ligases, possess an in vitro 
autoubiquitinylation activity (Citterio et al. 2004; Mori 2004; Jenkins et al. 2005; Karagianni et 
al. 2008). UHRF1 is able to target histones for ubiquitinylation in vitro and in vivo, though with 
a preference for histone H3 (Citterio et al. 2004; Karagianni et al. 2008).  
Northern Blot analysis of several human cancer cell lines revealed the existence of two 
mRNA species of 5.1 and 4.3 kb respectively which could account for the two bands that are 
often observed in Western Blot experiments for hUHRF1 (Bronner et al. 2007).  
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The expression of UHRF1 peaks in late G1 and during the transition from G2 to M phase in 
normal cells, whereas UHRF1 is continuously expressed at a high constant level in cancer 
cells (Mousli et al. 2003; Jeanblanc et al. 2005). UHRF1 mRNA is most abundant in 
proliferating tissues like thymus, fetal tissues, bone marrow, but low in quiescent cells, 
suggesting that UHRF1 is related to cell proliferation (Fujimori et al. 1998; Hopfner et al. 
2000). This is in agreement with the observation of increased expression of UHRF1 in cancer 
tissues of breast cancer, rhabdomyosarcoma, pancreatic adenocarcinoma, prostata and lung 
cancers.  
Both mRNA and protein levels of ICBP90 are down-regulated in response to DNA damage in 
human colon adenocarcinoma HCT-116 cells and lung carcinoma A549 cells (Jenkins et al. 
2005). DNA damage activates the p53-dependent checkpoint pathway that induces the 
expression of p21Cip1/WAF1 resulting in cell cycle arrest at G1/S transition by inhibition of cyclin-
dependent kinase (Cdk). Interestingly, the reduction of UHRF1 expression is inhibited by 
ATM kinase inhibitor and does not occur in p53-/- and p21-/- cells suggesting an 
ATM/p53/p21Cip1/WAF1 dependent regulation of UHRF1 expression after DNA damage (Arima 
et al. 2004). NP95 depleted murine embryonic stem cells were more sensitive to X-ray 
radiation, UV light and DNA damaging agents proposing a role as a component in the DNA 
response pathway or in the maintenance of genomic stability (Muto et al. 2002).  
Depletion of hUHRF1 using siRNA in Hela cells (Bronner et al. 2007) and NIH3T3 cells 
treated with shRNA to mUHRF1 (Bonapace et al. 2002) resulted in G1 arrest. These findings 
suggest UHRF1 being essential for S-phase entry. The role of ICBP90 in the G1/S transition 
seems to be controlled by the E2F1 transcription factor necessary for S-phase entry (Mousli 
et al. 2003). 
Another important fact to mention is that NP95 is indispensible for proper mice development 
since mUHRF1-/- mice died in midgestation (Muto et al. 2002).  
In immunoprecipitation UHRFBP1, a new 170kDa nuclear protein interacting with UHRF1 
was found (Unoki et al. 2004). Although little is known, it also bound to HDAC1 and is 
believed to relocate UHRF1. In a yeast-two-hybrid screen, the RbAp48 (pRB binding protein 
(Qian et al. 1993)) was identified as potential interaction partner of ICBP90 (Bronner et al. 
2002). This interaction is likely to occur in vivo, since HDAC1 interacts with UHRF1 and 
RbA48 (Nicolas et al. 2001). RbA48 binds directly to H4 (Nicolas et al. 2001) and could favor 
the deacetylation of histones. Accordingly, this association may link histone H3 
ubiquitinylation and H4 deacetylation to DNA methylation considering that UHRF1 binds to 
H3 and Dnmt1 (Citterio et al. 2004; Achour et al. 2007; Bostick et al. 2007; Karagianni et al. 
2008). Interestingly, RBAp46/48 are components of the human NURF remodeling complex 
(Clapier and Cairns 2009) and the PRC2 complex (Schuettengruber et al. 2007), hence are 
involved in both gene activation and repression respectively. 
During the cell cycle, the location of NP95 is dynamically changed. Although the 
observations are to some extent contradictory, NP95 co-localized with chromatin-bound 
PCNA during mid S-phase (Uemura et al. 2000; Miura et al. 2001). Distinct localization of the 
two proteins, however, is evident in very early and late S-phase, suggesting that Np95 is not 
directly involved in the replication machinery, but in other DNA replication-linked nuclear 
events (Miura et al. 2001). Ablation of NP95 upon siRNA knock-down showed that replication 
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of heterochromatin was greatly impaired during mid S- and late S-phase, whereas replication 
of euchromatin was not affected (Papait et al. 2007). Depletion of NP95 also caused 
hyperacetylation of lysines 8, 12 and 16 of heterochromatin H4 (Papait et al. 2007) whose 
deacetylated state is essential to maintain the compacted and silenced condition of these 
regions (Agalioti et al. 2002). As a consequence, an increase of pericentromeric major 
satellite transcription (Papait et al. 2007) was observed, suggesting a role in regulating the 
low level RNA transcription from major satellite repeats whose RNAs are involved in 
heterochromatin formation (Reinhart and Bartel 2002). 
Besides triggering deacetlyation of histone H4 probably through HDAC1 and thus conserving 
the integrity of heterochromatin, mUHRF1 was also found to be a factor responsible for 
maintaining global DNA methylation levels (Bostick et al. 2007; Sharif et al. 2007) since 
mUHRF1 knockout ES cells are characterized by massive global losses of DNA methylation. 
In addition, repetitive elements like LINEs, IAPs and SINEs, major and minor satellite repeats 
as well as imprinted regions (Igf2, Cdkn1c) were heavily affected by a decrease in 
methylation, although protein levels of maintenance and de novo methyltransferases were 
not altered. 
Furthermore, both UHRF1 and Dnmt1 depleted ES cells fail to properly differentiate and 
show embryonic lethality (Li et al. 1992; Muto et al. 2006), but both remain proliferative as ES 
cells. Both are found during mid S-phase at replication foci, and in late S-phase both are 
associated with DAPI stained heterochromatin (Bostick et al. 2007; Sharif et al. 2007). 
In NP95-/- ES cells the accumulation of Dnmt1 at replicating heterochromatin during mid S-
phase was abolished and its binding to heterochromatin changed to a diffuse localization 
pattern compared to wild-type (Sharif et al. 2007). Interestingly, mUHRF1 is dependent on 
the presence of hm DNA since in Dnmt triple knockout ES cells (TKO) NP95 showed a 
diffuse localization pattern and almost no enrichment in the newly synthesized 
heterochromatin. When transiently introducing Dnmt3a/Dnmt3b, both of which methylate 
DNA at pericentromeric heterochromatin (Bachman 2001; Lehnertz et al. 2003; Ge et al. 
2004), or their respective inactive mutants into TKO ES cells, NP95 localization to 
heterochromatin was restored whereas for the mutants not.  
Upon mUHRF1 knockdown Dnmt1’ s association with chromatin was severely reduced in co-
immnoprecipitation (Bostick et al. 2007), whereas vice versa mUHRF1 binding to chromatin 
was not affected. Disruption of the PCNA-Dnmt1 interaction resulted in only a small decrease 
in the efficiency of maintenance methylation (Schermelleh et al. 2007; Spada et al. 2007) 
confirming the existence of another Dnmt1 recruitment mechanism. Taken together, UHRF1 
binds to hm DNA and Dnmt1 via its SRA-domain (Bostick et al. 2007) (Achour et al. 2007) 
thereby recruiting Dnmt1 and facilitating efficient maintenance of CpG methylation.  
  
A.2.3 Histone ubiquitinylation 
Ubiquitinylation of histone molecules was found for histones H2A, H2B, H3, H4, H2A.Z, 
macroH2A and H1 (Zhang 2003; Kinyamu et al. 2005; Osley 2006). In most cases only a 
single ubiquitin moiety is attached to histones, which is not sufficient for targeting proteins for 
degradation via the 26S proteasome. During mitosis the core histones are globally 
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deubiquitinated at metaphase and reubiquitinylated as cells enter anaphase (Goldknopf et al. 
1980), indicating a continuous turnover of the ubiquitin mark during cell growth. 
Histone H1 was shown to be ubiquitinylated by TAFII250, the largest subunit of TFIID 
comprising both E1 ubiquitin activating and E2 ubiquitin conjugating activities (Pham and 
Sauer 2000). H2A was the first protein found to be ubiquitinylated (Goldknopf and Busch 
1975). The ubiquitinylation site was mapped to lysine K119 within the C-terminal histone fold 
domain. Interestingly, although H2Aub1 accounts for 5-15% of total H2A molecules it is 
restricted to higher eukaryotes and absent from S. cerevisiae (Osley 2006). In contrast, 
ubiquitinylated H2B (ubH2B) was also found in yeast at lysine K123 and K120 in higher 
eukaryotes and constitutes 1-2% of the total H2B pool (Osley 2006). H2A and H2B 
ubiquitinylation will be discussed in detail in the following sections.  
H3 is ubiquitinylated in rat spermatids, although the site is unknown (Osley 2006). The 
ubiquitin E3 ligase UHRF1 (A.2.2) specific for H3 was identified (Citterio et al. 2004; 
Karagianni et al. 2008), but the function of H3 ubiquitinylation remains elusive. Recently, 
histone H4 was found to be mono-ubiquitinylated at lysines K31 and K91 in both human and 
yeast (Osley 2006) and the complex EEUC responsible for ubiquitinylation has been 
identified. 
 
A.2.3.1 Histone H2A ubiquitinylation 
Ubiquitinylated H2A (ubH2A) was long thought to play a role in activation and repression of 
genes due to its association with active and inactive regions of chromatin respectively. 
Nowadays, ubH2A is recognized as an epigenetic mark involved in silencing. First indications 
came from immuno-fluorescence studies with mouse spermatocytes that showed ubH2A 
being present in the heterochromatin XY body of meiotic prophase cells (Baarends et al. 
1999). Additional cytological studies revealed that ubH2A is also present at the inactive X-
chromosome in female mammals, at unpaired autosomal regions in male meiosis and  at 
unpaired X and Y chromosomes in female meiosis ((Baarends et al. 2005). In proliferating 
cells, ubH2A is present throughout the cell cycle, but it is down-regulated during G2/M 
transition and is not present on condensed chromosomes (Mueller et al. 1985; Joo et al. 
2007). 
The RING finger containing E3 ubiquitin ligases, namely mouse Ring1B, human Ring2, fly 
dRing, that target H2A for ubiquitinylation in vitro have been identified in both vertebrates and 
flies as components of the Polycomb group (PcG) complex PRC1 (A.1.3) (de Napoles et al. 
2004; Wang et al. 2004a; Cao et al. 2005). In addition, PRC1 and ubH2A are enriched in 
regions of the genome that are subject to PcG-dependent transcriptional silencing such as 
the inactive X-chromosome and homeotic genes and the presence of the Ring E3 is required 
for H2A ubiquitinylation at these locations (de Napoles et al. 2004; Wang et al. 2004a). 
Interestingly, PRC1 contains two additional RING domain - containing proteins, Ring1A and 
Bmi1, but unlike Ring1B, neither possesses a functional ubiquitin ligase. However, the two 
proteins stimulate the activity of Ring1B in vitro, and regulate the H2AK119ub1 levels at 
silenced Hox genes in vivo (Cao et al. 2005). Further evidence of PRC1 complexes and 
ubiquitinylated H2A playing direct roles in the control of transcriptional silencing came from 
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RNAi experiments directed against the RING E3’s. In Drosophila, RNAi-mediated knockdown 
of dRing resulted in derepression of the homeotic gene Ubx (Wang et al. 2004a). Similarly, 
deprivation of cells of Bmi1 showed expression of a number of Hox genes that had been 
silenced before (Cao et al. 2005). In contrast, reactivation of the silenced X-chromosome did 
not occur upon depletion of ubH2a through double knockout of Ring1A and Ring1B in ES 
cells (de Napoles et al. 2004).  
Besides silencing in heterochromatic regions, ubiquitinylated H2A is also involved in the 
transcriptional repression in euchromatin (Osley 2006). In addition, ubiquitinylation of H2A 
was found to be highly dynamic, as suggested from varying global changes of ubH2A during 
the cell cycle, indicating the involvement in the regulation of cell cycle progression (Joo et al. 
2007). Accordingly, the existence of several mammalian H2A deubiquitinating enzymes 
belonging to the JAMM/MPN+ family (2A-DUB) and to the ubiquitin-specific protease family 
(USP3, USP16/Up-M, USP22) was reported (Joo et al. 2007; Nicassio et al. 2007; Zhu et al. 
2007b; Nakagawa et al. 2008; Zhang et al. 2008b). 
Recently, the deubiquitinase Ubp-M (also referred to as USP16) was identified to specifically 
target ubH2A but not ubH2B for deubiquitination in vitro and in vivo (Joo et al. 2007). Even 
more important, ablation of Ubp-M in Hela cells resulted in slow growth rates owing to 
defects in the mitotic phase of the cell cycle and showed that H2A deubiquitination is a 
prerequisite for H3S10ph and subsequent chromosome segregation. Furthermore, blocking 
the function of Ubp-M by injection of Ubp-M antibodies in Xenopus laevis embryos resulted in 
defects of posterior development indicating that Hox gene expression is regulated through 
H2A deubiquitination and counteracts the PcG mediated repression (Joo et al. 2007).  
Moreover, it was shown that chromatin assembled in vitro with ubH2A, but not H2A, 
specifically repressed the di- and tri-methylation of H3K4 and thus transcriptional initiation, 
but not elongation (Nakagawa et al. 2008). Furthermore, USP21, an ubiquitin-specific 
protease, was found to catalyze the hydrolysis of ubH2A and to relieve ubH2A mediated 
repression. Over-expression of USP21 in the liver up-regulated a gene that was normally 
down-regulated during hepatocyte regeneration (Nakagawa et al. 2008).  
A similar observation was made for the JAMM/MPN+ domain containing H2A deubiquitinase 
2A-DUB that participated in the transcriptional regulation of the androgen receptor gene (Zhu 
et al. 2007a). 2A-DUB forms a protein complex with the HAT p300/CBP associated factor 
(p/CAF) thereby regulating transcriptional initiation by stepwise coordination of histone 
acetylation, H2A deubiquitination and linker histone H1 dissociation. 
USP22 is the mammalian counterpart of the deubiquitinase Ubp8 in yeast specifically 
targeting ubH2B. As for Ubp8, USP22 is a component of the human co-activator complex 
SAGA (Zhang et al. 2008b; Zhao et al. 2008), but in addition to H2B, USP22 deubiquitinates 
H2A in vitro. Furthermore, USP22 was recruited to myc target genes through direct 
recruitment of the Myc transcription factor.  
In agreement to the role of transcriptional regulation through ubH2A, it was shown that the N-
CoR/HDAC1/3 repressor complex specifically recruited the E3 ubiquitin ligase 2A-HUB that 
catalyzed mono-ubiquitinylation of H2A and thus mediated a selective repression of a 
specific set of chemokine genes (Zhou et al. 2008b). In addition, H2A mono-ubiquitinylation 
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acted to prevent FACT recruitment at the transcriptional promoter region thereby blocking 
RNA polymerase II release at the early stage of elongation (Zhou et al. 2008b).  
Latest data identified the existence of ‘bivalent promoters’ (Bernstein et al. 2006) that are 
associated with histone marks characteristic of both active (H3K4me3) and inactive 
(H2K27me3) chromatin. Low-level transcription of the 5’ region of the coding region of these 
genes was detectable in WT cells, despite the presence of Ring1A/B and ubH2A (Stock et al. 
2007). In fact, S5pCTD RNA polymerase II was situated at these promoters at levels 
comparable to actively transcribed genes, indicating that ubH2A hinders transcription at early 
stages of elongation. 
As a summary, histone H2A ubiquitinylation is important for X-chromosome inactivation and 
Hox gene silencing mediated by Polycomb group proteins (A.1.3). Accumulating evidence 
indicates that H2A ubiquitinylation/deubiquitination through repressive and activating 
complexes regulate transcriptional silencing and activation respectively. The emergence of 
‘bivalent promoters’ renders the picture even more complex and suggests that ubH2A may 
act as a platform for recruitment of regulatory factors responsible for the fine-tuning of 
transcriptional initiation and elongation processes. Among transcriptional regulation, H2A 
ubiquitinylation was found to be involved in cell cycle progression.  
 
A.2.3.2 Histone H2B ubiquitinylation 
Histone H2B mono-ubiquitinylation (H2BK123 in yeast and H2BK120 in vertebrates) has in 
general been linked to active transcription, although there is evidence for a possible role in 
silencing. It was shown that H2BK123ub1 was a prerequisite for H3K4me3 and H3K79me3 
(Sun and Allis 2002; Wood et al. 2003a), whereas deubiquitination of H2BK123ub1 was 
necessary for methylation of H3K36 (Henry et al. 2003), indicative of a positive role in 
transcription. 
In S. cerevisiae, H2B mono-ubiquitinylation is catalyzed by the enzymes Rad6 (E2) and Bre1 
(E3) (Wood et al. 2003a). Additionally, the PAF elongation complex was shown to be 
required for RAD6-Bre1 catalytic activity but not for recruitment to the promoter (Wood et al. 
2003b). 
The human homologs of yeast Bre1, RNF20 and RNF40, are two RING domain proteins that 
are 15% identical and 28% similar to yeast Bre1 (Hwang et al. 2003). The E2 UbcH6 has 
been shown to interact with RNF20/RNF40 and to mediate H2B mono-ubiquitinylation 
together with hPAF as a trimeric complex in vitro. Furthermore, knockdown of RNF20 or 
components of the hPAF complex decreased whereas RNF20 over-expression increased 
H2Bub1 levels in vivo (Zhu et al. 2005).  
In S. cerevisiae H2B ubiquitinylation can be reversed by two deubiquitinating enzymes 
(USPs), namely Ubp8 and Ubp10. Ubp8 as a component of the Gcn5 (HAT) - containing co-
activator complex SAGA efficiently deubiquitinates H2Bub1 in vitro and in vivo, therefore 
combining deubiquitination and acetylation activities (Daniel et al. 2004). In fact, both H2B 
ubiquitinylation and Ubp8-dependent deubiquitination are required for proper transactivation, 
owing to a correct balance of H3K4 and H3K36 methylation set by sequential addition and 
removal of ubiquitin (Henry et al. 2003) (Kao et al. 2004). USP22 was found as the human 
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homolog of Ubp8 as part of the hSAGA/TFTC/STAGA complex (Zhang et al. 2008a; Zhao et 
al. 2008).  
In contrast, Ubp10 (Dot4) acts independently of SAGA and in contrast to Ubp8 that 
deubiquitinates H2B in transcriptionally active euchromatin, interacts with Sir4 to facilitate 
silencing of sub-telomeric regions and rDNA in S. cerevisiae. (Emre et al. 2005; Gardner et 
al. 2005). However, Ubp10 may also have a role in silencing of euchromatin as well, since 
Ubp10 deletion strains show derepression of a number of genes that are not in the vicinity of 
heterochromatin (Gardner et al. 2005). In relation, USP7 has been described as an H2Bub1 
deubiquitinating enzyme in Drosophila that is associated with Polycomb group proteins at the 
ubx-PRE (Polycomb responsive element) and at telomeres and chromocenters (van der 
Knaap et al. 2005). In addition, mutations of USP7 enhanced developmental defects of 
Polycomb protein knockout, further suggesting a role in PRC mediated silencing. Like 
Ubp10, USP7 might help to maintain transcriptionally inactive chromatin by removing the 
potentially activating ubiquitin moiety from H2B. 
Several lines of evidence further support a positive role for H2Bub1 in transcriptional 
regulation. Bre1/RNF20 are recruited to promoters by transactivators Gal4 in yeast and p53 
in human respectively, and the following ubiquitinylation of H2B was indispensible for full 
gene activation (Henry et al. 2003; Hwang et al. 2003). Over-expression and knockdown of 
RNF20 enhanced and reduced the induction of p53 - regulated p21 and MDM2 target genes 
(Kim et al. 2005). Moreover, Csp35, a protein that interacts with H3K4 HMT COMPASS and 
H3K79 HMT Dot1, is recruited to promoters by H2Bub1 (Lee et al. 2007a).  
CHIP-on-CHIP analysis of ubiquitinylated H2B in human cells revealed a predominant 
location of this modification in the intragenic region of highly expressed genes (Minsky et al. 
2008). In agreement, Rad6/Bre1 mediated H2Bub1 was abolished by mutations in subunits 
of protein complexes involved in transcriptional elongation (Espinosa 2008). Furthermore, 
H2Bub1 is required for full recruitment of Spt16 (a subunit of FACT) to intragenic regions 
(Fleming et al. 2008) and cooperates with FACT to promote transcriptional elongation 
through nucleosomal arrays (Pavri et al. 2006). In addition, Ubp8  
promotes phosphorylation of Ser2 at the C-terminal domain (CTD) of RNAPII (Wyce et al. 
2007), which is required for transcription elongation and co-transcriptional recruitment of 
mRNA processing factors (Ahn et al. 2004). A more detailed analysis in Bre1 mutants 
revealed that H2Bub prevented the recruitment of the Ser2-kinase Ctk1.  
MDM2 is a major negative regulator of the tumor suppressor p53 and uses its RING finger 
domain to ubiquitinylate p53 for proteasomal degradation (Michael and Oren 2003). 
Interestingly, MDM2 ubiquitinylated H2A and H2B in vitro, but predominantly H2B in vivo. In 
addition MDM2 and H2bub were localized to the p53 responsive gene p21. MDM2 binding to 
a promoter, following H2B ubiquitinylation showed silencing in a luciferase reporter assay 
(Minsky and Oren 2004). On the one hand this is in contrast to the above-mentioned 
observation that RNF20 over-expression led to increased expression of p21 (Kim et al. 
2005), but on the other hand it is an indication that H2BK120ub is either not necessarily the 
sole determinate of active transcription or that other E3 ligases and DUB’s might regulate 
transcription in a gene-specific context. Considering the necessity of deubiquitination on 
elongation, one could imagine that poised RNA Polymerase II is stalled at the p21 promoter 
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upon H2B ubiquitination by MDM2. Deubiquitination of H2B would allow phosphorylation of 
the CTD of RNAPII and subsequent promoter escape and transcriptional elongation. USP7, 
interacting with both p53 and MDM2 and regulating their stability via deubiquitination (Li et al. 
2002; Cummins and Vogelstein 2004) could be a candidate fulfilling H2B deubiquitination 
(van der Knaap et al. 2005).  
Taken together, ubiquitinylated H2B is required for different steps in the process of 
transcriptional activation and elongation suggesting a model that multiple rounds of 
ubiquitinylation and deubiquitination are required for full gene induction (Henry et al. 2003; 
Wyce et al. 2007). Alternatively, this mode of action was assigned to a ‘checkpoint’ model 
allowing for RNAPII pausing and coordination in early elongation with RNA processing 
(Espinosa 2008). The function of ubH2B in gene silencing seems to be restricted to the 
action of deubiquitinating enzymes, keeping low levels of ubH2B which in turn maintain low 
levels of histone marks associated with active transcription. 
 
A.2.4 USP7 – a ubiquitin specific protease 
Deubiquitinating enzymes (DUB’s) constitute a superfamily of thiol- and metallo-proteases 
specialized in the processing of ubiquitin and ubiquitin-like proteins. They are responsible for 
the disassembly of ubiquitin chains and for the cleavage of mono- and oligomers of this 
molecule, either in precursor form or attached to small nucleophiles and proteins (Amerik and 
Hochstrasser 2004; Nijman et al. 2005). Among, the DUBs, the ubiquitin specific proteases 
(USPs) constitute the largest family with 58 cysteine petidases identified so far (Nijman et al. 
2005). One of the most prominent members of this superfamily is USP7, also known as 
Herpes simplex virus associated ubiquitin specific protease (HAUSP) due to its discovery in 
the promyelocytic leukemia nuclear bodies (PML) of herpes simplex virus infected cells 
(Everett et al. 1997). USP7 comprises 1102 amino acids with a molecular weight of 
approximately 130kDa and is composed of three domains, an N-terminal TRAF domain, a 
proteolytic core domain and a C-terminal domain.  
 
Figure 7  Domain structure of USP7 (HAUSP) 
The domain structure of human USP7 (HAUSP) and the functions of the distinct domains are depicted. TRAF 
domain (TNF associated factor), catalytic core (catalytic residues are shown), C-terminal domain. 
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Due to the homology to the TNF receptor associated factors (TRAFs), the N-terminal domain 
of USP7 was named accordingly. The TRAF domain of USP7 is the interaction platform for 
several TRAF family proteins, EBNA1 nuclear antigen 1 (Holowaty et al. 2003), p53 (Hu et al. 
2002) and was shown to be responsible for the nuclear localization of USP7, albeit no NLS 
sequence is present (Zapata et al. 2001; Fernández-Montalván et al. 2007). 
Although the USPs make up for a highly divergent group, they all contain a catalytic core 
domain comprising eight conserved regions. The 3D crystal structure of the HAUSP core 
domain (aa208-560) was resolved and revealed an architecture composed of fingers, palm 
and thumb, which undergo dramatic conformational changes upon binding of the ubiquitin 
derivate Ubal (Hu et al. 2002). The C-terminal domain (aa560-1102) is composed of two 
domains (aa622-801 and aa885-1061) as determined through limited proteolysis mapping 
with the first of these polypeptides mediating the interaction of USP7 with the Herpes simplex 
virus protein ICP0 in vitro (Holowaty et al. 2003).  
The tumor suppressor protein p53 was described as a direct target of USP7 in vitro and in 
vivo deubiquitinating and stabilizing p53 and thus antagonizing the MDM2 (HDM2 in human) 
mediated ubiquitin dependent degradation (Li et al. 2002). USP7 over-expression led to p53 
accumulation and p53 mediated G1 arrest and apoptosis. In colon adenocarcinoma HCT-116 
cells, where both alleles of USP7 had been knocked-out, p53 displayed a much higher 
protein level (Cummins et al. 2004). This led to the observation that USP7 not only targets 
p53 but rather MDM2 for deubiquitination (Cummins and Vogelstein 2004). The current 
model for USP7 action indicates that in the absence of cellular stress, MDM2 is stabilized by 
the activity of USP7, maintaining low levels of p53. Upon cellular stress, the MDM2-USP7 
interaction is impaired likely via posttranslational modifications, destabilizing MDM2 by auto-
ubiquitinylation following proteasomal degradation. Free USP7 could eventually collaborate 
in stress-induced stabilization of p53 (Nijman et al. 2005). 
Recently, the Chfr (checkpoint protein with FH and RING domains) E3 ubiquitin ligase, that 
was identified as a protein defining a mitotic checkpoint, that delays transition to metaphase 
in response to mitotic stress (Scolnick and Halazonetis 2000), was found to be regulated by 
USP7 (Oh et al. 2007). As mentioned earlier, USP7 was initially discovered as an interactor 
of ICP0, a Herpes simplex virus protein that plays a role in the switch between lytic and latent 
infection. ICP0 possesses an E3 ubiquitin ligase activity in vitro, mediated by its RING finger 
domain and induces the degradation of several cellular proteins including components of 
PML bodies and centromers. ICP0 is protected from autoubiquitinylation in vitro by USP7 
and their interaction greatly increases the stability of ICP0 in vivo (Canning et al. 2004). Vice 
versa, ICP0 also targets USP7 for ubiquitination in vitro and proteasome dependent 
degradation in vivo (Boutell et al. 2005) suggesting a mutual regulatory mechanism on the 
activity and the stability of the two proteins. Recently the list of USP7 targets has been 
increased by the addition of FOXO4 transcription factor, which requires mono-ubiquitinylation 
for full trans-activation potential and is therefore deubiquitinated by USP7 resulting in 
exclusion of the nucleus (van der Horst et al. 2006).  
Homeotic gene silencing in fly larve is mediated by the Polycomb silencing complex (Wang 
et al. 2004a). USP7 has been characterized as an ubH2B deubiquitinase in vitro and is 
involved in epigenetic silencing of homeotic genes in flies since USP7 mutations enhanced 
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Polycomb phenotypes (van der Knaap et al. 2005). Notably, the USP7 gene is located on the 
X-chromosome and disruption of the gene is lethal to male and homozygous lethal in 
females. In addition, USP7 showed a distinct genome-wide distribution in larval salivary 
gland polytene chromosomes, suggesting potential functions in the regulation of multiple 
genes. Interestingly, USP7 was associated with several silenced regions including part of the 
chromocenter, telomeric regions and homeotic genes. The overall lack of co-localization with 
RNA Polymerase II suggested a role for USP7 in transcriptional silencing rather than 
activation. USP7 as an enhancer of Polycomb-mediated silencing deubiquitinating ubH2B 
would be in agreement with this notion (van der Knaap et al. 2005) .  
Unexpectedly, biochemical purification of USP7 from Drosophila embryo extracts identified 
the metabolic enzyme GMP-synthase, as a strong interactor, required for enhanced 
deubiquitinase activity towards ubH2B and p53. GMP-synthase is required for synthesis of 
guanine nucleotides whose expression is strongly induced in rapidly proliferating cells 
(Boritzki et al. 1981) suggesting a link between the proliferative/metabolic state of the cell 
and histone modifications in analogous fashion to NAD+-dependent histone deacetylases of 
the Sirtuin family (Holbert and Marmorstein 2005). 
Related to this, it is of interest to note that all ubiquitinylated histones, including the four H2A 
variants and the H2Bs are absent from isolated metaphase chromosomes (Wu and Bonner 
1981). Whether USP7 could be involved in this step is difficult to judge since no 
immunocytochemical data on the localization of USP7 during the cell cycle exist. Likewise, 
USP7 knockout cells (HCT-116 USP7-/- (Cummins and Vogelstein 2004)) are able to grow 
albeit slowly due to elevated p53 and p21 levels leading to G1 arrest. 
Ablation of USP7 by RNAi treatment had only marginal impact on the level of ubH2B in the 
total histone pool but H3K27me3 was strongly reduced (unpublished data, (van der Knaap et 
al. 2005). Hence, global changes in ubH2B levels probably require besides USP7 other 
USPs. The specific reduction of H3K27me3 that is mediated by the PRC2 component EZH2 
(Viré et al. 2005; Wu et al. 2008) suggests that this modification is dependent on USP7 at 
certain chromosomal loci and confirms a functional role between USP7 and PcG silencing.  
In summary, USP7 regulates the stability of factors that play a role in cell cycle checkpoints 
and progression and transcription through its deubiquitinating activity. The possible function 
of USP7 in gene silencing or activation correlated with H2B deubiquitination remains elusive. 
 
A.3 DNA methylation 
A.3.1 CpG methylation in eukaryotes 
In terms of evolution, DNA methylation is old and can be found in bacteriophages, bacteria, 
fungi, plants and animals. In bacteria, DNA methylation can occur at the C-5 and the N-4 of 
cytosine as well as the N-6 of adenine, whereas DNA methylation at the C-5 position of 
cytosine in the context of CpG is the only covalent modification of DNA in higher eukaryotes 
(Hermann et al. 2004a). In any case, the methyl groups are positioned in the major groove of 
the DNA where they do not interfere with the Watson/Crick base-pairing capacities and 
where they can easily be detected by proteins interacting with the DNA. Thereby, methylation 
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adds extra information to the DNA that is not encoded in the sequence and C-5 methylation 
of cytosine was thus referred to as the 5th letter of the genetic alphabet. 
Cytosine methylation accounts for 3-8% of all cytosine residues and for 60-90% of all CpG 
sites in mammalian genomes (Jeltsch 2002). Importantly, CpG sites are methylated on both 
strands of the DNA, resulting in a palindromically methlyated site. CpG sites in the genome 
are statistically underrepresented (5-10 fold) with respect to their expected normal frequency. 
This can be explained by the fact that deamination of 5-methyl-cytosine results in methyl-
cytosine – thymine transition, whereas cytosine is deaminated to uracil which can be readily 
repaired by DNA repair mechanisms in the cell. As a result, CpG sites have been depleted 
from vertebrate genomes over evolutionary time and constitute for major hotspots of 
mutations in germlines and for acquired mutations in somatic cells (Hermann et al. 2004a). 
However, small regions of the genome, in which CpG di-nucleotides are not 
underrepresented, are known as ‘CpG islands’ (Cooper et al. 1983; Bird et al. 1985). 
Interestingly, CpG islands cover only 0.57 % of the genome and contain only 5.5% of the 
total number of CpG sites (Rollins et al. 2006), but over 50 % of the non-methylated CpG 
sites. Typically, they are found in promoter regions of about 60% of all genes including 
housekeeping genes and 40% of tissue specific genes and occur mostly unmethylated 
(Cross et al. 1994). Intriguingly, CpG islands can remain methylation-free even when their 
associated gene is silent (as seen for the β-globin gene) (Bird 2002). A small but significant 
proportion of all CpG islands become methylated during development thus rendering the 
promoter stably silent. Developmentally programmed CpG island methylation of this kind is 
involved in genomic imprinting and X- chromosome inactivation. 
 
A.3.2 Biological role of DNA methylation 
DNA methylation has a variety of important functions in mammals such as gene repression, 
control of cellular differentiation and development, preservation of chromosomal integrity, 
parental imprinting and X-chromosome inactivation (Bird 2002; Li 2002b) ((Hermann et al. 
2004a) and references therein). 
Although methylation of CpG sites regulates gene expression through several distinct 
mechanisms, it is generally associated with gene repression. First, CpG methylation induces 
changes in the interaction between DNA and DNA binding proteins. Binding of transcription 
factors such as E2F or NFκB, can be abolished, whereas recruitment of 5-methyl-cytosine 
binding proteins (MECP) that ‘read’ DNA methylation patterns, is enhanced. Besides DNA 
methyltransferases themselves (Robertson 2002) MECPs are also associated with HDACs, 
thereby inducing chromatin condensation and stable transcriptional repression (Ng et al. 
1999; Zhang et al. 1999). 
Interaction with other chromatin modifying proteins such as histone methyltransferases, 
heterochromatin protein HP1 and chromatin remodelers further contribute to this regulation 
(Robertson 2002). 
The human genome contains approximately 40% of repetitive elements originating from 
transposons, retrotransposons and retroviruses (LTRs, LINEs, IAPs, SINEs) and are often 
referred to as ‘parasitic’ elements. Since random integration of transposable elements into 
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the genome constitutes for mutations, their spreading in the genome is inhibited by gene 
silencing and heterochromatin formation, mediated through extensive DNA methylation 
(Yoder et al. 1997; Smit 1999). In addition, repetitive DNA elements found in centromers, 
pericentromeric satellite repeats (minor and major α-satellites) and telomeres are highly 
methylated and densely packaged into heterochromatin, impairing homologous 
recombination events and thus providing chromosomal stability.  
Genomic imprinting is a mammalian-specific phenomenon that refers to parental-origin-
dependent mono-allelic expression in spite of identical nucleotide sequences (Li 2002b). 
Early experiments with nuclear transfer of male and female pronuclei from fertilized eggs into 
enucleated fertilized eggs showed that both paternal and maternal genomes express 
different sets of genes that were required for complete embryonic development (McGrath 
and Solter 1984). Subsequently, two genomic regions on mouse chromosome 2 and 11 that 
showed opposite phenotypes when present as either two maternal or paternal copies 
respectively indicated parental-specific gene expression (Reik 1989). The existence of 
genomic imprinting in mammals was proven with the identification of the first imprinted 
genes. Igf2r (Insulin-like growth factor type 2 receptor) and the H19 locus were identified as  
maternally expressed imprinted genes, whereas the Igf2 gene was found to be a paternally 
expressed imprinted gene (Bartolomei et al. 1991; DeChiara et al. 1991; Wutz and Barlow 
1998). 
To date, there are about 80 imprinted genes known in mouse and many of these occur in 
clusters (3-10 genes, covering 100-3000kb) that are localized to imprinting regions found on 
eight mouse autosomes (Verona et al. 2003). Of the six imprinted clusters characterized so 
far, all share a common DNA sequence known as differentially DNA methylated region 
(DMR). Furthermore, DNA methylation generally suppresses the action of gametic DMR of 
the same parental chromosome that expresses the clustered mRNA genes. Thus, in the 
absence of methylation, the DMR cannot function appropriately leading to the repression of 
both copies of imprinted genes. Notably, some of the DMRs, like in the Igf2r region 2, 
present portable methylation signals that can direct specific DNA methylation even if they are 
moved to another chromosomal location (Herman et al. 2003). In addition, it was shown that 
non-coding RNAs, like the AIR RNA, are involved in targeting and activation of de novo DNA 
methylation (Sleutels et al. 2002) although the exact mechanism remains elusive. 
Importantly, in germ cells, DNA methylation is removed in order to replace the existing 
methylation pattern by a gametic specific one that is maintained in somatic cells. In four 
clusters (Ifg2r, Kcnq1, Gnas, Pws), the gametic DMR has a maternal methylation imprint 
acquired during oogenesis whereas in two clusters (Igf2, Dlk1) it has a paternal imprint 
acquired during spermatogenesis. The DMR has been shown to control imprinted expression 
of the whole or part of the cluster and was therefore designated imprint control element (ICE) 
(Spahn and Barlow 2003). Interestingly, each cluster contains at least one non-coding RNA 
(ncRNA) that generally exhibits reciprocal parental-specific expression compared to the 
imprinted mRNA genes.  
Over the years, data has accumulated that DNA methylation is involved in a number of 
diseases and that aberrant methylation patterns play a pivotal role in the genesis of cancer 
(Feinberg 2004), including defects in genome-wide hypo- and hypermethylation of specific 
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CpG islands, as well as loss of genomic imprinting (LOI). Global DNA hypomethylation, 
which promotes stimulation of oncogenes, reactivation of retrotransposons and genomic 
instability, occurs concomitantly with local hypermethylation of tumor suppressor genes 
leading to repression and is often found in a significant subset of melanomas and colon 
cancers ((Feinberg 2004) and references therein).  
Furthermore, DNA methylation has been shown to be involved in ICF (Immunodeficiency, 
Centromeric instability, Facial abnormalities) and the Rett syndrome. ICF is an autosomal 
recessive disease characterized by hypomethylation of pericentromeric satellite repeats that 
is caused by a mutation in the Dnmt3b protein (Okano et al. 1999; Ehrlich et al. 2008). The 
Rett syndrome is an X chromosomal dominant disease that results from a mutation in the 
MeCP2 protein (Shahbazian and Zoghbi 2002; Kriaucionis and Bird 2003). MeCP2 is a 5-
methyl-cytosine binding protein that fails to repress transcription in its mutant form. 
Imprinting defects are found in solid tumors in childhood that arise from embryonic tissues. 
These so-called embryonal tumors comprising neuroblastoma (NB), Wilms tumor (WT), 
medulloblastoma (MB), rhabdomyosarcoma (RMS) and hepatoblastoma (HB) have been 
extensively studied in regard to epigenetic defects at the Igf2/H19 locus. Interestingly, 
defective imprinting of Igf2 and thus inappropriate activation of the maternal allele of the Igf2 
gene are found in about 50% of all WT (Ogawa et al. 1993) and RMS cases (Zhan et al. 
1994) as well as in about 25% of HB (Rainier et al. 1995; Hartmann et al. 2000). 
 
In mammals, there are developmental periods of genome-wide reprogramming of 
methylation patterns in vivo:  one during germ-cell development and one after fertilization. 
Typically, a substantial part of the genome is demethylated and after some time remethylated 
which occurs in a cell- or tissue-specific pattern (Reik et al. 2001; Li 2002a).  
During gametogenesis, primordial germ cells undergo demethylation independent of 
replication, erasing parental imprinting marks (Oswald et al. 2000). In the course of 
oogenesis and spermatogenesis, maternal and paternal specific genomic imprints are re-
established through de novo methylation activities of Dnmt3a and Dnmt3b and associated 
Dnmt3L (Hata et al. 2002; Hata et al. 2007). After zygote formation, the paternal DNA is 
demethylated by an active process (Oswald et al. 2000), while the maternal DNA is 
demethylated over several cell divisions by the lack of maintenance methylation (Rougier et 
al. 1998) resulting in global demethylation except for imprinted genes and retroviral 
sequences (Lucifero et al. 2004). After implantation, embryonic methylation patterns are 
reintroduced by a wave of de novo methylation. Genetic studies on zygote formation 
revealed that both maintenance and de novo methylation activities are indispensible for the 
formation of methylation patterns, and thus essential for embryonic development (Li et al. 
1992; Okano et al. 1999). 
 
A.3.3 The reaction mechanism of DNA methyltransferases. 
DNA-cytosine-5-methyltransferases (Dnmts) must perform two functions. On the one hand 
they recognize a specific DNA sequence and on the other hand catalyze the transfer of the 
methyl-group from the substrate S-adenosyl-methinone (SAM) onto the C-5 position of 
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cytosine. Prokaryotic and eukaryotic C-5 methyltransferases comprise a large and a small 
domain with 10 conserved sequence motifs, six of which are highly conserved (I, IV, VI, VIII, 
IX and X) (Pósfai et al. 1989; Cheng et al. 1993; Kumar et al. 1994).  
These motifs encompass the SAM binding pocket (I, IV, V, X) and the active site of the Dnmt 
(IV). The region between motifs VIII and IX is variable in different Dnmts and is believed to 
account for sequence specificity (Kumar et al. 1994). Notably, in contrast to other eukaryotic 
Dnmts, the catalytic domain of Dnmt1 is not catalytically active by itself, but requires 
allosteric activation by the N-terminal domain (Fatemi et al. 2001a).  
Due to great sequence homology of C-5 DNA methyltransferases, the catalytic mechanism of 
methyl-group transfer is thought to be identical with a reaction pathway of Micheal addition 
and enzymatic release by β-elimination (Pradhan and Esteve 2003). 
 
 
 
Figure 8  Reaction mechanism of C-5 DNA methyltransferases 
The reaction mechanism as described for M. HhaI DNA methyltransferase. The carboxyl-group is provided by Glu 
119 in the conserved sequence motif VI (ENV), the cysteine is provided by Cys 81 in sequence motif IV (PCQ). S-
adenosyl methionine (adoMET) and S-adenosyl-homocysteine (AdoHcy) are the cofactor and the end product of 
the reaction respectively. (Pradhan and Esteve 2003). 
 
After binding of DNA, recognition of the methylation site and binding of the co-substrate 
SAM, the DNA methyl-transfer reaction is initiated by nucleophilic attack of the cysteinyl 
thiolate of the Pro-Cys dipeptide in motif IV on the C6 position of the cytosine, resulting in a 
covalent complex intermediate between the enzyme and the DNA. The enzyme facilitates 
nucleophilic attack on the C6 by concomitant protonation of the N3 of the cytosine by a 
conserved glutamyl-residue in motif VI, forming a reactive enamine, which in turn attacks the 
sulphonium linked methyl-group of S-adenosyl-L-methionine. The methyl-group is 
subsequently transferred to the cytosine while simultaneously reprotonating the glutamyl-
residue. After a proton is abstracted from the C5 position by a base in the catalytic center, 
the enzyme is released by expulsion of the cysteinyl-thiolate group and the C5-C6 double 
bond in the newly formed 5-methyl-cytosine is reconstituted. By transfer of a proton from the 
protonated base to the thiolate group, the cysteine in the Pro-Cys dipeptide is restored and 
the protein is ready for the next reaction cycle.  
For all structures of C-5 methyltransferases in complex with target DNA, a base flipping 
mechanism was found as initially described for the uracil-DNA glycosylase in DNA repair 
((Jeltsch 2002) and references therein). The target base is completely flipped out of the DNA 
helix and bound in a hydrophobic pocket in the large domain of the enzyme, allowing sterical 
accessibility to the cytosine. Interestingly, the SRA domain of ICBP90 was recently identified 
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as the first example of a DNA binding module using this mechanism for sequence-specific 
DNA recognition (Arita et al. 2008; Avvakumov et al. 2008; Hashimoto et al. 2008).  
 
A.3.4 Identification of mammalian DNA methyltransferases 
Genomic patterns of DNA methylation in higher eukaryotes were initially established using 
DNA-methylation sensitive restriction enzymes. When analyzing a particular DNA strand, it 
was found that methylated CpG sites were always either not methylated or symmetrically 
methylated indicating the existence of a DNA methyltransferase that would complement the 
DNA methylation mark of the parental stand on the newly synthesized daughter strand during 
replication (Bird and Southern 1978). Further evidence for the heritability of DNA methylation 
patterns was made by transfection of either non-methylated (nm) DNA or in vitro methylated 
DNA into cultured cells (Wigler 1981) showing the retention of the DNA methylation status for 
many generations.  
Subsequently, Dnmt1 was the first cytosine-5 DNA methyltransferase to be isolated as a 
mammalian methyltransferase and identified via biochemical purification (Bestor and Ingram 
1983; Bestor 1988). In addition, the DNA methyltransferase activity purified from murine 
erythroleukemia cells showed inefficient methylation towards non-methylated (nm) compared 
to hemi-methylated (hm) DNA (Bestor and Ingram 1983) arguing for the role in maintenance 
of DNA methylation. Strong support for this view was provided by the fact that inactivation of 
Dnmt1 in mouse ES cells led to genome-wide loss of CpG methylation (Li et al. 1992).  
 
Table 1  Functions of mammalian DNA methyltransferases 
 
Dnmt Species Major activity Major phenotypes and loss-of-function mutations 
Dnmt1 mouse maintenance 
methylation of 
CpG sites 
genome-wide loss of DNA methylation, embryonic 
lethality at embryonic day 9.5 (E9.5), abnormal 
expression of imprinted genes, ectopic X-chromosome 
inactivation, activation of silent retrotransposons 
Dnmt2 mouse weak activity no change in CpG methylation, no obvious 
developmental phenotypes 
Dnmt3a mouse de novo 
methylation of 
CpG 
Postnatal lethality at 4-8 weeks, male sterility, and 
failure to establish imprints in both male and female 
germ cells 
Dnmt3b mouse de novo 
methylation of 
CpG 
Demethylation of minor satellite DNA, embryonic 
lethality around E14.5 days with vascular and liver 
defects (embryos lacking both Dnmt3a and Dnmt3b fail 
to initiate de novo methylation after implantation and die 
at E9.5 
Dnmt3b human de novo 
methylation of 
CpG 
ICF syndrome; loss of methylation in repetitive elements 
and pericentromeric heterochromatin 
 
Early experiments showed that nm DNA transfected into somatic cells tended to remain in a 
non-methylated state after multiple cell divisions, whereas transgenes introduced into morula 
stage pre-implantation mouse embryos by infection with Moloney murine leukaemia virus 
(MML-V) became de novo methylated and were blocked in expression (Jähner et al. 1982). 
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Further studies with embryonal carcinoma cells (EC) infected with MML-V revealed that in 
contrast to differentiated cells, expression of viral DNA was low and that proviral genomes 
were highly methylated as seen by their resistance to cleavage by SmaI. However, the 
proviral genomes were potentially infectious in cells that were treated with 5-aza-2’-
deoxycytidine – an inhibitor of DNA methyltransferases (Stewart et al. 1982). These results 
indicated that the process of de novo DNA methylation is confined to toti- and pluri-potent 
stages of embryogenesis and thus also embryonic stem cells, and that DNA methylation 
could silence expression of viral genome in vivo. Deletion of the Dnmt1 gene, however, did 
not interfere with de novo methylation of proviral DNA in ES cells, suggesting the existence 
of other DNA methyltransferases (Lei et al. 1996).  
By means of database search with four bacterial DNA cytosine methyltransferases, two new 
classes of DNA methyltransferases, namely Dnmt2 and Dnmt3 were found (Okano et al. 
1998). Although Dnmt2 contains all the conserved motifs shared by prokaryotic and 
eukaryotic DNA cytosine methyltransferases, inactivation of Dnmt2 in mouse ES cells neither 
perturbed de novo nor maintenance methylation of proviral DNA (Okano et al. 1998). In fact, 
several years later Dnmt2 was shown not to methylate DNA but the cytosine 38 in the 
anticodon loop of the tRNA(Asp) (Goll et al. 2006) and that this function is highly conserved 
from plant to human. 
Figure 9  Domain structures of mammalian DNA methyltransferases 
The mammalian DNA methyltransferases are divided into an N-terminal regulatory domain and a C-terminal 
catalytic domain with the latter showing strong amino acid sequence homology to prokaryotic DNA cytosine-5 
methyltransferases (conserved motifs for catalysis are indicated). Dnmt1: DMAP1 (Dnmt1 associated protein 1) 
binding domain, TS (targeting sequence) domain, Cys-rich region (ATRX type zinc finger, DNA binding), Pb-
domain (polybromo-1 protein homologous region containing two BAH domains) domains, GK (glycine-lysine) 
repeats. Dnmt3 family: PWWP domain, ATRX/PHD (cysteine-rich zinc finger domain of the ATRX/ plant homeo-
domain type). Modified according to (Hermann et al. 2004a). 
 
Dnmt3a and Dnmt3b were identified as the de novo methyltransferases in both mouse and 
human and cloned subsequently (Okano et al. 1998; Xie et al. 1999). Accordingly, unlike 
Dnmt1, these proteins showed no preference for hm DNA in vitro (Okano et al. 1998). 
Disruption of the genes for Dnmt3a and Dnmt3b blocked de novo methylation in ES cells and 
early embryos, but it had no effect on the maintenance of imprinted methylation patterns 
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(Okano et al. 1999). Interestingly, Dnmt3a and Dnmt3b exhibit non-overlapping functions in 
development, with Dnmt3b specifically required for methylation of pericentromeric minor 
satellite repeats. Furthermore, male and female germ cells lacking Dnmt3a or the associated 
regulatory factor Dnmt3L failed to establish distinct methylation patterns at imprinted genes 
(Bourc'his et al. 2001; Hata et al. 2002; Kaneda et al. 2004). Whereas inactivation of both 
Dnmt3a and Dnmt3b resulted in early embryonic lethality, loss of either gene caused severe 
defects in early embryonic development resulting in postnatal (Dnmt3a) or embryonic 
(Dnmt3b) lethality (Okano et al. 1999). 
 
A.3.5 Dnmt1 – the maintenance methyltransferase 
Dnmt1 is a 1616aa protein that comprises a large N-terminal regulatory domain 
(approximately 1100aa) that is linked via a glycine-lysine rich stretch (GK-repeats) to the 
conserved C-terminal catalytic domain (Figure 9). However, expression of either N- or C-
terminus has not yielded an active enzyme (Fatemi et al. 2001b). 
Enzymatic studies revealed a high preference of Dnmt1 towards hemi-methylated (hm) DNA 
and a high methylation processivity of hm DNA (Bacolla et al. 1999; Pradhan et al. 1999; 
Hermann et al. 2004b) reflecting the role of maintenance methylation in vivo (Bestor 2000). 
Analyses of its subnuclear localization is in agreement with this function. Dnmt1 shows a 
diffuse nuclear distribution during G1 and G2 phase, but associates with replication foci during 
S-phase (Leonhardt et al. 1992; Chuang et al. 1997).  
Dnmt1 directly interacts with PCNA through the PCNA-binding domain (PBD, aa163-174) 
(Chuang et al. 1997), promoting DNA methylation of the newly synthesized daughter strand 
during replication (Iida et al. 2002). Nevertheless, Dnmt1 exhibits an intrinsic high 
processivity and fidelity towards hm DNA irrespective this interaction (Vilkaitis et al. 2004). 
Moreover, the interaction with PCNA is highly dynamic in vivo and constitutes for a 2-fold 
increase in methylation efficiency, but it is not strictly required for maintaining global DNA 
methylation (Schermelleh et al. 2007). In addition, replication takes place faster than 
methylation (Schermelleh et al. 2005) indicating other mechanisms for Dnmt1 recruitment. 
Hence, the Targeting sequence domain of Dnmt1 (TS; aa316-601) (Leonhardt et al. 1992) 
was found to recruit Dnmt1 to replication foci, especially to ‘larger’ foci during mid and late S-
phase. This localization is mediated through the interaction of the TS domain with the SRA 
domain of UHRF1 (Achour et al. 2007), a heterochromatin associated protein (Karagianni et 
al. 2008) that binds preferentially to hm DNA (Unoki et al. 2004; Bostick et al. 2007; Arita et 
al. 2008) (A.2.2). The importance of the interaction with this factor becomes evident since 
UHRF1(-/-) ES cells revealed global and local hypomethylation and methylation defects of 
imprinted genes and retrotransposons (Sharif et al. 2007) – reflecting the situation of Dnmt1 
knockout in ES cells and mice (Li et al. 1992). The preference of Dnmt1 for hm DNA is 
approximately 20-25-fold compared to nm DNA (Pradhan et al. 1999; Hermann et al. 2004b). 
In spite of this fact introduction of de novo methylation could occur during each round of 
replication. UHRF1 acting as a sensor for hm DNA and associating with Dnmt1 could 
contribute to the fidelity of complementing DNA methylation patterns. 
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As already mentioned, Dnmt1 is essential during early stages of embryogenesis represented 
by death of Dnmt1 knockout mice during midgestation (Li et al. 1992) but it is also required 
for proliferation and survival in somatic cells (Jackson-Grusby et al. 2001; Egger et al. 2006). 
Dnmt1 is down-regulated during G0 and G1 phase in normal and tumor cells, albeit slightly 
elevated levels in the latter one (Robertson et al. 2000b). Considering the major function of 
Dnmt1 in the involvement of the replication process, the expression level of Dnmt1 should 
correlate with the proliferative status of the cell. However, Northern Blot analysis revealed a 
somewhat paradoxical picture that Dnmt1 is highly expressed in lung and placenta, but also 
in low-proliferative tissues such as heart and brain (Robertson et al. 1999).  
Three alternative splice variants of Dnmt1 exist, namely Dnmt1b, Dnmt1o and Dnmt1p, that 
are expressed in a tissue and development dependent manner. 
The Dnmt1b isoform contains an additional 48 bp exon between exons 4 and 5 that codes for 
16 additional amino acids (Hsu et al. 1999; Bonfils et al. 2001). Although Dnmt1b mRNA is 
ubiquitously expressed in all cell lines and the in vitro enzymatic properties of Dnmt1b are 
comparable to Dnmt1 (Bonfils et al. 2001), the exact function of Dnmt1b remains elusive.  
Dnmt1o is a truncated isoform of Dnmt1, lacking the N-terminal 118aa due to a second in-
frame start codon (Yoder et al. 1996). It is synthesized and stored in the cytoplasm of the 
oocyte and traffics to the eight-cell nucleus during preimplantation development, where it 
maintains DNA methylation patterns on alleles of imprinted genes (Ratnam et al. 2002). 
Notably, Dnmt1o is a degradation resistant form of Dnmt1 allowing for accumulation of high 
concentrations in non-cycling oocytes (Ding and Chaillet 2002). In accordance, the N-
terminal 120aa of Dnmt1 are involved in ubiquitin dependent proteasomal degradation (Zhou 
et al. 2008a). 
A larger form of Dnmt1 mRNA, referred to as Dnmt1p, was detected exclusively in pachytene 
spermatocytes (Mertineit et al. 1998), but it was not translated. An alternative Dnmt1 
transcript resembling Dnmt1p was found in myotubes (Aguirre-Arteta et al. 2000) indicating a 
role of Dnmt1p during gametogenesis and myogenesis. 
 
A.3.5.1 Interactions of Dnmt1 
The N-terminus of Dnmt1 serves as a regulatory domain in the process of DNA methylation 
but also as a binding platform for numerous proteins.  
The C-X-X-C domain of Dnmt1 is highly similar in sequence to zinc fingers and bound 
specifically to non-methylated CpG di-nucleotides (Pradhan et al. 2008). Deletion of this 
domain led to decreased activity in vitro, and over-expression of Dnmt1∆CXXC resulted in 
partial loss of methylation on rDNA loci. 
Recently another function was assigned to the TS domain. It was identified as the key 
determinate for dimerization of Dnmt1 in a head-to-head orientation (Fellinger et al. 2009) 
that could account for a possible prerequisite for recognition of hemi-methylated palindromic 
target sites. 
The only Dnmt1 complex purified by means of chromatographic fractionation from Hela 
nuclear extracts was a complex consisting of Dnmt1, pRB, E2F1 and HDAC1 that was 
shown to repress transcription from promoters containing E2F1 binding sites (Robertson et 
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al. 2000a). In fact, both Dnmt1 and pRB were shown to interact with HDACs to induce gene 
silencing (Luo et al. 1998; Magnaghi-Jaulin et al. 1998; Fuks et al. 2000). Another effect of 
pRB binding to Dnmt1 was found. Overexpression of pRB using an adenoviral construct led 
to inhibition of global DNA methylation irrespective the phosphorylation status of pRB 
(Pradhan and Kim 2002). Addition of methylated ds DNA to a reaction containing 
unmethylated substrate led to catalytic activation of Dnmt1, suggesting the end product could 
function as a ligand for allosteric activation (Bacolla et al. 1999; Fatemi et al. 2001a). 
Deletion of the N-terminal 501aa abolished this activation (Pradhan and Estève 2003). 
Interestingly, the RB protein bound to the allosteric site of hDNMT1 (aa 284-287) and 
inhibited methylation, suggesting pRb may compete with DNA binding and thus regulate 
methylation spreading (Pradhan and Estève 2003). Furthermore, A similar regulatory 
mechanism was proposed for p21 mediated PCNA-Dnmt1 complex destabilization (Chuang 
et al. 1997). 
Dnmt1 was also found to form another complex comprising HDAC2 and DMAP1 (Dmt1 
associated protein1) (Rountree et al. 2000). DMAP1 binds to the far N-terminus of Dnmt1, 
exhibits intrinsic transcriptional repressive activity, binds to the co-repressor TSG101 and is 
targeted to replication foci throughout S-phase. In contrast, HDAC2 joins Dnmt1 and DMAP1 
only during late S-phase providing for histone deacetylation and heterochromatin formation 
after replication. Further studies revealed the existence of two complexes, p33ING1-Sin3-
HDAC and DMAP1-DNMT1, that physically interact with one another through p33ING1 and 
DMAP1 and that are recruited independently to pericentromeric heterochromatin regions 
during late S-phase (Xin et al. 2004). Importantly, they are required for histone deacetylation 
and H3K9me3 and binding of HP1. Recent data attributed DMAP1 an important role in 
specific gene silencing forming a complex with Bmi1 of PRC1 and Dnmt1 (Negishi et al. 
2007). Knockdown of either Bmi1 or DMAP1 resulted in transcriptional derepression and loss 
of recruitment of the other factors. Moreover, the Bmi1 homologous polycomb protein NSPc1 
(Nervous System polycomb1) was shown to promote H2A ubiquitination and to cooperate 
with PRC2 and Dnmt1 dependent DNA methylation in Hox gene silencing (Wu et al. 2008). 
Furthermore, the PcG protein EZH2 interacts within the context of PRC2/3 complexes with 
Dnmt1 and recruits Dnmt activity to EZH2 target promoters in vivo (Viré et al. 2005). 
An example for specific transcriptional silencing in cancer is the recruitment of Dnmt1 and 
Dnmt3a to target sites by the leukemia-promoting PML-RAR fusion protein leading to 
promoter hypermethylation and silencing (Di Croce et al. 2002).  
The physical interaction of Dnmt1 with the de novo methyltransferases has been described in 
vitro and in vivo (Kim et al. 2002). Both Dnmt3a and Dnmt3b interact with their N-terminus 
(but not PHD domain) with two different regions in the far N-terminus of Dnmt1. The 
functional relevance of this interaction was underscored by studies with Dnmt knockouts in 
HCT-116 colon adenocarcinoma cells. Dnmt1 knockout in HCT-116 cells revealed only a 
20% reduction of global methylation (Rhee et al. 2000). Later studies revealed that the 
knockout strategy had failed and generated an active Dnmt1 hypomorph lacking a great part 
of the N-terminal domain (Li et al. 2007b). Nevertheless, double-knockout (DKO) of Dnmt1 
and Dnmt3b almost eliminated methyltransferase activity and reduced DNA methylation to 
5% showing demethylation of repeated sequences, loss of Igf2 imprinting, abrogation of 
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silencing of the tumour suppressor gene p16INK4a, and growth suppression (Rhee et al. 
2002). 
The ‘real’ Dnmt1 knockout in HCT-116 cells, that targeted the deletion of the catalytic 
domain, also showed only slight reduction of global methylation, suggesting a partial 
compensation of Dnmt3a and Dnmt3b, but led to G2/M checkpoint activation and G2 arrest (Li 
et al. 2007b). Furthermore, cells escaping this arrest showed severe mitotic defects and 
underwent cell death either during mitosis or after arresting in a tetraploid G1 state. 
 
Figure 10  Proteins directly/ functionally interacting with Dnmt1 
Dnmt1 interacts with various proteins generally involved in silencing. Specific functions are given in the text.  
 
After replication, the DNA is assembled into chromatin. The histone methyltransferase G9a 
being specific for H3K9me1/2 especially in euchromatic regions, is targeted by Dnmt1 to 
replication foci (Esteve et al. 2006). In vitro, the complex of Dnmt1 and G9a led to enhanced 
DNA and histone methylation of assembled chromatin substrates. Notably, G9a-null mice 
display severe growth retardation and die during embryonic development (Tachibana et al. 
2002) reminiscent of Dnmt1 knockout mice (Li et al. 1992). In agreement, ES cells lacking 
G9a showed a significant reduction in DNA methylation of retrotransposons, major satellite 
repeats and densely methylated CpG-rich promoters (Dong et al. 2008). 
Similar to G9a, the HMT Suv39H1 specific for H3K9me2/3 and HP1 binding to H3K9me3 
were both shown to interact with Dnmt1 (Fuks et al. 2003) indicating a functional connection 
between DNA and histone methylation.  
Furthermore, the methyl-DNA-binding proteins MeCP2 and MBD2 were shown to mediate 
gene repression by recruiting histone deacetylase complexes to methylated genes (Ng et al. 
1999). Dnmt1 was found to interact with the MBD2-MBD3 complex and co-localized to 
replication foci during late S-phase (Tatematsu et al. 2000). Importantly, the MBD2-MBD3 
complex showed a hitherto unreported affinity to hm DNA suggesting a role in 
heterochromatin formation after replication through recruitment of HDACs. MeCP2 also 
bound to hm DNA and associated with Dnmt1 (Kimura and Shiota 2003). Interestingly, 
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Dnmt1 substitutes the mSin3A-HDAC1 complex indicating the absence of HDAC activity in 
the MeCP2-Dnmt1 complex. Therefore, MeCP2 was postulated to contribute to maintenance 
methylation – a function that today is assigned to UHRF1 (see above; A.2.2). 
Besides the interaction of Dnmt1 with transcriptional regulators and chromatin modifying 
enzymes, ATP-dependent chromatin remodeling proteins (A.1.4) have been identified to play 
a role in DNA methylation (see section A.3.8).  
Taken together, DNA methylation is highly coordinated together with other chromatin 
modifications and Dnmt1 is regulated in a tightly cross-linked network of interactions.  
 
A.3.6 De novo DNA methyltransferases Dnmt3a and Dnmt3b 
Dnmt3a and Dnmt3b were both identified by a database-search (Okano et al. 1998). They do 
not exhibit any preference for hemi-methylated DNA in vitro and were thus considered as de 
novo methyltransferases (Okano et al. 1998; Gowher and Jeltsch 2002; Suetake et al. 2003). 
Both proteins are able to methylate cytosine bases outside the context of CpG sites, but the 
biological function of this phenomenon remains unclear (Gowher and Jeltsch 2001; Gowher 
and Jeltsch 2002; Lin et al. 2002). In addition, Dnmt3a shows preference for CpG sites that 
are flanked by pyrimidines rather than purines (Lin et al. 2002). In a more detailed study the 
flanking sequences of up to four base pairs surrounding the central CpG site were analyzed 
showing preferred RCGY over YCGR (R = purine; Y= pyrimidine) methylation by Dnmt3a 
and Dnmt3b and a preference of AT-rich flanks over GC-rich ones (Handa and Jeltsch 2005).  
They share homologous C-terminal catalytic domains that in contrast to Dnmt1 are 
catalytically active (Gowher and Jeltsch 2002), homologous cysteine-rich regions (also 
referred to as PHD/ATRX domain) (Xie et al. 1999) and PWWP domains (Qiu et al. 2002) 
that are approximately 100-150 aa in length and are often found within chromatin associated 
proteins. The PWWP domain from mouse Dnmt3b (amino acids 223--357) has been 
structurally characterized (Qiu et al. 2002) and exhibits DNA binding properties. However, 
the affinity of the PWWP domain of Dnmt3a towards DNA is smaller than that of Dnm3b 
(Chen et al. 2004). Notably, disruption of the PWWP domain in both proteins abolishes their 
association with pericentromeric heterochromatin and their abilities to methylate this region 
(Chen et al. 2004).  
Recently, the essential transcription factor SALL3 was identified as a novel inhibitor factor for 
Dnmt3a interacting via the PWWP domain (Shikauchi et al. 2009). Interestingly, SALL3 
expression reduced Dnmt3a mediated CpG island methylation in vivo and in vitro and 
affected chromatin association of Dnmt3a. 
The PHD/ATRX domain comprises approximately 50aa residues, is characterized by a 
conserved Cys4-HisCys3 zinc-binding motif and is found mainly in proteins involved in 
eukaryotic transcriptional regulation (Hermann et al. 2004a). Dnmt3a binds to RP58, a DNA 
binding transcriptional repressor found in heterochromatin, leading to methylation 
independent repression of genes (Fuks et al. 2001). Interestingly, this silencing was 
mediated by HDAC1 that associated with Dnmt3a through its PHD/ATRX-homology domain. 
Similar to Dnmt3a, Dnmt3b and Dnmt1 associate with HDAC1 leading to methylation 
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independent silencing (Rountree et al. 2000; Bachman 2001) although the latter does not 
share the PHD domain. 
As seen for Dnmt1, Dnmt3a interacts through its PHD/ATRX-homology domain with the 
H3K9 specific HMT Suv39H1 and HP1 (Fuks et al. 2003) indicating cooperation in formation 
or maintenance of heterochromatin. Similarly, Dnmt3a associated in vivo and in vitro via the 
PHD domain with the euchromatic HMT SETDB1 that is specific for H3K9me3 (Li et al. 
2006). Co-expression of both proteins was essential for recruitment to an artificial promoter 
and its repression. The list of proteins interacting with the PHD domain of Dnmt3a was 
recently expanded by the arginine methyltransferase PRMT5 that specifically promotes 
symmetric H4R3 di-methylation (Zhao et al. 2009). Interestingly, H4R3me2 serves as direct 
target for Dnmt3a through its PHD domain. Knockdown of PRMT5 and subsequent loss of 
H4R3me2 resulted in reduced Dnmt3a binding, DNA methylation and thus activation of the β-
globin locus. 
Figure 11  Interacting proteins of Dnmt3a and Dnmt3b 
Dnmt3a and Dnmt3b interact with various proteins. In the middle panel shared interaction partners are depicted 
whereas proteins associating only with Dnmt3a or only Dnmt3b are shown to the left and the right respectively. 
Details of protein function are given in the text.  
 
Like Dnmt3a, Dnmt3b has been shown to interact with factors involved in gene silencing 
such as HDAC1/2, Suv39H1, Hp1 and the ATP-dependent chromatin remodeling enzyme 
hSnf2H and to co-localize with these proteins to transcriptionally repressed, heterochromatic 
regions (Lehnertz et al. 2003; Geiman et al. 2004b). Moreover, Dnmt3b was purified via 
chromatographic fractionation from Hela nuclear extracts in a complex containing several 
components of the condensin complex (hCAP-C, hCAP-E and hCAP-G), KIF4A, HDAC1, the 
co-repressor SIN3A and hSnf2H (Geiman et al. 2004a). Dnmt3b co-localized with these 
components on condensed chromosomes throughout mitosis contrasting observations of 
Dnmt3b localization in murine ES cells and embryonic fibroblast cells (Bachman 2001).  
The structure of the catalytic domain of Dnmt3a in complex with the C-terminal domain of 
Dnmt3L was solved by X-ray crystallography (Jia et al. 2007). Both the structure and 
mutagenesis experiments suggest that the interaction with Dnmt3L is required for full 
Dnmt3a activity and for formation of nucleoprotein filaments (Jurkowska et al. 2008). 
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Furthermore, Dnmt3a interacts with subunits of the SUMOylation machinery and undergoes 
this posttranslational modification both in vivo and in vitro (Ling et al. 2004). SUMOylation 
inhibits the interaction with HDAC1 and HDAC2 and abolishes transcriptional repression by 
Dnmt3a. Recently, the human polycomb group protein Cbx4 (HPC2) was identified as the 
SUNO E3 ligase for Dnmt3a, SUMOylating its target in the far N-terminus in vivo and in vitro 
(Li et al. 2007a). Likewise, Dnmt3b interacts and co-localizes with SUMO-1 and the E2 
conjugating enzyme Ubc9, although the function remains elusive (Kang et al. 2001). 
 
Dnmt3a is ubiquitously expressed in most adult tissues, whereas Dnmt3b is only detectable 
in testis, thyroid and bone marrow. In contrast, both Dnmt3a and Dnmt3b expression is 
elevated in several tumor cell lines to levels comparable to Dnmt1 (Xie et al. 1999) 
underscoring the notion of aberrant methylation in cancer cells.  
Like Dnmt1, Dnmt3a and Dnmt3b were shown to exist in different splice variants. There are 
two isoforms of Dnmt3a, namely Dnmt3a1 and Dnmt3a2 that differ in the first 223aa (Chen et 
al. 2002). Dnmt3a1 is the major form in adult tissues, where it co-localizes with 
heterochromatin, whereas Dnmt3a2 is the predominant form in ES cells and embryonal 
carcinoma cells and can be detected in testis, ovary, thymus and spleen. Accordingly, 
Dnmt3a and Dnmt3a2 may have distinct DNA targets and different functions in development. 
To date, five human splice variants of Dnmt3b, Dnmt3b1 – Dnmt3b5 have been identified 
and were shown to be expressed in a tissue specific manner (Robertson et al. 1999). 
Dnmt3b1, 3b2, 3b3 represent the major slice variants (Okano et al. 1998). Dnmt3b1 is the 
longest form and is regarded as the typical gene product of DNMT3B. All other splice 
variants encode smaller proteins. Dnmt3b2 lacks approximately 25 aa between the PHD and 
the PWWP domain and was shown to be catalytically active (Qiu et al. 2002). Dnmt3b3 
resembles Dnmt3b2 but lacks additional 63aa in the catalytic domain rendering the enzyme 
inactive (Aoki et al. 2001). Dnmt3b4 and Dmt3b5 are expected to be inactive due to 
truncations of the catalytic domain (Robertson 2002). Details about their functions remain 
unclear. 
 
Unlike Dnmt1, which localizes to replication foci during S-phase in murine embryonic 
fibroblasts, Dnmt3a co-localizes with HP1α and MeCPs throughout the cell cycle to late-
replicating pericentromeric heterochromatin (Bachman 2001). In contrast to Dnmt3a, Dnmt3b 
remained diffuse in the nucleus of embryonic fibroblasts at all cell cycle stages. However, 
Dnmt3a and Dnmt3b co-localized to these pericentromeric heterochromatin regions in 
murine ES cells – even in Dnmt1-null ES cells, that lose the majority of methylation in these 
regions. These results indicate that Dnmt3a and Dnmt3b acquire unique functions during the 
transformation from ES cells to embryonic fibroblast cells and that localization to 
heterochromatin is not dependent on preexisting methylation marks. 
As already mentioned (A.3.4), both enzymes are crucial for development as indicated by the 
lethality of the respective knockout mice (Okano et al. 1999). Two revealing publications 
clearly underscore the functional differences of Dnmt3a and Dnmt3b. With conditional 
knockout technology, the effect of Dnmt3a and Dnmt3b ablation during gametogenesis was 
monitored (Kaneda et al. 2004). Offspring from Dnmt3a conditional mutant females died in 
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utero and lacked methylation and allele-specific expression at all maternally imprinted loci 
examined. Furthermore, Dnmt3a conditional mutant males showed impaired 
spermatogenesis and lacked methylation at two of three paternally imprinted loci. By 
contrast, Dnmt3b conditional mutants and their offspring showed no apparent phenotype. 
The phenotype of Dnmt3a conditional mutants was virtually indistinguishable from that of 
Dnmt3L knockout mice.  
A detailed methylation analysis of the paternally methylated DMRs (H19, Dlk1/Gtl2 and 
Rasgrf1), interspersed repeats (SineB1, IAP and LINE1) and satellite repeats (major and 
minor) in male germ cells from Dnmt3a and Dnmt3b knockout mice demonstrated that 
Dnmt3a mainly methylated DMRs of H19 and Dlk1/Gtl2 and SineB, whereas Dnmt3b 
exclusively methylated satellite repeats. Interestingly, both proteins were required for the 
methylation the Rasgrf1 DMR and IAPs and LINEs showing some overlapping function. 
Importantly, all sequences analyzed showed moderate to severe hypomethylation in 
Dnmt3L-deficient prospermatogonia, indicating a critical role for both de novo 
methyltransferases (Hata et al. 2007). 
The unique function of Dnmt3b methylating satellite repeats is reflected by the ICF syndrome 
(Okano et al. 1999; Ehrlich et al. 2008). In agreement, the catalytic domain of Dnmt3a 
methylates DNA in a distributive whereas Dnmt3b in a more processive manner accelerating 
methylation of macromolecular DNA in vitro.  
As a summary, Dnmt3a and Dnmt3b are highly related proteins endowed with similar in vitro 
enzymatic properties and protein domains that generally direct interactions with chromatin 
associated factors. Nevertheless, in vivo, especially during gametogenesis and development 
they have unique and only minor overlapping functions. 
 
A.3.7 Dnmt3L 
The DNMT3L gene was initially found through homology search of zinc finger containing 
proteins (Aapola et al. 2000) and was isolated from mouse (Aapola et al. 2001). Both human 
and mouse Dnmt3L show similarity with zinc finger ATRX/PHD domains of proteins of the 
SNF2 family and the de novo methyltransferases Dnmt3a and Dnmt3b (Aapola et al. 2001). 
In addition, the C-terminal domain shares motifs of the catalytic domain of Dnmt3a and 
Dnmt3b but on the one hand is truncated and on the other hand lacks the consensus amino 
acid residues PC in motif IV and ENV in motiv VI which form the catalytic center of cytosine-5 
methyltransferases (Hata et al. 2002) (Figure 9). 
Although catalytically inactive, Dnmt3L was shown to repress transcription through 
recruitment and interaction of HDAC1 via its PHD-like domain (Aapola et al. 2002; Deplus et 
al. 2002). Dnmt3L was found to be essential for embryonic development due to the 
establishment of maternal imprints and the appropriate expression of imprinted genes 
(Bourc'his et al. 2001; Hata et al. 2002). Dnmt3L knockout mice failed to establish maternal 
methylation imprints as seen for Dnmt3a-/- and Dnmt3b+/- mice. In addition, both Dnmt3a 
and Dnmt3b interact with Dnmt3L in vivo and the lack of Dnmt3a, like the lack of Dnmt3L, 
resulted in disrupted spermatogenesis and thus male sterility (Hata et al. 2002). Latest 
studies revealed an important role of Dnmt3L in de novo methylation of long-terminal-repeats 
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(LTR) and non-LTR retrotransposons in precursors of spermatogonial stem cells (Bourc'his 
and Bestor 2004) whereas tandem repeats in pericentromeric regions were normally 
methylated. 
In vivo analysis with replicating minichromsomes carrying various imprinting centers showed 
that co-expression of Dnmt3L and Dnmt3a resulted in a striking stimulation of de novo 
methylation whereas co-expression of Dnmt3L and Dnmt3b led to little changes in target 
methylation (Chedin et al. 2002).  
In vitro studies revealed that Dnmt3L also had a stimulatory effect on the de novo 
methylation (Suetake et al. 2004; Gowher et al. 2005a). Through the interaction with Dnmt3L, 
the in vitro methylation activity of Dnmt3a and Dnmt3b on oligonucleotides was increased 15 
fold whereas on longer DNA fragments >200bp only 1.5-3 fold. It was shown that the C-
terminal domain was sufficient for stimulation (Suetake et al. 2004; Gowher et al. 2005a). In 
particular, association of Dnmt3L with Dnmt3a was proposed to induce a conformational 
change and thus to lower the KM value for DNA and SAM. After DNA binding, Dnmt3L would 
dissociate from the Dnmt3a/DNA complex, suggesting a role for Dnmt3L as an exchange 
factor (Gowher et al. 2005a). By means of surface plasmon resonance and filter binding 
assays Dnmt3L was able to bind to DNA (Gowher et al. 2005a), contrasting gel retardation 
assays where no binding was observed (Suetake et al. 2004). Recently, the crystal structure 
of a Dnmt3a/Dnmt3L tetrameric complex of the respective C-terminal domains was solved 
(Jia et al. 2007). Dnmt3a forms a dimer with two catalytic centers at the interface and one 
helical turn of DNA apart, suggesting the periodicity of 8-10bp in methylation of maternally 
imprinted genes. The Dnmt3L/Dnmt3a interaction is required for the stability of the Dnmt3a 
dimer and thus the enzymatic activity (Jia et al. 2007). Rather than binding as individual 
tetramers, Dnmt3a/Dnmt3L complexes formed a nucleoprotein filament in vitro (Jurkowska et 
al. 2008). 
Immunoprecipitation of Flag-tagged Dnmt3L from embryonic stem cells, showed association 
of Dnmt3a2, Dnmt3b and the four canonical histones (Ooi et al. 2007). Further studies on the 
association of Dnmt3L with histone tails identified the first seven N-terminal amino acids of 
histone H3 to be the target for binding. Interestingly, non-methylated H3K4 was indispensible 
for binding through the PHD-like domain of Dnmt3L whereas other modification such as 
H3K9me3 did not disturb the interaction (Ooi et al. 2007). Methylation of lysine 4 on histone 
H3 has recently been suggested to protect gene promoters from de novo methylation which 
is compatible with these findings.  
 
A.3.8 DNA methylation in the context of chromatin 
Both, de novo DNA methyltransferases Dnmt3a and Dnmt3b and the maintenance DNA 
methyltransferase Dnmt1 have been extensively studied with regard to their enzymatic 
properties ((Bacolla et al. 1999; Pradhan et al. 1999; Aoki et al. 2001; Gowher and Jeltsch 
2001; Gowher and Jeltsch 2002; Yokochi and Robertson 2002; Suetake et al. 2003). All 
these results were obtained through in vitro studies involving naked DNA as a substrate. 
However, the DNA of eukaryotic cells is packaged into a compact nucleoprotein complex 
whose elemental structure is nucleosomes (Woodcock and Horowitz 1995). 
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Recently, DNA methylation activity towards reconstituted mono-nucleosomes as substrate 
was reported (see below). 
Robertson showed that the catalytic efficiency of Dnmt1 and Dnmt3a towards mono-
nucleosomes with linker DNA (5S rDNA) decreased 8 fold and 17 fold respectively, although 
binding to the substrate and maximal velocity was comparable to naked DNA (Robertson et 
al. 2004). Different observations were reported by Okuwaki who found out that Dnmt1 was 
intrinsically capable of methylation within the nucleosome core, but to a much lesser extent 
and in a sequence dependent manner (Okuwaki and Verreault 2003). On the contrary, H. 
Gowher (Gowher et al. 2005b) found comparable methylation efficiency for DNA and 
nucleosomal templates (147bp) for Dnmt1 and Dnmt3a irrespective the sequence. In 
contrast, distinct roles of Dnmt3a and Dnmt3b in the methylation of DNA and nucleosome 
were described. The methylation activity of Dnmt3a seemed to be inhibited by mono-
nucleosomes whereas Dnmt3b showed low but significant methylation within the nucleosome 
(Takeshima et al. 2006). Moreover, Dnmt3a was shown to preferentially methylate linker 
DNA which is impaired by binding of histone H1 (Takeshima et al. 2008). 
Interestingly, not only the enzymes’ intrinsic properties seem to have an effect on the 
methylation in chromatin, but also components of ATP-dependent chromatin remodeling 
factors.  
Deletion of DDM1 in Arabidopsis or its mouse homolog Lsh, members of the SNF2 family of 
remodeling enzymes, resulted in global loss of methylation, especially in repetitive elements 
like satellites and rDNA (Bartee and Bender 2001; Dennis et al. 2001; Fan et al. 2005). 
Recently, it was shown that acquisition of DNA methylation of non-methylated episomes 
required Lsh and that Lsh interacted specifically with the de novo DNA methyltransferases 
(Zhu et al. 2006). In particular, Lsh was demonstrated to recruit Dnmt3b to some Hox genes 
and to regulate Dnmt3b dependent DNA methylation and PRC mediated histone 
modifications (Xi et al. 2007). In another study, the function of Lsh as a recruitment factor 
was further underscored showing the cooperation with Dnmt1, Dnmt3b and HDAC1/2 in 
gene silencing (Myant and Stancheva 2008). 
Mutation in the ATRX gene, belonging to the Rad54 subfamily (Snf2 family) (Flaus et al. 
2006a) results in a human genetic disease called X-linked α-thalassemia mental retardation 
(ATR-X) syndrome. Interestingly, unlike for DDM1 and Lsh, methylation defects in ATR-X 
patients are restricted to selected regions of the genome such as rDNA repeats, and are 
characterized by both hypo- and hypermethylation (Gibbons et al. 2000).  
NoRC, a nucleolar remodeling complex containing hSnf2H (ISWI – like subfamily) (Strohner 
et al. 2001), represses rDNA transcription by recruiting DNA methyltransferase and histone 
deacetylase (Santoro and Grummt 2005). Furthermore, interaction of Dnmt1 with hSnf2H 
has been shown to increase the affinity of Dnmt1 towards nucleosomes (Robertson et al. 
2004). 
In addition, Dnmt3b was shown to interact with hSnf2H (Geiman et al. 2004b) and Dnmt3a 
forming a complex with Brg1 (Snf2 like subfamily) in mouse lymphosarcoma cells (Datta et 
al. 2005).  
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B OBJECTIVES 
B.1 Identification of new Dnmt1 interacting proteins 
DNA methylation is an epigenetic modification that is integrated in a highly dense network of 
regulatory mechanisms that control a great variety of essential cellular processes such as 
cell differentiation and proliferation, genomic integrity, DNA repair, imprinting of genes during 
development and X-chromosome inactivation in females.  
Aberrant methylation is a hallmark of many cancers leading to silencing of tumor suppressor 
genes, activation of oncogenes and retrotransposons and defective imprinting. Dnmt1 as the 
maintenance DNA methyltransferase was shown to be implicated in these processes. Albeit 
many interactors of Dnmt1 had been identified, the underlying mechanisms that result in 
‘mistargeting’ of Dnmt1 or recruitment to specific methylation sites in tumors remain largely 
unclear.  
In this study, the aim was to identify new Dnmt1 containing complexes from native tissue 
(human placenta as an extra-embryonal tissue) and the subsequent comparison of complex 
composition from embryonal tissues such as Wilms tumors. As a reference the human cervix 
carcinoma cell line Hela S3, growing in suspension, was chosen. 
The presence or absence of specific factors could modulate Dnmt1’s targeting to specific loci 
or its enzymatic activity. In addition, new proteins of unknown function could be identified and 
further characterized. 
 
B.2  De novo DNA methylation in the context of chromatin 
The human genome is highly compacted in the nucleus through package into chromatin. The 
basic repeating unit of chromatin is the nucleosome that consists of 147bp of DNA wrapped 
around a histone octamer. On the one hand nucleosomal DNA represents a constraint as 
DNA accessibility is impaired but on the other hand features a level of regulation.  
Dnmt3a and Dnmt3b are de novo methyltransferases that introduce new methylation marks 
at specific sites and at specific time points in development. The DNA methylation enzymes 
also have to cope with nucleosomal substrates.  
Although some data on DNA methylation in the context of chromatin exist, we sought to 
systematically address the properties of nucleosome and DNA binding of Dnmt3a and 
Dnmt3b2 and subsequently their methylation characteristics. With this information, the 
molecular function of ATP-dependent chromatin remodeling enzymes in DNA methylation 
could be further investigated.  
Moreover, the Dnmt3L protein interacting with and positively affecting the activity of the de 
novo methyltransferases in vitro and in vivo was found to bind to non-methylated H3K4. 
Therefore the role of Dnmt3L in binding and methylation of nucleosomes by Dnmt3a and 
Dnmt3b was under investigation. 
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C RESULTS 
C.1 Towards identifying new interaction partners of Dnmt1 
C.1.1 MALDI analysis of putative Dnmt1 interaction partners 
Nuclear extracts from human placenta and Hela S3 cells (E.1.11) were generated as 
described (E.2.9.2) and subjected to immunoprecipitation with the Dnmt1 specific antibody 
2C1 cross-linked to proteinG sepharose (E.1.6; E.2.12.2). Through comparison of proteins 
pulled down with the 2C1-beads and proteins bound unspecifically to the proteinG sepharose 
used for preclearing, possible candidates only found in the “beads” lane were cut out and 
sent for MALDI analysis to the “Zentrallabor für Proteinanalytik” (Prof. A. Imhof) at the LMU in 
Munich (Figure 12). 
 
Figure 12  MALDI analysis of proteins co-
immunoprecipitated with Dnmt1 
Dnmt1 was immunoprecipitated with the 2C1 antibody (E.1.6), 
coupled to 50µl proteinG sepharose from 9.0mg of human 
placenta nuclear extract, 4.5mg Hela S3 nuclear extract and 
2.0mg MNase released nuclear extract (E.2.9.2). Beads were 
boiled in 40µl HU buffer and subjected to 4%-12% SDS-PAGE 
and Coomassie Blue staining. ‘B’ denotes 2C1 coupled 
proteinG sepharose, and ‘P’ proteinG beads used for 
preclearing of the extracts. Molecular weight marker and 
proteins bands cut out for MALDI analysis are indicated. 
 
Although there was a lot of unspecific binding of proteins to proteinG sepharose under the IP 
conditions chosen, some bands could be well identified as unique for the specific IP reaction. 
Table 2 summarizes the MALDI results from the gel-bands. Proteins displaying possible 
candidates were shadowed in grey. ICBP90 (Bostick et al. 2007) and PCNA (Chuang et al. 
1997) had already been described as Dnmt1 interaction partners. Dnmt1 was identified as 
bait protein before (data not shown). In addition, a prominent Dnmt1 degradation product 
was present in placenta nuclear extract. USP7 also known as HAUSP was found to be a new 
possible interaction partner of Dnmt1 in Hela S3 nuclear extracts. The IP reaction was 
repeated and more bands were sent for MALDI analysis (data not shown).  
As a summary, USP7 was found as unique band in IP’s from all extracts tested, whereas 
ICBP90 could only be confirmed as interaction partner from Hela MNase released nuclear 
extracts. This is in agreement with published data that ICBP90 is a chromatin - associated 
factor (Citterio et al. 2004; Bostick et al. 2007; Sharif et al. 2007; Karagianni et al. 2008). In 
vivo co-immunoprecipitation experiments with Hela S3 nuclear extracts and MNase released 
extracts suggest that most of ICBP90 is associated with chromatin (C.1.4). In WCE from 
HEK293 cells (E.2.6.3) over-expressing EGFP-tagged Dnmt1 or USP7 (E.2.6.5), ICBP90 
was hardly present in the soluble fraction but resided in the pellet (data not shown). ICBP90 
from mouse was only properly released from nuclei that had been treated with DNAseI 
before (Citterio et al. 2004) (Prof. H. Leonhardt, personal communication). Accordingly, it 
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seems as if the fraction of Dnmt1 interacting with ICBP90 was not properly released in 
placenta and Hela S3 nuclear extracts prepared according to the method of F. Pugh (E.2.9.2) 
and thus no prominent protein band was found in the respective ‘bead’ lane. 
 
Table 2  MALDI results for Dnmt1 immunoprecipitation from nuclear extracts 
 
# name score / alternate description 
1 USP7 209 for gi|34851150, ubiquitin-specific protease 7 isoform [Homo sapiens] 
2 ICBP90 138 for gi|6815251, transcription factor ICBP90 [Homo sapiens] 
3 USP7 266 for gi|150378533, ubiquitin specific protease 7 [Homo sapiens] 
4 CRA_E 
87 for gi|119627830, splicing factor proline/glutamine-rich (polypyrimidine tract binding 
protein associated), isoform CRA_e [Homo sapiens] 
5 Actin 178 for gi|32698757, actin-like 8 [Homo sapiens] 
6 PCNA 77 for gi|4505641, proliferating cell nuclear antigen [Homo sapiens] 
7 Dnmt1 176 for gi|6684525, DNA (cytosine-5)-methyltransferase [Homo sapiens] 
8 HSP70 76 for gi|62897129, heat shock 70kDa protein 8 isoform 1 variant [Homo sapiens] 
9 CRA_B 
65 for gi|119616871, cytidine monophosphate N-acetylneuraminic acid synthetase, 
isoform CRA_b [Homo sapiens] 
 
C.1.2 MALDI analysis with iTRAQ labeling 
Gel-based MALDI evaluation has the disadvantage of proteins of interest being masked by 
unspecific proteins that show the same running behavior in SDS-PAGE. In addition, the 
visualization of proteins is limited to the detection limit of Coomassie Brilliant Blue or silver 
staining.  
MALDI analysis using the iTRAQ labeling technique (Applied Biosystems) refers to a 
multiplexed protein quantitation strategy that provides relative and absolute measurements of 
protein in complex mixtures (Ross et al. 2004; Chen and Andrews 2009). The core of this 
methodology is a multiplexed set of isobaric reagents  (iTRAQ, 114, 115, 116 and 117) that 
yield amine-derivatized peptides. The derivatized peptides are indistinguishable in MS, but 
exhibit intense low-mass MS/MS signature ions that support quantitation. Thus, differential 
labeling of peptides eluted from IgG control proteinG sepharose and from target protein 
directed antibodies, following separation of combined peptides on a reversed phase 
chromatography (Nano-HPCL) and MALDI analysis allows the determination of enrichment 
of specific peptides compared to IgG control. 
Samples were digested in solution with trypsin following in silico differential isobaric labeling 
of peptides from IP sample and proteinG sample with different iTRAQ reagents (Applied 
Biosciences) (E.2.14.3). Labeled peptides were mixed and separated on a reversed phase 
chromatography (nano-flow HPLC-system Dionex) (E.2.14.3) applying a linear gradient from 
5% - 95% of buffer B (80% acetone-nitril, 0.05% TFA) and spotted with 5 volumes of CHCA-
matrix (2mg/ml in 70% acetonitrile, 0.1% TFA) on a MALDI-target by the probot-system 
(Dionex). Spotted fractions were analyzed with the 4700 series MALDI-TOF/TOF system 
(Applied biosciences) with the kind help of S. Jakob. 
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Figure 13  Dnmt1 co-immunoprecipitation – iTRAQ MALDI analysis 
Dnmt1 specific immunoprecipitation with Hela nuclear extract was done as described (E.2.14.2). Trypsin digest of 
IP samples, in silico iTRAQ labeling of respective peptides and subsequent separation on a reversed phase 
chromatography (nano-flow HPLC) was performed (E.2.14.3). Separated peptides were spotted on MALDI targets 
and analyzed with a MALDI-TOF/TOF-system of the 4700 series (Applied Biosystems). Usually 6-7 peptides in 
each spot were further fragmented in MS/MS mode. The measured m/z ratios were assigned to the peptides and 
the respective proteins by MASCOT database search in the human database. The ratio of specific IP versus 
proteinG control (114/116) is plotted against the proteins identified. For the 5 strongest hits the amount of 
peptides identified are listed above the bars. 
 
Although all three extracts (C.1.1) were analyzed, only results for the IP reaction from Hela 
S3 nuclear extracts were obtained (Figure 13). The signals of the Hela S3 MNase extract 
were not strong enough for adequate MALDI performance and the placenta nuclear extract 
was contaminated with vast amounts of parental IgG from the preparation. These peptides 
masked other relevant peptides and thus tainted the evaluation. 
As shown in Figure 13, the ratio of specific IP versus proteinG control is plotted as iTRAQ 
labeling ratio 114/116 against the peptide hits acquired from the evaluation process. For the 
five highest score results, the number of peptides found are given. Accordingly, Dnmt1 as 
bait and USP7 as prey are highly enriched as seen with the gel-based MALDI analysis 
(C.1.1). Although actin and PTPM14 (protein tyrosine phosphatase) are better or equally well 
enriched compared to Dnmt1, less peptides were found and thus not considered as potential 
interaction partners of Dnmt1. 
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C.1.3 Dnmt1, ICBP90, USP7 co-migrate in gelfiltration 
Nuclear extracts from human placenta and Hela S3 cells (E.2.9) were separated on a 
Superose6 gelfiltration column (GE Healthcare) (E.2.3.6). 500µl fractions were collected, 
TCA precipitated (E.2.3.4) and subjected to SDS-PAGE following either silver staining or 
Western Blot analysis. 
 
Figure 14  Gelfiltration analysis of nuclear extacts from Hela S3  
500µl of Hela S3 nuclear extacts (4.5mg salt extracted, 2.0mg MNase released nuclear extract) were applied on a 
supererose6 gelfiltration column (GE Healthcare). 500µl fractions were collected, TCA precipitated (E.2.3.4) and 
subjected to SDS-PAGE following either silver staining (E.2.3.2) or Western Blot analysis (E.2.3.3). A WB 
analysis of every second fraction of Hela S3 nuclear extract with the antibodies indicated (E.1.6). B same as for 
A, but silver staining of respective fractions. C same as for A but for Hela S3 MNase released extract. Migration of 
histones as determined from D is indicated. D same as for C but Silver staining of respective fractions. Apparent 
molecular weight and SEC markers are indicated. 
 
According to Figure 14, Dnmt1, ICBP90 and USP7 are present in all fractions. Dnmt1 and 
USP7 show a distinct peak between 440-669kDa for both salt extracted nuclear extract and 
MNase released nuclear extract. Interestingly, ICBP90’s monomer peak between 66-232kDa 
is shifted to higher molecular weight and co-migrates with Dnmt1 and USP7 in the MNase 
released extract. As seen from the silver gel, this shift is accompanied by histones present in 
these fractions. Whether the co-migration of ICBP90 with Dnmt1 and USP7 is due to a 
specific interaction with these proteins, either directly or nucleosome - mediated, or whether 
a different histone containing ICBP90 complex with a similar molecular weight exists, cannot 
be concluded from the gelfiltration data alone. Considering the co-IP data (C.1.1; C.1.4) the 
gelfiltration data underscore the picture of a well extractable Dnmt1/ USP7 dimer and a 
possible trimeric complex of Dnmt1, ICBP90 and USP7 more tightly associated with 
chromatin. 
Placenta nuclear extract separated on size exclusion chromatography (SEC) (Figure 15) 
shows a very similar result for Dnmt1, USP7 and ICBP90 as seen for the Hela S3 nuclear 
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extract. This is in accordance with the fact that the purification protocol after the step of 
nuclei preparation is virtually the same (E.2.9). Notably, ICBP90 is detected to a much lesser 
extent, although approximately double the amount was loaded. This reflects the observation 
that the expression level and protein level is low in quiescent cells and high in proliferating 
cells (Jenkins et al. 2005) and the fact that only a sub-population of the cells of placenta is in 
S-phase. In addition, in cancer cells ICBP90 is highly expressed throughout the cell cycle 
whereas its expression peaks during late G1 and the transition of G2 – M-phase in lung 
fibroblast cells (Mousli et al. 2003). 
Figure 15  Gelfiltration analysis of nuclear extracts from human placenta  
500µl of placenta nuclear extract (9.0 mg/ml) (E.2.9) were applied on a superose6 gelfiltration column (GE 
Healthcare). 500µl fractions were collected, TCA precipitated (E.2.3.4) and subjected to SDS-PAGE following 
Western Blot analysis (E.2.3.3). Immuno-detection of all fractions with the antibodies as indicated (E.1.6). 
Apparent molecular weight and SEC markers are given. 
 
C.1.4 Dnmt1, ICBP90 and USP7 interact with one another in vivo  
In order to investigate the possible existence of a trimeric complex, co-immunoprecipitations 
with Dnmt1, ICBP90 and USP7 as bait from Hela S3 MNase released nuclear extracts were 
performed. The immunoprecipitation was done as described (E.2.12.1) with the following 
modifications: 50µl slurry proteinG sepharose was used for the specific IP and preclearing 
reactions. 2.0µg of anti-USP7 antibody, anti-ICBP90 antibody (Hopfner et al. 2000) and 
irrelevant anti IgG antibody control (E.1.6) and 50µl of anti-Dnmt1 2C1 cross-linked proteinG 
beads (E.2.12.2) were used.  
Samples were separated on 6% SDS-gels and subjected to Western Blotting following 
immuno-detection with the respective antibodies. LaminA/C served as control for a nuclear 
protein that should not interact with the POIs. 
All antibodies chosen not only immunoprecipitate their target protein but also co-
immunoprecipitate the other two proteins of interest (Figure 16). The MALDI result for the 
immunoprecipitation of Dnmt1 with the same extract is confirmed (C.1.1). LaminA/C as a 
nuclear protein is not precipitated and serves as a control for the specificity of the interaction.  
Together with the gelfiltration data (C.1.3), it cannot be ruled out that the observed interaction 
is truly protein-protein based but mediated via DNA or nucleosomal interactions. 
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Figure 16  Co-immunoprecipitation of Dnmt1, ICBP90, USP from Hela S3 MNase released 
extracts 
POIs were subjected to immunoprecipitation with 200µl of Hela S3 MNase released extract (2.0mg/ml) (E.2.9.3) 
with 2.0µg of USP7 and ICBP90 antibodies (E.1.6) and 50µl slurry proteinG sepharose and 50µl anti Dnmt1 2C1 
cross-linked proteinG sepharose. Prior to immunoprecipitation, extracts were precleared with 50µl slurry proteinG 
beads supplemented with 2.0µg irrelevant IgG control antibody (E.1.6). Input, flowthrough (FT), preclearing beads 
(pre B), ‘specific’ beads (B), molecular weight markers and antibodies used for immuno-detection (E.2.3.3) are 
indicated. 
 
In order to further pursuit this aspect, 3.0mg of high salt extracted Hela S3 nuclear extract 
(E.2.9.2) were treated with 60U DNAseI (Roche) while performing the immunoprecipitation 
procedure as mentioned above (Figure 17).  
 
Figure 17  Co-immunoprecipitation of Dnmt1, ICBP90, USP from Hela S3 nuclear extracts 
treated with DNAseI 
A.) DNAseI digest (Roche, 10U) of 15µg of Hela genomic DNA and 50µl of Hela S3 nuclear extract (3.0mg/ml) for 
5 hours at 4°C. Samples were proteinaseK digested, ethanol precipitated (E.2.2.2) and subsequently the DNA 
was analyzed on a 1% agarose gel with SYBR Safe staining (Invitrogen). Molecular weight marker (NEB) is 
indicated. B.) POIs were subjected to immunoprecipitation with 300µl of Hela nuclear extract (10mg/ml) (E.2.9.2), 
supplemented with 1x DNAseI reaction buffer and 60U of DNAseI (Roche). 2.0µg of USP7 and ICBP90 antibodies 
(E.1.6) and 50µl slurry proteinG sepharose and 50µl anti Dnmt1 2C1 cross-linked proteinG sepharose were used. 
Prior to immunoprecipitation, extracts were precleared with 50µl slurry proteinG beads supplemented with 2.0µg 
irrelevant IgG control antibody (E.1.6). Input, flowthrough (FT), preclearing beads (pre B), ‘specific’ beads (B), 
molecular weight markers and antibodies used for immuno-detection (E.2.3.3) are indicated. * denotes modulation 
of the immunoblot signal to a stronger contrast. 
 
Although the better control experiment would have been the DNAseI digest of the MNase 
released nuclear extract, several conclusions can be drawn. First, all three proteins seem to 
RESULTS 
46 
interact with one another, indicating a protein-protein based interaction. Especially the Dnmt1 
and USP7 IP do not differ from the results seen for the MNase released extract (Figure 16). 
Second, ICBP90 is well precipitated but only little amounts of Dnmt1 and USP7 are co-
precipitated. Thus, besides a protein-protein interaction, the greater part of a possible 
trimeric complex might exist in the context of chromatin. 
 
C.1.5 Dnmt1, ICBP90 and USP7 interact with one another in vitro 
Direct interactions were tested with co-immunoprecipitation experiments (E.2.12.1) using 
recombinant proteins, either expressed from bacteria or insect cells (E.2.8; E.2.7).  
Dnmt1 was demonstrated to be recruited to hemi-methylated DNA via ICBP90 (Bostick et al. 
2007; Sharif et al. 2007). By deletion studies and yeast-2-hybrid experiments, the TS domain 
of Dnmt1 could be identified as the region in Dnmt1 mediating the interaction with the SRA 
domain of ICBP90 (Achour et al. 2007; Bostick et al. 2007). 
Figure 18  Co-immunoprecipitations of recombinant proteins 
Recombinant proteins were expressed in bacteria or Sf21 insect cells as described (E.2.8; E.2.7). 50µl slurry 
proteinG beads coupled with the specific antibodies (E.1.6) were incubated with 2.5µg of bait protein in 200µl IP 
buffer (50mM Tris ph 7.5, 150mM NaCl, 1mM EDTA, 0.05%NP-40) for 2h at 4°C on a rotating device. After 
washing, 2.5µg of prey protein was added and further incubated for 2 hours. Beads were washed and 
resuspended in 50µl HU buffer. Samples were subjected to SDS-PAGE and Western Blot analysis following 
immuno-detection with the indicated antibodies. Molecular weight marker, input, preclearing beads (pre B) and 
specific beads (B) are indicated. * denotes modulation of the immunoblot signal to a stronger contrast. 
 
As shown in Figure 18, the in vitro interaction of Dnmt1 and the TS domain with ICBP90 and 
vice versa can be confirmed. In addition, Dnmt1, its TS domain and ICBP90 also interact with 
USP7. These results argue against a sole trimeric complex since Dnmt1 interacts with its TS 
domain with both ICBP90 and USP7. It rather suggests the existence of three different dimer 
complexes namely Dnmt1/ICBP90, Dnmt1/UP7 and ICBP90/USP7.  
For reasons of curiosity, the co-immunoprecipitations of ICBP90 and USP7 were also done 
for the de novo methyltransferases Dnmt3a and Dnmt3b2. At least under the in vitro 
conditions tested, they both interact with ICBP90 and USP7. 
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In order to further map the interaction surface of USP7, USP7 domains (roughly 200-300aa 
in length, E.2.8.4) fused to GST were expressed in E. coli and bound to gluthatione 
sepharose (GE Healthcare). GST-USP7 domains or GST were incubated with the 
recombinant proteins of interest (E.2.12.1) and subsequently analyzed with SDS-PAGE and 
Western Blot (Figure 19).  
The results obtained are very conclusive. First, Dnmt1 and its hTS domain interact strongest 
with USP7 domain 3 (aa561-916), whereas ICBP90 interacts with the TRAF domain (aa1-
215) of USP7. Hence, a trimeric complex with USP7 being the interaction ‘platform’ is in 
principle possible. Second, the de novo methyltransferases Dnmt3a and Dnmt3b2 bind to 
USP7 domains 1-3, but clearly, the TRAF domain seems to exert the strongest interaction.  
Furthermore, a similar experiment with the SRA domain of ICBP90 fused to GST was bound 
to glutathione sepharose and pull-down experiments performed as described above (Figure 
19). The interactions of the SRA-domain with Dnmt1 and the TS domain are in line with the 
results obtained (C.1.4, Figure 18) as well as published data (Achour et al. 2007; Bostick et 
al. 2007). In addition, the SRA domain seems to be sufficient for the interaction with USP7 
and the de novo methyltransferases.  
 
Figure 19  Interaction map of USP7 domains and the SRA domain of ICBP90 
GST and USP7-domains fused to GST were purified from E. coli as described (E.2.8.4). GST-SRA expressed in 
Sf21 insect cells was kindly provided by A. Neu. Purification via glutathione sepharose was done as for the GST-
USP7 domains. Recombinant proteins of interest (2.5-3.0µg) were incubated with 2.5µg of glutathione sepharose 
bound bait protein in 200µl IP buffer (50mM Tris ph 7.5, 150mM NaCl, 1mM EDTA, 0.05%NP-40) for 2h at 4°C on 
a rotating device. After washing 3x with IP buffer, beads were resuspended in 50µl HU buffer. Samples were 
subjected to SDS-PAGE and Western Blot analysis following immuno-detection with the indicated antibodies. 
Molecular weight marker, input and GST-beads are indicated.  
 
Taken together, although no other domains had been tested, the TS domain of Dnmt1 and 
the SRA domain of ICBP90 are sufficient for the interaction with the other proteins of interest. 
In contrast, USP7 preferentially binds ICBP90 via its TRAF domain whereas Dnmt1 (and TS 
domain) is bound by domain 3. Accordingly, a trimeric complex with USP7 binding to Dnmt1 
and ICBP90 as well as three different combinations of dimeric complexes are possible. 
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C.1.6 Dnmt1 and histones impair the autoubiquitinylation activity of ICBP90 
ICBP90 and ICBP90∆RING which lacks ubiquitinylation activity, were expressed as C-
terminal His-tagged proteins in E. coli (E.2.8.3). In order to verify the enzymatic activity, in 
vitro auto-ubiquitinylation reactions were performed (Figure 20) (E.2.11.3). Furthermore, the 
effect of Dnmt1, inactive USP7 C223S, histones from Drosophila and hTS added at the onset 
of the reaction was examined. 
ICBP90 and ICBP90∆RING were detected as double bands in Western Blot with both anti-
ICBP90 antibody and anti-His antibody (Figure 20). This is in agreement with the two bands 
visible after the Ni-NTA purification on SDS-PAGE and Coomassie Blue staining (E.2.8.3). 
Considering the C-terminal His-tag, detection with the anti-His antibody suggests an N-
terminal degradation product. ICBP90∆RING shows a weak band running slightly higher in 
SDS-PAGE reflecting ubiquitinylation. As stated in the manual, the E2 conjugating enzyme 
(UbcH5c, Biomol) is also capable of ubiquitinylation of certain target proteins and thus could 
be responsible for the low background detected. 
 
Figure 20  Autoubiquitinylation of ICBP90 
A. ICBP90 activity assay is performed with 500ng ICBP90 or ICBP90∆RING and 10µg ubiquitin (bovine, Sigma) 
for 1h at 37°C (E.2.11.3). Samples were analyzed by Western Blot and immuno-detection with anti-His antibody 
(Dianova). * indicates immuno-signal from His-tagged E1 conjugating enzyme, ubi marks ubiquitin adducts. B. 
ICBP90 activity assay performed as in A but in the presence of 1.0µg of Dnmt1, USP7 C223S, 2.0µg hTS or 
2.0µg histones from drosophila. Immuno-detection was performed with anti-ICBP90 antibody (E.1.6). 
 
Nevertheless, it is evident that ICBP90 exerts autoubiquitinylation activity that is mediated by 
its RING domain. When incubated with histones from Drosophila this activity was completely 
abolished. Dnmt1 and USP7 C223S seemed to impair autoubiquitinylation, whereas hTS did 
not have any effect. Whether these changes in activity were due to sole protein interactions 
and thus conformational changes or sterical hindrance, or whether Dnmt1, USP7 C223S and 
histones represented competing targets for ubiquitinylation remains to be clarified.  
 
C.1.7 ICBP90 ubiquitinylates histone H3 – a substrate for USP7 
In order to detect only ubiquitinylation products, the ICBP90 activity assay was performed in 
the presence of Flag-tagged ubiquitin (Figure 21). As already seen before, Dnmt1 and USP7 
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C223S show a weak, histone octamers a strong reduction of ubiquitinylation of ICBP90. 
Interestingly, the histones by themselves do not impair the auto-ubiquitinylation reaction as 
strong as the octamers. One explanation could be a salt dependent inhibitory effect, since 
recombinant human octamers (stored in a 1M NaCl containing buffer) raise the salt 
concentration in the reaction by 200mM. 
The histone containing reactions were also loaded on a 17% SDS-gel and subjected to 
Western Blotting followed by immuno-detection with antibodies directed against each histone 
(Figure 21, B). As already described, ICBP90, in contrast to NP95, only ubiquitinylates 
histone H3 (Citterio et al. 2004; Karagianni et al. 2008). 
In another ICBP90 activity assay containing histone H3, either no protein, USP7 or the 
inactive site mutant USP7 C223S were added at the onset of the reaction. USP7 was able to 
deubiquitinate histone H3, whereas USP7 C223S or Mock control were not (Figure 21, C).  
To summarize, histone H3 is targeted in vitro by ICBP90 for ubiquitinylation and by USP7 for 
deubiquitination. ICBP90 did not ubiquitinylate the other histones in vitro.  
 
Figure 21  Histone H3 is mono-ubiquitinylated by ICBP90 and deubiquitinated by USP7 
A. ICBP90 activity assay (E.2.11.3) was performed with 500ng ICBP90 or ICBP90∆RING and 100ng Flag-
ubiquitin in the presence of 1.0µg of Dnmt1, USP7 C223S, 2.0µg histone octamer or 2.0µg histones for 2h at 
37°C. Recombinant human histones were expressed in E coli. Histones and octamers were kindly provided by C. 
Huber. Samples were analyzed by Western Blot and immuno-detection with anti-Flag antibody. B. Histone 
reaction from A. subjected to SDS-PAGE on a 17% gel following Western Blot and immuno-detection with histone 
specific antibodies (E.1.6). For comparison, recombinant histones (rec) and sample (s) are shown. C. Reaction as 
for B but in the presence of 10mM DTT, 1.0µg Flag-ubiquitin, 500ng USP7 or USP7 C223S catalytic site mutant 
and 5.0µg histone H3. Molecular weight markers are indicated. * indicates modulation of immuno-blot signal to 
stronger contrast. ++ marks unknown signal. 
RESULTS 
50 
C.1.8 USP7 and Dnmt1 are targeted for ubiquitinylation by ICBP90 
Dnmt1, ICBP90 and USP7 are able to interact with one another in vivo as well as in vitro 
(C.1.4, C.1.5). Besides recruitment to certain loci or the concomitant action of three different 
enzymatic activities in gene regulation, one could also speculate that ICBP90 regulates 
Dnmt1’s and USP7’s specific activity or protein turnover by ubiquitinylation.  
To follow up this idea, ICBP90 activity assays with either no additional protein, Dnmt1 or 
USP7 C223S in the presence or absence of Flag-ubiquitin were performed, following an 
immunoprecipitation with antibodies directed against ICBP90, Dnmt1 and USP7 respectively. 
Preclearing beads and ‘specific’ beads were boiled in Lämmli dye, subjected to SDS-PAGE 
and Western Blotting. Ubiquitinylated species were detected with an anti-Flag antibody and 
subsequently reprobed with protein specific antibodies (Figure 23). 
Figure 22  ICBP90 ubiquitinylates USP7 and Dnmt1 in vitro 
A) ICBP90 activity assay (5x) was performed (E.2.11.3) in the presence of 5.0µg Flag-ubiquitin, 2.5µg Dnmt1 or 
2.5µg USP7 C223S for 3h at 37°C. A control reaction in the absence of Flag-ubiquitin was run in parallel. The 
reactions were filled up to 200µl with IP buffer (50mM Tris pH7,5, 150mM NaCl, 0,1mM EDTA, 0,05% NP40), 
precleared with 20µl proteinG beads for 1h at 4°C, following incubation with 20µl proteinG beads coupled with 
1.0µg of the indicated antibodies for 2 hours. The beads were washed 3x with EX-300 and boiled in 20µl HU 
buffer at 65°C for 10min. Samples were separated on a 6% SDS-PAGE, following Western Blot and immuno-
detection with anti-Flag antibody to screen for ubiquitinylated species. 5% Input and 25% beads were loaded. B) 
The same blots were reprobed with protein specific antibodies as indicated. Molecular weight markers are 
indicated. * marks ubiquitinylated USP7.  
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ICBP90 induced its own ubiquitinylation as seen before (C.1.6). According to the Western 
Blot signal, it seemed as if ICBP90 and its ubiquitinylated species were co-
immunoprecipitated by USP7 C223S and Dnmt1. Nevertheless, USP gives a unique signal 
(*) at roughly 140-150kDa, which is not present in the Input or IP lanes of ICBP90. When 
reprobing the blot with anti-USP7 antibody, no other signals but the signal at 140-150kDa 
appear. This suggests USP7 being mono- possibly to some extent oligo-ubiquitinylated. The 
increase in molecular weight of 10kDa for Flag-ubiquitin cannot be properly displayed in the 
molecular weight region of USP7. In addition, if only a subpopulation is mono- or di-
ubiquitinylated and immuno-detection is performed with a POI specific antibody, the signal of 
the unmodified protein usually covers the much weaker signal of the modified protein. Hence, 
detection is not possible. 
Dnmt1, although extremely well precipitated, does not show any significant signal of correct 
size that could account for a specific ubiquitinylated species. But a ‘smear’ of poly-
ubiquitinylated proteins is clearly enriched in the Dnmt1 immunoprecipitation lane compared 
to Input, although considering different loading. Therefore, it could well be that Dnmt1 was 
poly-ubiquitinylated, however not very efficiently. 
The results presented lead to the conclusion that ICBP90 targets USP7 and probably Dnmt1 
for ubiquitinylation in vitro. The question whether this situation is also relevant in vivo is an 
interesting aspect to follow up. 
 
C.1.9 USP7’s in vitro activity is not influenced by Dnmt1 and ICBP90 
USP7’s activity was tested with an ubiquitin specific cleavage assay on an ubiquitin-like 
substrate fused to GST (GST-Ub52, (Baker and Board 1991)) as essentially established in 
the laboratory of R. D. Everett (Canning et al. 2004) (E.2.11.4). In order examine whether the 
binding of ICBP90 or Dnmt1 to USP7 could affect conformational changes and thus have an 
effect on the activity of USP7 in vitro, USP7 and the model substrate GST-UB52 were 
incubated with increasing amounts of either ICBP90 or Dnmt1 (Figure24). 
Although interactions of Dnmt1 and ICBP90 with USP7 were shown (C.1.5), the binding did 
not impair USP7’s activity on the model substrate GST-Ub52 whereas the activity is inhibited 
by NEM.  
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Figure 23  Dnmt1 and ICBP90 do not influence USP7’s activity in vitro 
A. 5.0ng of USP7 were incubated at 37°C with 1.0µg GST-UB52 linear model substrate for increasing time 
(E.2.11.4). USP7 C223S (inactive mutant) was used as control with the longest time point. Reactions were 
stopped after the indicated time points with the addition of Lämmli dye and boiling at 95°C. B. 5.0ng of USP7 
were incubated with increasing amounts of Dnmt1 (10-800ng) and ICBP90 (3-500ng) for 10min at 37°C. As 
control either no protein or 10mM NEM DUB inhibitor was added. After the addition of 1.0µg GST-ub52, the 
reactions were stopped after 10min. Samples were analyzed by SDS-PAGE (15% gel) and Coomassie Blue 
staining. Molecular weight markers are indicated.  
 
C.1.10 USP7 deubiquitinates ubiquitinylated histones and ICBP90 in vitro 
In Drosophila melanogaster, the essential USP7 protein was found to contribute to epigenetic 
silencing of homeotic genes by Polycomb (PC) and to selectively deubiquitinate histone H2B 
but not H2A (van der Knaap et al. 2005). ICBP90 and its mouse homologue NP95 contain a 
RING finger domain that confers E3 ubiquitin ligase activity which induces their own 
ubiquitinylations (C.1.6). Besides autoubiquitinylation, NP95 ubiquitinylates recombinant 
histones H2A, H2B and H3 in vitro but only histone H3 when precipitated from WCE together 
with NP95 (Citterio et al. 2004). In contrast, ICBP90 was shown to ubiquitinylate only histone 
H3 in vitro (C.1.7) (Karagianni et al. 2008).  
Interestingly, USP7 and ICBP90 form a complex, although they possess antagonistic 
enzymatic activities (C.1.4, C.1.5). In order to investigate the role of human USP7 in histone 
deubiquitination, histones were purified from HEK293 cells by acidic extraction (E.2.3.5) in 
the presence of 10mM NEM – an inhibitor of deubiquitinating enzymes (DUB). Extracted 
histones were subjected to the USP7 specific activity assay (E.2.11.4) with either no enzyme 
(Mock), USP7 or inactive USP7 C223S. Samples were analyzed by Western Blot following 
immuno-detection with histone specific antibodies (E.1.6). 
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Figure 24  USP7 deubiquitinates histones in vitro 
Total histones were purified from HEK293 cell by acidic extraction (E.2.3.5) and 10µg subjected to the USP7 
activity assay (E.2.11.4) with either no USP7, 1.0µg of USP7 or 1.0µg of the inactive USP7 C223S mutant. 
Samples were boiled in Laemmli dye, separated on a 17% SDS-gel and Western Blot was performed. Immuno-
detection was done with the indicated histone specific antibodies. * indicates modulation of the immuno-signal to 
a stronger contrast. + marks an unknown background signal. 
 
Mono-ubiquitinylated H2A and H2B comprise 5-15% and 1% of the total H2A and H2B pool 
respectively (Vissers et al. 2008). Although not clearly stated, mono-ubiquitinylated H3 
seems to be less abundant than mono-ubiquitinylated H2A and H2B. As seen in Figure 24, 
the proportion of mono-ubiquitinylated histones is reflected as described before. In addition, 
USP7, but not USP7 C223S and Mock control, exerts deubiquitination activity towards 
ubiquitinylated histones H2A, H2B and H3. Whether histone H4 is ubiquitinylated in vivo and 
whether it would be a potential target for USP7 cannot be judged due to the weakness of the 
antibody. 
Last, an ICBP90 activity assay was performed (E.2.11.3) in the presence of Flag-ubiquitin 
and 10mM DTT for 2 hours at 37°C. USP7 or USP7 C223S were added in substoichiometric 
amounts compared to ICBP90 either at the onset of the reaction or added after stopping the 
auto-ubiquitinylation reaction with 20mM EDTA. The total reaction was stopped by adding 
Lämmli dye and boiling at 95°C. Samples were analyzed by Western Blot and immuno-
detection with anti-Flag antibody (Figure 25). 
As seen before, ICBP90 possesses autoubiquitinylation activity (C.1.6) that is impaired by 
binding of inactive USP7 C223S even when substoichiometric amounts of USP7 C223S are 
used. Interestingly, USP7 C223S partially prevents the formation of higher oligo- and poly-
ubiquitin chains indicating that the ubiquitin moiety is bound to the catalytic domain and 
protected from further ubiquitinylation. Active USP7 efficiently removes ubiquitin moieties 
from ICBP90 when added at the beginning of the reaction, whereas when added after the 
reaction has been stopped, only the signal corresponding to the mono-ubiquitinylated 
species disappears. This observation suggests that USP7 preferentially removes mono-
ubiquitins which is in agreement with previous data (Canning et al. 2004).  
 
RESULTS 
54 
Figure 25  USP7 prevents ICBP90 from autoubiquitinylation 
ICBP90 activity assay was performed with 250ng ICBP90, 100ng flag-ubiquitin and 100mM DTT for 2h at 37°C 
(E.2.11.3). USP7 or USP7 C223S (5ng and 50ng each) were added either at the onset (white triangle) of the 
reaction or after having stopped the reaction with 20mM EDTA (grey triangle). The reaction was allowed to 
continue for 2h at 37°C. Samples were boiled in Lämmli dye, subjected to SDS-PAGE (6% gel) and Western Blot 
analysis with anti-Flag antibody (M2, Sigma). Molecular weight marker and ubiquitin adducts are indicated. 
 
C.1.11 USP7, Dnmt1, ICBP90 are ubiquitinylated in vivo 
Recombinant ICBP90 and ICBP90 over-expressed in mammalian cells were shown to induce 
their own ubiquitinylation in vitro (Karagianni et al. 2008) (Jenkins et al. 2005). It was 
reported that Dnmt1 was selectively degraded by a proteasomal pathway upon 5-aza-2’-
deoxycytidine treatment (Ghoshal et al. 2005) and inhibition of HDAC1 (Zhou et al. 2008a). 
In order to study the role of USP7 on the in vivo ubiquitinylation levels of Dnmt1 and ICBP90 
upon knockdown and over-expression, the ubiquitin binding protein Dsk2p from S. cerevisiae 
fused to GST (E.2.8.6) (Anindya et al. 2007) was used for the purification of ubiquitinylated 
proteins from WCE. 
All three proteins under investigation are ubiquitinylated in vivo (Figure 26). The specific 
binding of ubiquitinylated proteins to GST-dsk2p was confirmed by reprobing the Western 
Blot with an anti-ubiquitin antibody. Curiously, only a single ubiquitin signal was detected, 
although one would expect a smear to higher molecular weight indicating poly-
ubiquitinylation. Typically, in vivo ubiquitinylation studies are performed with over-expressed 
POIs and tagged-ubiquitin (HA-tag or His tag; (Treier et al. 1994)). This is due to the fact that 
on the one hand good antibodies against ubiquitin do not exist and on the other hand 
ubiquitinylated proteins present a subpopulation. Since ubiquitinylation of endogenous 
proteins was pursued with the dsk2p-system, it might well be that only the most prominent 
ubiquitinylated species, namely mono- or di-ubiquitin, were detectable. 
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Figure 26  Dnmt1, ICBP90, USP7 are ubiquitinylated in vivo 
A. WCE from Hela cells were prepared in 1xPBS+0.3% Triton-X-100 supplemented with 10mM NEM (E.2.6.3). 
50µl of GST or GST-dsk2p (ubiquitin binding protein, (E.2.8.6) were incubated with 5.0mg of WCE in 1.0ml 
MobiCol columns at 4°C overnight. After centrifugation the flowthrough was collected and the beads washed 3x 
times with 500µl lysis buffer and 3x with EX-300+0.05%NP40 with 5min incubation steps in between. Bound 
proteins were eluted together with GST or GST-dsk2p from the glutathione sepharose with 50µl elution buffer 
(50mM Tris pH 8.0, 150mM NaCl, 10mM reduced glutathione) for 1h at 16°C shaking at 1300rpm. Samples were 
analyzed by Western Blot following immuno-detection with antibodies directed against the proteins of interest. ** 
indicate two bands for ICBP90 as seen in vitro (C.1.6) B. Western Blots from A were reprobed (++) with an 
ubiquitin specific antibody (E.1.6). Input, flowthrough (FT), elution (E) and molecular weight markers are indicated.  
 
C.1.12 Effects of USP7 levels on Dnmt1 and ICBP90 in vivo 
ICBP90 ubiquitinylated USP7 and vice versa USP7 was able to deubiquitinate ICBP90 in 
vitro (C.1.8, C.1.10). Dnmt1 was shown to be ubiquitinylated in vivo (see above) and 
represented a target for ubiquitinylation by ICBP90 in vitro, albeit not very efficiently (C.1.8). 
In the following three experiments, the effects of USP7 knockdown and over-expression were 
examined in regard to the following aspects. 
a.) Does USP7 have a regulatory effect on the protein levels of Dnmt1 and ICBP90? 
b.) Are ICBP90 and Dnmt1 targets of USP7 and thus does their ubiquitinylation status 
change upon USP7 knockdown or over-expression (C.1.13)? 
c.) Do levels of ubiquitinylated H2A and H2B change upon USP7 knockdown or over-
expression globally (C.1.12)? 
For USP7 knockdown and over-expression studies, cell lines based on the colorectal 
adenocarcinoma cell line LS174T, carrying plasmids with either shRNA (LS88) or N-myc-
USP7 (LS89) under the control of a tetracycline/doxycycline inducible promoter were kindly 
provided by M. Maurice (E.1.11) (Van De Wetering et al. 2003; Meulmeester et al. 2005; 
Kessler et al. 2007). For doxycycline treatment, cells were grown as described (E.2.6.6) and 
seeded on tissue culture plates with a cell number giving rise to 50-60% confluency on the 
day of harvest. WCE were prepared in the presence of 10mM NEM (E.2.6.3) and used for 
both Western Blot analysis and the purification of ubiquitinylated proteins (C.1.13). From the 
residual pellet histones were purified by the method of acidic extraction (E.2.3.5) and 
analyzed for changes in ubiquitinylation (C.1.14). 
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Figure 27  USP7 knockdown and over-expression upon doxycycline treatment 
LS cell lines (E.1.11) were grown in RPMI1640/Hepes (GIBCO) supplemented with blasticidin (10µg/ml), zeocin 
(200µg/ml; normally 500µg/ml) and TET-FBS (clonetech #631106). Cells were seeded on tissue culture plates 
with a cell number giving rise to 50-60% confluency on the day of harvest. Doxycycline induction was performed 
with the addition of doxycycline to a final concentration of 1µg/ml. Cells were harvested (indicated days post-
induction) and WCE prepared (E.2.6.3) in the presence of 10mM NEM. 30µg of WCE of the cell line LS89 and 
50µg of the cell lines LS174T and LS88 were taken for Western Blotting following immuno-detection with the 
indicated antibodies. 
 
Whereas USP7 was over-expressed up to 4-fold in LS89 cells already after 24 hours of 
induction, endogenous USP7 levels could be reduced to 25% after 3 days of doxycycline 
treatment in the LS88 cell lines (Figure 28).  
The stability of the tumor suppressor p53 is directly controlled through the interaction with 
USP7 and its deubiquitination activity (Li et al. 2002). However, USP7 also indirectly affects 
p53 stability and activity by associating with and deubiquitinating Hdm2 leading to Hdm2 
stabilization (Meulmeester et al. 2005). USP7 ablation results in a phenotype opposite to 
predicted. Rather than decreasing p53 levels associated with increased p53 ubiquitination, 
the absence of USP7 resulted in p53 accumulation accompanied by decreased p53 
ubiquitination. The basis for this phenotype was traced to the increased ubiquitinylation of 
MDM2 (mouse homologue of Hdm2), a negative regulator of p53 levels (Cummins and 
Vogelstein 2004). 
In the knockdown cell line LS88, p53 levels were slightly, in LS89 cells stronger increased 
reflecting the dual regulatory mechanism by Hdm2 and USP7. In contrast, Dnmt1 levels were 
unaffected by changes in USP7. Although the effects were quite low, ICBP90 levels seemed 
to be reduced upon USP7 knockdown owing to possible higher auto-ubiquitinylation and thus 
degradation. ICBP90 was demonstrated to be down-regulated by p53/p21Cip1/WAF1-dependent 
DNA damage checkpoint signals (Arima et al. 2004). In order to exclude a p53/p21 
dependent down-regulation, p21 protein levels should be analyzed. 
Upon doxyclycline treatment, USP7 levels were already up-regulated by a factor of 4 after 24 
hours and then slightly decreasing the following days (LS89). ICBP90 levels were also 
increased which could be a direct effect of deubiquitination by USP7.  
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C.1.13 Effects of USP7 levels on ubiquitinylated Dnmt1 and ICBP90 in vivo  
WCE (3.0mg) derived from LS cell lines treated with doxycycline (C.1.12) were incubated 
with either 50µl ubiquitin binding protein Dsk2p from S. cerevisiae fused to GST or GST 
(E.2.8.6) (Anindya et al. 2007). Ubiquitinylated proteins were eluted as described and 
subjected Western Blotting following immuno-detection with antibodies directed against 
proteins of interest. 
As seen before (C.1.12), USP7 levels were decreased and increased upon doxycycline 
induced knockdown and over-expression. The level of ubiquitinylated USP7 seemed to follow 
this observation leading to the effect that in LS88 cells less ubiquitinylated USP7 was 
present. Curiously, in LS89 cells more ub-USP7 was precipitated although equal amount of 
total USP7 was present. Dnmt1, whose protein level was not affected by alterations in the 
amount of USP7 (Figure 28), did not show any difference in the degree of ubiquitinylation, 
indicating no direct regulation of stability by USP7 in vivo (Figure 29). As discussed above, 
USP7 knockdown led to an increase of p53 but the predicted increase of ubiquitinylated p53 
could not be confirmed (Cummins and Vogelstein 2004). It rather seemed that the amount of 
ubiquitinylated p53 was the same compared to untreated cells, which might be due to the 
fact that USP7 levels were reduced the most to 25% (LS88) compared to total ablation in 
HCT-116 USP7 -/- cells. In contrast, USP7 over-expression not only led to increased p53 
levels but also to increased ubiquitinylated p53. Hdm2 mediated p53 ubiquitinylation and 
USP7 dependent deubiquitination would be balanced on higher p53 protein level. 
Figure 28  Ubiquitinylation status of Dnmt1 and ICBP90 upon USP7 knockdown or 
overexpression 
WCE were prepared in 1xPBS+0.3% Triton-X-100 supplemented with 10mM NEM (E.2.6.3) and incubated with 
50µl of GST or GST-dsk2p (E.2.8.6) (3.0mg WCE) in 1.0ml MobiCol columns at 4°C overnight. Beads were 
washed 3x times with 500µl lysis buffer and 3x with EX-300+0.05%NP40 with 5min incubation steps in-between. 
Bound proteins were eluted together with GST or GST-dsk2p from the glutathione sepharose with 50µl elution 
buffer (50mM Tris pH 8.0, 150mM NaCl, 10mM reduced glutathione) for 1h at 16°C shaking at 1300rpm. Samples 
were analyzed by Western Blot following immuno-detection with antibodies directed against the proteins of 
interest. Antibodies, molecular weight and cell lines are indicated. 
 
ICBP90 as observed to slightly decrease upon USP7 knockdown (Figure 28) showed 
reduced levels of ubiquitinylated ICBP90 although expected the other way round. If ICBP90 
RESULTS 
58 
is deubiquitinated by USP7, a respective over-expression of USP7 should lead to increased 
ICBP90 protein levels and less ubiquitinylated ICBP90. For the latter there is almost no 
difference to Mock control detectable. 
Importantly, it has to be taken into account that the cells were treated with DUB inhibitor 
NEM upon cell harvest and WCE preparation, but that no proteasome inhibitor (like MG132) 
had been added to the culture medium prior to cell harvest. This could have been helpful to 
stabilize ubiquitinylated intermediates and thus to better evaluate such weak effects.  
 
Taken together, neither the Dnmt1 protein level nor the ubiquitinylated Dnmt1 level were 
affected by changes in the amount of USP7 in the cell. ICBP90 protein level showed an up- 
and down-regulation in dependence of increased or decreased levels of USP7. The 
ubiquitinylation status of ICBP90 was altered but not necessarily according to the 
expectation. In order to verify the direct effect of USP7 on the ubiquitinylation status of 
ICBP90, it would be better to work with cells that are transfected with three plasmids, 
carrying for example Flag-tagged ICBP90, HA-tagged ubiquitin and USP7 (WT or active site 
mutant). With the prerequisite of almost complete transfection efficiency, the amount of 
ubiquitinylation could be detected with an anti-HA antibody after Flag-purification. 
 
C.1.14 USP7 levels have no global effect ubiquitinylated H2A and H2B in vivo 
USP7 was capable of removing the ubiquitin moiety from histones H2A, H2B and H3 in vitro. 
In the course of analysis on the effects of knockdown and over-expression of USP7, also 
ubiquitin levels of histones H2A and H2B were under investigation. 
Histones were purified with the method of acidic extraction (E.2.3.5) from 2x107 LS cells 
either treated with doxycycline or untreated. 10µg of histones were subjected to SDS-PAGE 
and Western Blot analysis with histone specific antibodies. 
As shown before (C.1.10), USP7 deubiquitinates H2A and H2B in vitro (Figure 30). Although 
NEM, inhibitor of deubiquitination enzymes, was present in the histone purification 
procedure, no difference in the global ubiquitinylation levels of H2A and H2B upon 
knockdown and over-expression were detectable. Histone H3 could not be included in the 
analysis due to the weak signals of apparent ubiquitinylated H3. 
Ablation of USP7 in Drosophila upon siRNA treatment had only marginal impact on the level 
of uH2B in the total histone pool but strongly reduced the level of H3K27 methylation 
(unpublished data; (van der Knaap et al. 2005)). This indicates a probable redundancy of 
H2B deubiquitination by more deubiquitinating enzymes and possibly strong involvement of 
USP7 in PRC mediated silencing.  
If USP7 dependent histone deubiquitination plays a role in gene regulation together with 
ICBP90 and Dnmt1, the analysis of changes in histone modifications and DNA methylation 
patterns at specific loci should be in focus. 
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Figure 29  Ubiquitinylation status of H2A and H2B upon USP kd or over-expression 
LS cell lines (E.1.11) were grown for subsequent doxycycline treatment as described (E.2.6.6). Doxycycline 
induction was performed with the addition of doxycycline to a final concentration of 1.0µg/ml. Cells from the LS88 
cell line were harvested 3 days post-induction and cells from LS89 cell line 24 hours post-induction. WCE 
preparation and acidic extraction of histones (E.2.3.5) were performed in the presence of 10mM NEM. Non-
induced cells were treated in parallel. A. Western Blot of extracted histones (10µg load) with anti-H2A antibody. 
Samples from non-induced cells are loaded next to samples from doxycycline induced cells. Deubiquitination 
reaction of histones from HEK293 cells by USP7 (C.1.10) serves as a control for the detection of ubiquitinylated 
H2A. B. same as for A but immuno-detection with an anti-H2B antibody. Coomassie Blue staining of extracted 
histones serves as loading control. 
 
C.1.15 CHIP analysis of Dnmt1, ICBP90 and USP7 
Dnmt1, ICBP90 and USP7 exert enzymatic activities that can affect chromatin composition 
and structure and thus accessibility. DNA methylation and histone ubiquitinylation could also 
serve as binding platforms for other modulating factors to be recruited (Vissers et al. 2008). 
In search for genomic regions that are targeted by Dnmt1 or ICBP90, three genes were 
finally chosen for a more detailed analysis with chromatin immunoprecipitation (CHIP) 
(E.2.16.5, see below).  
Dnmt1 was found to interact with Polycomb group protein (PcG) EZH2 (enhancer of zeste 
homolog 2) and localized to several target promoters in dependency of EZH2 (Viré et al. 
2005). In addition for the identified target gene WNT1 (wingless-type MMTV integration site 
family, member 1), it was shown that the CpG methylation status was controlled by EZH2 
through direct recruitment of Dnmt1. 
In another publication (Wu et al. 2008), NSPc1, a component of the PRC1 complex, 
promotes H2A ubiquitinylation and cooperates with Dnmt1 in HoxA7 gene silencing. 
Interestingly, both are directed by EZH2 (PRC2) but NSPc1-mediated H2A ubiquitination and 
Dnmt1 dependent DNA methylation are interdependent in gene silencing. 
In the group of Dr. R. Kappler, the CpG island of the IGFBP3 gene promoter was methylated 
as seen with methylation specific PCR (MSP) and was found to be partially demethylated 
upon ICBP90 knockdown (personal communication). 
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Figure 30  Gene targets for chromatin immunoprecipitation 
A.) Genomic regions of target genes chosen for CHIP analysis are displayed. CpG islands are depicted in grey 
shading. Locations of qPCR primers (E.2.16.5) are depicted with black arrows. Their names and amplicon sizes 
as well as the genomic region are given. ‘//’ denotes partial presentation of the gene. B.) Chromatin 
immunoprecipitations were performed with 2.0x107 HCT-116 cells, formaldehyde cross-linked for 20min 
(E.2.15.3). Cross-linked chromatin was solubilized and DNA fragments with an average size of 500-1000bp 
generated through sonication (E.2.15.4). Chromatin was subjected to immunoprecipitation with the antibodies of 
interest (E.1.6), the precipitated DNA subsequently purified (E.2.15.6) and qPCR analysis performed (E.2.16.1). A 
detailed description of the evaluation is given (E.2.16.6). The average of three independent CHIP experiments for 
Dnmt1, ICBP90 and USP7 and the average of two CHIP experiments for RNAPII are shown. Standard deviations, 
target genes of interest (Figure 30) and antibodies used for CHIP (E.2.15.2) are indicated. The enrichment of 
specific IP versus IgG background is plotted against the genes under investigation. Note that the RNAPII 
enrichment at the POLR2A locus is displayed as 1/5th. 
 
The POLR2A gene is highly expressed in proliferating cells and was therefore chosen as a 
reference for silenced genes. 
In Figure 30, the target genes that were chosen for CHIP analysis are displayed. CpG 
islands as determined with the UCSC genome browser, locations of qPCR primers (E.2.16.5) 
and the chromosomal regions are indicated. 
Dnmt1 and ICBP90 are associated with the three repressed genes WNT1, IGFBP3 and 
HoxA7 (Figure 30) whereas RNAPII is absent. This is in agreement with the observation that 
RNAPII is found at transcriptionally active loci as seen for the POLR2A gene promoter. Albeit 
different functions, ICBP90 was described as a chromatin associated factor responsible for 
Dnmt1 recruitment (Bostick et al. 2007; Sharif et al. 2007). Hence, the association of ICBP90 
together with Dnmt1 at loci that are silenced or maintained in a repressed state is in 
accordance with the CHIP data obtained. 
In contrast to Dnmt1 and ICBP90, USP7 that was neither described as a DNA binding factor 
nor harboring a DNA binding domain, is not associated with the WNT1 promoter but found 
enriched at the IGFBP3 and HoxA7 genes together with Dnmt1 and ICBP90. Interestingly, 
besides RNAPII, USP7 and Dnmt1 are present at the POLR2A gene promoter, contradicting 
the general belief of DNA methylation solely associated with repression and silencing. 
The CHIP data suggest the existence of three different complexes located at different loci:  
at the WNT1 gene, a Dnmt1/ ICBP90 dimer, at the IGFBP3 and HoxA7 loci a trimer complex 
of Dnmt1/ ICBP90 and USP7 and last a Dnmt1/ USP7 dimer at the POLR2A gene can be 
observed. 
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On the first glance, the possible function of these complexes is not conclusive and will need 
further investigation (see discussion). 
 
C.2 Characterization of Dnmt3b complexes 
Besides Dnmt1 which showed an elution profile between 440 and 230 kDa, placenta nuclear 
extracts (E.2.9.1) were also screened for larger Dnmt3b complexes on size exclusion 
chromatography. 
Different antibodies directed against Dnmt3b recognized proteins of different size in Western 
Blot analysis. The first immunoblot was performed with a mouse monoclonal anti-Dnmt3b 
antibody (abcam, ab13603; E.1.6) that recognized a signal of approximately 65kDa 
compared to the expected signal of 95-100kDA. Since Dnmt3b splice variants cannot 
account for the observed difference in size and placenta nuclear extracts were more prone to 
protein degradation than nuclear extracts from Hela cells (data not shown), the detected 
Dnmt3b elution profile was verified with the DNA methyltransferase specific activity assay 
(E.2.11.1) with nm and hm oligonucleotides as substrate. 
As seen in Figure 31, the activity profile of the fractions with nm DNA corresponds to the 
Western Blot signals detected for Dnmt3b (ab 13604). A higher activity can be observed in 
the elution fractions of Dnmt1, reflecting Dnmt1’s preference for hm DNA whereas it is not 
present in the fractions that only contain Dnmt3b.  
Another commercial antibody (ab 2851) and the rat monoclonal antibody D3b2-2C1 (E.1.6) 
directed against Dnmt3b detect signals of 50 kDa and 120 kDA respectively. Interestingly, 
the signals reflect the elution profile with a 1MDa Dnmt3b complex but not for mid-weight 
complexes (440-230 kDa). This discrepancy could be explained with a possible cross 
reactivity of the mouse monoclonal anti-Dnmt3b antibody (abcam, ab13603) with Dnmt1 
degradation products that are not recognized by the rat monoclonal anti D3b2-2C1 antibody 
and the anti-Dnmt3b antibody (ab2851; E.1.6). 
Accordingly, higher molecular weight complexes of Dnmt3b seem to exist in extracts of 
human placenta. So far, the establishment of Dnmt3b specific antibodies capable of 
immunoprecipitation has failed (data not shown). Thus, a straight-forward approach for 
identifying Dnmt3b protein complexes and new interaction partners has moved beyond 
reach. 
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Figure 31  Dnmt3b and Dnmt1 from placenta extracts on SEC 
Placenta nuclear extract (500µl, 18,5mg/ml; E.2.9.1) was separated on a Superose6 gelfiltration column (GE 
Healthcare) in 20mM Tris pH 8.0, 150mM NaCl, 1mM MgCl2, 10% glycerol, 1mM DTT. 500µl fractions were 
collected and 30µl of each fraction was subjected to SDS-PAGE and Western Blot analysis. Immunodetection 
was performed with the following antibodies (E.1.6): Dnmt1 (2G3, rat monoclonal), Dnmt3b (D3B2-2C1, rat 
monoclonal), Dnm3b1 (mouse monoclonal, ab13604), Dnmt3b (rabbit polyclonal, ab2851). Molecular weight 
marker, fractions and gelfiltration standards are indicated. DNA methyltransferase assay was performed with 10µl 
of each fraction for 1 hour at 37°C as described (E.2.11.1) in the presence of 1µM oligonucleotide (either non-
methylated (nm) or hemi-methylated (hm)). 
 
C.3 Dnmt3a/b2 dependent de novo DNA methylation in the context 
of chromatin 
Recently, DNA methylation activities towards DNA reconstituted into nucleosomes have 
been examined. However the results from the literature were rather contradictive (see 
introduction, A.3.8). Therefore, we sought to examine in detail the conditions of DNA and 
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nucleosome binding, followed by single molecule analysis of DNA methylation of 
nucleosomal matrices. 
 
C.3.1 Minimal DNA binding length of Dnmt3a and Dnmt3b2 in vitro 
Prior to experiments regarding the methylation of mono-nucleosomes with different linker 
lengths, basic characterization on DNA binding properties was performed. Despite the 
capability of Dnmt3a and Dnmt3b2 to methylate oligonucleotides in vitro (20-30nt, E.2.11.1), 
the minimal DNA length for proper binding was determined. Dnmt3a (N-His, Sf21 cells) and 
Dnmt3b2 (C-His, E. coli) were purified (E.2.7.3; E.2.8.2) and increasing amounts of protein 
were incubated with an Ultra low range DNA marker (Fermentas). Reactions were loaded on 
a 12% PAA gel and stained with ethidium bromide (Figure 32). Both Dnmt3a and Dnmt3b2 
bind first to the longest DNA fragments, although the DNA amount (weight) per lane is almost 
the same (exception: 50bp; 2.5x as much), suggesting a cooperative binding mechanism 
resulting in binding preferentially to longer DNA. In accordance, the C-terminal domain of 
mouse Dnmt3a oligomerized on DNA to form a nucleoprotein filament (Jia et al. 2007; 
Jurkowska et al. 2008). According to the EMSA analysis, only DNA fragments >35bp are 
stably bound (Figure 32). In gelfiltration experiments with the C-terminal domain of mDnmt3a 
incubated with DNA fragments of different size (12, 20, 30, 45bp), Dnmt3a C-terminal 
domains partially shifted with DNA >20bp to higher molecular weight corresponding to 2, 3-4, 
and 5 five proteins bound respectively (Jia et al. 2007). EMSA studies performed with 
fluorescently labeled annealed oligonucleotides (15, 30, 45, 60bp) revealed weak association 
with DNA fragments of 45bp and 60bp of size, whereas DNA fragments 15bp and 30bp long 
were not shifted at all (data not shown). 
 Figure 32  Minimal DNA length required for binding of Dnmt3a and Dnmt3b2 
Dnmt3a (N-His, Sf21 cells) and Dnmt3b2 (C-His E. coli) were purified as described (E.2.7.3; E.2.8.2), incubated 
for 15min at 26°C with 125ng of an Ultra low ranger DNA marker (Fermentas) in binding buffer (20mM Tris pH 
7.6, 30mM KCl, 5mM EDTA, 1mM DTT, 5µM SAM, 20% glycerol) and loaded on a 12% PAA gel in 0.4x TBE. The 
gel was subsequently stained with ethidium bromide. Dnmt3a titration was performed with 75ng – 2.4µg, Dnmt3b2 
titration with 62.5ng – 4.0µg respectively. DNA molecular weight marker is indicated. * indicates minimal DNA 
length that is required for binding. 
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As a summary, although DNA fragments of 20bp and 30bp are methylated in vitro (E.2.11.1), 
stable protein-DNA interactions are observed with DNA fragments >35bp with EMSA. A co-
operative binding effect of the de novo methyltransferases Dnmt3a and Dnmt3b2 is reflected 
by DNA binding preferences for longer DNA fragments 
 
C.3.2 Dnmt3a and Dnmt3b2 show binding mobility towards naked DNA in 
vitro 
In order to see whether Dnmt3a and Dnmt3b2 stay stably bound to DNA in vitro and thus 
reflect a DNA/protein filament (Jurkowska et al. 2008), proteins were incubated with a 342bp 
DNA fragment (20ng; MF79/80) for 15min at 26°C to allow for complex formation. Linearized 
competitor DNA was added, mixed, placed on ice and immediately loaded on a 12% PAA 
gel. Dnmt3a and Dnmt3b2 almost completely shift the 342bp DNA fragment with raising 
amounts of protein (Figure 33, lane 2,3; A and B) resulting in DNA/protein complexes at the 
top of the gel. When adding increasing amounts of linearized competitor DNA, complex 
formation with the other DNA strand occurs, releasing the shorter DNA fragment. In a time 
course experiment with the addition of competitor DNA in the range of 3-20sec and 
immediate loading on a ‘running’ gel led to the same observation (data not shown). 
Accordingly, DNA binding in vitro of both Dnmt3a and Dnmt3b2 is a highly dynamic process. 
Figure 33  Binding mobility of Dnmt3a/b2 towards DNA 
Dnmt3a (N-His, Sf21 cells) and Dnmt3b2 (C-His E. coli) were purified as described (E.2.7.3; E.2.8.2), incubated 
for 15 min at 26°C with 20ng of MF79/80 DNA fragment (342bp) in binding buffer (20mM Tris pH 7.6, 30mM KCl, 
5mM EDTA, 1mM DTT, 5µM SAM, 20% glycerol). Competitor DNA (linearized DNA 2890bp) was added in 
increasing amounts (5-80ng) following incubation for 5min. The reaction mix was loaded on a 12% PAA gel in 
0.4x TBE. The gel was subsequently stained with ethidium bromide. Lane (1); DNA (342bp) and competitor DNA 
are loaded A. Dnmt3a titration with two concentrations of Dnmt3a (lane 2 an 3). With the highest concentration, 
the competition reaction with competitor DNA is performed (lane 4-9). B. same as for A but with Dnmt3b2.  
 
C.3.3 In vitro binding of mono-nucleosomes by Dnmt3a and Dnmt3b2  
DNA templates with the 601 nucleosome positioning sequence ((Thåström et al. 2004a); 
referred to as WID, 147bp) flanked either on one side (asymmetric) or on both sides 
(symmetric) with DNA linkers of different size were PCR amplified (E.2.10.4) and partially 
assembled with Drosophila histones by salt dialysis (E.2.10.2). Figure 34 displays the 
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different partially assembled mono-nucleosomes that were used for binding studies with 
Dnmt3a and Dnmt3b2.  
It is important to note that for comparative analysis the amount of DNA and nucleosomes 
loaded were adjusted to ethidium bromide staining. Of course, ethidium bromide staining 
depends on intercalation into dsDNA that is certainly impaired in DNA wrapped around a 
histone octamer. In addition, the number of molecules differs from DNA/nucleosomal 
template to another. Nevertheless, qualitative differences on DNA/protein or 
nucleosome/protein associations can be seen and thus conclusions on the binding properties 
towards DNA and nucleosomes of Dnmt3a and Dnmt3b2 can be drawn (Figure 35).  
In Figure 35, partially assembled symmetric and asymmetric mono-nucleosomes with 
different lengths of linker DNA were incubated with rising amounts of Dnmt3a and Dnmt3b2 
and subsequently loaded on a 5% PAA gel. Dnmt3a preferentially bound to the 77WID77 
mono-nucleosome over symmetric nucleosomes with shorter linker DNA as well as free DNA 
(Figure 35 A, lanes 3-5). Interestingly, asymmetric nucleosomes and free DNA revealed 
equal binding by Dnmt3a (Figure 35 B, lanes 3-5). In another experimental setup, increasing 
amounts of Dnmt3a were incubated with a mixture of different nucleosomal species, namely 
77WID77, 77WID and WID, and DNA (210bp) (Figure 35 C, lanes 3-5). Again, Dnmt3a first 
bound to nucleosomes 77WID77 followed by DNA and the 77WID nucleosome.  
Figure 34  Symmetric and asymmetric mono-nucleosomes with different linker length 
DNA fragments of different length with the 601 nucleosome positioning sequence ((Thåström et al. 2004a); 
referred to as WID, 147bp) situated at different positions were PCR amplified as described (E.2.10.4) and partially 
assembled with Drosophila histones by salt dialysis (E.2.10.2). Assembled nucleosomes were analyzed on a 5% 
PAA gel in 0.4x TBE following staining with ethidium bromide. DNA linker lengths are indicated. M indicates DNA 
marker. Lane 9 asymmetric mono-nucleosomes and lane 10 symmetric mono-nucleosomes as a mixture with the 
WID mono-nucleosome. 
 
Dnmt3b2 behaved differently in a way that preferentially DNA and nucleosomes with longer 
DNA overhangs were favored over nucleosomes with short linker DNA (Figure 35 A, lanes 7-
9; B lanes 7-9) indicating that DNA is the first and DNA linker length the second determinant 
of nucleosome binding. When Dnmt3b2 is incubated with the mixture of different 
nucleosomal templates and DNA (Figure 35 C, lanes 7-9), Dnmt3b2 bound to 77WID77 
equally well as to free DNA followed by 77WID. As seen before, DNA seems to be the 
preferred substrate of binding and not the nucleosome itself.  
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Figure 35  Binding behavior of Dnmt3a and Dnmt3b2 to mono-nucleosomes with different 
linker length 
DNA fragments of different length with the 601 nucleosome positioning sequence ((Thåström et al. 2004a); 
referred to as WID, 147bp) situated at different positions were PCR amplified as described (E.2.10.4) and partially 
assembled with Drosophila histones by salt dialysis (E.2.10.2). Indicated assembled nucleosomes were incubated 
with Dnmt3a (N-His, Sf21 cells, 0.6-2.4µg, lanes 3-5) or Dnmt3b2 (C-His E. coli, 1.0-4.0µg, lanes 7-9) in binding 
buffer (20mM Tris pH 7.6, 30mM KCl, 5mM EDTA, 1mM DTT, 5µM SAM, 20% glycerol) for 15 min at 26°C. The 
reaction was stopped on ice and loaded immediately on a 5% PAA gel in 0.4x TBE. The gel was subsequently 
stained with ethidium bromide. A. Dnmt3a/b2 are incubated with symmetric nucleosomes of different linker length. 
B. same as in A but with asymmetric nucleosomes. C. same as in A but with mixture of DNA and symmetric and 
asymmetric nucleosomes. * marks free DNA; M indicates DNA molecular weight marker. 
 
Therefore, generally Dnmt3a binds DNA and mono-nucleosomes comparably well, whereas 
Dnmt3b2 shows higher affinity to free/accessible DNA than to the nucleosomal core. 
Although not shown, in individual reactions both Dnmt3a and Dnmt3b2 were able to bind to 
the 147bp mono-nucleosome comparable to mono-nucleosomes with linker DNA, indicating 
that it can serve as substrate. 
 
C.3.4 Mono-nucleosomes are not disrupted by Dnmt3a and Dnmt3b2 in vitro 
Dnmt3a and Dnmt3b2 associate with nucleosomal templates in vitro (C.3.3) albeit probably 
by different means. In order to test whether binding of Dnmt3a/b2 disrupts the nucleosome, 
nucleosome binding was competed with linear DNA (Figure 36). 
 
Figure 36  Dnmt3a/b2 do not disrupt mono-
nucleosomes upon binding 
Dnmt3a (N-His, Sf21 cells) and Dnmt3b2 (C-His E. coli) 
were purified as described (E.2.7.3; E.2.8.2), incubated for 
15 min at 26°C with 80ng of the 40WID fragment (187bp, 
E.2.10.4) fully assembled with drosophila histones by the 
method of salt dialysis in binding buffer (20mM Tris pH 7.6, 
30mM KCl, 5mM EDTA, 1mM DTT, 5µM SAM, 20% 
glycerol). Competitor DNA (linearized DNA 2890bp) was 
added in increasing amounts (50-200ng) following 
incubation for 5min. The reaction mix was loaded on a 5% 
PAA gel in 0.4x TBE. The gel was subsequently stained 
with ethidium bromide. M indicates DNA marker. 
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Without competitor DNA, the nucleosome is well bound by Dnmt3a and Dnmt3b2 and shifted 
to the top of the PAA gel (Figure 36, lane 2 and 7). Upon addition of increasing amounts of 
competitor DNA, both Dnmt3a and Dnmt3b2 dissociated from the 40WID nucleosome. The 
released mono-nucleosomes (lane 4-6 and lane 8-10) migrated in the gel as the unbound 
reference 40WID nucleosome (lane1) indicating that no loss of histones or changes in the 
position of the nucleosome occurred. 
 
C.3.5 In vitro methylation of DNA and mono-nucleosomes by Dnmt3a and 
Dnmt3b2  
In vitro methylation of nucleosomes by the maintenance and de novo DNA 
methyltransferases have already been under investigation, although the results were rather 
inconsistent (Robertson et al. 2004; Gowher et al. 2005b) (Takeshima et al. 2006).  
Two DNA templates (MF79/80 342bp; MF124/125 147bp, (E.2.13.1) harboring an altered 
601 nucleosome positioning sequence were amplified by PCR (pGA-BN601 Mr Gene; E.1.8) 
and assembled into nucleosomes (E.2.10.2) (Figure 37, A). In vitro DNA methyltransferase 
assays (E.2.11.1) with 100nM of Dnmt3a and Dnmt3b2, 480nM SAM (1.5µCi) and 480nM 
CpG sites of either the free DNA or the nucleosomal DNA were performed. ‘Naked’ DNA and 
accessible DNA in the linker region of mono-nucleosomes were equally well methylated, 
whereas the 147bp nucleosome was almost not methylated at all (Figure 37, B). Although 
the overall methylation efficiency of Dnmt3a and Dnmt3b2 differed (different protein 
preparations), methylation of the nucleosome (MF124/125 nuc) was decreased 35-fold and 
27-fold compared to ‘naked’ DNA for Dnmt3a and Dnmt3b2 respectively (as determined from 
the 40min timepoint). 
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Figure 37  Radioactive DNA methylation assay with DNA and mono-nucleosomes 
A. DNA fragments and mono-nucleosomes used for Dnmt specific radioactive methylation assay. The MF79/80 
(342bp) and MF124/125 (147bp) DNA fragments that bear a modified 601 nucleosome positioning sequence 
(from pGA BN601 Mr Gene) were PCR amplified as described (E.2.13.1) and fully assembled with Drosophila 
histones by salt dialysis (E.2.10.2). Analysis on a 5% PAA gel in 0.4x TBE with ethidium bromide staining. 
Molecular weight marker is indicated B. Radioactive DNA methylation assay was performed (E.2.11.1) in the 
presence of 480nM SAM (1.5µCi), 100nM N-His Dnmt3a (Sf21 cells) and C-His Dnmt3b2 (E. coli), 480nM CpG 
sites of the indicated templates. At the given time points samples were withdrawn, stopped and treated as 
described (E.2.11.1). Radioactivity (cpm) was determined in a scintillation counter and plotted against the 
individual samples for each time point.  
 
C.3.6 Bisulfite analysis of in vitro methylated DNA and mono-nucleosomes 
In order to study in detail in vitro DNA methylation of Dnmt3a and Dnmt3b2 towards mono-
nucleosomes, the PCR-fragment MF79/80 (342bp, 27 CpG sites, amplified on pGA BN601 
Mr Gene E.1.8) was reconstituted with Drosophila histones by the method of salt dialysis 
(E.2.10.2) (Figure 38, A). The assumed position of the nucleosome was verified by restriction 
enzyme digesting analysis (Figure 38, B).  
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Figure 38  Reconstitution and mapping of the nucleosome binding site 
A. The MF79/80 (342bp) DNA fragment that bears a modified 601 nucleosome positioning sequence (from pGA 
BN601 Mr Gene) was PCR amplified as described (E.2.13.1) and assembled in different ratios with Drosophila 
histones by salt dialysis (E.2.10.2) in the presence of competitor DNA (pCpGL basic, 250ng). Analysis on a 5% 
PAA gel in 0.4x TBE with ethidium bromide staining. Molecular weight marker is indicated. Arrow denotes 
nucleosomal template used for non-radioactive in vitro DNA methylation assay B. Although the high-affinity 601 
nucleosome positioning sequence is present, its location was mapped. Partially assembled nucleosomes were 
digested with the indicated restriction enzymes (RE) and either directly (I.), or after proteinaseK digest and 
ethanol precipitation (Xref) (II.) loaded onto a 5% PAA gel. StyI cuts within the proposed nucleosomal region. In I. 
the 342bp DNA fragment is cut and shifted to smaller sizes (* denotes the theoretic position). After proteinaseK 
treatment, the DNA fragment (*) that had been protected from RE digest appears. Smaller fragments are no 
longer visible due to inefficient ethanol precipitation.  
 
Non-radioactive DNA methylation reactions with Dnmt3a, Dnamt3b2 and the bacterial 
methyltransferase M.SssI as control were performed as described (E.2.11.1) and methylated 
DNA subjected to bisulfite treatment (E.2.13.3). Bisulfite converted DNA was PCR amplified 
using two different primer pairs for the sense and the anti-sense strand respectively. PCR 
products were cloned into pGEM-T-EASY vector (Promega) and transformed into chemically 
competent Xl1 Blue E. coli cells following Blue/White selection on Bluo-Gal/ampicillin LB- 
plates. DNA was isolated and sent for sequencing. Analysis of bisulfite converted DNA was 
done with BiQ ANALYZER software (http://biq-analyzer.bioinf.mpi-inf.mpg.de/) that had been 
provided by C. Bock (Bock et al. 2005).  
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Figure 39  Bisulfite analysis of nucleosomal methylation by M.SssI, Dnmt3a and Dnmt3b2 
The DNA methylation reaction with Dnmt3a/b was carried out in a reaction volume of 40µl in DNA 
methyltransferase buffer (20mM Hepes, pH 7.6, 1mM EDTA, 1mM DTT). Dnmt3a and Dnmt3b2 were used at a 
concentration of 600nM and 200nM, DNA or nuclesomal DNA (MF79/80 on pGA BN601 Mr Gene, 27 CpG sites) 
between 12.5 and 20nM CpG sites, BSA at 0.2µg/µl and SAM (Sigma A7007, 10mM) at 250µM. M.SssI was used 
as control in a separate reaction with 1x NEB buffer 2 and 4U M.SssI. The reactions were mixed well and 
incubated for 1 hour at 37°C. Another 250µM SAM were added following incubation for 1-1,5 hours. This step was 
repeated twice. The reactions were heat-inactivated at 65°C for 20min. and 40µl of the reaction were directly 
subjected to bisulfite conversion (E.2.13.3). After bisulfite conversiton, the (+) strand and the (-) strand were PCR 
amplified with the primer pairs MF89/90 and MF112/113 respectively. PCR products were cloned into the pGEM-
T-EASY vector (Promega) following transformation into Xl1Blue E.coli cells. Isolated DNA from positive clones 
selected by Blue/White screening were sent for sequencing. Evaluation of the data was described elsewhere 
(E.2.13.6). M.SssI DNA(+) 22clones, M.SssI DNA(-) 13clones, M.SssI nuc (+) 19clones, M.SssI nuc (-) 11clones, 
D3b2 DNA (+) 31clones , D3b2 DNA (-) 37 clones, D3b2 25nuc (+) 25clones, D3b2nuc (-) 22clones, D3A DNA (+) 
23clones, D3A nuc (+) 22clones. Black bars denote nucleosomal, light grey bars represent DNA templates. 
 
The bacterial methyltransferase M.SssI (NEB) efficiently methylated both the upper and 
lower DNA strands whereas the DNA protected by the nucleosome was almost not 
accessible for methylation (Figure 39). Dnmt3b2 methylated the sense and anti-sense DNA 
strands, but to a lower extent compared to M.SssI and with an apparent sequence specificity, 
since some CpG sites were more frequently methylated than others. Analysis of the (+) and 
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the (-) strands was intended to see whether the DNA strand facing outwards of the 
nucleosome could be accessible for DNA methylation. As seen for M.SssI, Dnmt3b2 was 
also not able to methylate the DNA within the nucleosomal region except for some CpG sites 
situated at the entry/exit sites of the nucleosome indicating that nucleosomes represent a 
barrier for de novo methylation and the need for other mechanisms such as moving of 
histones or disassembly of histones to allow for DNA methylation.  
The reaction efficiency of Dnmt3a was extremely low, for both the naked DNA and the 
nucleosomal template, although the picture of methylation, as for Dnmt3b2 and in 
comparison to the radioactive data (C.3.5), can be envisioned. After having recapitulated 
enzymatic prerequisites of Dnmt3a, it seemed that the amount of DNA/nucleosmal template 
with 20nM CpG sites was extremely below the KM value of 250nM-2500 CpG sites as 
reported in the literature (Aoki et al. 2001; Gowher and Jeltsch 2001; Yokochi and Robertson 
2002; Suetake et al. 2003). Latest results by C. Neuhäuser showed an increase of DNA 
methylation by Dnmt3a in a reaction setup with 600nM CpG sites to meet the KM value 
requirements. 
As a summary, Dnmt3a and Dnmt3b2 are able to methylate DNA and linker DNA, but hardly 
within the nucleosome suggesting the need for enzymatic activities like chromatin remodeling 
enzymes moving the histone octamer and thus providing accessibility. 
 
C.4 Dnmt3L is associated with histones 
Dnmt3L functions in vivo and in vitro as a stimulatory factor for de novo methylation (Chedin 
et al. 2002; Suetake et al. 2004; Gowher et al. 2005a). The interaction with Dnmt3a is of 
particular interest as the crystal structure of a tetrameric complex was solved (Jia et al. 2007) 
and Dnmt3L and Dnmt3a knockout mice showed the same methylation defects of maternally 
and paternally imprinted genes (Bourc'his et al. 2001; Hata et al. 2002). 
The co-purification of Dnmt3L with Dnmt3a2, Dnmt3b and histones and the interaction with 
non-methylated H3K4 tails (Ooi et al. 2007) raises the question which effects Dnmt3L exerts 
on the methylation of nucleosomes by the de novo methyltransferases. 
 
C.4.1 Dnmt3L is associated with histones in vivo 
hDnmt3L was purified from Sf21 cells via its C-terminal Flag-tag (E.2.7.6). Interestingly, large 
amounts of DNA were co-purified (Figure 40, A). Further analysis showed the presence of 
histones (Figure 40, B) confirming the observation that Dnmt3L co-purified histones from ES 
cells (besides Dnmt3a2 and Dnmt3b) (Ooi et al. 2007) through the specific interaction of non-
methylated lysine 4 on histone H3. The DNA fragment size of 500-1000bp reflects the 
sonication procedure during protein purification rather than putative binding to higher order 
chromatin structures. Applying a second purification step with an anion exchange matrix (Q-
FF, GE Healthcare), histones and DNA could be well separated from Dnmt3L (Figure 40). 
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Figure 40  hDnmt3L purification from 
Sf21 insect cells 
A. Protein samples after Flag and Q FF 
purification (E.2.7.6) (50µg each) were treated 
with proteinaseK and DNA was phenol 
chloroform extracted followed by ethanol 
precipitation. Analysis on a 1% agarose gel and 
ethidium bromide staining. B. SDS-Page analysis 
of the hDnmt3L two-step purification with 1.) 
Flag-tag and 2.) Q-FF column (E.2.7.6). 
Recombinant human histones (kindly provided by 
C. Huber) were loaded as reference.  
 
C.4.2 De novo DNA methyltransferases and the effect of Dnmt3L 
Dnmt3L was purified from Sf21 cells via Flag-tag following a second purification step on an 
anion exchange column (C.4.1). The protein’s integrity, although no precipitation occurred 
during purification, was verified by monitoring the stimulatory effect on DNA methylation for 
Dnmt3a and Dnmt3b (Suetake et al. 2004; Gowher et al. 2005a). Dnmt3a and Dnmt3b2 
(100nM each), 480nM CpG sites (342bp) and 480nM SAM (1.5µCi) were incubated either 
alone or with increasing concentrations of Dnmt3L (108-1740nM) at 37°C for 30min. 
Reactions were stopped, spotted on a DE81 filter (Whatman) and subjected to scintillation 
counting. With rising concentrations, Dnmt3L exerted a stimulatory effect on the in vitro DNA 
methylation efficiency of Dnmt3a and Dnmt3b (Figure 41).  
 
Figure 41  Dnmt3L stimulates the in vitro methylation activity of Dnmt3a and Dnmt3b2 
In vitro methylation reaction was performed (E.2.11.1) with 100nM N-His Dnmt3a (Sf21 cells) and C-His Dnmt3b2 
(E.coli), 480nM SAM (1.5µCi), 480nM CpG sites (200ng of 342bp MF79/80 PCR fragment) and rising amounts of 
hDnmt3L (Q-FF purified; 108-1740nM) for 30min at 37°C. The reactions were stopped with the addition of 10µM 
‘cold’ SAM and spotted onto a DE81 filter (Whatman). After washing and drying, the filters were subjected to 
scintillation counting for 1min. A. Cpm of each sample is plotted against the Dnmt3L concentration. Black bars 
represent Dnmt3a samples whereas light grey represent Dnmt3b2 samples. B. The stimulatory effect of Dnmt3L 
is shown as ratio of each Dnmt3L reaction/Dnmt3L-free reaction plotted against the Dnmt3L concentration.  
 
In agreement with previous data on DNA fragments >200bp (Suetake et al. 2004), the DNA 
methylation efficiency was increased 1.6-fold to almost 3-fold for Dnmt3a and Dnmt3b 
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respectively. Interestingly, high concentrations of Dnmt3L seemed to have an inhibitory effect 
although Dnmt3L was titrated up to 15µM with no apparent inhibitory effect (Gowher et al. 
2005a). Dnmt3L was described as an exchange factor for SAM and DNA thus accelerating 
the methylation efficiency Dnmt3a (Gowher et al. 2005a). Considering the SAM 
concentration and Dnmt3L concentrations, it might well be that the methylation system was 
depleted of the substrate SAM, hence DNA methylation declined. Nevertheless, Dnmt3L had 
the expected stimulatory function and the proteins integrity was confirmed. 
As Dnmt3L was described to form nucleoprotein filaments in cooperation with Dnmt3a and to 
bind to nucleosomes via non methylated H3K4 tails (A.3.7), Dnmt3L was tested for its ability 
to bind to DNA and nucleosomes in EMSAs. Furthermore, the effect of Dnmt3L on DNA and 
nuclesome association by the de novo DNA methyltransferases was examined. 
In Figure 42 increasing amounts of Dnmt3L (Q-FF, no DNA/histones present) were incubated 
with DNA alone (342bp) or together with Dnmt3a or Dnmt3b2. In accordance with data from 
Suetake (Suetake et al. 2004), Dnmt3L could not bind to DNA in EMSA, contrasting results 
obtained through surface plasmon resonance and filter binding assays (Gowher et al. 2005a) 
When Dnmt3a and Dnmt3b were incubated with DNA and increasing amounts of Dnmt3L 
(molar ratio approximately 1:1 – 1:16, 1:2 – 1:10 respectively) a little increase on DNA 
binding in EMSA could be observed (Figure 42), In agreement, Dnmt3L was required for the 
stability of the Dnmt3a dimer and thus for DNA binding  (Jia et al. 2007). Moreover, one 
could imagine that nucleoprotein filament formation with Dnmt3a/Dnmt3L or 
Dnmt3b2/Dnmt3L tetramers requires less complexes than Dnmt3a or Dnmt3b2 potential 
dimers. Therefore, addition of Dnmt3L leads to more DNA molecules bound. 
 
Figure 42  Effects of Dnmt3L on DNA binding 
EMSA of 20ng of 342bp DNA fragment with Dnmt3L alone (A), Dnmt3a/Dnmt3L (B) or Dnmt3b2/Dnmt3L (C).     
A) Increasing amounts of hDnmt3L (0.15-2.4µg) (two step purification, E.2.7.6) were incubated with DNA. After 
incubation for 15min at 26°C in binding buffer (20mM Tris pH 7.6, 30mM KCl, 5mM EDTA, 1mM DTT, 5µM SAM, 
20% glycerol), samples were loaded onto a 5% PAA 0.4xTBE and stained with ethidium bromide. B/C.) Two 
different amounts of N-His Dnmt3a (300ng, 600ng, B, lane 2-3) and C-His Dnmt3b2 (500ng, 750ng, C, lane 2-3) 
as indicated that led to increased DNA binding respectively. The lower amount of Dnmt3a/b2 was incubated with 
rising amounts of Dnmt3L (0.15-2.4µg, lanes 5-10).  
 
In a similar experimental setup, increasing amounts of Dnmt3L or Dnmt3L with Dnmt3a and 
Dnmt3b2 were incubated with a mixture of mono-nucleosome of varying DNA linker length 
(Figure 43). Unexpectedly, Dnmt3L did not bind to mono-nucleosomes although tight 
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association was observed during purification (C.4.1). According to Prof. Dr. A. Imhof 
(personal communication), non-methylated H3K4 accounts for at least 50% of the histones 
isolated from Drosophila, hence partial binding should be observed. EMSA with nucleosomes 
composed of recombinant human histones (kindly provided by C. Huber) as well did not 
show any shift (data not shown). 
 
Therefore, either other histone tail modifications (Jenuwein and Allis 2001) in cis or trans 
might influence directly the interaction with Dnmt3L or the structural architecture of a 
nucleosomal region might provide a platform for Dnmt3L binding. Furthermore, an 
unidentified transient loading factor could have been responsible for the recruitment and 
deposition of Dnmt3L onto chromatin. 
In contrast to DNA, Dnmt3L does not positively affect the binding of Dnmt3a and Dnmt3b2 to 
nucleosomal substrates. It rather seems that binding affinities are somehow affected, thus 
leading to an unclear binding phenomenon.  
 
Figure 43  Effects of Dnmt3L on nucleosome binding by Dnmt3a and Dnmt3b2 
EMSA of a mixture of mono-nucleosomes with different linker length and free DNA (*) with Dnmt3L alone (A), 
Dnmt3a and Dnmt3a/Dnmt3L (B) or Dnmt3b2 and Dnmt3b2/Dnmt3L (C.). A) Increasing amounts of hDnmt3L 
(0.15-2.4µg) (two step purification, E.2.7.6) were incubated with mono-nucleosomes. B/C.) Incubation of mono-
nucleosomes with Dnmt3a/Dnmt3b2 alone (0.6-2.4µg; 1.0-4.0µg, lanes 2-5) or with Dnmt3a/Dnmt3b2 (0.6µg; 
1.0µg) and rising amounts of Dnmt3L (0.15-2.4µg, lanes 7-10). After incubation for 15min at 26°C in binding 
buffer (20mM Tris pH 7.6, 30mM KCl, 5mM EDTA, 1mM DTT, 5µM SAM, 20% glycerol), samples were loaded 
onto a 5% PAA 0.4xTBE and stained with ethidium bromide. 
 
C.4.3 Analysis of chromatin binding by Dnmt3L in vivo and in vitro 
As Dnmt3L associated with endogenous nucleosomes but did not bind to mono-
nucleosomes in EMSA, the question of association to higher chromatin structures was 
addressed. 
First, Dnmt3L associated with endogenous nucleosomes (C.4.1) (40µg) was applied onto a 
15%-45% sucrose density gradient (Figure 44). After centrifugation, fractions were taken and 
analyzed for the distribution of the nucleosomal species, Dnmt3L and histone H3 (E.2.10.6). 
Nucleosomes were separated according to their size (1n, 2n, 3n).  Interestingly, Dnmt3L 
stayed tightly associated with chromatin, as it is distributed over the whole gradient. Although 
the immuno-blot signals were very weak, histone H3 could also be detected in some 
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fractions confirming association with nucleosomes. Nevertheless, a substantial part of the 
Dnmt3L population ran in fractions 15-17 where almost no DNA/chromatin was detectable. 
But it has to be kept in mind that the DNA/chromatin constituted of fragments of different size 
rather than distinct bands, making detection at low concentrations very difficult.  
 
Figure 44  Recombinant Dnmt3L from Sf21 cells is tightly associated with nucleosomes 
40µg of Dnmt3L (Flag-tag purification; roughly 6-7µg DNA; E.2.7.6) associated with nucleosomes was subjected 
to 10%-45% sucrose density gradient separation. After centrifugation (18h, 30,000rpm, SW40, no brake) 400µl of 
the 600µl fractions were collected, ethanol precipitated overnight with ammonium-acetate (E.2.2.2), loaded onto a 
1.3% agarose gel and stained with ethidium bromide. 20µl of each fraction were subjected to SDS-PAGE (12%) 
following Western Blot analysis. Immuno-detection was performed with an antibody directed against the C-
terminal Flag-tag of Dnmt3L and histone H3 (E.1.6). 
 
In order to prove the hypothesis of recombinant Dnmt3L binding to larger nucleosomal 
templates, 5µg of a mixture of plasmid DNA, linearized plasmid DNA and 200bp DNA 
fragments fully assembled with Drosophila histones by salt dialysis (E.2.10.2) were dialyzed 
together with Dnmt3L against EX-100 buffer (no glycerol) and loaded onto a 15%-45% 
sucrose density gradient as described above. After centrifugation, fractions were taken and 
analyzed for the distribution of the nucleosomal species and Dnmt3L (E.2.10.6). Poly-
glutamic acid (PGA) generally facilitates nucleosome assembly and generates salt 
assembled chromatin with more uniform spacing. Hence, in order to provide a regular 
nucleosomal array that might affect Dnmt3L binding, PGA (2mg/ml) was added to the dialysis 
step prior to loading. For comparison, Dnmt3L alone and Dnmt3L with DNA not assembled 
into nucleosomes were analyzed as well (Figure 45).  
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The major fractions of different nucleosomal templates applied could be well separated with 
the nucleosomal plasmid running in various DNA topologies at highest density (fr. 1-7, >3kb), 
followed by assembled linear DNA (fr. 9-13, 3.0kb) and mono-nucleosomes (fr. 12-13, 
200bp) (only one run is shown since no difference between the runs could be observed).  
Figure 45  Sucrose gradient analysis of Dnmt3L and chromatin 
Different nucleosomal species were separated on a 10%-45% sucrose gradient in EX-50 buffer (without glycerole) 
during centrifugation (18h, 30,000rpm, SW40, no brake) (E.2.10.6). Circular and linear plasmid DNA as well as 
200bp DNA fragments (including the 601 nucleosome positioning sequence) were fully assembled into chromatin 
with histones from Drosophila by salt dialysis (E.2.10.2). 10µg Dnmt3L were either loaded alone, together with 
5µg DNA or together with 5µg chromatin or in combination with 5µg chromatin and PGA (2mg/ml). Prior to 
loading, samples (100µl) were dialyzed for 1.5 hours against Ex-100 buffer (without glycerol). Analysis of 
chromatin and DNA was done as described (figure xx). Since no significant differences were visible, only one 
agarose gel for the nucleosomal derived DNA and one agarose gel for the DNA are shown. 
 
Mono-nucleosomes migrated in fraction 13 as seen for the endogenous mono-nucleosomes 
co-purified with Dnmt3L (Figure 44). Importantly, some residual templates were also found in 
the other fractions. This is either due to chromatin interactions and thus co-migration with 
other chromatin templates or partial disassembly resulting in an altered running behavior of 
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free DNA in the density gradient. The latter cannot be completely excluded since direct 
analysis of the DNA/chromatin could not be performed due to low concentrations of DNA in 
the fractions.  
Dnmt3L alone hardly entered the sucrose gradient and was present in fraction 17 and 18 
(Figure 45). Dnmt3L together with chromatin entered the gradient further to fraction 14/15. 
Addition of PGA did not significantly change the running behavior of Dnmt3L. Notably, no 
Dnmt3L associated with the major nucleosomal fractions. Considering fast on/off rates of 
Dnmt3L binding to chromatin, it is well conceivable that Dnmt3L co-migrates with 
nucleosomes, but loses contact that cannot be reestablished due to further migration of the 
higher molecular weight nucleosomal matrices.  
When applying Dnmt3L in combination with free DNA onto the sucrose gradient (Figure 45), 
the DNA species entered the sucrose gradient not as far as observed for their nucleosomal 
counterparts which is in agreement with the absence of the additional molecular weight of 
histones. In addition, a ‘smeary’ running behavior of the free DNA could be seen, suggesting 
this to be a property of the sucrose gradient. Hence, the separated chromatin was intact and 
did not partially disassemble during the run in the sucrose gradient. Interestingly, Dnmt3L 
associated with free DNA entered the gradient (fractions 14-18) comparable to Dnmt3L with 
nucleosomes. However, the distribution of Dnmt3L along these fractions is different 
indicating different binding properties towards DNA and nucleosomal matrices.  
 
C.5 Structural analysis of Dnmt1 
Through the interaction of the SRA domain with the targeting domain (TS) of Dnmt1 
(Leonhardt et al. 1992; Achour et al. 2007), ICBP90 facilitates the loading of Dnmt1 to 
replicating regions (Bostick et al. 2007; Sharif et al. 2007).  
However, the molecular mechanism that controls the activity of Dnmt1 and the recognition of 
hemi-methylated DNA remains largely unknown. 
 
C.5.1 Dnmt1 – disruption of a protein dimer 
Recombinant Dnmt1 was subjected to size exclusion chromatography (E.2.3.6) on a 
Superdex200 gel filtration column (GE Healthcare) followed by immunoblot analysis 
(E.2.3.3). Dnmt1 runs at an apparent molecular size of 400kDa which corresponds 
approximately to twice the molecular weight of Dnmt1 (183 kDA). The presence of 2M NaCl 
in the running buffer could not disrupt the intramolecular protein interaction, indicating a 
probable hydrophobic interaction domain (Figure 46). 
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Figure 46  Recombinant Dnmt1 – an apparent dimer 
A.) Recombinant Dnmt1 was loaded on a Superdex200 gelfiltration column (GE Healthcare) in running buffer 
(200mM NaCl/2M NaCl, 20mM Tris, pH 8.0; 1mM MgCl2, 10% glycerol). Upper panel. Dnmt1 in running buffer 
supplemented with 200mM NaCl. Lower panel. Dnmt1 in running buffer with 2M NaCl. B.) Dnmt1 (30µg) was 
adjusted to the indicated SDS concentration and either incubated for 30min at 37°C or directly loaded on a 
Superose6 gelfiltration column (GE Healthcare) in running buffer (150mM NaCl, 20mM Tris, pH 7.5; 1mM EDTA, 
10% glycerol) supplemented with the indicated concentrations of SDS. For both columns, 500µl fractions were 
collected, TCA precipitated and subjected to SDS-PAGE and Western Blot analysis (detection with D1-2G3 rat 
monoclonal antibody; E.1.6). Molecular weight standards and fractions are indicated 
 
To further test this assumption, Dnmt1 was run on a Superose6 gelfiltration column in the 
presence of 0,01% SDS at 4°C and 0,1% SDS at room temperature. SDS seemed to partially 
disrupt the Dnmt1 dimer (Figure 46). Higher concentrations of SDS or incubation of the 
sample at 37°C for 30min prior to loading dramatically enhanced this effect. Not only the 
dimer peak vanished and Dnmt1 was shifted to fractions of lower molecular weight, but also 
multimerization could be observed. Tertiary structure and intramolecular interactions were 
disturbed allowing for intermolecular hydrophobic interactions to occur.  
Taken together, these data indicate a Dnmt1 dimer, whose interaction might be mediated by 
a hydrophobic part of multiple parts of the protein.  
 
C.5.2 Dnmt1 interacts with the TS domain 
The human TS domain was expressed as MBP fusion construct and purified as described 
(E.2.8.7). Dnmt1 was purified from baculovirus infected Sf21 cells (E.2.7.2). Individual 
proteins together with BSA or Dnmt1 and hTS in a 1:6 molar ratio were incubated for 1h at 
30°C and loaded on a gelfiltration column. Immunoblot analysis of collected fractions showed 
that Dnmt1 eluted in a fraction corresponding to a molecular mass of about 400 kDa (Figure 
47, A). This is approximately two-fold the molecular weight of Dnmt1 (183 kDa) indicating the 
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presence of a dimeric complex. The hTS domain eluted with a distinct peak at about 65 kDa 
corresponding to a TS dimer and higher molecular weight complexes in the size range above 
500 kDA indicating multimerization of the TS domain (Figure 47). 
Dnmt1 incubated with hTS showed partial disruption of both Dnmt1 and hTS dimers. Dnmt1 
was shifted to higher molecular weight driven by multimerization together with hTS and a 
downshift of multiple fractions of lower molecular weight suggesting Dnmt1-hTS 
heterodimers. Signals of Dnmt1 in fractions smaller than its own molecular weight can be 
explained by an altered structural conformation together with the hTS resulting in a different 
running behavior. In contrast, the hTS domain showed an altered distribution over the 
fractions of the column, directly inverse to the observation of Dnmt1. Incubation of TS with 
Dnmt1 led to a downshift of multimerized TS domains and a peak broadening in the low 
molecular weight region.  
Accordingly, the hTS domain which by itself can form a stable dimer, seems to be the 
determinant of dimerization of Dnmt1. 
In order to further test the interaction properties of Dnmt1 with the TS domain, a co-
immunoprecipitation was performed. Dnmt1 was bound to proteinG sepharose coupled with 
Dnmt1 specific antibody 2E8 (E.1.6) and incubated with an excess of hTS. As indicated in 
Figure 47 (B), Dnmt1 is able to interact with and precipitate the TS domain.  
In a recent publication, K. Fellinger (Fellinger et al. 2009) provides evidence by means of 
biochemical characterization that Dnmt1 forms a stable dimer. The parallel orientation of the 
Dnmt1 dimer is mediated by the interaction of the TS domain. 
 
Figure 47  Dnmt1 interacts with hTS domain – gelfiltration analysis 
A.) Molecular interactions between Dnmt1 and the TS domain were analyzed by gelfiltration on a Superdex200 
column in 20mM Tris, pH 7.5, 150mM NaCl, 1mM EDTA, 1mM DTT. Dnmt1 and the TS domain were analyzed 
after mixing both proteins for 1 h at 30°C in a 1:6 ratio. For reference, individual proteins were incubated together 
with BSA. The proteins were visualized by Western blot with the 2C1 rat monoclonal antibody recognizing both, 
Dnmt1 and the TS domain (E.2.8.7, E.2.7.2). The proteins (Dnmt1 : d and hTS : t) and the migration of the size 
standards are indicated. B.) Dnmt1 co-immunoprecipitates the TS domain. MBP-TS was cleaved with TEV 
Protease (lane 2) and incubated with the Dnmt1 specific antibody 2E8 coupled to proteinG beads. 2% of the 
flowthrough and 50% of the beads were loaded (lanes 3 and 4). Recombinant Dnmt1 (lane 6) was incubated with 
a 50 fold excess of the hTS domain for 1h at 30°C. The reaction was incubated with the 2E8 antibody coupled to 
beads and 10% of the flowthrough and 50% of the beads were loaded on a 6% SDS-PAGE (lane 7 and 8). 
Proteins were stained with Coomassie Blue and the position of Dnmt1, the antibody heavy chain (HC), the 
Maltose Binding Protein (MBP) and the human TS domain are indicated 
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C.6 Phosphokanamycin – inhibitor of Swi/Snf remodeling enzymes 
Chromatin remodeling complexes are implicated as positive and negative regulators of 
transcription, replication and repair (Schnitzler 2008).  
Due to their ability to read out DNA sequence/structure elements that direct nucleosome 
positioning (Rippe et al. 2007a), they might provide for an additional mechanism that defines 
the chromatin structure of the genome.  
Phosphokanamycin (PK) was described as a specific inhibitor of the Swi/Snf remodeling 
complex (Muthuswami et al. 2000). ATP- dependent changes of nucleosome positions can 
be assessed in in vitro nuclesome sliding reactions as initially established by Längst (Langst 
et al. 1999). PK was shown to inhibit the remodeling machines ACF and Mi2 (Langst et al. 
1999; Brehm et al. 2000) as well as the activity of Snf2H and the chromatin remodeling 
complex NoRC in a dose dependent manner (Santoro et al. 2002; Strohner et al. 
2004a)(Felle et al., manuscript in preparation), whereas kanamycinA did not affect 
nucleosome remodeling. 
 
C.6.1 PK does not globally inhibit ATPases or affect the integrity of chromatin 
In order to exclude a global inhibitory effect of PK, the ATPase activities of chromatin 
assembly (E.2.10.1) and murine transcription extracts (Langst et al. 1997) were monitored in 
the presence of 500µM of PK or kanamycin A respectively (Figure 48, A). The rate of ATP 
hydrolysis was followed by an enzymatic assay that couples ATP hydrolysis to NADH 
synthesis (Lindsley 2001)(E.2.11.5). No obvious differences in ATP hydrolysis rates were 
observed with PK compared to kanamycinA or Mock control, indicating that PK selectively 
inhibits ATPases that belong to the Snf2 family and does not globally affect ATPases present 
in the partially purified extracts. 
Notably, a bi-phaseal course of ATP consumption could be observed for both DREX and 
mouse transcription extract (Figure 48, A). A scenario in which at first the nucleosomes 
would be loaded onto the DNA and moved to their final positions could account for the higher 
ATP hydrolysis rate at the onset of the reaction. At later time points, the slower ATP 
consumption rate could derive from continues interactions of remodeling enzymes and 
nucleosomes situated at their final positions.  
One model system to study chromatin dynamics and molecular mechanisms of gene 
regulation in chromatin is the Drosophila chromatin assembly extract (Becker and Wu 1992). 
Chromatin reconstitution with this extract results in efficient nucleosome deposition with 
regular spacing (Figure 48, B). As Phosphokanamycin might affect the chromatin assembly 
function of the extract by inhibiting the remodeling complexes, PK was included once 
chromatin assembly was completed. The addition of kanamycinA and PK after 4 hours did 
not change the chromatin structure of the rDNA minigenes, as revealed by MNase digestion 
and visualization of the nucleosomal ladder (Figure 48, B).  
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Figure 48  Effect of PK on chromatin assembly and transcription extracts 
A.) Measurement of ATP hydrolysis rates in the Drosophila embryo extract and the murine transcription extract. 
Extracts were incubated with 500µM kanamycin A or PK and the rate of ATP hydrolysis was measured as 
described in (E.2.11.5).  Arrow indicates addition of 0.3mM ATP. B.) PK does not impair the integrity of chromatin. 
MNase digestion of chromatin assembled on plasmid DNA (E.2.10.3). Chromatin reconstituted with the 
Drosophila extract (E.2.10.1) was digested with MNase for 0.5 to 3min (lanes 1-3) or for 0.5 to 6min (lanes 4-8) in 
the presence of 600 µM PK. The nucleosomal ladder (1n .. 5n) and the DNA marker (M; 1kb ladder) are indicated. 
 
C.7 Dnmt1 antibody epitope mapping 
A classical approach in the purification of nuclear multi protein complexes comprises the 
preparation of nuclear extracts of high protein concentration and subsequent multiple column 
purifications using matrices with different chemical characteristics that eventually enrich 
one’s POI together with interacting proteins while depleting protein contaminations.  
The composition of purified protein complexes and the identity of the proteins can then be 
analyzed with the MALDI technique (Matrix assisted laser desorption/ionization). 
Another method that facilitates this often laborious process is the use of antibodies that 
specifically immunoprecipitate one’s POI out of a complex protein mixture. This technique 
can be applied either on cell lysate, nuclear extracts or protein samples that had already 
been purified with one or two column purification steps. 
In order to ease SDS PAGE based protein identification or to perform in vitro activity assays, 
the aim is to release one’s POI from the antibody by competition with peptides that 
correspond to the epitope the target protein. 
In the course of this study, the epitopes for four rat monoclonal antibodies directed against 
full length Dnmt1 (2C1, 2G3, 2E8, 2G3; E.1.6) was mapped and peptide elution of antibody 
bound Dnmt1 performed. 
C.7.1 Antibody domain mapping 
For a rough survey which domains of Dnmt1 are recognized by the individual antibodies, six 
different domains were expressed in bacteria and subjected to Western Blot analysis 
(E.2.3.3) using the respective antibodies.  
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Figure 49  Protein domains of Dnmt1 for antibody mapping 
Schematic overview of the Dnmt1 domains used. N-terminal and C-terminal (catalytic domain) domain are 
indicated. White colored domains were cloned into pRSETa expression vector (Invitrogen), grey colored domains 
were expressed as MBP fusion proteins (E.2.8.7). 
 
According to Western Blot analysis, the epitope for the Dnmt1 antibodies 2C1 and 2C12 lies 
within the TS domain (aa 316-601) and for the antibodies 2E8 and 2G3 within the first 290 
amino acids of Dnmt1. 
 
Figure 50  Western Blot analysis and immunodetection of Dnmt1 domains 
Dnmt1 domains cloned into pRSETa vector were transformed into Bl21 E. coli cells and protein expression 
induced. Cells were lysed in Laemmli buffer and boiled at 95°C for 10min. MBP-Dnmt1 aa 1-290 was handled as 
the other domains, whereas MBP-Dnmt1 aa 316-601 was purified via amylose resin (E.2.8.7). Recombinant 
human Dnmt1 was purified as described (E.2.7.2). All samples were resolved on a 15% SDS-PAGE, subjected to 
Western Blot following immunodetection. A.) Immunodetection with 2C1 antibody (2C12 shows the same result; 
not shown). B.) Immunodetection with 2E8 antibody (2G3 is the same, not shown). 
 
C.7.2 Epitope mapping of anti-Dnmt1 2C1 and 2C12 
The exact epitope that is recognized by the antibodies 2C1 and 2C12 was mapped applying 
a limited proteolysis approach with V8 serine protease from Staphylococcus aureus 
(E.2.12.3). The purified native MBP-hTS C-Flag (E.2.8.7) was digested with V8 protease 
which cleaves after glutamyl residues. Only accessible sites that lie in the linker regions 
between protected protein domains are cleaved. Western Blot analysis following comparison 
of immunodetected (anti-Flag antibody serves as control) cleavage products allows a rough 
estimation of the epitope region. 
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Figure 51  Limited proteolysis of MBP-hTS C-Flag and immunodetection 
A.) Limited proteolysis of MBP-hTS C-Flag with V8 protease in a 200:1 molar ratio in 100mM Tris pH 7.8, 0,2% 
SDS. The reaction mixture was incubated at 37°C. Samples were withdrawn at different time points (0, 5’, 10’, 15’, 
20’, 30’, 45’, 60’, 75’, 90’, 120’), boiled in Laemmli buffer at 95°C and subjected to SDS PAGE (15%). B.) Samples 
from 0’, 45’ and 120’ time points were further analyzed by Western Blot and immunodetection with anti Flag (4H3, 
1:2000) and anti Dnmt1 2C1 and 2C12 (1:20; result for 2C12 not shown since the same). Position I denotes 
fragment that is recognized by both 2C1 and Flag antibody whereas cleavage fragment at position II is not 
detected by 2C1 suggesting that the epitope of 2C1 lies between the last 30-35kDa corresponding to roughly 60-
70 aa, thus aa 316-376/386 of hDnmt1. 
 
The epitope region for 2C1 and 2C12 (aa 316- 376/ 386 of hDnmt1) was further narrowed by 
expression of MBP fusion proteins with 14 amino acids with 7 amino acids overlap and again 
Western Blot analysis. The epitope recognized best in immunodection corresponds to aa 
316-330 (DEDEKEEKRRKTTP). 
Limited proteolysis of the MBP-Dnmt1 aa 1-290 construct could not be performed since its 
purification failed. 
 
Figure 52  Epitope fine mapping of anti Dnmt1 2C1 
antibody 
MBP fusion proteins with 14aa of Dnmt1 starting at position aa 316 
(with a 7aa overlap) were expressed in E. coli as described for MBP-
hTS (E.2.8.7). Induced cells were lysed in SDS sample buffer and 
boiled at 95°C for 10min. Samples were immunodetected with 
antibody 2C1 after SDS PAGE on a 15% gel and Western Blot. The 
result for antibody 2C12 is not shown since it recognizes the same 
epitope. 
 
The following peptides were ordered and dissolved in 50mM Tris pH 7.5, 150mM NaCl at 
concentrations of 5-10mg/ml (P1:DEDEKEE, P2:KRRKTTP, P3:  DEKEEKRRK, P4: 
KDEDEKEEKRRKTT). Peptide release of immunoprecipitated recombinant hDnmt1 in IP-
buffer (50mM Tris pH 7.5, 150mM NaCl, 0,05%) supplemented with 2,5mg/ml peptide failed 
(data not shown). 
As a summary, Dnmt1 specific antibodies 2E8 and 2G3 recognize aa 1-290 and antibodies 
2C1 and 2C12 aa 316-330 of hDnmt1 respectively. Only the antibody 2E8 recognizes mouse 
Dnmt1 (data not shown). 
 
DISCUSSION 
84 
D DISCUSSION 
D.1 Dnmt1 interacts with ICBP90 and USP7 
In search of new interaction partners of Dnmt1, ICBP90 (also referred to as UHRF1) and 
USP7 were identified by co-immunoprecipitation with Dnmt1 from Hela S3 and human 
placenta nuclear extracts following MALDI analysis (C.1.1,C.1.2). Gelfiltration 
chromatography (C.1.3), in vivo pull-down experiments (C.1.4) as well as in vitro interaction 
studies with the recombinant proteins or protein domains (C.1.5) revealed a Dnmt1/ICBP90 
(Achour et al. 2007; Bostick et al. 2007) and a Dnmt1/USP7 interaction. Furthermore, the 
data point out that UHRF1 directly interacts with USP7 and that a trimeric complex could 
exist with USP7 binding to ICBP90 and Dnmt1 with domains 1 (aa1-215) and 3 (aa651-916) 
respectively. Chromatin immunoprecipitation of these proteins and subsequent qPCR 
analysis confirmed the observation of different combinations of Dnmt1/ ICBP90/ USP7 
occupying four different gene loci in vivo (C.1.15). 
Furthermore, the RING-type E3 ubiquitin ligase ICBP90 promotes autoubiquitinylation 
(C.1.6), and ubiquitinylation of histone H3 (Karagianni et al. 2008) (C.1.7) and USP7 (C.1.8) 
in vitro. Notably, binding of either the inactive USP7 C223S or Dnmt1 impaired 
autoubiquitinylation of ICBP90 in vitro (C.1.6) whereas active USP7 prevented 
autoubiquitinylation by removing ubiquitin moieties from ICBP90 (C.1.10). Although the 
results are not absolutely conclusive, USP7 might also be involved in regulating the stability 
of ICBP90 in vivo (C.1.12). 
USP7 deubiquitinated H2A, H2B and H3 in vitro (C.1.10) but knockdown or over-expression 
of USP7 did not affect global levels of ubiquitinylated H2A and H2B in vivo (C.1.14). Binding 
of ICBP90 and Dnmt1 to USP7 did not influence the in vitro activity of USP7 (C.1.9). 
Moreover, Dnmt1 seemed to be a target for ubiquitinylation by ICBP90 in vitro (C.1.8) but 
was not affected in vivo in regard to protein stability (C.1.12) and ubiquitinylation (C.1.13) 
upon knockdown or over-expression of USP7.  
 
We have purified a new complex consisting of Dnmt1/ICBP90/USP7 but are still lacking 
knowledge about its biological functions. The aim of this discussion is to address the roles of 
histone ubiquitinylation/deubiquitination and DNA methylation in epigenetic regulation. 
 
D.1.1 Dnmt1, ICBP90 and USP7 form multiple complexes in vitro and in vivo 
In vivo immunoprecipitation studies as well gelfiltration chromatography point out the 
existence of different complexes, namely Dnmt1/ICBP90 and Dnmt1/USP7 and possible 
trimeric complex of Dnmt1, ICBP90 and USP7. Moreover, the data suggest that the 
interactions are stabilized on chromatin.  
 
In order to test chromatin association of complexes/interactions and recruitment in vitro, a 
biotinylated nucleosomal array could be coupled to streptavidin coated beads following 
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binding of either Dnmt1, ICBP90 and USP7. Retention of proteins-of-interest either alone or 
in different combinations could be analyzed. Differences in binding to purified and crude 
chromatin could account for possible other recruitment or stabilizing factors.  
Different nucleosomal substrates could be applied providing for optimal initial binding. A 
nucleosomal array consisting of hemi- or fully methylated DNA might present a better 
substrate for ICBP90 (Unoki et al. 2004). Dnmt1 was immobilized on DNA (Schermelleh et 
al. 2005). Reconstituted nucleosomes with chemically linked ubH2B might target USP7 
(McGinty et al. 2008).  
 
In vitro studies (C.1.5) further dissected the interrelation of Dnmt1, ICBP90 and USP7 
revealing interaction of all proteins with one another indicating the following dimeric 
complexes: Dnmt1/ICBP90, Dnmt1/USP7, and ICBP90/USP7 (Figure 53). Interaction of 
Dnmt1 with ICBP90 and respectively the interaction of the TS domain with the SRA domain 
confirm published data (Achour et al. 2007). Second, ICBP90 binds via its SRA domain and 
Dnmt1 binds through its TS domain to domain 1 (TRAF domain, aa1-215) and domain 3 of 
USP7 (aa561-916) respectively, suggesting a trimeric complex of USP7 simultaneously 
associating with Dnmt1 and ICBP90 (Figure 53). Third, the de novo methyltransferases also 
precipitated ICBP90 and USP7 but in contrast to Dnmt1 bound preferentially to the TRAF 
domain of USP7.  
Chromatin immunoprecipitations (CHIP) with antibodies directed against Dnmt1, ICBP90, 
USP7 and RNA polymerase II following the analysis on the occupation of four different loci 
(C.1.15) are in agreement with the concept of dynamic complexes.  
Although the absolute or relative amounts of the protein-of-interests in the cell are difficult to 
judge, the gelfiltration data (C.1.3) suggest a larger population of Dnmt1/USP7 dimers 
(compared to ICBP90). ICBP90 as a tightly chromatin associated factor could be the 
recruitment factor of Dnmt1/USP7 to either sites of replication or sites of specific gene 
regulation (Unoki et al. 2004; Bostick et al. 2007). Different models on how dynamic 
Dnmt1/ICBP90/USP7 complexes may act are discussed below.  
 
 
Figure 53  Complex formation of Dnmt1, ICBP90 and USP7 
Possible complex formations as deduced from in vitro  and in vivo studies (C.1.5). A.) Dimeric complexes, namely 
ICBP90/USP7, Dnmt1/USP7, Dnmt1/ICBP90. ICBP90 containing complexes are chromatin associated B.) 
Possible trimeric complex of Dnmt1/ICBP90/USP7. TRAF domain (TNF associated factor, orange, aa1-215), SRA 
domain (SET and RING finger associated, green, aa 409-616), hTS domain (Targeting domain, brown, aa316-
601).  
DISCUSSION 
86 
In one model, ICBP90 is bound to a promoter or a genomic region through interaction with a 
specific sequence or methylated CpG sites. ICBP90 would promote its own and/or histone 
H3 ubiquitinylation (C.1.7). The Dnmt1/USP7 complex would be targeted by ICBP90 to direct 
DNA methylation and deubiquitination of ubiquitinylated ICBP90 and ubH3 by USP7 
(C.1.10). 
USP7 may change the enzymatic properties of Dnmt1. Therefore, Dnmt1 would be inactive 
in a Dnmt1/USP7 complex until recruited to a specific target site. This potential function could 
easily be tested in vitro. As long as USP7 is engaged with removing ubiquitin moieties from 
H3, possible inhibition could be relieved and Dnmt1 could act together with ICBP90 in DNA 
methylation. Interestingly, so far it has not been shown whether ICBP90 is able to directly 
stimulate Dnmt1’s activity towards DNA or nucleosomes. Therefore, besides a recruitment 
factor, ICBP90 could also act as an activator of DNA methylation.  
In a second model, ubH3 could be the targeting signal for USP7 delivering Dnmt1 for ICBP90 
mediated DNA methylation. Whether ICBP90 or ubH3 is the major target for USP7 could be 
tested on in vitro ubiquitinylated nucleosomal arrays. Inactive ICBP90∆RING associated with 
the array would not promote H3 ubiquitinylation (C.1.6) but could recruit USP7 as the SRA 
domain was shown to be the interacting domain of ICBP90 (C.1.5). 
Considering the bulky ubiquitin moieties on histones H3, DNA methylation could take place in 
a more open chromatin structure. Ubiquitin from H3 would be removed by USP7 leading to 
possible chromatin rearrangements that could limit DNA methylation. 
It is unclear whether Dnmt1, ICBP90 and USP7 would stay associated as a trimeric complex 
or as a Dnmt1/ICBP90 dimer and free USP7. 
Both Dnmt1 and ICBP90 could maintain in cooperation with other factors a repressive 
chromatin state. Notably, ICBP90’s ubiquitinylation activity was reduced upon binding of 
Dnmt1 (C.1.6), hence new H3 ubiquitinylation could be impaired. Moreover, a trimeric 
complex could also be stably associated within a heterochromatin environment. DNA 
methylation would be maintained and the activity of ICBP90 controlled by USP7 (C.1.6; 
C.1.10). 
 
D.1.1.1 USP7 is absent from the WNT1 gene locus 
Dnmt1 and ICBP90 were present at the Wnt1 locus (C.1.15) that had previously been 
described to be silenced in dependency of the H3K27me3 HMT EZH2 of PRC2 and Dnmt1 
mediated DNA methylation (Viré et al. 2005). Dnmt1 was absent from the Wnt1 locus upon 
knockdown of EZH2. It is well conceivable that ICBP90 is targeted by H3K27me3 in 
analogous fashion to H3K9me3 (Karagianni et al. 2008), directly by EZH2 or by a methylated 
CpG mark as mentioned above. The first notion could be tested with a peptide binding assay 
on H3K27me3 tails, the second with in vitro interactions studies and the last one with 
knockdown of the de novo DNA methyltransferases following CHIP. Dnmt/USP7 could be 
recruited either through ICBP90 or ubH3. Upon ‘delivery’ of Dnmt1 USP7 would remove 
ubH3 and dissociate whereas Dnmt1 interacting with EZH2 and ICBP90 would stay at the 
Wnt1 locus.  
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Figure 54  Possible mechanisms in transcriptional regulation 
Possible mechanism on how Dnmt1, ICBP90 and USP7 could function in gene silencing. A.) ICBP90 binding to 
hemi-methylated DNA (red *) or H3K9me3 ubiquitinylates itself and histone H3. USP7 might inhibit Dnmt1’s 
activity. The Dnmt1/USP7 complex might be recruited either by ICBP90 or ubH3. B-I.) USP7 might bind to 
ICBP90 forming a possible trimeric complex. USP7/Dnmt1 impair ubiquitinylation activity of ICBP90. USP7 
removes ubiquitin from ubH3 and ICBP90. ICBP90 might stimulate Dnmt1 for DNA methylation. B-II.) USP7 
delivers Dnmt1 which interacts with ICP90 (TS-SRA binding). Relieve of possible inhibition of Dnmt1 and 
stimulation of DNA methylation activity by ICBP90. USP7 removes ubiquitin from H3 and ICBP90. C.) Depending 
on the genomic context, the association of different factors (HDACs, PcG complexes. MeCP2) or the presence of 
ubiquitinylated H2A/H2, USP7 might stay associated or dissociate.  
 
D.1.1.2 Dnmt1, ICBP90 and USP7 form a trimeric complex at the IGFBP3 gene 
Dnmt1, ICBP90 and USP7 occupied the IGFBP3 gene promoter in CHIP analysis (C.1.15), 
an observation that could be explained with the above-mentioned model. Interestingly, 
IGFBP3 was found to be mostly hyper-methylated in lung cancer cells (Chang et al. 2004) 
concomitant with association of HDAC and MeCP2. Both, Dnmt1 and ICBP90 interact with 
HDAC1 in gene regulation (Robertson et al. 2000a; Unoki and Nakamura 2003) and Dnmt1 
with MeCP2 (Kimura and Shiota 2003). Therefore, the occupancy of Dnmt1 and ICBP90 at 
the IGFBP3 gene agrees with this observation. Additionally, association of HDAC1/2 could 
be tested in CHIP.  
DISCUSSION 
88 
The possible regulatory mechanism that could account for the IGFBP3 gene is difficult to 
decipher in vivo. Albeit knockdown of USP7 is efficient, it is not complete and thus (C.1.12) 
residual Dnmt1/USP7 complexes could be recruited. In order to verify USP7’s role as a 
targeting and inhibitory factor in vivo total ablation of USP7 in knockout cells could prove this 
assumption. Over-expression of USP7 could lead to competition of free USP7 and 
Dnmt1/USP7 complexes. Hence, H3 deubiquitination without concomitant Dnmt1 mediated 
methylation could occur which should be seen in reactivation of gene expression and at least 
partial demethylation.  
Such a recruitment competition could also be analyzed using a biotinylated nucleosomal 
array system. Although this would be a sophisticated experimental setup, the biotinylated 
array system could be used to address the question of interrelation of DNA methylation and 
H3 deubiquitination.  
 
D.1.1.3 Dnmt1/ICBP90/USP7 might be involved in ‘bivalent’ gene regulation 
As for the IGFBP3 gene, the three proteins also occupied the HoxA7 gene (C.1.15). This 
gene was shown to be silenced by the action of both Polycomb repressive complexes PRC1 
and PRC2 as well as Dnmt1 (Wu et al. 2008). Association of ICBP90 could occur in a similar 
fashion as just outlined for the Wnt1 gene or ICBP90 could be recruited by some other 
unidentified transcriptional repressor. Dnmt1/USP7 would be recruited and function as 
pointed out before, with the exception that USP7 would stay associated either with 
Dnmt1/ICBP90 or components of the PRC1 complex. USP7 associated with the Polycomb 
protein (dPRC1) on the Ubx PRE in Drosophila (van der Knaap et al. 2005).  
Ubiquitinylated H2A plays a role in gene silencing as knockdown of RING E3s resulted in re-
expression of a number of Hox genes in both flies and human (Wang et al. 2004a; Cao et al. 
2005). Therefore, on the first glance it seems rather unlikely that USP7 would deubiquitinate 
H2A.  
In contrast, Hox genes were found in clusters of highly conserved non-coding elements 
(HCNE) that constitute ‘bivalent domains’ in ES cells (Bernstein et al. 2006). ‘Bivalent 
domains’ combine both large regions of repressive (H3K27me3) and smaller regions of 
activating (H3K4me3) modifications. These domains tend to coincide with genes expressed 
at low levels and assembled RNAP II – S5P–CTD indicative of transcription initiation 
competent. Conditional deletion of RING1A/B led to sequential loss of ubH2A, release of 
poised RNAPII and subsequent gene de-repression (Stock et al. 2007).  
Importantly, also HoxA7 was found to be controlled by such a bivalent promoter mechanism 
(Stock et al. 2007). Unphosphorylated RNA Polymerase II (antibody 8GW16 (Thompson et 
al. 1989; Xie et al. 2006)) was not bound to the HoxA7 locus which is in agreement with the 
CHIP data from HCT-116 cells (C.1.15). Accordingly, besides Dnmt1 ‘delivery’ and 
controlling ICBP90 and H3 deubiquitination, USP7 could possibly remove ubiquitin from H2A 
in a PcG regulated environment and thus contribute to low-level transcription. 
Considering this function, over-expression and knockdown of USP7 would lead to reduced 
and increased ubH2A levels respectively concomitant with elevated and decreased gene 
expression. It is important to note that ‘bivalent domains’ are replaced by either active or 
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repressive gene configurations in differentiated cells (Bernstein et al. 2006). Therefore, 
although very attractive, the question remains whether USP7 functions as a H2A 
deubiquitinase in differentiated HCT-116 cells.  
Another scenario also considering a bivalent regulation strategy would take up the idea of 
ubiquitinylated H2B (A.2.3.2). USP7 could help to maintain a transcriptionally ‘low-active’ 
chromatin state or assist in gene repression by constantly removing the activating ubiquitin 
moiety from H2B. Considering this idea, USP7’s function would not be restricted to homeotic 
gene regulation but affect gene regulation in general or in response to cell signaling due to 
extracellular stimuli, stress response or cell damage. 
However, a different observation was made in Drosophila that pointed towards a specific role 
in homeotic gene regulation. Global H3K27me3 levels were strongly reduced upon 
knockdown of USP7 whereas global ubH2B levels were not affected ((van der Knaap et al. 
2005), unpublished data; C.1.14). Importantly, the histone demethylase UTX associates with 
promoters of Hox gene clusters and interacts with the HMT MLL2/3 during retinoic acid 
signaling, resulting in H3K27 demethylation and H3K4 methylation respectively (Lee et al. 
2007b). An increase of ubH2B would induce a chromatin environment prone to active 
transcription concomitant with H3K27 demethylation.  
As speculated for ubH2A, USP7 could assume additional functions dependent on the gene 
context and other transcription/repressive factors associated besides regulation of 
Dnmt1/ICBP90 activity. 
 
D.1.1.4 Dnmt1 remains inactive at the POLR2A gene 
USP7 and Dnmt1, but not ICBP90 were associated with the actively transcribed POLR2A 
gene. As depicted before, USP7 could inhibit the enzymatic activity of Dnmt1 -  an idea that 
we will address in the future. Furthermore, ICBP90 as a possible activator of Dnmt1 is absent 
from the POLR2A promoter resulting in impaired DNA methylation. The association of 
Dnmt1/USP7 further suggests that there are other targeting mechanisms besides ICBP90. 
Therefore, targeting of Dnmt1/USP7 could be mediated by either an unknown factor or 
possibly even ubiquitinylated H2B. USP7 could act like USP21, being involved in the gene 
transactivation processes that require multiple rounds of histone H2B ubiquitinylation and 
H2B deubiquitination (A.2.3.2) or gene repression. 
 
D.1.2 USP7 could be involved in mammalian development 
The associations of USP7 with DNA methyltransferases and UHRF1 point towards a role in 
epigenetic regulation. Moreover, USP7 is essential in Drosophila and mutations enhance 
defects of Polycomb mutations (van der Knaap et al. 2005). Since USP7 interacts with 
UHRF1 and Dnmt1 but as well with Dnmt3a and Dnmt3b (C.1.5), it would be interesting to 
unravel the role of USP7 during mammalian development especially in regard to DNA 
methylation.  
With conditional knockout mice, the effect of USP7 on imprinting and methylation of repetitive 
elements during gametogenesis could be monitored. The effect of USP7 knockout on DNA 
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methylation could also be analyzed in ES cells. The localization of USP7 to certain genomic 
regions in a Dnmt double-knockout (DKO; Dnmt3a/b(-/-)) or triple-knockout background 
(TKO, Dnmt1, 3ab (-/-)) could be studied to answer whether Dnmts represent major 
recruitment factors for USP7 to heterochromatic regions. Importantly, studies on the cellular 
localization of all three proteins have not been performed yet but would give intriguing 
answers on the possible function. 
Moreover, although DNA methylation is absent from Drosophila, USP7 localized to silenced 
homeotic gene clusters and CHIP analysis demonstrated occupancy of USP7 and Polycomb 
(PRC1 component) at the ubx PRE (van der Knaap et al. 2005). All three proteins were 
bound at the HoxA7 locus (C.1.15) and Dnmt1 had been shown to interact with components 
of PRC1 and PRC2 complexes (Viré et al. 2005; Negishi et al. 2007; Wu et al. 2008) 
indicating a function in a PcG dependent context. 
Thus, direct interaction of USP7 with prominent factors of PcG and analysis on the co-
localization with Hox gene clusters either with FISH or PcG proteins could shed light into this 
particular aspect of USP7 in vivo function. 
 
D.1.3 USP7 could regulate the stability of ICBP90 
ICBP90 and USP7 are endowed with two antagonistic enzymatic activities (A.2.2, A.2.4) that 
suggest reciprocal regulation (D.1). 
Dnmt1 is recruited to sites of hemi-methylated DNA by ICBP90 (Bostick et al. 2007; Sharif et 
al. 2007). The expression of ICBP90 peaks during G1/S-phase transition and is down-
regulated during G0 and G1 (Fujimori et al. 1998; Hopfner et al. 2000), although it is 
expressed at slightly elevated levels throughout the cell cycle in cancer cells . As seen in 
vitro (C.1.10), USP7 could prevent the poly-ubiquitinylation of ICBP90 and possibly of Dnmt1 
during S-phase by constantly removing ubiquitin moieties. After replication, USP7’s activity 
could be impaired by several means such as posttranslational modification {(Fernández-
Montalván et al. 2007)}, binding of an inhibitor protein or exclusion from the nucleus (Zapata 
et al. 2001), eventually leading to degradation of ICBP90. Subsequently, Dnmt1 would 
dissociate from ICBP90 consistent with its diffuse localization in the nucleoplasm during G1 
and G0 (Leonhardt et al. 1992).  
The in vivo studies on ICBP90 protein levels and ubiquitinylation status upon knockdown and 
over-expression of USP7 were difficult to interpret (C.1.12, C.1.13), firstly due to the fact that 
MG132 - a potent proteasome inhibitor – was not added prior to cell harvest and thus 
ubiquitinylated species were not properly accumulated. Secondly, ubiquitinylated species do 
only account for a subpopulation of the target protein, making purification of sufficient 
amounts with the dsk2p ubiquitin binding protein a bold venture.  
A probably better method for investigation of the reciprocal activities of ICBP90 and USP7 in 
vivo are transfection experiments that should be performed with HA-tagged ubiquitin (Treier 
et al. 1994) and the two POIs expressed with different tags. Flag-ICBP90 could be 
immunoprecipitated from WCEs and the effect of USP7 or its inactive site mutant USP7 
C223S on deubiquitination detected with an anti HA-antibody. Vice versa, the ubiquitinylation 
status of USP7 C223S could be monitored when either co-transfecting with ICBP90 or the 
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inactive ICBP90∆RING. The ubiquitinylation/deubiquitination of Dnmt1 by ICBP90 and USP7 
could be revised as well. For optimal results, transfection efficiency must be close to 100% 
which can be visually checked with fluorescence microscopy or when the gene of interest 
precedes an internal ribosome entry site (IRES) and a GFP gene. Alternatively, transfected 
cells could be sorted with FACS. In order to express the two effector proteins in equal 
amounts, an expression vector with a bidirectional promoter should be used.  
The method of ‘pulse-chase’ with 35S-labeled methionine could also be applied to examine 
protein stability. Cells deprived of methionine are treated with medium containing radioactive 
methionine (‘pulse’). After incubation for 30-40min, the medium is removed, fresh medium 
added and cells harvested at given timepoints (‘chase’). WCE are prepared and proteins 
subjected to SDS-PAGE following radiography. The decline of radioactively labeled proteins 
is a degree for the half-life thus stability of the protein. When comparing cells either 
transfected with USP7 or USP7 C223S, the effect on the protein stability of tagged-ICBP90 
could be monitored. In order to circumvent p53 dependent G1 arrest upon over-expression of 
USP7, it would be advisable to work with HCT-116 p53 (-/-) cells. 
If ubiquitinylated H3 represents a binding platform for other factors or affects chromatin 
structure or formation especially during replication, loss of ubH3 could result in possible 
severe effects that could be visible in immunocytochemistry. By use of a knock-down-knock-
in system (Hölzel et al. 2007), the endogenous ICBP90 could be down-regulated and 
replaced by the inactive ICBP90∆RING (or a point mutation in the RING domain). Besides 
localization and possible effects on genomic stability or cell cycle, inactive ICBP90 could be 
purified (by Flag-tag) and associated histones analyzed for ubiquitinylated H3. Furthermore, 
changes on global ubH3 levels could be analyzed by Western Blot for acidic extracted 
histones.  
 
D.1.4 Is USP7 involved in silencing of telomeres and rDNA genes? 
As summarized in the introduction, ubiquitinylated H2A is generally associated with gene 
silencing and ubiquitinylated H2B with gene activation (A.2.3.1; A.2.3.2) (Osley 2006; 
Shilatifard 2006). In S. cerevisiae, Ubp10 was found to deubiquitinate H2B at telomers thus 
providing for an environment devoid of histone marks associated with active genes and 
allowing for Sir4 spreading and silencing (Emre et al. 2005; Gardner et al. 2005). In addition, 
a function in silencing of genes that are not in the vicinity of heterochromatin was found. 
Although not investigated in detail, Utp10 was also enriched at the rDNA locus which is 
silenced in dependency of Sir2 (Rusche et al. 2003) and Utp10-knockout increased 
H3K4me3 in these regions (Emre et al. 2005). Recently, the importance of DNA methylation 
of subtelomeric regions for telomere length and telomere recombination was demonstrated 
(Gonzalo et al. 2006; Benetti et al. 2007). In human cells lacking Dnmt1 but not Dnmt3b, a 
decrease in DNA methylation and an increase in H4K16ac at the rDNA genes could be 
observed (Espada et al. 2007) concomitant with the absence of SirT1 (the homolog of yeast 
Sir2) from the rDNA.  
From these observations, one could outline a function of USP7 related to Ubp10 in S. 
cerevisiae. In this scenario, not USP7 but Dnmt1 would be recruited, hence in Dnmt1 
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knockout cells, USP7 would no longer be targeted to the rDNA genes following increasing 
levels of ubH2B. Ubiquitinylated H2B in turn would affect increase of H3K4me3 and 
H3K79me3 that counteract SirT1 binding and spreading.  
Localization of USP7 to telomeric regions and rDNA repeats on acrocentric chromosomes 
(Henderson et al. 1972) in combination with FISH should give an idea of this possible 
function. Chromatin immunoprecipitation would be another method to prove occupancy at 
these genomic regions. In order to elucidate the functional importance in silencing and 
nucleolar and telomeric stability together with SirT1, knockdown of USP7 might affect SirT1 
recruitment and spreading, although it is not known whether DNA methylation and other 
heterochromatic marks are sufficient to maintain the heterochromatic state. Disruption of 
telomeric and nucleolar structures would not be visible. Local analysis of alterations of 
histone modifications and occupancies of factors with chromatin immunoprecipitation would 
probably display a more detailed picture and could probably unravel less severe effects of 
USP7 ablation. 
 
D.1.5 USP7 –  the next steps 
Considering the above-mentioned data and the interaction of USP7 with Dnmt1 and ICBP90, 
both being heterochromatin associated factors, it is intriguing to analyze the role of factor 
recruitment, regulation of enzymatic activity and thus regulation of transcription.  
The order of factor binding to DNA/nucleosomal templates as well as the effect on DNA 
methylation, H3 ubiquitinylation/deubiquitination by ICBP90 and USP7 could be verified in 
vitro on reconstituted biotinylated DNA.  
The question of protein ubiquitinylation/deubiquitination could be revised and possible 
consequences on enzymatic activity tested, especially in regard to DNA methylation. Above 
all, the notion of a possible inhibitory effect of USP7 and a stimulatory effect of ICBP90 
towards Dnmt1 mediated DNA methylation should be answered. In regard, a 
Dnmt1/ICBP90/USP7 complex could be reconstituted in vitro and the activity analyzed. The 
intriguing role of ubH3 could be addressed with the knock-down-knock-in system, replacing 
active ICBP90 by its inactive counterpart.  
In order to reveal the function of USP7 in silencing, future work should predominately 
address localization by means of microscopy and chromatin immunoprecipitation. 
USP7 was shown to localize to the nucleus via its N-terminal TRAF-domain (Zapata et al. 
2001). However, the distribution of USP7 within the nucleus and the localization to specific 
regions such as telomeres, centromers or other regions of heterochromatin have not been 
analyzed although they could already be indicative of possible functions. In particular, the 
localization of USP7 during the cell cycle and the question of its co-localization with Dnmt1 
and ICBP90 during S-phase are important clues of functional relevance.  
In order to verify a possible co-localization or even interaction with certain factors in vivo, 
analysis by means of chromatin immunoprecipitation would be the method of choice. In 
regard to the role of ubiquitinylated H2A and H2B in gene silencing, antibodies directed 
against H2AK119ub1 (Vassilev et al. 1995) and H2BK120ub1 (Minsky et al. 2008), histone 
marks for repression (H3K9me3, H3K27me3) or activation (H3K4me3, H3K36me3, 
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H3K79me3, H4K20me3) and specific proteins associated with certain genomic regions or 
transcriptional states should be applied. Of particular interest are the changes in occupancy 
of factors or histone marks at a certain gene loci upon over-expression or knockdown of 
USP7. Further elucidation of possible mutual regulatory mechanisms, order of factor 
recruitment or the interdependency of histone marks would require the knockdown/over-
expression of co-localizing factors. 
 
D.2 DNA methylation in chromatin 
D.2.1 Binding of DNA and nucleosomes by Dnmt3a and Dnmt3b2 in vitro 
The minimal DNA length that was required for stable binding of the de novo DNA 
methyltransferases in EMSA was found to be >35 bp (C.3.1). In contrast, studies with C-
terminal domains of mouse Dnmt3a revealed partial binding to DNA >20bp of size in 
gelfiltration chromatography (Jia et al. 2007), suggesting that the N-terminal domain might 
affect protein conformation and thus DNA binding properties. Furthermore, a preference of 
binding to longer DNA fragments was observed, indicating a mechanism of cooperative 
binding of the de novo DNA methyltransferases. Recently, the C-terminal domains of Dnmt3a 
and Dnmt3L were found to form nucleoprotein filaments that are in agreement with the notion 
of cooperative binding (Jurkowska et al. 2008). Albeit the feature of cooperative binding 
association with DNA was shown to be highly dynamic (C.3.2). This observation may reflect 
a property of distributive DNA methylation that has been assigned to Dnmt3a and Dnmt3b 
compared to processive maintenance DNA methylation by Dnmt1 (Gowher and Jeltsch 2001; 
Hermann et al. 2004b).  
In accordance with previous data Dnmt3L stimulated the activity of Dnmt3a and Dnmt3b 
roughly 1.6- and 3.0-fold respectively (Suetake et al. 2004). Dnmt3L could not bind to DNA 
(C.4.2) confirming previous EMSA data (Suetake et al. 2004), but contrasting results that 
were obtained by surface plasmon resonance and filter binding assays (Gowher et al. 
2005a). In agreement with the observation of filament formation, Dnmt3L enhanced binding 
of free DNA by Dnmt3a and Dnmt3b2 (C.4.2). 
Is there a biological relevance of filament formation on ‘naked’ DNA, taking into account that 
DNA is packaged into chromatin in vivo? As already outlined in the introduction (A.3.7), the 
Dnmt3a/Dnmt3L tetrameric complexes that form nucleoprotein filaments (Jia et al. 2007; 
Jurkowska et al. 2008) could explain the periodical DNA methylation pattern of 8-10bp of 
maternally imprinted DMRs. This would imply either complete eviction of nucleosomes in the 
region to be imprinted or a mechanism such as FACT for RNA Polymerase II transcription 
(LeRoy et al. 1998) that removes or partially disassembles nucleosomes for the ‘growth’ of 
the D3a/D3L or possible D3b/D3L filament.  
The aspect of filament formation could be addressed in vitro with chromatin reconstitution on 
circular DNA with Drosophila embryonic extract (DREX), reflecting dynamic properties of 
cellular chromatin (E.2.10.1). The Dnmt3a/Dnmt3L dependent removal of nucleosomes could 
be analyzed with a DNA supercoiling assay revealing the number of nucleosomes present on 
the DNA. Filament formation could be monitored in vivo when either Dnmt3a or Dnmt3L 
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fused to a DNA binding domain was tethered to a specific site. DNA methylation, 
endonuclease digestion and indirect endlabeling experiments could reveal potential 
spreading of Dnmt3a/Dnmt3L tetramers. 
Although the interaction of the de novo DNA methyltransferases with free DNA might function 
similarly, different nucleosomal matrices with different lengths of linker DNA and linker DNA 
on either one or both sides demonstrated differences in the binding behavior of Dnmt3a and 
Dnmt3b2 (C.3.3).  
Except for preferential binding to the 77WID77 nucleosome, Dnmt3a generally bound to 
mono-nucleosomal substrates and DNA equally well (C.3.3). Studies on the 5S rDNA 
fragment (208bp) revealed a similar behavior for Dnmt3a with comparable effects on ‘naked’ 
DNA and mono-nucleosomes (Robertson et al. 2004). Although examined in individual 
EMSA reactions rather than in an internally controlled mixture, DNA and nucleosomal 
templates (MMTV-A145/242bp, 5S rDNA 155/220bp) were all shifted with equal amounts of 
Dnmt3a, indicating no preference for either substrate.  
Dnmt3b2 behaved differently in a way that free DNA and nucleosomes with longer DNA 
linkers were preferred over mono-nucleosomes with shorter linker DNA. These observations 
point out that DNA is the preferred substrate by Dnmt3b2. In accordance, EMSAs with 
Dnmt3b together with different DNAs and a mixture of nucleosomal templates revealed 
preferential binding to nucleosomes with linker DNA compared to nucleosomes without linker 
DNA (Takeshima et al. 2006). Moreover, the PWWP domain of Dnmt3b showed higher DNA 
binding affinities than the one of Dnmt3a (Chen et al. 2004) reflecting different binding 
characteristics. 
Considering the difference of binding between symmetric and asymmetric nucleosomes, one 
could imagine two possible modes of binding. Either two linker DNAs provide double the 
amount of binding sites and possibly binding of one strand by Dnmt3 somehow facilitates 
binding of another Dnmt3 protein to the second linker DNA or the DNA at the entry/exist site 
of the nucleosome, forming a cruciform-like structure, is preferentially bound. With the latter 
mechanism and the difference of DNA affinity exhibited by the PWWP domain of Dnmt3a 
and Dnmt3b, the observations could be explained. 
With regard to this idea, Dnmt3b2’s binding affinity towards a potential cruciform DNA would 
be comparable to that of the PWWP domain towards free DNA whereas for Dnmt3a the latter 
would be lower. Hence, symmetric mono-nucleosomes with long linker DNA and free DNA 
would represent comparable binding substrates for Dnmt3b2. In contrast, Dnmt3a would 
rather bind to mono-nucleosomes with long linker DNA than to DNA. When comparing 
binding properties of Dnmt3b2 towards ‘naked’ DNA and asymmetric nucleosomes without 
potential cruciform structure, the amount of free DNA available for binding would become the 
key determinant. In contrast Dnmt3a’s DNA binding affinity is lower, thus free DNA and 
asymmetric mono-nucleosomes would be shifted comparably well in EMSA.  
The potential binding of Dnm3a and Dnmt3b2 to cruciform structures could be tested with in 
vitro formed cruciform DNAs that could be verified with antibodies directed against cruciform 
structures or cruciform binding proteins. Moreover, the DNA length for optimal binding to a 
nucleosomal cruciform could be analyzed. Linker histone H1, located at the entry/exit sites of 
the nucleosome (Woodcock et al. 2006), was shown to inhibit DNA methylation of di-
DISCUSSION 
95 
nucleosomes by Dnmt3a (Takeshima et al. 2008). Therefore, potential binding of Dnmt3a 
and Dnmt3b to the entry/exit sites of nucleosomes could be inhibited by H1. 
Another approach to elucidate the binding mechanism of Dnmt3s to nucleosomes would be 
the determination of the exact binding sites of Dnmt3a and Dnmt3b2 on different 
nucleosomal templates. Footprint assays could be performed on distinct Dnmt3/nucleosome 
complexes.  
 
D.2.2 Dnmt3L is stably associated with endogenous nucleosomes 
Dnmt3L did not bind to nucleosomal templates in EMSA experiments (C.4.2) despite of 
stable association during purification from Sf21 cells (C.4.1). Furthermore, EMSAs with 
nucleosomes assembled with recombinant histones from E. coli constituting 100% of non-
methylated H3K4 showed the same behavior. Accordingly, the data suggest either an 
unknown loading factor or a possible set of specific histone modifications to a specific 
sequence or structure that could serve as a stable binding platform for Dnmt3L. When the de 
novo methyltransferases were incubated with nucleosomal templates and Dnmt3L, an 
altered binding behavior was observed, although the results were not conclusive (C.4.2). 
Therefore, changes in binding behavior to different nucleosomal species should be analyzed 
individually. 
 
Interestingly, Dnmt3L remained associated with endogenous nucleosomes when separated 
on a sucrose density gradient whereas ‘free’ Dnmt3L incubated with DNA or reconstituted 
chromatin (C.4.1) entered approximately one third of the gradient suggesting that DNA and 
reconstituted chromatin do not represent the optimal binding substrate.  
Hence, the question remains why Dnmt3L stays stably associated with endogenous 
nucleosomes from Sf21 cells. In order to address these questions in the future, the following 
experiments could be envisioned. 
First, Dnmt3L should either be stably or transiently transfected into mammalian cells and the 
association with endogenous histones should be verified. Comparison of posttranslational 
modifications of co-purified histones with histones obtained through acidic extraction would 
allow determination of modifications being responsible for potentially binding of Dnmt3L.  
Second, although no other prominent proteins except for histones were detected during the 
Dnmt3L purification procedure, a possible loading factor that either transiently interacts with 
Dnmt3L or is present in substoichiometric amounts could be imagined. Formaldehyde cross-
link of cells following Dnmt3L purification and SDS-PAGE analysis could disclose temporarily 
associated factors. Third, to test for sequence dependent binding or specific chromatin 
structures, mammalian nuclei could be exposed to different MNase conditions following 
purification of Dnmt3L. In addition, it would be interesting to find out which regions of the 
genome are associated with Dnmt3L. Chromatin immunoprecipitation following Micro-Array 
analysis (CHIP-on-CHIP) could reveal whether Dnmt3L is associated with imprinted DMRs 
and retrotransposons (LINEs) or randomly distributed. 
Fourth, in order to examine the role of RNA in the Dnmt3L/nucleosome interaction, Dnmt3L 
and co-purified chromatin could be treated with RNAse. 
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Another approach that could be applied is chromatin assembly with the DREX system in the 
presence of Dnmt3L following analysis on the sucrose gradient. If stable association 
occurred, one could address whether Dnmt3L is an integral part of the reconstituted 
chromatin and therefore, needs to be added at the onset of the reaction, or tightly associates 
to chromatin structure, hence addition after assembly should be sufficient.  
 
D.2.3 DNA methylation of mono-nucleosomes 
Radioactive DNA methyltransferase assays with Dnmt3a and Dnmt3b2 were performed with 
three different substrates: free DNA (MF79/80; 342bp), mono-nucleosomes with symmetric 
linker DNA (MF79/80; 342bp) and mono-nucleosomes without linker DNA (MF124/125; 
147bp) (C.3.5).  
In a reaction setup with substrate saturating conditions, both Dnmt3a and Dnmt3b2 
methylated free DNA and mono-nucleosomes with linker DNA equally well although the 
overall methylation efficiency differed from Dnmt3a to Dnmt3b2. This is in agreement with the 
notion that DNA and mono-nucleosomes with long linker DNA were bound similarly well 
(C.3.3). 
Affirmative, comparable maximum velocities for the methylation of DNA and mono-
nucleosomes with linker DNA (220bp, 5S rDNA) were found for Dnmt3a and Dnmt3b 
(Robertson et al. 2004; Takeshima et al. 2006). However, the amount of CpG sites applied 
were 5-15 fold higher for mono-nucleosomes indicative of different KM values for DNA and 
mono-nucleosomes although similar association constants for both substrates were 
determined in EMSA experiments (Robertson et al. 2004; Takeshima et al. 2006).  
Interestingly, nucleosomal DNA was hardly methylated at all (C.3.5). Quantitative analysis 
revealed a 35-fold and a 27-fold reduction of absolute DNA methylation towards mono-
nucleosomes (147bp) of Dnmt3a and Dnmt3b2 respectively. This clearly indicates that DNA 
wrapped around the histone octamer represents a major obstacle to DNA methylation by the 
de novo DNA methyltransferases. From the extremely low activity of mono-nucleosomes 
(roughly 3% compared to ‘naked’ DNA), it is hard to judge whether it is caused by residual 
free DNA from the nucleosome assembly or from specific methylation within the nucleosome.  
Therefore, a detailed single-molecule analysis of DNA methylation with the method of 
bisulfite conversion (E.2.13) was performed (C.3.6). In contrast to the incorporation of 3H- or 
14C labeled methyl-groups, following scintillation counting or PAGE-based quantitation 
respectively, this technique allows both analysis of each potential CpG target site and 
discrimination between sense and anti-sense strands.   
The bacterial DNA methyltransferase M.SssI which served as a reference, efficiently 
methylated both the (+) and the (-) strand of the ‘naked’ and the nucleosomal template. DNA 
methylation did not occur within the nucleosomal core which in accordance with previously 
described data (Kladde et al. 1999) (Okuwaki and Verreault 2004). 
Similarly, Dnmt3b2 methylated both the upper and the lower strand, but less efficient than 
M.SssI indicating possible sequence preferences (Handa and Jeltsch 2005). Residual DNA 
methylation was found at CpG sites located at the entry/exist sites of the nucleosome and for 
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two positions within the nucleosome. The methylation pattern suggests that residual 
methylation in the 3H-assay originates from a low-level of nucleosomal methylation. 
Other data on the methylation of nucleosomes by Dnmt3b pointed out that Dnmt3b was able 
to methylate within the nucleosome (Takeshima et al. 2006). However, the DNA methylation 
read-out was based on an error prone radioactive assay analyzing MNase treated and gel-
purified nucleosomal fragments. The method of bisulfite treatment is superior since single 
molecules can be analyzed and possible contamination of free DNA directly be seen.  
 
The reaction efficiency of Dnmt3a towards DNA and nucleosomal matrices was extremely 
low which originated from a non-saturated reaction setup regarding the amount of template 
used. Nevertheless, the overall picture of DNA methylation in chromatin by Dnmt3a 
resembles the results given by Dnmt3b2. In fact, latest DNA methylation experiments using 
optimal reaction conditions (data not shown) reveal a similar picture of nucleosomal DNA 
methylation by Dnmt3a. 
In contrast, published data claimed equal methylation efficiencies of Dnmt3a towards free 
DNA and mono-nucleosomes (147bp) (Gowher et al. 2005b) as determined from gel 
separation based quantitation. However, their bisulfite analysis of nucleosomal DNA showed 
a methylation efficiency comparable to that of Dnmt3b2, indicating that indeed DNA 
methylation is restricted within the nucleosome. 
In agreement with my results, recent data showed that Dnmt3a scarcely methylated the DNA 
within the core region, but preferentially methylated the linker DNA between two 
nucleosomes in vitro (Takeshima et al. 2006; Takeshima et al. 2008). 
 
Our data suggest that DNA methylation within nucleosomes does not occur in vivo at all 
considering nucleosomal arrays and higher order chromatin structures. In addition, histone 
H1 was found to inhibit DNA methylation of linker DNA by Dnmt3a (Takeshima et al. 2008). 
Nucleosomes represent a major barrier for de novo DNA methylation in vitro indicating that 
enzymatic activities like chromatin remodeling enzymes that move or assemble/disassemble 
nucleosomes are required. 
As described in the introduction, Dnmt3a and Dnmt3b were found in complexes with 
remodeling enzymes (A.3.8). Recently, it was demonstrated that different chromatin 
remodeling machines with intrinsic binding preferences of nucleosomes establish specific 
nucleosome positioning patterns (Rippe et al. 2007b). Accordingly, in vivo distinct chromatin 
structures could be created defining DNA accessibility for DNA methyltransferases and other 
chromatin associated factors. In fact, nucleosome remodeling dependent silencing by NoRC 
was shown to be a prerequisite for histone H4 deacetylation, H3K9 methylation and DNA 
methylation at a defined CpG site in the upstream control element of the rDNA gene 
promoter (Santoro and Grummt 2005). 
From a mechanistic point of view, it will be interesting to decipher the underlying molecular 
mechanisms of chromatin remodeling and DNA methylation.  
Since DNA methylation does not occur within the nucleosome, the first question to follow up 
is whether moving of histones by chromatin remodeling enzymes is sufficient to create 
accessibility for CpG site methylation. DNA methyltransferase assays with simultaneous 
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nucleosome ‘sliding’ could be performed. In vitro chromatin remodeling reactions are 
substoichiometric in regard to remodeling enzymes, hence once the nucleosome is moved, 
the remodeler should dissociate and not interfere with binding of Dnmts. This notion would 
imply that the reaction would follow an endpoint and therefore, the released nucleosome 
position would represent a low-affinity target for the remodeler. With a different chromatin 
remodeling enzyme, the remodeling reaction could be much more dynamic, i.e. the adjusted 
nucleosome position also serves as a substrate for the remodeling enzyme and is then 
moved back to its original position. Whether a ‘window of opportunity’ for DNA methylation 
between the forward and reverse reaction exists remains elusive. In this regard, it would be 
intriguing to see whether DNA methylation can affect the DNA sequence/nucleosome affinity 
of the remodeling machine. If the affinity was lowered by DNA methylation, the nucleosome 
would be moved back to its original position but would not be relocated again, leading to an 
equilibrium on the side of the ‘starting’ position but with methylated DNA. If the affinity was 
increased, the equilibrium would be shifted to the side of the second nucleosome position.  
Therefore, modulation of substrate affinities of chromatin remodeling machines through DNA 
methylation could be a trigger to adjust certain nucleosome positions conferred with a certain 
transcriptional state. So far unknown active DNA demethylation enzymes or other 
remodelers with a different substrate affinity could reverse this process. 
Alternatively to nucleosome ‘sliding’, disassembly of the nucleosome could be required for 
full methylation, following nucleosome assembly analogous to chromatin formation after 
replication.  
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E MATERIALS AND METHODS 
E.1 Chemicals, radioactive material, enzymes and media 
Unless otherwise stated, all common chemicals and materials were ordered at Merck, 
Roche, Roth and Sigma. Radioactive S’adenosyl methionine was ordered at GE Healthcare/ 
Amersham (TRK581-250UCi, 9.25MBeq with 1.0mCi/ml 63.0Ci/mmol). 
 
E.1.1 Chemicals 
BSA (albumin fraction V) Genaxxon 
BSA (fatty acid free; CHIP) SIGMA A-7511 
Bluo-Gal Invitrogen 
P-Per (bacterial protein extraction Kit) Pierce 
Bromphenolblue Serva  
Dimethylsulfoxid (DMSO) Merck 
Dithiothreitol (DTT) Merck 
Ethidiumbromide 10 mg/ml Roth 
Glycogen (CHIP) Roche (901-393) 
β-Mercaptoethanol (14,3 M) Sigma 
Milk powder Sucofin 
Protein A/G sepharose GE Healthcare; E. Kremmer GSF 
Phenylmethylsulfonylfluoride (PMSF) Roth 
Phenol/ Cholorform/ Isoamylalcohol 25/ 24/ 1 Roth 
Polyethyleneglycol 8000 Roth 
RNasin 40U/µl NEB 
S’adenosly methionine (SAM) Sigma A7007  
Salmon Sperm DNA (CHIP) Invitrogen Gibco (15632-011) 
SYBR Safe Invitrogen 
N,N,N',N'-Tetramethylethylendiamine (TEMED) Roth 
 
E.1.2 Standard solutions 
Stock solutions, buffers and bacterial growth media were made according to standard 
protocols (Sambrook and Russel 2001; LabFAQS, Roche). Additional buffers are described 
in the individual method sections. If not stated differently, all buffers are stored at room 
temperature 
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E.1.3 Enzymes 
Restriction endonucleases were purchased from New England Biolabs if not stated 
differently.  Other enzymes used are given in the respective section. 
 
E.1.4 Protease inhibitors, antibiotics 
Aprotinin bovine Genaxxon (M6361.01) 
Ampicillin Sigma 
Kanamycin Sigma 
Tetracycline Sigma 
Blasticidin S hydrochloride Invivogen 
Gentamycin sulfate  Genaxxon (M3121) 
Leupeptin hemisulfate Genaxxon (M6100.0100) 
MG132 (Z-Leu-Leu-Leu-al) Sigma (C2211) 
N-Ethylmaleimide (NEM) Sigma (E3876) 
Pepstatin A Genaxxon (M6359.01) 
Penicillin/Streptomycin Invitroge/ Gibco (15140) 
Zeocin  Invivogen 
 
E.1.5 Software and online tools 
 
Application Author 
Biq Analyzer Bock, 2005 #1802} www.biq-analyzer.bioinf.mpi-inf.mpg.de/ 
NEB double digest finder New England Biolabs (www.neb.com) 
Oligo Perfect designer Invitrogen  (www.invitrogen.com) 
PeptideCutter Gasteiger et al., 2005(www.expasy.org) 
Phyre Benett-Lovsey et al. (2008)  (http://www.sbg.bio.ic.ac.uk) 
Primer 3 www.primer3.sourceforge.net/webif.php 
Reverse Complement (www. bioinformatics.org) 
VectorNTI Invitrogen  (www.invitrogen.com) 
Netprimer Premierbiosoft  (www.premierbiosoft.com) 
 
E.1.6 Antibodies 
List of antibodies used for Western Blot analysis and immunoprecipitation 
. 
Table 3  antibodies 
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antibody source species application comment 
anti 
actin 
Sigma 
A2066 
rabbit 
polyclonal 
WB: very good signal 
on HeLA WCE 30µg 
with 1:2500 dilution 
Antigene: the C-terminal actin fragment 
(C11 peptide, Ser-Gly-Pro-Ser-Ile-Val-
His-Arg-Lys-Cys-Phe) attached to 
Multiple Antigen Peptide (MAP) 
backbone. 
anti 
Dnmt1 
2G3-1 
E. Kremmer, 
Helmoltz 
Gesellschaft 
rat 
monoclonal, 
IgG2a 
TCS, WB 1:20- 
1:100, IP 20µl 
proteinG beads + 
400µl TCS 
recognizes aa 1-300 of human Dnmt1. 
anti 
Dnmt1 
2E8-1 
E. Kremmer, 
Helmoltz 
Gesellschaft 
rat 
monoclonal, 
IgG2b 
TCS, WB 1:20- 
1:100, IP 20µl 
proteinG beads + 
400µl TCS 
recognizes aa 1-300 of human Dnmt1. 
Also recognizes mouse Dnmt1 (acc. To 
U. Rothbauer) 
anti 
Dnmt1 
2C1 
E. Kremmer, 
Helmoltz 
Gesellschaft 
rat 
monoclonal, 
IgG2b 
TCS, WB 1:20- 
1:100, IP 20µl 
proteinG beads + 
400µl TCS 
recognizes aa 316-330 of human 
Dnmt1. Does not recognizes mouse 
Dnmt1. 
anti 
Dnmt1 
2C12-1 
E. Kremmer, 
Helmoltz 
Gesellschaft 
rat 
monoclonal, 
IgG2b 
TCS, WB 1:20- 
1:100, IP 20µl 
proteinG beads + 
400µl TCS 
recognizes aa 316-330 of human 
Dnmt1. Does not recognizes mouse 
Dnmt1. 
anti -
Dnmt3a 
abcam 
ab16704 
rabbit 
polyclonal 
IgG 
WB, use at 1:1000 
dilution 
raised against human Dnmt3a aa 10-
118 
anti -
Dnmt3a 
abcam 
ab2850 
rabbit 
polyclonal 
IgG 
WB, use at 1:1000 
dilution 
raised against mouse Dnmt3a aa 86-
100. 
anti 
D3A2 
6A4 
E. Kremmer, 
Helmoltz 
Gesellschaft 
rat 
monoclonal 
TCS, WB 1:20- 
1:100, IP 20µl 
proteinG beads + 
400µl TCS 
raised against peptide 
KRKRDEWLARWKREAE of human 
Dnmt3a1 conjugated to BSA. Does not 
recognize Dnmt3a2 (mistake).  
anti 
Dnmt3b1 
abcam ab 
13604 
mouse 
monoclonal, 
IgG1 
WB, use at 1:500 
dilution 
raised against histagged recombinant 
Dnmt3b 
anti 
Dnmt3b 
abcam ab 
2851 
rabbit 
polyclonal, 
IgG 
WB, use at 1:1000 
dilution 
raised against mouse Dnmt3b aa 1-14, 
might cross react with D3a in WB 
anti 
D3B2-
2C1 
E. Kremmer, 
Helmoltz 
Gesellschaft 
rat 
monoclonal 
TCS, WB 1:20- 
1:100, IP 20µl 
proteinG beads + 
400µl TCS 
raised against peptide 
CYNNGKDRGDEDQS of human 
Dnmt3b conjugated to BSA. 
Recognizes Dnmt3b1(aa 403- 416) and 
Dnmt3b2 (aa383-396).  
anti Flag 
M2 Sigma 
mouse 
monoclonal 
WB, use at 1:3000 
dilution raised against Flag-epitope DYKDDDD 
anti H2A upstate 07-146 
rabbit 
polyclonal 
WB, use at 1:1000 
dilution 
epitope: KLH-conjugated, synthetic 
peptide corresponding to amino acids 
88-97 (IRNDEELNKL-C) of human 
Histone H2A; used by (Nicassio et al. 
2007) 
anti H2B upstate- 07371 
rabbit 
polyclonal 
WB, use at 1:1000 
dilution 
epitope: peptide corresponding to 
amino acids 118-126 (CG-
AVTKYTSSK) of human Histone H2B 
(used by (van der Knaap et al. 2005; 
Nicassio et al. 2007)) 
anti H3 abcam ab 1791 
rabbit 
polyclonal 
WB, use at 1:1000 
dilution 
epitope: synthetic peptide conjugated to 
KLH derived from within residues 100 
to the C-terminus of Human Histone H3 
(used by (Nicassio et al. 2007; Németh 
et al. 2008) 
anti H4 upstate 07-108 
rabbit 
polyclonal 
WB, use at 1:1000 
dilution  
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anti 
HAUSP/ 
USP7 
Bethyl 
laboratories 
rabbit 
polyclonal 
WB, use at 1:5000 
dilution 
raised against human HAUSP  aa 1-50, 
tested in Hela extracts; WB testet 
1:5000- 1:10000 with 10-20µg of 
extract. (1µg/µl concentration). IP on 
recombinant and endogenous protein 
(2µg antibody/ 1-2mg WCE from HeLa 
or HEK 293 cells) 
anti 
HDAC1 
Santa Cruz; 
sc-7872 
rabbit 
polyclonal 
WB, use at 1:500 
dilution 
HDAC1 (H-51) is a rabbit polyclonal 
antibody raised against amino acids 
432-482 of HDAC1 
anti His Qiagen mouse monoclonal 
WB, use at 1:3000 
dilution anti-penta His antibody 
anti 
ICBP90/
NP95 
BD 
Transduction 
laboratories 
612264 
mouse 
monoclonal, 
IgG2a 
WB, use at 1:1000-
2000 dilution 
Immunogen raises against human 
ICBP90 aa 199-298. According to the 
references (Hopfner et al. 
2000),(Hopfner et al. 2001) it might be 
the same antibody sent by C. Bronner.  
(Used in CHIP (Unoki et al. 2004; 
Jeanblanc et al. 2005)) 
anti 
ICBP90 
C.Bonner, 
Hopfner et al 
2000 
mouse 
monoclonal 
WB, use at 1:5000 
dilution 
mouse monoclonal antibody 1RC1C-
10, raised against C-term starting from 
D263.(1µg/µl) WB  recognizes both 
recombinant and endogenous ICBP90 
in 10µg WCE at 100kDA.  IP on 
recombinant and endogenous protein 
(2µg antibody/ 1-2mg WCE from HeLa 
or HEK 293 cells) 
anti 
Lamin 
A/C 
Santa Cruz, 
sc-20681 
rabbit 
polyclonal 
WB, use at 1:500 
dilution WB on Hela nuclear extract 
anti p53 
(DO-1) 
Santa Cruz, 
sc-126 
mouse 
monoclonal, 
IgG2a 
WB, use at 1:1000 
dilution 
(conc: 0,2mg/ml), recognizes well p53 
in Hela and LS174T cell extracts 
anti Sp1 Upstate 07-645 
rabbit 
polyclonal  Used for CHIP 
anti 
ubiquitin 
Covance 
P4G7 
mouse 
monoclonal, 
IgG1 
WB, use at 1:1000 
dilution 
WB on recombinant ubiquitin works 
fine. On Extract and purified histones 
cross reaction with histones. 
 
Commercial standard secondary antibodies (anti-rat, anti-mouse, anti rabbit, horseradish 
peroxidase conjugate) were used at a 1:3000 dilution. 
 
E.1.7 Oligonucleotides 
Oligonucleotides were all purchased from Eurofins MWG Operon and diluted with MilliQ-
water to a final 100µM solution. Oligonucleotides for PCR amplification and sequencing 
reactions were designed to show a minimum of secondary structure, primer dimerization and 
with a melting temperature Tm of 60°C with the freely available netprimer software provided 
by premierbiosoft (http://www.premierbiosoft.com). 
Oligonucleotides used for cloning, sequencing and colony PCRs are deposited on the Längst 
account on addgene (www.lablife.org) and named MF (number). Oligonucleotides used for 
the amplification of nucleosomal fragments, denoted, AP (number), were deposited by Anna 
Schrader on addgene (www.lablife.org)  
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E.1.8 plasmids 
List plasmids used for the experiments shown. A complete list of all plasmids generated, 
acquired or requested during this study is available on the Längst account on addgene 
(www.lablife.org). 
 
Table 4  plasmids 
 
# name vector backbone 
N-
TAG 
C-
TAG  
bacterial 
resistance cloning strategy created by 
8 
pRSETa 
human 
Dnmt1 
aa1100-
1600 
HindIII 
E. coli, T7 
Promotor, N-
6xHis, EK 
recognition 
site 
N-His   Ampicillin, ORI (E.coli) 
HindIII fragment of C-
terminus of Dnmt1from 
pEGFP-C1 Dnmt1  
cloned into pRSETa 
single cut HindIII 
M. Felle; E. 
Silberhorn 
9 
pRSETb 
human 
Dnmt1 aa 
1-1100 
E. coli, T7 
Promotor, N-
6xHis, EK 
recognition 
site 
N-His   Ampicillin, ORI (E.coli) 
KpnI /HindIII fragment 
of pEGFP-C1 Dnmt1 
human fl (first KpnI, 
then HindIII)  inserted 
into pRSET KpnI/HindIII 
M. Felle; E. 
Silberhorn 
10 
pRSETb 
human 
Dnmt1 aa 
870-1100 
E. coli, T7 
Promotor, N-
6xHis, EK 
recognition 
site 
N-His   Ampicillin, ORI (E.coli) 
BamHi/HindIII fragment 
/735bp) of pEGFP-C1 
Dnmt1 human fl 
inserted into pRSEtb 
BamH/HindIII 
M. Felle; E. 
Silberhorn 
11 
pRSETb 
human 
Dnmt1 aa 
530-830 
E. coli, T7 
Promotor, N-
6xHis, EK 
recognition 
site 
N-
Flag   
Ampicillin, 
ORI (E.coli) 
BamHI fragment 
1080bp) of pEGFP-C1 
Dnmt1 human fl 
inserted into pRSEtb 
BamH 
M. Felle; E. 
Silberhorn 
15 
pMal c2x 
TEV 
human 
Dnmt1 TS 
aa 316-
601-Flag 
cytoplasmic 
expression 
of MBP 
fusion 
protein with 
TEV, altered 
MCS 
N-
MBP 
TEV 
  Ampicillin, ORI (E.coli) 
Amplification of the hTS 
with Primer MF26 and 
MF27 to give insert with 
N-terminal EcoRI and 
C-terminal Flag STOPP 
XhoI and HindIII. 
Cloning into MCS of 
pMAL c2x cut with 
EcoRI and HindIII 
M. Felle; E. 
Silberhorn 
17 
pMal c2x 
TEV -C-
Flag 
human 
Dnmt1 aa 
1-290 
cytoplasmic 
expression 
of MBP 
fusion 
protein with 
TEV 
N-
MBP 
TEV 
C-
Flag 
Ampicillin, 
ORI (E.coli) 
KpnI/BglII fragment 
(aa1-290) of pRSETb 
hDnmt1 ligated into 
pMalc2x TEV C-Flag 
cut with KpnI/BamHI 
M. Felle; E. 
Silberhorn 
21 pENTR3C -Dnmt3a 
shuttle 
vector for 
Baculoviros 
expression 
    Kanamycin;  ORI E.Coli 
BamHI/EcoRI fragment 
of pRSETa Dnmt3a is 
ligated into pENTR3C 
cut with BamHI/EcoRI 
M. Felle; E. 
Silberhorn 
22 pENTR3C -Dnmt3b2 
shuttle 
vector for 
Baculoviros 
expression 
    Kanamycin;  ORI E.Coli 
BamHI/EcoRI fragment 
of pRSETa Dnmt3b2 is 
ligated into pENTR3C 
cut with BamHI/EcoRI 
M. Felle; E. 
Silberhorn 
35-
43 
pMal c2X 
TEV -C-
Flag 
hDnmt1 aa 
316-386,ab 
mapping 
2C1/2C12 
cytoplasmic 
expression 
of MBP 
fusion 
protein with 
TEV, altered 
MCS 
N-
MBP 
TEV 
C-
Flag 
Ampicillin, 
ORI (E.coli) 
Cut pMal c2x TEV C-
Flag with EcoRI and 
NheI and ligate 
oligonucleotide duplex 
coding for respective 
aa 316-386, 323-337, 
331-344, 338-352, 345-
358, 353-366, 359-372, 
367-378, 373-386 
M. Felle; E. 
Silberhorn 
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46 
pETM 
Dnmt3a N-
Flag C-His 
E. coli, T7 
Promotor, N-
Flag; C-
Thrombin 
6xHis 
N-
Flag C-His 
Ampicillin, 
ORI (E.coli) 
Cut pet 11 N-Flag 
Dnmt3a (#12) with 
Nhe/Nsi (removes Stop 
codon) and ligate C- 
Thrombin -6x His 
fragment iincluding 
SalI. 
M. Felle; E. 
Silberhorn 
47 
pETM 
Dnmt3b2 
N-Flag C-
His 
E. coli, T7 
Promotor, N-
Flag; C-
Thrombin 
6xHis 
N-
Flag C-His 
Ampicillin, 
ORI (E.coli) 
Cut pet 11 N-Flag 
Dnmt3b2 (#13) with 
Nhe/Nsi (removes Stop 
codon) and ligate C- 
Thrombin -6x His 
fragment including SalI. 
M. Felle; E. 
Silberhorn 
48 
pGEX 4 N-
GST 
Dnmt3a-
Do2 
E. coli, tac 
Promotor, N-
GST, lac 
operator; 
thrombin 
cleavage site 
N-
GST 
Thro
mbin 
  Ampicillin, ORI (E.coli) 
Dnmt3a Domain2 
(aa386-616) was 
amplified with primer 
MF46/46and cloned in 
frame after the N-
terminal GST and 
Thrombin of pGEX 4t-1 
with a C-terminal Flag 
tag. 
M. Felle; E. 
Silberhorn 
51 
pENTR3C 
hTS 
aa316-601 
C-terminal 
Flag 
shuttle 
vector for 
Baculoviros 
expression 
 C-Flag 
Kanamycin;  
ORI E.Coli 
hTS is PCR amplified 
with MF60/61 with a C-
terminal Flag and KpnI 
and EcoRV sites on 
pMal c2x TS C-Flag. 
Digested and cloned in 
pENTR3C. 
M. Felle; E. 
Silberhorn 
56 pGA4 BN-601-m1 
carries mod. 
601 seq for 
Bisulfite 
sequencing; 
T7 promotor, 
T3 
termination 
    Ampicillin, ORI (E.coli) 
the modified 601 
sequence can be 
amplified with MF77/78 
MR Gene 
61 pGEX-ub52 
Amp, GST 
N-terminal 
N-
GST   
Ampicillin, 
ORI (E.coli) 
(Everett), EcoRI/XhoI 
insert sequence verified 
(Canning 
et al. 2004) 
69 
pGEX 
USP7-2 
aa212-561 
E. coli, tac 
Promotor, N-
GST, lac 
operator; 
thrombin 
cleavage site 
N-
GST   
Ampicillin, 
ORI (E.coli) 
quired form Barbara 
Härtl (Dobner lab-
>MTA) BamHI/XhoI 
cloning of fragment 
B. Härtl 
(Dobner 
lab) 
70 
pGEX 
USP7-3 
aa561-916 
E. coli, tac 
Promotor, N-
GST, lac 
operator; 
thrombin 
cleavage site 
N-
GST   
Ampicillin, 
ORI (E.coli) 
aquiredf orm Barbara 
Härtl (Dobner lab-
>MTA) BamHI/XhoI 
cloning of fragment 
B. Härtl 
(Dobner 
lab) 
71 
pGEX 
USP7-3 
aa913-
1102 
E. coli, tac 
Promotor, N-
GST, lac 
operator; 
thrombin 
cleavage site 
N-
GST   
Ampicillin, 
ORI (E.coli) 
aquired form Barbara 
Härtl (Dobner lab-
>MTA) BamHI/XhoI 
cloning of fragment 
B. Härtl 
(Dobner 
lab) 
73 pCpGL-basic 
R6P origin, 
only in cells 
with pir gene 
    Zeocin, for PIR1 cells 
Michael Rehli, Maja 
Klug 
(Klug and 
Rehli 
2006) 
85 
pGEX 4T1 
USP7 
TRAF aa1-
215  
E. coli, tac 
Promotor, N-
GST, lac 
operator; 
thrombin 
cleavage site 
N-
GST   
Ampicillin, 
ORI (E.coli) 
generated using the LR 
recombinase reaction 
between pGEX 4T1 
stopp DEST and 
pENTR USP7 TRAF 
domain 
Max Felle 
90 
pDONOR2
21_Dnmt3
L human 
attL sites, 
ENTRY 
clone 
    Kanamycin; ORI E.Coli 
form Dirk Kuck, from 
RZPD, Dnmt3L human 
full length, no stopp 
Dirk Kuck 
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92 
pDEST10 
Dnmt3b2 
human 
ori, Amp 
resistance, 
gentamicin 
resistence, 
N-
His, 
TEV 
  
Ampicillin, 
gentamycin, 
ORI (E.coli) 
LR clonase reaction of 
pENTR3C Dnmt3b2 
and pDEST10 
Max Felle 
94 
pDEST10 
USP7 fl 
stopp 
ori, Amp 
resistance, 
gentamicin 
resistence, 
N-
His, 
TEV 
  
Ampicillin, 
gentamycin, 
ORI (E.coli) 
LR clonase reaction of 
pDONR USP7 fl stopp 
and pDEST10 
Max Felle 
97 
pDM7 C-
His 
ICBP90 
bacterial 
expression, 
Amp 
  C-His Ampicillin, ORI (E.coli) 
LR reaction with 
pENTR SD ICBP90 no 
stopp, pDM7 C-His 
Max Felle 
99 
pDM7 C-
His 
ICBP90 
∆RING 
bacterial 
expression, 
Amp 
  C-His Ampicillin, ORI (E.coli) 
LR reaction with 
pENTR SD ICBP90 
∆RING no stopp, pDM7 
C-His 
Max Felle 
101 
pDFB6 C-
Flag 
Dnmt3L 
ori, Amp 
resistance, 
gentamicin 
resistence, 
  C-Flag 
Ampicillin, 
gentamycin, 
ORI (E.coli) 
LR clonase reaction of 
pDONR Dnmt3L no 
stopp and pDFB6 C-
flag 
Max Felle 
105 
pGEM -T-
EASY- 
BN601 
MF79/80 
pGEM-T- 
EASY, Amp, 
pUC origin 
for TA-
cloning 
    Ampicillin, ORI (E.coli) 
BN601 sequence 
Bisulfite experiments 
was amplified with 
MF79/80 on pGA-
Vector BN601(Mr 
Gene), cloned into 
pGEM-T-EASY 
Promega 
Max Felle 
107 GST-Dsk2p 
pGEX 
(Amersham) 
N-
GST   
Ampicillin, 
ORI (E.coli) 
(Anindya et al. 2007), 
Dsk2p ubiquitin binding 
protein from 
S.cerevisiae 
Robert 
Steinbauer 
 
E.1.9 GATEWAY vectors 
The GATEWAY plasmids used for the experiments are listed. A complete list of all 
GATEWAY plasmids generated, acquired or requested during this study is available on the 
Längst account on addgene (www.lablife.org). 
 
Table 5  GATEWAY vectors 
 
# name gene/ protein vector backbone TAG selection strategy 
created 
by 
GW
2 
pDONR22
2 Entry vector 
ORI 
(E.coli), T7 
promotor,  
  
Kanamycin, 
chloramphenic
ol, ccdB gene 
  
Invitroge
n, K. 
Rippe 
GW
3 pDEST10  
Viral 
destination 
vector for 
Bac to Bac 
ORI 
(E.coli), 
polyhydrin 
promotor 
N-His 
6x, 
TEV 
Ampicillin, 
chloramphenic
ol, gentamicin, 
ccdB gene,  
Stopp codon has to 
come from donor 
vector 
Invitroge
n 
GW
4 pENTR3C Entry vector 
 ORI 
(E.coli)   
Kanamycin, 
ccdB gene carries RBS site 
Invitroge
n 
GW
25 
pDM7 C-
His 
Bacterial 
expression 
vector 
ORI 
(E.coli), T7 
promotor, 
lac 
repressor 
 C-
His 
Ampicillin, 
chloramphenic
ol, ccdB gene 
PCR of gateway 
conversion cassette 
of pDM1 with 
MF110/MF111 cut 
with EcoRV/Nsi and 
cloned into pDM1 
cut with NdeI, then 
blunt end with 
T4Pol then cut with 
NsiI 
Max 
Felle, A. 
Neu 
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GW
39 
pDFB6 C-
Flag 
Viral 
destination 
vector for 
Bac to Bac 
ORI 
(E.coli), 
polyhydrin 
promotor 
 C-
Flag 
Ampicillin, 
chloramphenic
ol, ccdB gene, 
gentamicin 
Gateway cassette 
amplification on 
pDM1 with 
MF103/MF104, cut 
KpnI/SacI, cloned 
into pFASTBAC1 
Max 
Felle, A. 
Neu 
 
E.1.10 Bacteria and cells 
Sf21 (Spodoptera frugiperda) insect cells were used for Baculovirus-directed protein 
expression. The following bacterial strains were available as chemical competent cells in the 
institute and stored at -80°C. 
 
Table 6  Bacterial strains – plasmid propagation 
 
strain description resistance genotype 
DB3.1 The gyrA462 enables ccdB containing plasmid propagation. streptomycin 
F- gyrA462 endA1 glnV44 
Δ(sr1-recA) mcrB mrr 
hsdS20(rB-, mB-) ara14 galK2 
lacY1 proA2 rpsL20(Smr) xyl5 
Δleu mtl1 
DH5alpha general DNA plasmid propagation none 
F- φ80lacZ∆M15 ∆(lacZYA-
argF) U169 endA1 recA1 
hsdR17 (rk-, mk+) supE44 thi-
1 gyrA96 relA1 phoA  
DH10BAC 
E. coli strain that carries the baculoviral 
shuttle vector bMON14272 with a low-
copy number mini-F replicon with a 
kanamycin resitance marker and Tn7 
transposon attachment sites within the 
LacZa peptide. The helper plasmid 
pMON7124 encodes for the transposase 
and confers resistance to tetracycline. 
tetracycline, 
kanamycin Bac-to-Bac Invitrogen 
DH10EMBacYFP 
E. coli strain that carries a modified 
baculoviral shuttle vector bMON1427 
having the v-cath and chiA genes replaced 
by an ampicillin marker and  LoxP sites. 
The EYFP gene under the control of the 
polyhydrin promotor was inserted via 
Cre/lox recombination  (Modified 
Dh10MultiBac bacmid) 
tetracycline, 
kanamycin, 
ampicillin 
(Berger et al. 2004) 
TOP10 general DNA plasmid propagation streptomycin 
F- mcrA Δ(mrr-hsdRMS-
mcrBC) φ80lacZΔM15 
ΔlacX74 nupG recA1 araD139 
Δ(ara-leu)7697 galE15 galK16 
rpsL(StrR) endA1 λ- 
XL1 Blue F´episome, general DNA plasmid propagation, blue/ white screening tetracycline 
recA1 endA1 gyrA96 thi-1 
hsdR17 supE44 relA1 lac 
[F'proAB lacIqZDM15 Tn10 
(Tetr)] 
 
Table 7  Bacterial expression strains 
 
BL21 (DE3)     F
-ompT gal hsdSB (rB-mB-) dcm 
lon λDE3  
BL21 (DE3) 
pLysS 
low supression of T7-induced 
background expression chloramphenicol 
F-ompT gal hsdSB (rB-mB-) dcm 
lon λDE3 pLysS (CamR)  
Rosetta 2 (DE3) 
pLysS 
BL21 derivative encodes rare 
eucaryotic codons chloramphenicol 
F–ompT hsdSB (rB–mB–) gal dcm 
(DE3) pLysSRARE2 (CamR) 
K12 TB1 NEB  F– ara Δ(lac-proAB) [φ80dlac Δ(lacZ)M15]  
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E.1.11 Mammalian cell lines 
List of mammalian cell lines that were cultured in the course of this study.  
 
Table 8  Mammalian cell lines 
 
name description source growth conditions remarks 
Hela S3 Human cervix carcinoma 
DSZM No: 
ACC 161; from 
Becker 
institute 
37°C, 5% CO2;  RPMI 
1640 + glutamax, 10% 
FBS; cells that are 
adjusted to growth in 
solution, but are also 
able to grow as 
adherent cells 
cell line is a subclone of its 
parent Hela (DSM ACC 57) 
derived in 1955; human flat-
moded hypotriploid karyotype 
with 32% polyploidy; epithelial-
like cells growing in monolayers, 
in principal adjusted to growht in 
solution; 25-30h doubling time 
HEK 
293 T 
Human embryonal 
kidney 
DSZM No: 
ACC 305; A. 
Nemeth 
37°C, 5% CO2; D-MEM 
+ glutamax, 10% FBS 
human near-triploid karyotype 
with 6% polyploidy; adherent 
fibroblastoid cells growing as 
monolayer; 25-30h doubling 
time 
HCT-
116 
human colon 
carcinoma 
DSZM No: 
ACC 581; from 
A. Nemeth 
37°C, 5% CO2; 
McCoy's 5A + 10% 
FBS + 2 mM L-
glutamine (alternatively 
D-MEM + glutamax, 
10% FBS, adjustment 
within 3 passages) 
human near-diploid karyotype 
with 3% polyploidy; epithelial-
like small cells growing as 
monolayer; 25-30h doubling 
time; Dnmt3b expression 
according to (Rhee et al. 2002). 
LS174 
TR 
human colorectal 
adenocarcinoma; 
LS174T + TET 
repressor 
(LS174T: 
ATCC No: Cl-
188) provided 
by Madelon 
Maurice, ;(Van 
De Wetering et 
al. 
2002);(Kessler 
et al. 2007). 
37°C, 5% CO2; 
RPMI1640 + 25mM 
Hepes + glutamx, 10% 
FBS; 10µg/ml 
blasticidin 
human diploid; 45,X; one X 
chromosome missing; no other 
chromosomal aberrations; 
adherent growth in cell patches; 
doubling time < 24h. A TET-
repressor (TR) was stably 
integrated in the LS174T cell 
line confering blasticidin 
resistance.  
LS88 
human colorectal 
adenocarcinoma;  
LS174TR + shRNA 
against USP7 
provided by 
Madelon 
Maurice;  
(Meulmeester 
et al. 2005); 
Kessler, 2007 
#265}. 
37°C, 5% CO2; 
RPMI1640 + 25mM 
Hepes + glutamx, 10% 
FBS; 10µg/ml 
blasticidin, Zeocin 
500µg/ml 
LS174TR cell line + pTER-
USP7-1 plasmid carrying a 
shRNA for USP7 (Zeocin 
500µg/ml); k.d of USP7 upon 
doxycycline treatment (1µg/ml) 
within 48-72hours down to 25% 
LS89 
human colorectal 
adenocarcinoma; 
pTER-USP7-N-myc 
plasmid carrying a 
N-myc-USP7  
provided by 
Madelon 
Maurice;  
(Meulmeester 
et al. 2005); 
Kessler, 2007 
#265}. 
37°C, 5% CO2; 
RPMI1640 + 25mM 
Hepes + glutamx, 10% 
FBS; 10µg/ml 
blasticidin, Zeocin 
500µg/ml 
LS174TR cell line + pTER-
USP7-N-myc plasmid carrying a 
N-myc-USP7  (Zeocin 
500µg/ml); overexpression of N-
myc USP7 upon doxycycline 
treatment (1µg/ml) within 24-48 
up to 300-400% 
LS126 
human colorectal 
adenocarcinoma; 
pTER-USP7-3 
plasmid carrying a 
shRNA for USP7  
provided by 
Madelon 
Maurice;  
(Meulmeester 
et al. 2005); 
Kessler, 2007 
#265}. 
37°C, 5% CO2; 
RPMI1640 + 25mM 
Hepes + glutamx, 10% 
FBS; 10µg/ml 
blasticidin, Zeocin 
500µg/ml 
LS174TR cell line +pTER-USP7-
3 plasmid carrying a shRNA for 
USP7 (Zeocin 500µg/ml); k.d of 
USP7 upon doxycycline 
treatment (1µg/ml) within 48-
72hours down to 25%; grow 
more slowly than LS88 and 
LS89. 
MCF-7 human breast adenocarcinoma 
DSZM No: 
ACC 115; from 
Dr. Michael 
Nevels; 
Universitätskli
nikum R. 
37°C, 5% CO2; D-MEM 
+ glutamax, 10% FBS 
(alternatively RPMI 
1640 + glutamax, 10% 
FBS) 
human hypotetraploid karyotype 
with 8% polyploidy; epithelial-
like cells growing as 
monolayers; 50-70h doubling 
time, Dnmt3a, Dnmt3b 
expression according to (Roll et 
al. 2008). 
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Molt-4 human T cell leukemia 
DSZM No: 
ACC 362; from 
Becker 
institute 
37°C, 5% CO2; RPMI 
1640 + glutamax, 15% 
FBS 
human flat-moded 
hypertetraploid karyotypey; 
round cells growing in 
suspension, singly or in cluster; 
40h doubling time, maximal 
denisty at  1.3 x 10^6 cells/ml 
NCCIT 
Human 
teratocarcinoma/ 
embryonic 
carcinoma cell line  
PD Dr. Stefan 
Schweyer; 
Universität 
Göttingen 
37°C, 5% CO2; RPMI 
1640+ 25mM Hepes + 
glutamax, 10% FBS 
Epithelial-like cells growing as 
monolayers with patch like 
structure; 24h doubling time, 
Dnmt3a, Dnmt3a2, Dnmt3b 
expression according to (Chen 
2002). 
 
E.1.12 Baculoviruses for S21 cells 
List of baculoviruses used for protein expression in Sf21 cells. Baculovirus containing 
supernatants were stored at 4°C protected from light. 
 
Table 9  Baculoviruses for S21 infection 
 
Virus source Passage Volume 
(ml) 
remark 
hDnmt3a N-6x-His M. Felle; 
baculodirect Kit, P5 
P6 50 Used for protein expression 
hDnmt3b2 N-6x-
His 
M. Felle; bac-to-bac 
Invitrogen, P2 
P3 50 Protein expression: 100µl/1x10^7cells; 
60h infection 
hDnmt3L C-Flag M. Felle; bac-to-bac 
DH10EMBacYFP, 
P1 
P2 100 Two positive clones: #6, #7; 
200µl/1x10^7 cells, 48h infection 
hDnmt1 N-6x His DNMT1 (Karo) 
16.08.06 
  20µl/15cm plae (1,2x10^7 cells) 
hSnf2h N-Flag Low MOI infection of 
P2 
P3 50ml 100-150µl/1x10^7 cells; 60 hours 
infection 
mTIP5 N-myc M. Felle; bac-to-bac 
Invitrogen, P3 
P3 50 NoRC: hSnf2H P3 25µl. TIP5 125µl  on 
1x10^7cells, 72 hours infection 
hUSP7/ HAUSP M. Felle; bac-to-bac 
DH10EMBacYFP,  
P3 200 Two low MOI infections: #15, #100. 
protein expression with 100µl/1x10^7cells, 48-60h 
infectio 
hUSP7/ HAUSP 
C223S 
(Canning et al 
2004) 
Infection on 15cm 
plate with 
1,2x^7cells 
P3 30 Protein expression with 400µl/1x10^7 
cells, 72 hours infection 
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E.2 Methods 
E.2.1 Escherichia coli (E. coli) 
Growth of E. coli in liquid culture, cryo preservation and transformation of chemical- and 
electro-competent cells, prepared at the department, were done according to standard 
methods (Sambrook and Russell 2001, Molecular cloning). 
E.2.2 Working with DNA 
E.2.2.1 Standard procedures 
In general, amplification of plasmid DNA in bacteria, purification, concentration 
determination, restriction enzyme digestion, ligation of DNA fragments, analysis of DNA on 
agarose and polyacrylamide gels, and amplification of the DNA by the polymerase chain 
reaction (PCR) were performed according to the standard protocols (Sambrook and Russell 
2001, Molecular cloning). In addition, plasmid DNA was prepared with plasmid purification 
kits (Invitrogen) for different amounts of DNA. Isolation of DNA fragments from agarose gels 
was performed using the Qiagen Gel Extraction kit. 
 
E.2.2.2 DNA precipitation methods 
Ammonium-acetate and sodium-chloride precipitation was done as described (Sambrook 
and Russell 2001, Molecular cloning). 
PEG8000 precipitation 
The use of of polyethylenglycol 8000 at different concentrations allows the selective removal 
of smaller DNA fragments (Paithankar and Prasad 1991). 
DNA fragments smaller than 200bp do not precipitate when using PEG8000 at 10% and 
MgCl2 at 10mM final concentration. Depending on the volume of the DNA solution, fill up with 
TE-buffer. Add ½ volume of PEG solution (30% PEG8000, 30mM MgCl2), vortex well and 
incubate 10-30min on ice (more efficient than at room temperature). Precipitates, although 
almost not visible, were pelleted (22°C, 13000g, 15-30min), washed with 70% ethanol, air-
dried and dissolved in an appropriate volume of either MilliQ or TE-buffer. 
 
E.2.2.3 Polyacrylamide and agarose gel electrophoresis 
Agarose gel electrophoresis was generally performed with gels containing 0,8 -1,2% agarose 
in 1X TBE buffer, 1:10000 SYBR Safe (Invitrogen), in 1x TBE running buffer at a constant 
voltage of 100-120V.  
In contrast to agarose gel electrophoresis, DNA was separated by polyacrylamide gel 
electrophoresis (PAGE) in 0.4 X TBE at 4°C at 100V. In order to remove unpolymerized 
acrylamide the gel was prerun for 1 hour at 80V. For visualization the gel was stained after 
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the gel run in 0,4x TBE containing ethidiumbromide (0,5mg/ml) for 15min and washed twice 
with water for 10min each.  
 
E.2.2.4 DNA methylation with M. SssI 
DNA was methylated using M. SssI methylase (NEB) according to the manufactor’s 
instructions with some minor modifications. Briefly, 1µg of DNA was incubated with 4U 
enzyme and 1000µM SAM (Sigma A7007) for 2h at 37°C. For larger DNA amounts, the 
incubation time was prolonged. After the reaction had completed, the methylase was heat 
inactivated at 65°C for 20min.  
 
E.2.2.5 Colony PCR 
A pipet tip was dipped into a bacterial colony on an agar plate and the adhering cells were 
resuspended in 25µl water in a 0,2ml PCR tube and subsequently gridded on fresh LB plates 
containing the necessary antibiotics. All tubes were placed in the PCR cycler and cells lysed 
by heating to 100°C for 10min. Then, 25µl of colony PCR master mix were added to each 
tube in the PCR cycler, and the thermocycler program for colony PCR was started. 
Afterwards, the PCR reactions were analyzed on an agarose gel for presence of the 
amplicon. 
50 µl 1 x (µl) 
Primer for 100µM 0,5 
Primer rev 100µM 0,5 
dNTP´s 10 mM 1 
Taq-Puffer 10x 5 
Taq-Polym. 1 
H2O + Kolonie 25 
H2O 17 
Total volume 50 
PCR-Programm 35 Cycles 
2 min 94°C // 40 sec 94°C/ 40 sec 55-58°C / 40 sec 72°C// 10 min 72°C 
 
E.2.3 Protein analysis: standard procedures 
Protein analysis was performed according to the standard protocols (Sambrook and Russell 
2001, Molecular cloning). Generally, proteins were kept on ice (4°C), in the presence of 
protease inhibitors (either complete® (Roche), or a mix of Leupeptin, Pepstatin, Aprotinin (all 
1 µg/ml), PMSF (0.2 to 1 mM)) and reducing agents (DTT 1mM, or ß- mercaptoethanol 
5mM).  
 
E.2.3.1 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Resolving and stacking gels were prepared according to standard protocols using ready-to-
use polyacrylamide solutions from Roth (Rotigel, 30%, 49:1 (for buffers see also E.1.2). For 
electrophoresis, protein samples were mixed with either SDS-PAGE sample buffer or 1/3 
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volume HU buffer, heat-denatured for 5min at 95°C or 10min at 65°C respectively and 
directly loaded onto the gel. Proteins were separated at 50mA until the dye front had reached 
the end of the gel. Following electrophoresis, proteins were stained with either Coomassie 
Blue, silver or subjected to Western blotting. 
 
E.2.3.2 Silver staining of protein gels 
The staining of protein gels with silver nitrate solution was carried out according to the 
protocol of Blum (Blum et al. 1987).  
E.2.3.3 Semi dry Western Blot and immuno-dectection 
Western Blot was performed as described (Sambrook and Russell 2001, Molecular Cloning) 
with the Towbin transfer buffer (192mM glycine, 25mM Tris, 20% methanol, 0.05% SDS). 
Blocking and antibody incubations were done in blocking solution (1x PBS, containing 5% 
dried milk and 0.1% Tween-20) whereas washing was performed in 1x PBST. 
 
E.2.3.4 TCA precipitation of protein samples 
Samples with low protein content can be TCA precipitated following resuspension in a 
smaller volume of loading dye. In general 10% of 100% TCA solution and 1µl of 2% 
deoxycholate solution are added to the protein sample. After vigorous vortexing, proteins are 
precipitated by centrifugation (13000g, 30min, 4°C), washed once with ice-cold 100% 
acetone and resuspended in 1/10th of the original volume in 2x Lämmli dye. 
 
E.2.3.5 Acidic extraction of histiones 
The following protocol was adapted from a protocol from R. Eskeland for the extraction of 
histones from S2 cells.  
Mammalian cells (HEK293, LS174 and derivates, E.1.11) (stored in small aliquots of 2x107 
cells at -80°C) were resuspended in 1ml 1xPBS supplemented with protease inhibitors. 
Triton-X-100 was added to a final concentration of 0.3% following incubation for 10min at 
4°C. NEM was added to 10mM final concentration for cells that were intended for ubiquitin 
analysis. After centrifugation (10min, 3500rpm, 4°C) the nuclear pellet was resuspended in 
200µl ice-cold 0.4M HCl and incubated on a rotating device at 4°C overnight. 
After centrifugation (20min, 13000g, 4°C) the supernantant was saved on ice, the nuclear 
pellet once more extracted by adding ½ volume of 0.4M HCl and incubated for 1h at 4°C. 
After centrifugation the supernatants were combined and dialyzed against three changes of 
1l 100mM acetic acid for 1h each (MW cut off: 6-8kDa). The extracted histones were snap-
frozen in liquid nitrogen, lyophilized overnight and dissolved in roughly 200µl of milliq water. 
The concentration was determined measuring the OD at 230nm (epsilon: 4.3 Abs. units/mg 
histone per 1ml) yielding roughly 200µl with 5-20mg/ml. Histones were stored at -80°C in 
small aliquots. 
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E.2.3.6 Size exclusion chromatography 
Size exclusion chromatography (SEC), also referred to as gelfiltration chromatography, is a 
technique for the separation of proteins and polymers based on their molecular weight or 
more exact on their hydrodynamic radius given by their shape.  
SEC was used for the analysis of higher molecular weight complexes from nuclear extracts 
from human placenta and Hela cells as well as for Dnmt1 dimerization studies.  
For gelfiltration runs, superose6 or superdex200 gelfiltration columns (GE Healthcare) were 
washed with two column volumes (CV) water and equilibrated with running buffer for at least 
two CVs. If not stated differently, samples were centrifuged for 30min at 13.000g prior to 
loading with a maximum volume of 500µl.  Separation was performed in SEC buffer (20mM 
Tris pH7.5, 150mM NaCl, 1mM EDTA, 1mM DTT) with a flow rate of 0.5ml/min and 500µl 
fractions taken.  
Gelfiltration columns were calibrated with protein standards that meet the requirement of 
being spherical and inert.  
 
E.2.4 GATEWAY technology 
Although many different well evaluated expression systems exist, the expression of one’s 
personal protein-of-interest (POI) still remains an elusive and laborious process based on 
trial and error. 
In order to have a system that meets the requirement to rapidly monitor protein expression 
either constitutive or inducible in different organisms (E. coli, insect cells, mammalian cells), 
with different tags, different combination and location of tags (N- or C- terminal), a large 
library of expression vectors (destination vectors) using the GATEWAY technology from 
Invitrogen was acquired (E.1.9). 
 
E.2.4.1 GATEWAY - vectors 
Three different GATEWAY adapted vectors are available. 
GATEWAY vector Characteristics 
Donor vector (pDONR) Contains attP sites. Used to clone attB-flanked PCR products and 
genes of interest to generate entry clones 
Entry vector (pENTR) Contains attL sites. Used to clone PCR products or restriction 
fragments that do not contain att sites to generate entry clones 
Destination vector (pDEST) 
Contains attR sites. Recombines with the entry clone in an LR 
reaction to generate an expression clone. It contains elements 
necessary to express the gene of interest in the appropriate system 
(i.e. E. coli, mammalian, yeast, insect) 
 
To enable recombinational cloning and efficient selection of entry or expression clones, most 
GATEWAY vectors contain two att sites flanking a cassette containing: 
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The ccdB gene (see below) for negative selection (present in donor, destination, entry 
vectors) and the chloramphenicol resistance gene (CmR) for counterselection (present in 
donor and destination vectors). 
After a BP or LR recombination reaction (refer to the Invirogen manual for details), this 
cassette is replaced by the gene-of-interest (GOI) to generate the entry clones and 
expression clones, respectively 
 
The presence of the ccdB gene allows negative selection of the donor, destination and some 
entry vectors in E. coli following recombination and transformation. The CcdB protein 
interferes with E. coli DNA gyrase, thereby inhibiting growth of most E. coli strains (e.g. 
DH5α, TOP10, but not XL1 blue). When recombination occurs, the ccdB gene is replaced by 
the GOI. Cells that take up unreacted vectors carrying the ccdB gene or by-product 
molecules retaining the ccdB gene will fail to grow. This allows high-efficiency recovery of the 
desired clones. 
For propagation of ccdB gene containing vectors (pENTR3C, all donor and destination 
vectors) the DB3.1 E. coli strain needs to be used. It contains a gyrase mutation (gyrA462) 
that renders it resistant to the CcdB effects (E.1.10). 
 
E.2.4.2 Creation of an Entry clone 
There are three ways to create entry clones that contain your GOI. 
For all three methods it is necessary to consider later applications like the organism of 
protein expression such as E. coli, insect cells and mammalian cells with their specific 
translational control elements (Shine Dalgarno, Kozak sequence), N- or C-terminal tags, as 
well as cleavage site for unique proteases (TEV, enterokinase). Especially the introduction of 
a stop codon needs to be taken into account. 
The following three methods were applied to generate ENTRY clones. 
A PCR product or a restriction enzyme fragment was cloned into a pENTR-vector to replace 
the ccdB gene. In our laboratory the pENTR3C vector containing a Shine Dalgarno and 
Kozak sequence was available. 
A PCR-product with a specific blunt sequence overhang was directly cloned in pENTR TOPO 
directional vector using the TOPO-cloning technique from Invitrogen. This method worked 
quite well with 2-3 clones out of five clones being positive.  
Generation of a PCR product containing attB sites and subsequent BP recombinase reaction 
with a pDONR-vector yielded efficiently positive ENTRY-clones.  
 
E.2.4.3 Creation of a Destination clone 
In order to create an expression clone a LR-clonase reaction (LR Clonase II mix) between a 
pENTR-GOI vector (attL sites, kanamycin resistance gene) and a pDEST vector (attR sites, 
ampicillin resitance gene, ccdB gene, chloramphenicol marker) has to be performed. 
The reaction mixture is then transformed into DH5alpha or TOP10 competent cells and 
plated onto LB/Amp plates. Only the bacteria containing a pDEST-GOI plasmid are able to 
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grow, since the ccdB gene was replaced. Remaining entry vectors do not confer ampicillin 
resistance. 
 
E.2.5 Sf21 insect cells and baculovirus protein expression system 
E.2.5.1 General 
Baculoviruses are a group of large double-stranded DNA viruses infecting insects. They 
feature a narrow host range with each type of baculovirus being virulent only to a specific 
insect species, while not infecting other insects, plants or mammals. AcNPV, Autographa 
californica Nuclear Polyhedrosis Virus, is a well-studied type that is, together with Sf 
(Spodoptera frugiperda) ovary tissue culture, a useful tool for recombinant protein 
expression. 
During the baculovirus life cycle, two different forms of virus are produced by the infected 
host cell: extracellular virus particles bud during the early stage of infection (release 24 hours 
post infection) and spread infection to other organs of the insect. During the late stage of 
infection, occluded virus particles form in the nucleus of the host cell. Occluded virus consists 
of many nucleocapsids enveloped by a matrix mainly formed polyhedrin, a structural protein 
expressed at very high abundance. The polyhedrin matrix allows the virus to last in the 
environment after the death of the host. After ingestion of occluded virus, virions are released 
in the mid-gut of the next host and enter adjacent cells by endocytosis. In vitro, polyhedrin is 
not necessary for virus replication and can be deleted or replaced. As the polyhedrin 
promoter is the strongest promoter known at present, it allows for very high levels of 
expression of the heterologous protein placed under its control. In addition, the baculovirus 
genome and capsid structure tolerate insertions of sequence well so that large coding 
sequences may be introduced (Berger et al. 2004; Fitzgerald et al. 2006). Baculovirus 
expression systems are very versatile tools for protein expression as they allow high-level 
expression of large proteins providing also signal peptide cleavage, intron splicing, nuclear 
transport, phosphorylation, glycosylation and acetylation, the lack of which often limits the 
use of bacterial expression systems.  
 
E.2.5.2 Growth and maintenance of Sf21 cells 
Sf21 cells are cultivated in Sf-900 II medium (Invitrogen) supplemented with 63mg/l penicillin, 
50mg/l streptomycin and 10% fetal bovine serum (Invitrogen). Sf21 cells were grown in 
suspension in either spinner bottles (75rpm) or Erlenmeyer flasks (approximately 100rpm) at 
27°C. For a continuous and stable growth behavior, which is crucial for best and reproducible 
protein expression, Sf21 cells were kept in logarithmic growth, i.e. at cell densities between 
5x105 and 2x106 cells/ml. 
Freezing of Sf21 cells and thawing of cells was done according to the ‘Insect’ manual 
(Invitrogen). 
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E.2.5.3 Construction of recombinant baculoviruses 
During the course of this study baculoviruses were created using three different systems: 
BaculoDirect Baculovirus Expression Kit (Invitrogen) 
The BaculoDirect System (Invitrogen) takes advantage of the in vitro GATEWAY LR reaction 
to transfer your GOI into the BaculoDirect linear DNA, thereby replacing the Herpes Simplex 
Virus type 1 thymidine kinase (HSV1 tk) gene and lacZ gene.  
This reaction is catalyzed by LR Clonase II Enzyme Mix for BaculoDirect Kits. 
 
The baculodirect Kit was used for the following proteins 
Protein name Vector  strategy 
Dnmt3a human  pENTR3C -Dnmt3a BamHI/EcoRI fragment of pRSETa Dnmt3a is ligated into pENTR3C cut with BamHI/EcoRI 
Dnmt3b2 human  pENTR3C -Dnmt3b2 BamHI/EcoRI fragment of pRSETa Dnmt3b2 is ligated into pENTR3C cut with BamHI/EcoRI 
Dnmt1 mouse pENTR3C mDnmt1 full length 
KpnI/NotI fragment of pet11 N-HisII mDnmt1 full length ligated 
into pENTR3c vector cut with the respective enzymes 
Dnmt1 d553-578 
mouse 
pENTR3C mDnmt1 full 
length delta 553-578 
KpnI/NotI fragment of pet11 N-HisII mDnmt1 full 
lengthdelta553-578  ligated into pENTR3c vector cut with the 
respective enzymes 
 
The baculodirect Kit procedure was only successful for Dnmt3a which resulted in a N-6x His 
tagged Dnmt3a full-length recombinant baculovirus. Therefore the Baculodirect Expression 
Kit was discarded and not further applied. 
 
Bac-toBac system (Invitrogen) 
The Bac-to-Bac system was used to obtain fast and efficient recombinant baculoviruses. 
Briefly, the cDNA was cloned into a suitable pFastBac vector or transferred from the 
GATEWAY pENTR-vector into an appropriate pDEST vector using the LR reaction.  
The pFastBac or pFastBac based pDEST vectors (E.1.9) contain the polyhedrin promoter, 
the GOI and a gentamycin resistance marker flanked by transposition elements (tn7). The 
pFastBac-GOI plasmid was transformed into E. coli DH10bac competent cells (E.1.10), 
which contained the bacmid DNA (tetracycline resistance marker) and a helper-plasmid 
(encoding a transposase, kanamycin resistance marker). Triple antibiotic and blue-white 
selection resulted in the selection of the recombinant bacmid DNA (transposition of the GOI + 
gentamycin into the bacmid DNA destroying the lacZ gene). The presence of the desired 
cDNA in the high molecular weight bacmid DNA was verified by PCR (with GOI and bacmid 
primer). The recombinant bacmid DNA was transfected into Sf21 cells (9x105 cells in one 
well of a 6-well plate) with Cellfectin (Invitrogen) to produce a first viral stock. This virus stock 
was amplified and used for protein expression (see below). 
 
The baculoviruses for the following proteins were successfully generated using the bac-to-
bac system. 
MATERIALS AND METHODS 
116 
Protein name Vector  strategy 
Dnmt3b2 human  pDEST10 -Dnmt3b2 LR reaction of pENTR3c- Dnmt3b2 with pDEST10 creating an N- 6x His Dnmt3b2. 
mTIP5 pFastbac- N-myc mTIP5 (R. Strohner)  
 
Bac-to-bac/ Multibac system (Imré Berger) 
The Bac-to-bac system was further improved to give rise to the possibility of expressing 
multiple proteins-of-interest from one bacmid (Berger et al. 2004; Fitzgerald et al. 2006). The 
system is based on two features:  
Two different plasmids are available that either integrate into the bacmid DNA via tn7 
transposition or via the Cre/lox system. For each plasmid exists a multiplication module that 
allows up to four genes to be separately cloned and expressed. 
In our laboratory we have acquired the E. coli strain DH10EMBacYFP (E.1.10) (Berger et al. 
2004) in which the bacmid DNA was modified in a way that the v-cath and chiA genes had 
been replaced by an ampicillin marker and LoxP sites. The v-cath gene encodes for a 
cathepsin L-like proteinase and the chiA for a chitinase that acts as a chaperone for proV-
CATH. Thus the infected cells are less prone to cell lysis during infection and to proteolytic 
degradation, which results in a higher yield of full-length recombinant protein. The EYFP 
gene under the control of the polyhydrin promotor was inserted via Cre/lox recombination 
and allows the monitoring of protein expression via fluorescence measurement during the 
course of infection. 
 
The baculoviruses for the following proteins were successfully generated using the bac-to-
bac- “Berger” system. 
Protein name Vector  strategy 
hDnmt3L  pDFB6-C-Flag hDnmt3L 
LR reaction of pDONR hDnmt3L no stopp with pDFB6 C-flag 
creating an C-Flag hDnmt3L 
hUSP7/ HAUSP pDEST10 hUSP7  LR reaction of pDONR hUSP7 stopp with pDEST10 creating an N- 6x His TEV hUSP7 
 
This is the system of choice to quickly generate suitable baculoviruses. 
 
E.2.5.4 Transformation of DH10EMBacYFP cells 
Chemically competent DH10EMBacYFP E. coli cells (prepared by E. Silberhorn; 100µl) were 
transformed with 60ng of pFastbac-GOI /pDEST-GOI plasmid. Selection by means of 
blue/white selection was done as described in the ‘bac-to-bac’ manual (Invitrogen).  
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E.2.5.5 Isolating recombinant bacmid DNA 
After having transformed your pFastBac construct into DH10Bac or DH10EMBacYFP E.coli 
cells and performed the transposition reaction, recombinant bacmid DNA from positive white 
transformants was purified according the ‘bac-to-bab’ manual (Invitrogen). 
Purified bacmid DNA is suitable for use in PCR analysis or transfection into Sf21 insect cells. 
 
E.2.5.6 Transfection of Sf21 cells 
The bacmid DNA preparations are transfected into Sf21 cells using the Cellfectin reagent 
(Invitrogen). For each protein-of-interest two bacmid DNA clones with two wells transfected 
each are used. 
The transfection procedure was done according to the ‘bac-to-bab’ manual (Invitrogen). 
 
E.2.5.7 Low MOI baculovirus amplification 
Amplification of baculovirus is undertaken to preserve the virus stock and to gain a higher 
titer of virus of the initial virus stock that can be used for protein expression. 
MOI (multiplicity of infection) is defined as the number of baculoviruses/ Sf21 cell. In order 
not to accumulate defective virus particles, that eventually would lower protein expression, 
baculovirus amplification with a MOI of 0.1or less is the method of choice. 
Low MOI infection is performed in spinner flasks with 50-100ml culture volume and at a 
constant cell density of 1x106 cells/ml (always dilute back to this cell number). Once infected, 
Sf21 cells have to at least double once during the first 24 hours post-infection (e.g. 10% of 
the cells were infected, whereas the other 90% doubled). With this prerequisite growth arrest 
is usually observed another 24 hours later. If the baculovirus titer is lower it might take some 
days (passages) until growth arrest is reached (multiple rounds of virus amplification took 
place). Budded virus is released starting from 24 hours after infection. 
As a rule of thumb, harvest the viral supernatant 48 hours after the calculated growth arrest. 
 
E.2.5.8 Test expression of recombinant proteins in Sf1 cells 
Once the baculovirus is amplified, the bacualoviral titer for large-scale high MOI protein 
expression needs be determined. 
In a 6-well plate 1x106 cells are seeded per well in 2ml of culture medium. For the amount of 
virus added per well, assume a viral titer between 1x107 pfu/ml and 5x108 pfu/ml and a 
desired high MOI of 3 for optimal protein expression.  
Add the estimated amount of virus (e.g. mock infection, 100, 40, 20, 10, 5 µl of virus) and 
evenly distribute the virus by putting the plate on a horizontal shaking platform for 1 hour. 
Seal the 6-well plate with parafilm and incubate for 48 -72 hours at 27°C recording daily 
growth behavior and infection process which allows a rough titer determination.  
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Cells are harvested by scrapping cells off the plates, washing once with ice-cold PBS and 
freezing of the pellet in liquid nitrogen. Presence of the recombinant protein and functionality 
of the affinity tag were analyzed in a small-scale purification. 
 
E.2.5.9 High MOI protein expression in Sf21 cells 
Protein expression with baculovirus infection is performed with a MOI of 2-3 so that on 
average 2-3 baculoviruses infect one Sf21 cell. 
Cells are grown in suspension in either spinner flasks or Erlenmeyer flasks (200-400ml) and 
are infected at a cell density of 1x106 cells/ml with the respective amount of recombinant 
baculovirus (as determined before with test infections and/or fluorescence measurement). 
After 48 -72 hours cells are harvested (@ 5 -10min, 500g), snap frozen in liquid nitrogen and 
stored at -80°C until use. 
 
E.2.6 Mammalian Tissue culture 
E.2.6.1 Maintenance 
Mammalian cells in culture were propagated in their recommended medium (E.1.11), 
containing 10% FCS and penicillin/streptomycin. All media were warmed to room 
temperature before used, but stored at 4°C. The medium of the cultures was changed every 
2-3 days depending of the confluency of the cells. The cells were split at an estimated 
confluency of 70%. For splitting, trypsin/EDTA solution was added to the cells (3ml per P15 
dish) and the dish incubated for 3-4min at 37°C. . The reaction was stopped by adding 
culture medium at three time the volume as EDTA/Trypsin. After determination of cell 
density, an appropriate volume of cells was transferred to a new flask and filled with medium 
to the final volume. Cells were incubated in a humidified incubator reserved for mammalian 
tissue culture at 37°C and 5% CO2. 
 
E.2.6.2 Harvesting cells 
For cells to be used in experiments instead of further propagation, no sterility precautions 
were taken. Medium was removed and 1ml 1x PBS added (for less FCS contaminations, 
cells were once washed with PBS). Cells were removed from the flask surface using a cell 
scraper. The cell suspension was then centrifuged for 3min at 4000 rpm. After removing the 
supernatant, the cell pellet was snap frozen in liquid nitrogen and stored at -80°C. 
 
E.2.6.3 Preparing cleared mammalian whole cell extracts (WCE) 
All solutions were precooled on ice and all work was performed at 4°C. Cell pellets, either 
freshly prepared or frozen and thawed on ice, were resuspended in lysis buffer. For P15 
plates with cells at 70% confluency, 150µl lysis buffer containing protease inhibitors were 
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used. The cell suspension was then incubated on ice for 30min, while vigorously vortexing 
every 10min. Afterwards, it was centrifuged for 30min at 13000 rpm at 4 °C on a tabletop 
centrifuge. The supernatant was saved and its protein concentration determined using a 
Bradford protein assay. The protein concentration was usually between 10 and 20mg/ml.  
 
Cell line Lysis buffer 
Hela, HEK 293, 
LS174T 
20mM Tris pH 7.5, 100mM NaCl, 0.1mM EDTA, 0.5% NP40 
MCF7, NCCIT, 
HCT-116 
50mM Tris pH 7.5, 150mM NaCl, 0.1mM EDTA, 0.1%NP40, 0.3% Triton-X100 
 
E.2.6.4 Transient transfection of mammalian cells 
Linear polyethylenimine (PEI, MW 25,000) with secondary amines was used for the 
transfection of plasmid DNA into HEK293 and HeLa cells. 
PEI is prepared as a 1mg/ml solution in water adjusted to pH 7,4 and stored at -20°C. 
The plasmid DNA (roughly 20-30µg/ 4-5x106 cells on P15) is diluted in 1/10th of culture 
volume in serum free medium. PEI is thawed and vortexed vigorously for 10 seconds prior to 
addition to the DNA. 3µl of the PEI solution/1µg DNA is added to the DNA solution, mixed for 
10 seconds and incubated for 20min at room temperature to allow for complex formation. 
While slowly moving the culture dish the DNA/lipid mixture is added drop wise to the cells 
cultured in complete medium. PEI does not have to be withdrawn from the medium. 
 
E.2.6.5 Purification of EGFP fusion proteins from mammalian cells 
The following proteins were expressed in HEK293 cells (E.1.11) as C-terminal fusion 
proteins with EGFP (enhanced green fluorescent protein) after transient transfection of the 
respective plasmids (E.1.8) carrying the gene-of-interest with an N-terminal EGFP 
HEK293 T cells were maintained as described (E.2.6.1) and transient transfection was 
carried out according to the protocol mentioned above (E.2.6.4) with the subsequent 
specifications.  
For each construct four P15 plates with HEK293 T cells at roughly 70% confluence (1,2-
1,4x107 cells) were transfected with 30µg of plasmid DNA/plate. Transfection efficiency 
reached approximately 30% after 72 hours as estimated from microscope visualization 
(Zeiss, Axiovert200). Cells were harvested (E.2.6.2) and cell lysates prepared (E.2.6.3) in 
lysis buffer (20mM Tris pH 7.5, 100mM NaCl, 0.1mM EDTA, 0.5% NP40 supplemented with 
protease inhibitors). 
15µl of GFP-binding protein coupled to sepharose (referred to as GFP binder; Rothbauer et. 
Al 2008) equilibrated with wash buffer (20mM Tris/HCl, pH 7,5, 150mM NaCl, 0.5mM EDTA) 
was incubated with WCE from one P15 plate diluted 1:2 with wash buffer for 2 hours at 4°C 
on a rotating device. Immunocomplexes were pulled down by centrifugation (@2500rpm, 
4°C, 2min) and the supernatant collected (referred to as flowthrough). 
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Beads were washed three times with EX-300 +0.05% NP40 and either boiled in SDS-PAGE 
sample buffer for subsequent SDS-PAGE and Western Blot analysis or resuspended in 60µl 
EX-100 buffer supplemented with 20% glycerol and 0.05% NP40 and stored at -80°C for 
functional in vitro assays. 
 
E.2.6.6 Knockdown and overexpression of target proteins in mammalian cells 
For USP7 knockdown and overexpression studies, cell lines based on the colorectal 
adenocarcinoma cell line LS174T, carrying plasmids with either shRNA (LS88, LS126) or N-
myc-USP7 (LS89) under the control of a tetracycline/doxycycline inducible promoter were 
kindly provided by M. Maurice (E.1.11) (Van De Wetering et al. 2003; Meulmeester et al. 
2005; Kessler et al. 2007).  
For doxycycline treatment, cells were seeded on a 10cm tissue culture plate with a cell 
number giving rise to 50-60% confluency on the day of harvest. Cells were grown in 
RPMI1640/Hepes (GIBCO) supplemented with blasticidin (10µg/ml), Zeocin (200µg/ml; 
normally 500µg/ml) and TET-FBS (clonetech #631106; special approved FBS for tetracycline 
inducible systems). Doxycycline (1mg/ml in water; store at -20°C in the dark) induction was 
performed with the addition of doxycycline to a final concentration of 1µg/ml (1:1000). 
Cell harvest and preparation of WCE were done as described (E.2.6.2, E.2.6.3) but in the 
presence of 10mM NEM. 
 
E.2.6.7 Purification of ubiquitinylated proteins with dsk2p 
WCE were prepared in 1xPBS+0.3% Triton-X-100 supplemented with 10mM NEM – an 
inhibitor of deubiquitinating enzymes. 
The residual pellet was used for acidic extraction of histones (E.2.3.5).  
50µl of GST or GST-dsk2p (ubiquitin binding protein, E.2.8.6) were incubated with 3mg of 
WCE in 1ml MobiCol columns at 4°C overnight. After centrifugation the flowthrough was 
collected and the beads washed 3x times with 500µl lysis buffer and 3x with EX-
300+0.05%NP40 with 5min incubation steps in-between.  
Bound proteins were eluted together with GST or GST-dsk2p from the glutathione sepharose 
with 50µl elution buffer (50mM Tris pH 8.0, 150mM NaCl, 10mM reduced glutathione) for 1h 
at 16°C shaking at 1300rpm. Optional a second elution can be performed. Residual beads 
were washed twice with lysis buffer and resuspended in 50µl HU buffer. 
Samples were analyzed by Western Blot following immuno-detection with antibodies directed 
against the proteins of interest. 
 
E.2.7 Purification of recombinant proteins from Sf21 cells 
Figure 55 shows a combined result of the most commonly purified proteins during this thesis. 
Expression and purification was optimized for each protein as described in the following 
sections. 
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Figure 55  Purified recombinant proteins: 
hDnmt1, hDnmt3a, hUSP7, hDnmt3L 
The indicated proteins were expressed in S21 
cells using the baculovirus system, purified and 
analyzed by SDS- PAGE. Proteins were visualized 
by Coomassie Blue staining. Relative protein sizes 
are indicated (kDA). 
 
 
 
 
 
E.2.7.1 Preparing Sf21 cleared cell lysate 
After optimizing protein expression and initial test purifications, a typical large-scale 
expression started from 2,0-2,5x108 insect cells. Purification was performed in the cold room 
and samples were always kept on ice. Protease inhibitors PMSF (1mM), Leupeptin (1-
10µg/ml), Aprotinin, Pepstatin (1µg/ml) were added to buffers prior to use. 
Sf21 cell pellets were resuspended in 10ml lysis buffer corresponding to the affinity tag with 
which the protein of interest was to be purified. 
The cell suspension was snap frozen in liquid nitrogen and thawed in cold water. The freeze-
thaw procedure was repeated twice and the suspension subsequently treated with five 
strokes of A-type pestle (loose) and five strokes of B-type pestle (tight) in a dounce 
homogenizer. Cells were further lysed by sonification with a Branson Sonifier 250D (large tip; 
3x for 30s at 50% amplitude and 50% duty cycle with a cooling period 30s of in between). 
The lysate was cleared by centrifugation (@ 30min, 20000g, 4 °C) and subsequently used for 
protein purification.  
 
E.2.7.2 Purification of His-tagged hDnmt1 (two steps) 
Recombinant histidine-tagged hDnmt1 from Sf21 cells was purified in two steps, by Ni-NTA 
agarose (Qiagen) purification followed by conventional chromatography (ResourceQ, GE 
Healthcare). Ni-NTA purification was done as described (Yokochi and Robertson 2002). 
Elution fractions were either directly dialyzed against two changes of 1 liter of dialysis buffer 
(Ex200-buffer, 2mM ß-mercaptoethanol) or applied onto a Hi Trap Desalting column (GE 
Healthcare) for further purification on an anion exchange matrix (ResourceQ). 
Anion exchange chromatography (Resource Q 6ml, GE Healthcare) 
The eluate of the desalting column (20mM Hepes, pH 7.9; 50mM NaCl, 1mM EDTA; 1.5 
mMMgCl2; 10% Glycerol; 1mM DTT) was loaded onto ResouceQ column equilibrated with 
desalting buffer (DB50) and eluted with a linear gradient from 50-600mM NaCl. Peak 
fractions (1ml) of Dnmt1 (250-300mM NaCl) were pooled, supplied with fresh protease 
inhibitors, b-mercaptoethanol, and snap frozen in liquid nitrogen and stored at -80°C. 
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Heparin chromatography 
Dnmt1 was once further purified for analytical ultracentrifugation analyis. 
Briefly, the Dnmt1 eluate of the ResourceQ column (aproximatedly 250-300mM NaCl) was 
applied onto a Heparin HP 1ml column (GE Healthcare) equilibrated DB250 (20mM Hepes, 
pH 7.9; 250mM NaCl, 1mM EDTA; 1.5mM MgCl2; 10% Glycerol; 1mM DTT), step eluted with 
DB600 buffer and finally transferred into DB100 using a desalting column. 
 
E.2.7.3 Purification of His-tagged hDnmt3a 
Histidine-tagged hDnmt3a was expressed in Sf21 cells and purified via Ni-NTA agarose 
(Qiagen) as described by Robertson (Yokochi and Robertson 2002). 
 
E.2.7.4 Purification of His-tagged hDnmt3b2 
Although the hDnmt3b2 baculovirus established gave good results in preliminary infection 
experiments, the purification of histidine tagged Dnmt3b2 from Sf21 cells did neither work 
very well with the protocol for hDmt3a purification from Sf21 cells nor with the hDnmt3b2 
purification protocol from bacteria.  
Therefore the purification procedure was not further optimized. 
 
E.2.7.5 Purification of His-tagged USP7 
The purification of histidine-tagged USP7/USP7 C223S from Sf21 cells was done as 
described previously (Canning et al. 2004). 
 
E.2.7.6 Purification of hDnmt3L (two steps) 
The purification of Flag-tagged Dnmt3L was done as described for Flagged-tagged hSnf2H 
by R. Srohner (Strohner et al. 2004b).  
Although hDnmt3L was purified via Flag-tag to high purity, DNA and histones were 
associated with the preparation.  
Dnmt3L eluted from Flag-M2 agarose (Sigma) in EX-300/ 0.05% NP40 buffer was diluted 
with EX-0/ 0.05% NP40 buffer to 150mM KCl concentration and loaded on a Q FF column 
(1ml, GE Healthcare) equilibrated with loading buffer. hDnmt3L was eluted applying a linear 
gradient from 150-600mM KCl in EX-buffer/ 0.05% NP40  over 10 column volumes. Peak 
fractions (250-300mM KCl) were pooled, snap frozen in small aliquots and stored at -80°C. 
 
E.2.8 Expression and purification of recombinant proteins from E. coli 
Figure 56 shows a combined result of the proteins purified from E. coli during this thesis. 
Expression and purification was optimized for each protein as described in the following 
sections. 
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Figure 56  Recombinant proteins from E. coli: Dnmt3a, Dnmt3b2, ICBP90, ICBP90∆RING, GST-
USP7 domains I-IV, GST-Ub52, GST, GST-dsk2p 
The indicated proteins were expressed in E. coli cells, purified and analyzed by SDS- PAGE. Proteins were 
visualized by Coomassie Blue staining. Relative protein sizes are indicated (kDA). 
 
E.2.8.1 Preparation of a cleared bacterial cell lysate 
Induced bacteria (prepared as described in each individual section) were harvested by 
centrifugation at 9000 rpm (A.6.9 rotor, centricon) for 15 min and 4°C. The supernatant was 
discarded, the pellet washed once with 1x PBS and subsequently stored at -80°C until use. 
On the day of purification, 10ml of lysis buffer supplemented with protease inhibitors per 1g 
of bacterial pellet was added to the frozen cells, thawed in cold water and transferred to ice. 
Lysozyme was added (1mg/1ml lysate) following incubation on a rotating device for 30min at 
4°C. Cells were further opened by treatment with five strokes of a B-type pestle (tight) in a 
dounce homognizer. The suspension (usually viscous at this point) was then cooled using a 
freezing mixture and sonified using a Branson digital sonifier 250D (big tip) 5 times for 30 
seconds at 50% amplitude and 50% duty cycle with 30 seconds pause in between. 
Afterwards, the insoluble fraction was removed by centrifugation for 30min at 20000g and 
4°C. The resulting supernatant was then used for further purification. 
 
E.2.8.2 Purification of His-tagged Dnmt3a and Dnmt3b2 (1-2 steps) 
The expression and purification of N-Flag-C-His Dnmt3a/3b2 was initially adapted from A. 
Jeltsch (Gowher and Jeltsch 2001) and modified. 
Expression 
Bl21 cells were transformed with the respective plasmids (pETM Dnmt3a/Dnmt3b2, E.1.8). 
An overnight culture was inoculated and grown at 37°C at 180 rpm overnight in SOB/Amp 
(100µg/ml) medium.  
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Expression culture (usually 5 liter culture volume total, with 1 liter culture volume in 2 liter 
Erlenmeyer flask) was inoculated with an OD600 of 0.1 and grown at 30°C up to an OD600 of 
0.5-0.6. Culture flasks were cooled down on ice for five minutes and protein expression was 
induced with 1mM IPTG for 3h at 24°C (cells usually grew up to OD600  1.1-1.2). Cells were 
harvested (@, 15min, 9000rpm, A6.9), washed once with ice-cold 1xPBS (@ 10min, 
4500rpm, 4°C), snap frozen in 1 liter culture pellet (50ml falcon tube) and stored at -80°C 
until use. 
Before and after induction an aliquot (usually 1ml) of the culture was removed and 
centrifuged (1min, 13000g). The bacterial cell pellet was resupended in 15µl HU buffer/0.1 
OD600, boiled for 10min at 65°C, sonified (Branson sonifier, 3x bursts, output 20%) and 
loaded onto a SDS-PAGE of adequate percentage to check for recombinant protein 
expression. 
Ni-NTA agarose purification 
Purification was performed in the cold room and samples were always kept on ice. Protease 
inhibitors PMSF (1mM), Leupeptin (1-10µg/ml), Aprotinin, Pepstatin (1µg/ml) and ß 
mercaptoethanol (5mM) were added to buffers prior to use. 
 
Lysis buffer: 20mM NaP, pH 7.4; 500mM NaCl; 0.1% NP-40; 5mM imidazole 
Wash buffer1: 20mM NaP, pH 7.4; 500mM NaCl; 0.1% NP-40; 20mM imidazole 
Wash buffer2: 20mM NaP, pH 7.4; 500mM NaCl; 0.1% NP-40; 40mM imidazole 
Elution buffer: 20mM NaP, pH 7.4; 500mM NaCl; 1mM EDTA, 0.1% NP-40; 250mM 
imidazole, 10% glycerole 
 
Bacterial cell lysate was prepared as described above (E.2.8.1). 
Ni-NTA agarose beads (Qiagen) (500µl solid beads/ 1g cell pellet) equilibrated in batch with 
lysis buffer and incubated with the hDnmt3a/3b2 load on an overhead shaker for 1-1.5 hours 
at 4°C. After centrifugation (3min, 1000rpm, 4°C) the resin was washed once with lysis 
buffer, twice with wash buffer1 and twice with wash buffer2. All washing steps are performed 
with 10ml/g cell pellet and five minutes incubation a rotating device. The Ni-NTA agarose 
was transferred into a 2ml reaction cup (max. 1ml agarose beads) and bound proteins were 
batch - eluted from the beads with the addition of elution buffer (4x times bead volume) with 
10 min incubations in between the elution steps. 
Elution fractions were combined and directly dialyzed against two changes of 1 liter of 
dialysis buffer1 (EX-100-buffer, 0.05% Np40, 5mM ß-mercaptoethanol) or dialysis buffer2 
(EX-500 buffer, 0.05% Np40, 5mM ß-mercaptoethanol). 
 
When performing a dialysis in lower salt concentrations (50-250mM NaCl) Dnmt3a and 
Dnmt3b2 form precipitates (roughly 40-50% and 80% of protein content respectively), which 
can be removed by centrifugation (@30min, 13000g, 4°C), whereas 500-1000mM salt seems 
to stabilize misfolded Dnmt3a/b2. 
This effect is reflected by the higher specific activity of EX100 versus EX500 hDnmt3a/3b2 
preparations. The overall yield of recombinant protein is very low, especially for Dnmt3b2. 
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Out of six liter culture (almost 20g cell pellet) the overall yield for Dnmt3a and Dnmt3b2 were 
1,3mg and 160µg respectively. 
In low salt buffer (EX-100) Dnmt3a was usually soluble at a concentration of 100ng/µl, 
whereas Dnmt3b2 only at 20-25ng/µl. Under high salt conditions (500-1000mM KCl) protein 
concentrations up to 1µg/µl were possible. 
SP FF chromatography 
Both Dnmt3a and Dnmt3b2 bind to a cation exchange matrix (SP FF, GE Healthcare) under 
physiological pH conditions. Imidazole containing elution buffer was replaced either by 
dialysis or desalting column with SP-200 buffer (200mM NaCl, 20mM Tris, 7.5, 2mM MgCl2, 
1mM EDTA, 10% glycerol, 1mM DTT). 
Precipitated material was removed by centrifugation (30min, 4°C, 13,000g) and filtration 
(0,45µm). The sample was loaded onto the SP FF column, washed with SP-300 buffer and 
step eluted with SP-500 buffer. Peak fractions were combined, either directly or after 
dialyosis snap frozen in small aliquots in liquid nitrogen and stored at -80°C.  
During this dialysis step, Dnmt3b2 precipitates formed. 
 
E.2.8.3 Purification of His-tagged ICBP90 and ICBP90∆RING 
Bl21 cells were transformed with the respective plasmids (pDM7 C-His ICBP90, pDM7 C-His 
ICBP90∆RING, E.1.8).  
Expression of recombinant proteins was done as described for Dnmt3a/b2 (E.2.8.2). The Ni-
NTA purification was performed previously for USP7 (E.2.7.5). 
ICBP90 and ICB90∆RING were very well expressed in Bl21 cells and could be well purified. 
2 liter of culture yielded approximately 9mg of recombinant protein. 
 
E.2.8.4 Purification of GST-tagged USP7 domains 
The plasmids pGEX USP7-2 (aa 212-561), USP7-3 (aa561-916), USP7-4 (aa913-1102) 
(E.1.8) were kindly provided by B. Härtl/H. Götze (unpublished; Prof. Dr. Dobner, Heinrich 
Pette Institut, Molekulare Virilogie, Hamburg) and pGEX 4T1 USP7 TRAF domain (aa1-215) 
were transformed into Bl21 cells. 
Expression 
Expression culture (200ml) was inoculated in SOB/Ampicillin medium (100µg/ml) with an  
OD600 of 0.1 and grown at 37°C up to an  OD600  of 0.5-0.6. Protein expression was induced 
with 1mM IPTG for 3,5h at 37°C (cells usually grew up to an OD600 of 1.3).  
Purification via Glutathione sepharose 
Purification was performed in the cold room and samples were always kept on ice. Protease 
inhibitors PMSF (1mM), Leupeptin (10µg/ml), Aprotinin, Pepstatin (1µg/ml) were added to 
buffers prior to use. 
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Cells were harvested and bacterial cell lysate from 200ml culture was prepared as described 
above (E.2.8.1) in lysis buffer (20mM Tris pH 7.5, 100mM NaCl, 1mM EDTA, 0.1% NP40). 
Glutathione sepharose (2ml 50% slurry, GE Healthcare) was equilibrated in batch with lysis 
buffer and incubated with the GST-USP7 constructs load on an overhead shaker for 1 hour 
at 4°C. After centrifugation (5min, 200g, 4°C) the beads were washed three times for five 
minutes each with 50ml lysis buffer. The resin was transferred into 2ml reaction tubes (1ml 
beads max.) equilibrated three times with EX-300 buffer (with 20% glycerol, no NP40). A 
50% slurry soltion was prepared and 100µl aliquots were snap frozen in liquid nitrogen and 
stored at -80°C. 
 
E.2.8.5 Purification of GST-tagged Ub52 
The plasmid pGEX-Ub52 (E.1.8) was kindly provided by R. D. Everett (Canning et al. 2004) 
and transformed into Bl21 cells. Expression and purification was done as previously 
described. 
E.2.8.6 Purification of GST and GST-dsk2p ubiquitin binding protein 
The plasmids for GST and GST-dsk2p expression (E.1.8) were kindly provided R. Steinbauer 
(Anindya et al. 2007) and transformed into Bl21 cells. Expression and purification was done 
as described for the GST-USP7 domains (E.2.8.4). 
 
E.2.8.7 Purification of MBP-hTS (Two steps) 
The “targeting domain” (TS) of hDnmt1 is purified as a C-terminal fusion protein to maltose 
binding protein (MBP). The MBP moiety is cleaved with TEV-protease and separated through 
an anion exchange chromatography step. 
The plasmid pMal c2x TEV hTS C-Flag (aa 316-601) (E.1.8) was transformed into K12TB1 
E. coli cells and expression carried out as described for GST-USP7 domains (E.2.8.4). 
Purification via Amylose resin (NEB) 
Purification was done as decribed in the manula for purification of MBP-fusion proteins 
(NEB). 
TEV protease cleavage 
TEV protease is expressed and provided by the department (U. Stöckl). The molar ratio, 
incubation time and temperature for optimal cleavage were titrated in a preliminary 
experiment. For the given TEV protease batch (2.5mg/ml) the following conditions were 
determined: a molar ratio MBP-hTS/ TEV: 1:30 (protein conc: 1:100), incubation at 16°C 
overnight. 
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Q FF chromatography 
The TEV eluate was loaded on a Q FF column (GE Healthcare) (20mM Tris pH 7.5, 2mM 
MgCl2, 1mMEDTA, 10% glycerol, 1mM DTT). Under these conditions MBP and TEV 
protease do not bind to the matrix. hTS could be step eluted from the Q FF column with 
column buffer +400mM NaCl. The peak fractions were pooled, shock frozen in liquid nitrogen 
and stored at -80°C 
 
Figure 57  MBP-hTS purification 
Potein analysis of MBP-hTS purification on 12% SDS-PAGE 
and Coomassie blue staining A.) Purified MBP-hTS and hTS 
and MBP after TEV cleavage. B.) hTS is separated from MBP 
and TEV with Q FF chromatography.  
 
 
 
 
 
 
 
E.2.9 Preparation of nuclear extracts 
E.2.9.1 Nuclear extracts from human placenta 
The following protocol for the preparation of a nuclear extract from human placenta was 
established on a protocol provided by Dr. J. Griesenbeck and on published data for Dnmt1 
preparations from human placenta (Wang et al. 1984; Pfeifer et al. 1985; Gorski et al. 1986; 
Yoo et al. 1987). 
Purification was performed in the cold room and samples were always kept on ice. Protease 
inhibitors PMSF (1mM), Leupeptin (10µg/ml), Aprotinin, Pepstatin (1µg/ml) were added to 
buffers prior to use. (Since Leupeptin, Aprotinin and Pepstatin are very expensive, they were 
used only for buffer volumes > 100ml) 
Fresh human placenta was received directly after birth and placed into ice-cold wash buffer 
1x PBS supplemented with 1mM DTT and 1mM PMSF. 
Human placenta is extensively rinsed three times with wash buffer to wash away blood. 
Fibrous membrane, fat and connective tissue are removed and remaining soft tissue is cut 
into small pieces (approximately 1-2cm3, referred to as nuggets) that are directly shock 
frozen in liquid nitrogen and stored at -80°C until use.  
Nuclei preparation 
Approximately 1l of buffer A (20mM Hepes pH 7.6, 2mM EDTA, 1mM EGTA, 15mM KCl, 
10% glycerol, 0.01% NP-40, 0.2mM spermidine, 0.5mM spermine, 1mM DTT) is added to 
300g of placenta nuggets in a plastic bag. Nuggets are pre-thawed under running water to 
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facilitate homogenization and subsequently homogenized three times in a Waring Blender for 
20sec each at full speed. 
The homogenate is successively filtered through metal gauze of two different pore sizes 
(1500µm and 500µm respectively; (Uchida et al. 1993)) and centrifuged (@10min, 1300g, 
4°C) 
The pellet is resuspended in 100ml buffer A, filtered through metal gauze of two different 
pore sizes (200µm and 75µm respectively) and centrifuged. Again the pellet is resuspended 
in 100ml buffer A (supplemented with leupeptin, aprotinin, peptstatin) using a donce 
homogenizer (loose pestle) and filtered through three layers of Miracloth to remove fat). 
The filtrate is centrifuged (@ 5min, 4500rpm, 4°C, 50ml falcon tube) and roughly 25ml NPV 
(nuclear packed volume) of crude nuclei are recovered (white color, fat containing). 
The quality of prepared nuclei can be checked visually performing a DAPI stain. 
A tip of a small spatula of nuclei are resuspended in 1x PBS, DAPI (stock 40µg/µl, stored in 
the dark) is added to a 1:100 dilution and incubated on ice for 3min. Nuclei are washed 3x 
times with 1x PBS (@2min, 2000rpm, 4°C) and resuspended in 200µl 1x PBS. A small drop 
is put on a microscope slide and covered with a glass slip. Visualization is performed with 
confocal microscope (Zeiss, Axiovert200).  
 
Figure 58  Nuclei from human placenta 
Nuclei prepared from human placenta are DAPI stained. Size bar is indicated in red.  
Nuclear extraction 
0,9 volumes of buffer C (20mM Hepes pH 7.9, 20% glycerol, 420mM NaCl, 1.5mM MgCl2, 
0.2mM EDTA, 1mM DTT) are added to the nuclear pellet followed by douncing 3-5 times with 
a loose pestle (L-type) and 3 times with a tight pestle (S-type). The solution is transferred into 
Beckman Ti45 centrifugation tubes and while stirring, 5M NaCl is slowly added drop wise to 
raise the salt concentration by 100mM to approximately 300mM. The nuclear extract is 
incubated on a rotating device with 3-5x vortexing for 30-45 minutes and subsequently 
centrifuged (Beckman ultracentrifuge, 4°C, 120,000g, 90min) 
Fat on top of the supernatant (referred to as nuclear extract) is removed with kimwipe and 
chromatin on the bottom of the tube is avoided as much as possible.  
The nuclear extract is saturated with ammonium sulfate to 60-65% (0.33g AS/ml extract) 
over a period of 15min followed by a 30min incubation time. 
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After centrifugation (@30000g, 4°C, Kontron A8.24, 30min) the pellet (rather slimy) is 
properly resuspended with Dounce homogenizer in 3.5ml buffer D50 (20mM Hepes pH 7.9, 
20% glycerol, 50mM NaCl, 2mM MgCl2, 1mM EDTA, 1mM DTT with all protease inhibitors). 
Dialysis is performed twice for 2h against 2l of buffer D50 (do not dialyze overnight) and 
centrifuged (30min, 13000g, 4°C). The resulting nuclear extract (referred to as NucD60) with 
approximately 4ml and an average yield of 20mg/ml was stored in aliquots at -80°C. 
 
E.2.9.2 Nuclear extracts from HelaS3 cells 
The protocol for the preparation of nuclear extracts from Hela cells was done as described by 
F. Pugh (Pugh 1995). 
HelaS3 cells (E.1.11) were grown in spinner flasks in RPMI 1640 supplemented with 
glutamax, 10% FBS and penicillin/streptomycin at 37°C, 5% CO2. Cells of a 10 liter culture 
were harvested with a cell density of approximately 1x106 cells/ml (@ 15min, 4°C 4650g). 
The quality of the prepared nuclei was checked visually with DAPI stain (see nuclei 
preparation from placenta, E.2.9.1). 
 
Figure 59  Nuclei prepared from HelaS3 cells 
Nuclei prepared from human placenta are DAPI stained. Size bar is indicated in red. 
 
E.2.9.3 MNase prepared nuclear extracts from HelaS3 cells 
In order to prepare a nuclear extract that is also enriched in protein associated with 
chromatin, HelaS3 nuclei (prepared as described above) were enzymatically treated with 
MNase (Micrococcal nuclease) and mechanically treated with a Dounce homogenizer to 
solubilise nuclear proteins normally tightly bound to nucleosomes.  
The following protocol was modified according to G. Längst (Langst et al. 1997).  
 
The nuclear pellet (10ml) is washed twice with buffer A (15mM Hepes pH 7.6, 15mM NaCl, 
60mM KCl, 2mM MgCl2 suplemented with 1mM PMSF, 10µg/ml leupeptin, 1µg/ml aprotinin 
and pepstatin.). After centrifugation (5min, 1000g, 4°C) the nuclear pellet is resuspended in 2 
nuclear packed volumes final (add 1 NPV) in buffer A, CaCl2 is added to a final concentration 
of 1mM, followed by incubation in a water bath until the temperature of the nuclei solution 
reaches 25°C. A 100µl aliquot for later DNA analysis is removed. 
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After addition of 3000U MNase/ml NPV (Sigma, N5386, 3U/µl of NPV), the nuclei solution is 
incubated for 20min at 25°C on a rotating device. The MNase reaction is stopped with the 
addition of ¼ volume of 4x Stop solution (20mM EDTA, 20mM Hepes pH 7.6). A 100µl 
aliquot is withdrawn for DNA analysis. 
The nuclei are dounced with 20-40 strokes in a Dounce homogenizer (S=B-type pestle) and 
subsequently centrifuged (@ 30min, 13000g, 4°C). Fat and fluffy stuff floating on top are 
avoided.  
DNA analysis 
The 100µl aliquots are dounced 30x and centrifuged (@13000g, 30min). 300µl of 4x stop 
buffer and 100µl of 4% SDS are added. RNAse digest (50µg) is performed for 1 hour at 37°C 
and proteinaseK digest (50µg) for 1h at 55°C. DNA is precipitated and analyzed on 1.5% 
agarose gel. 
 
E.2.10 Chromatin – assembly and analysis of arrays 
Figure 60 shows the results of a typical MNase digest analysis of DREX assembled DNA and 
a DNA nucleosome assembly using the salt gradient dialysis method. The amount of DNA, 
DREX extract, MNase und nucleosomes had to be optimized for each experiment as 
described in the following sections 
 
Figure 60  MNase digest and 
chromatin salt assembly 
(A.) Micrococcal nuclease (MNase) analysis 
of chromatin assembled with Drosophila 
embryo extracts (DREX). DREX assembled 
plasmid DNA was digested with increasing 
time (15, 30, 60, 90, 120 seconds) with 
MNase. The regular fragment ladder 
indicative of the nucleosomal array is shown 
(1n-6n). B) Reconstitution of chromatin 
arrays using gradient salt dialysis. Different 
ratios (1.3; 1.5; 1.7:1) of histone to DNA 
(77WID) were used in salt assembly and 
tested for nucleosome occupancy. On a 5% 
PAA gel in 0.4X TBE. Nucleosomes and 
DNA were visualized by agarose gel 
electrophoresis and ethidium bromide 
staining. 
 
E.2.10.1 Chromatin assembly using the Drosophila embryo extract (DREX) 
Drosophila embryo extract (DREX; provided in the lab) assembly was performed as 
described (Becker and Wu 1992). A standard assembly reaction contained 900ng of circular 
DNA, 12µl McNAP (30mM MgCl2, 10mM DTT, 30mM ATP, 300mM creatine phosphate, 
10µg/ml creatine phosphate kinase (diluted in 100mM imidazole)) and varying amounts of 
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Drosophila embryo extract (20-70µl, depending on extract). The volume was increased with 
EX-100 to a final volume of 120µl. Chromatin assemblies were performed in 0.5ml PCR 
tubes in a Perkin Elmer PCR machine for 6 hours at 26°C. The quality of the assembled 
chromatin was analyzed by MNase digestion. 
 
E.2.10.2 Chromatin assembly using the salt gradient dialysis technique 
Chromatin assembly of DNA fragments with histone octamers from drosophila using the salt 
dialysis technique were routinely performed by our technician R. Gröbner-Ferreira. 
Nucleosomes were assembled from DNA and histones by the salt gradient dialysis technique 
according to Rhodes (Rhodes and Laskey 1989). 
 
E.2.10.3 Chromatin analysis by Micrococcal Nuclease (MNase) digestion 
Micrococcal nuclease (MNase; Sigma N5386) cleaves DNA preferentially in the linker region 
between individual nucleosomes. Partial MNase digestion generates a regular DNA fragment 
ladder, thereby allowing qualitative analysis of the obtained grade of chromatin assembly. 
Typically, 900ng of chromatin was partially digested with MNase (MNase concentration has 
to be optimized for each assembly method) for 30, 60, and 120 sec in EX-100 buffer 
supplemented with 3mM of 3mM CaCl2 at 20°C. In order to have reproducible results the 
MNase-mix (180µl) and DNA samples (120µl) were separately incubated for 5min at 20°C. 
The reaction was stopped by the addition of 0.2 volumes of stop solution (4% SDS, 100 mM 
EDTA). Prior to deproteinization, DREX assembled chromatin was incubated with RNase 
(1µg) for 1 hour at 37°C. All reactions were supplemented with proteinase K (10µg/ reaction) 
and glycogen (10µg) and deproteinized for at least 1 hour at 45°C or overnight at room 
temperature. The DNA was purified by ethanol precipitation (0.5 vol 7,5M NH4Ac and 2.5 vol 
100% ethanol were added, incubated for 30min on ice, centrifuged for 30min at 13000g and 
washed once with 70% ethanol), air dried, dissolved in 10µl loading buffer and analysed on 
1.3% agarose gels (stained afterwards with ethidium bromide).  
E.2.10.4 DNA fragments 
DNA fragments assembled by salt dialysis were PCR amplified on purified restriction 
fragments from the SLONING DNA provided by A. Schrader. The SLONING DNA consists of 
three repeats of the nucleosome positioning sequence 601 ((Thåström et al. 2004a); referred 
to as WID, 147bp) flanked by a partial rDNA promoter sequence (approximately 70bp) on the 
left and a partial HSP7 promoter sequence (approximately 70bp) on the right. By using 
different combinations of restriction enzymes, symmetrical and asymmetrical DNA overhangs 
of variable length, relative to the WID sequence, can be generated. The DNA fragments were 
amplified by PCR and purified DNA fragments (E.2.2.2) were subsequently used for 
nucleosome assembly reactions. 
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Figure 61  SLONING DNA 
A section of the SLONING DNA is shown with the position of the flanking sequences with the indicated restriction 
enzymes. 
 
Template 
 Primer_fw Primer_rev 
DNA template 
(PCR) 
Annealing 
Tm 
15WID AP16  AP8 NcoI/NheI 58°C 
15WID15 AP16 AP17 NcoI/AflII 58°C 
22WID22 AP3 AP13 NcoI/AflII 58°C 
40WID40 AP5 AP14 NdeI/XbaI 55°C 
60WID AP11 AP8 BglII/NheI 55°C 
60WID60 AP11 AP12 BglII 55°C 
77WID77 AP1 AP15 BglII 58°C 
22WID AP3 AP8 NcoI/NheI 57°C 
40WID AP5 AP8 NdeI/NheI 57°C 
77WID AP1 AP8 BglI/NheI 57°C 
WID AP7 AP8 BamHI/NheI 57°C 
 
E.2.10.5 EMSA (electromobility shift assay) 
The ability of proteins such as transcription factors or DNA binding proteins to bind to DNA or 
nucleosomes can be assessed according to the running behavior in an agarose or 
polyacrylamide gel system (E.2.2.3). If binding to DNA or nucleosomes occurs, the mobility is 
impaired resulting in either a slower migration velocity or a complete loss of migration, i.e the 
protein-DNA/ nucleosome complex cannot enter the gel and is retained in the pocket. 
EMSAs for Dnmt3a/b were performed in 20µl reaction volume in 20mM Tris pH 7.6, 30mM 
KCl, 5mM EDTA, 1mM DTT, 5µM SAM, 20% glycerol. Dnmt3a/b was incubated with DNA or 
nucleosome for 15min at 26°C to allow for complex formation. After incubation the samples 
were put on ice loaded on either a 1.5% agarose gel or a 5%-15% polyacrylamide gel in 0,4X 
TBE (E.2.2.3) and run at 4°C. 
 
E.2.10.6 Separation of chromatin applying sucrose gradient 
Nucleosomal templates of different size can be separated on a sucrose gradient. The 
puc18:12x601 plasmid was digested with AvaI yielding 12x601 fragments (approximately 
200bp, 601 sequence centered) and the puc18 backbone (approximately 2500bp). 
Restriction fragments and plasmid DNA was subsequently assembled into nucleosomes with 
Drosophila histones by the method of salt dialysis (E.2.10.2). 2.5µg of mono-nucleosomes 
and 2.5µg of nucleosomal plasmid were loaded on 10-45% sucrose gradient in EX-50 buffer 
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without glycerole and separated by centrifugation (18h, 30,000rpm, SW40, no brake). 400µl 
of the 600µl fractions collected were ethanol precipitated overnight with ammoniumacetate 
(E.2.2.2) and loaded onto a 1.3% agarose gel. 
Analysis of Dnmt3L with chromatin/DNA was performed as described in the following: 
10µg Dnmt3L, 5µg chromatin or DNA, 200µg/µl BSA (and PGA 2mg/ml) were dialyzed in 
100µl against EX-100 buffer (w/o glycerole) for 1.5 hours prior to loading. For Western Blot 
analysis, 20µl of each fraction was supplemented with Lämmli dye and loaded onto a 12% 
SDS PAGE. The sucrose gradient and DNA analysis were performed by our technician R. 
Gröbner-Ferreira. 
 
E.2.11 Activity assays 
E.2.11.1 In vitro DNA methyltransferase assay for Dnmt3a/b 
The enzymatic activity of Dnmt3a and Dnmt3b can be monitored in a radioactive in vitro 
assay, in which the transfer of the [3H]- labelled methyl-group from S’adenosyl-methionine 
(GE Healthcare, TRK581-250UCi, 9.25MBeq with 1.0mCi/ml 63.0Ci/mmol) to the C-5 
position of cytosine in a CpG dependent context is catalyzed. 
In a reaction volume of 50µl, Dnmt3a and Dnmt3b2 were typically used at a concentration of 
100nM, linear or circular DNA (CpG sites) at 500nM, oligonucleotides (CpG sites) at 5µM, 
BSA at 0.2µg/µl and [3H]-SAM at 480nM (1.5µl) in DNA methyltransferase buffer (20mM 
Hepes, pH 7.6, 1mM EDTA, 1mM DTT). 
The following templates were used: 
Oligonucleotides: 
Nonmethylated (nm) and (m) methylated primers were diluted to a final concentration of 100 
pmol/µl. Nm-forward and nm-reverse oligos were mixed in a reaction tube to yield non-
methylated, nm-forward and m-reverse oligos to yield hemimethylated substrates 
respectively. The reactions were heated to 95°C in a thermomixer for 10min, then the heating 
was switched off, and the reaction was allowed to cool to room temperature. 
air_met_up TGC GGA Atx GTC TAA xGx GTG GAA TxG TCC CCT TG 
air_up TGCGGAATCGTCTAACGCGTGGAATCGTCCCCTTG 
air_do CAAGGGGACGATTCCACGCGTTAGACGATTCCGCA 
x denotes methylated cytosine 
 
DNA: 
Plasmid/ PCR length (nt) CpG sites 
pRSETB Dnmt1 BamHI 3967 227 
BN601 MF79/80 PCR 342 27 
BN601 MF124/125 PCR 147 15 
PCR fragments were generated with the indicated primer pairs on pGA4 BN-601-m1 (#56). 
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Procedure: 
Mix Buffer, BSA, Dnmt3a/b and water 
Add [3H]- labeled SAM (see above) and incubate for 5min at 37°C  
Withdraw “0” timepoint; “no DNA” sample (background reference), stop with the addition of 
10µl of 10mM non-labeled SAM and put on ice 
add respective DNA template 
incubate at 37°C for 20-60min. 
at the desired time points add 10µl 10mM unlabeled SAM (this stops further incorporation of 
radioactive SAM) 
spot the whole reaction onto DE81 filter (2,5cm diameter; Whatman) and put directly into a 
0.2M ammonium carbonate solution 
3x10min wash with a 0.2M ammonium carbonate solution 
1x H2O wash 
1x 100% EtOH wash 
dry filter in 37°C incubator for 30min 
put dried filter into Mini-Poly-Q Vial 
add 5ml Ultima Gold LSC-Cocktail per vial 
measure each sample for 1min in Scintillation counter 
 
E.2.11.2 In vitro DNA methyltransferase assay for Dnmt1 
Dnmt1 – the maintenance DNA methyltransferase – preferentially methylates hemi-
methylated (hm) DNA (Pradhan et al. 1999). Dnmt1’s enzymatic activity is measured in a 
radioactive DNA methyltransferase assay, as described for the de novo methyltransferases 
Dnmt3a and Dnmt3b2 with the following exceptions. 
Dnmt1 is used at a concentration of 60nM, [3H]-SAM at 320nM (1.0µl) in Dnmt1 reaction 
buffer (10mM Tris pH 7.6, 100mM KCl, 1mM EDTA, 1mM DTT.  
 
E.2.11.3 In vitro ubiquitinylation assay 
Components: 
E1 activating enzyme (Biomol, UW9410; 320ng/µl; MW 119kDA; His tagged recombinant 
protein; 20mM Tris pH 7.5, 0.5mM DTT) 
E2 conjugating enzyme UBCH5c (BioMol, UW9070, 1mg/lml, MW 17kDA, His tagged 
recombinant protein; in 20mM Tris pH 7.5, 0.5mM DTT) 
ICBP90 and ICBP90∆RING (own preparation E.2.8.3, C-terminal His tag) 
Ubiquitin from bovine erythorcytes (Sigma U- 6253, 2mg/ml, in water)  
Flag tagged ubiquitin (Boston Biochem, U-120; 5mg/ml; N-terminal flag tagged human 
recombinant ubiquitin, in water) 
Methylated ubiquitin (Boston Biochem, U-502, 5mg/ml; human recombinant ubiquitin with 
methylated lysines that only allows fro monoubiqutinylation; in water) 
MATERIALS AND METHODS 
135 
1x reaction buffer (50mM Tris pH 7.5, 50mM NaCl, 5mM MgCl2, 0.05% NP40, 1mM DTT, 
5mM ATP; prepared as 5x reaction buffer; ATP stored in small aliquots and DTT are add 
prior to use) 
Standard ubiquitinylation reactions (10µl) contained 100ng E1 activating enzyme, 300ng E2 
conjugating enzyme, 1µg ubiquitin/ methyl- ubiquitin or 100ng flag tagged ubiquitin and 250-
500ng ICBP90 or ICBP90∆RING in 1x reaction buffer. The reaction was usually carried out in 
duplicate, incubated for 2 hours at 37°C and stopped with the addition of HU-buffer (E.1.2) 
and boiled for 10min at 65°C. Samples were resolved by SDS-PAGE (E.2.3.1) and 
ubiquitination reaction was analyzed by Western Blot (E.2.3.3) using antibodies directed 
either against ICBP90 (Hopfner et al. 2000; Hopfner et al. 2001), His tag or flag tag. 
 
E.2.11.4 In vitro USP7 activity assay 
USP7’s potential activity as an ubiquitin specific protease was tested with an ubiquitin 
specific cleavage assay on an ubiquitin like substrate fused to GST (GST-Ub52, E.2.8.5) 
(Baker and Board 1991) as essentially established in the laboratory of R. D. Everett (Canning 
et al. 2004). 
 
E.2.11.5 Coupled ATPase activity assay 
The ATPase activites of the DREX and mouse transcription extracts were measured using 
an enzyme coupled assay, adapted from Lindsley (Lindsley 2001). ATP that is consumed in 
chromatin remodeling reactions is continuously regenerated while NADH is oxidized to NAD+ 
(Figure 62). The decline of NADH is monitored at a wavelength of 355nm in a GeniosPRO 
plate reader (GeniosPRO; XFLUOR4GENIOSPRO Version: V 4.64) in a 96 well format, and 
20sec intervals at 29°C. 
 
Figure 62  Coupled ATPase activity assay 
Overview of coupled ATPase activity assay (Lindsley 2001) that indirectly couples the 
regeneration of ADP + phosphoric acid to ATP with the consumption of NADH to NAD+. 
 
The ATPase activity of 5µl of the mouse TX extract and 0.5µl of the DREX extract was 
followed in a 100µl reaction mixture containing 50mM Tris, pH 7.6, 5mM MgCl2, 150mM 
KAc, 6mM phophoenolpyruvate, 0.3mM NADH, 15U pyruvate kinase, 20U lactate 
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dehydrogenase and 2µg of DNA. The inhibitor Phophokanymycin (Muthuswami et al. 2000) 
and its Mock-inhibitor Kanamycin were added to 0.5mM final concentration. The ATPase 
reaction was started with the addition of 0.3mM ATP. All measurements were performed in 
triplicates. 
 
E.2.12 Working with antibodies 
E.2.12.1 Immunoprecipitation 
The high affinity of an antibody for its antigen is used in immunoprecipitation to precipitate a 
target protein out of a complex mixture by binding it with a specific antibody that is 
immobilized on a solid phase, usually proteinA/G sepharose. Interaction partners of the 
target protein, such as proteins, DNA or RNA, can be co-purified by this method and 
identified or confirmed in subsequent experiments. 
All steps were carried out on ice or at 4°C and buffers supplemented with protease inhibitors 
PMSF (1mM), Leupeptin (1-10µg/ml), Aprotinin, Pepstatin (1µg/ml) prior to use. If not stated 
differently, the following IP buffer was used for IP experiments:  
50mM Tris pH 7.5, 150mM NaCl, 0.1mM EDTA, 0.05% NP-40. 
 
Per IP experiment, 100µl of proteinG bead slurry were washed three times with 850µl IP 
buffer by resuspending, centrifuging shortly in a tabletop centrifuge and removing the 
supernatant.  
In order to verify that the binding of one’s protein-of-interest (POI) is not due to unspecific 
interaction with the bead matrix, half of the equilibrated proteinG beads were added to the 
protein mixture to be analyzed (recombinant proteins, WCE, nuclear extract). 10x IP buffer 
was added to obtain a final concentration of 1x. The suspension was incubated on the 
rotating wheel at 4°C for 2 hours. As an additional control, commercially available 
immunoglobulins (IgG) isolated from the same species of the target specific antibody, can be 
added (2.5-5µg). The precleared sample/ lysate was stored at 4°C until further usage and the 
proteinG beads referred to as either “preclearing beads” or “IgG control”. 
The second half of the washed proteinG beads was charged with antibodies from tissue 
culture supernatant (TCS). 25µl of solid beads were incubated with 400µl TSC for 2h at 4°C 
on the rotating wheel. Afterwards, the beads were washed twice with 1000µl IP buffer added 
to the previously prepared precleared sample/lysate and incubated at 4°C for 14h on the 
rotating wheel. The beads were then washed three times with 1000µl IP buffer and 
resuspended in 50µl HU buffer after removal of the supernatant. The suspension was heated 
to 65°C for 10 min and subjected to SDS PAGE analysis.  
 
E.2.12.2 Cross–linking of antibodies to proteinA/G sepharose 
Dimethyl pimelimidate dihydrochloride (Sigma D8388, DMP) is a homobifunctional cross-
linking reagent that reacts with primary amines to form amidine bonds. Hence, antibodies 
can be covalently attached to proteinA/G sepharose not interfering with later gel analysis. 
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Components: 
Sodium borate solution pH 9.0 (200mM sodium borate is soluble when heated to 60°C. pH 
is adjusted with HCl) 
Dimethyl pimelimidate (stored at -20°C; prior to use incubate for 30min at 37°C; remove 
amount needed and to sample in 200mM sodium borate solution pH 9.0) 
Ethanolamine solution (200mM, pH8.0; dilute stock solution with water and adjust pH with 
HCl) 
Coupling of antibodies to proteinA/G sepharose beads 
All steps are performed at 4°C. 1000µl of proteinA/G sepharose is equilibrated with 20 
column volumes (CV) of 1x PBS and incubated with antibody (purified) or tissue culture 
supernatant (TCS) for 1 hour or over night. For optimal saturation of proteinA/G beads with 
antibodies the TCS should be titrated. In general 200-400µl of TCS (monoclonal antibodies) 
completely saturated 20µl solid proteinA/G beads. To warrant optimal binding 1/10th of 1.0M 
Tris buffer pH 8.0 is added to the TCS.  
Beads are recovered by centrifugation (@ 3min, 200g, 4°C), following two washes with 10 
CV of 100mM Tris pH 8.0 and three washes with 10CV of 10mM Tris pH 8.0 with 5min 
incubations in between.  
Cross linking of antibodies 
All steps are performed at room temperature. 
ProteinA/G sepharose coupled with antibody is equilibrated three times with 20 CV of sodium 
borate solution for 10min each on a rotating device (@3min, 200g). Beads are resuspended 
in 10 CV of sodium borate solution. After addition of 50mg of dimethyl pimelimidate (20mM 
final) beads are incubated for 30min on a rotating device. This step is further repeated twice.  
The cross-linking reaction is stopped by washing the beads once with 10-20CV of 
ethanolamine followed by incubation for 2 hours. 
The following steps are carried out at 4°C. 
Beads are washed twice with 10CV with 1x PBS and not cross-linked antibodies eluted with 
100mM glycine pH 3.0. First they are washed once with 100mM glycine pH 3.0 (10 CV; 
@3min, 200g, 4°C) and then incubated for 5min in the same buffer. Beads should not be 
incubated longer since this might affect the stability of the antibody. 
Finally antibody coupled proteinA/G sepharose is washed three times with 10 CV of 1x PBS, 
resuspended in 1 CV of 1x PBS supplemented with 0.02% sodium azide and stored at 4°C. 
 
E.2.12.3 Limited proteolysis for domain mapping  
The domain structure of a protein can be elucidated using limited proteolysis. In this method, 
a protease with recognition sites distributed all over the protein to be analyzed is incubated 
with the protein at a protease concentration and reaction time that will only lead to partial 
proteolysis. V8 protease (Sigma P6181; 0.1mg/ml in water) is a serine endoprotease from 
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the Staphylococcus aureus strain V8 that exhibits a high specificity for peptide bonds on the 
carboxy terminal side of aspartic and glutamic acid residues.  
For V8 limited proteolysis, a molar ratio of substrate to protease of 200:1 was used in 100mM 
Tris pH 7.8, 0.2% SDS. One reaction was set up and preincubated without protease for 
15min at 37°C.  After addition of V8 protease, samples (60µg of protein) were withdrawn at 
the desired time points (i.e. after 0, 5, 10, 15, 30, 45, 60, 90, and 120min), mixed with 
Laemmli buffer and immediately at 95°C for 10min to fully inactivate V8 protease.  
1/3rd of the reaction was subjected to SDS-PAGE (15% SDS gel) and Coomassie Blue 
stainging to confirm the success of proteolysis. For subsequent Western blotting, 1/10th of the 
reaction was applied.  
 
E.2.13 Bisulfite conversion and analysis of CpG site methylation 
The methylation status of a DNA sequence can best be determined using sodium bisulfite 
treatment. Incubation of the target DNA with sodium bisulfite results in conversion of 
unmethylated cytosine residues into uracil, leaving the methylated cytosine unchanged. 
Therefore, bisulfite treatment gives rise to different DNA sequences for methylated and 
unmethylated DNA. 
E.2.13.1 DNA template for bisulfite conversion 
For DNA methylation studies, a DNA fragment from the pGA BNA-601-m1 vector (E.1.8) 
carrying a modified 601 nucleosome positioning sequence ((Thåström et al. 2004b), modified 
according to G. Längst) and flanking regions was PCR amplified with oligonucleotides 
MF79/80 (E.1.7) yielding a 342bp DNA fragment with 27 CpG sites. 
PCR reaction was performed as described (E.2.10.4) and PCR fragments PEG precipitated 
(E.2.2.2). Nucleosomal template was prepared with drosophila histones by salt dialysis 
(E.2.10.2) with a histone to DNA ratio that would yield exclusively nucleosomal DNA. As 
competitor DNA the CpG less vector pCpGL-basic was used (E.1.8). 
  
E.2.13.2 DNA methylation reaction 
The DNA methylation reaction with Dnmt3a/b was carried out in a reaction volume of 40µl in 
DNA methyltransferase buffer (20mM Hepes, pH 7.6, 1mM EDTA, 1mM DTT). Dnmt3a and 
Dnmt3b2 were used at a concentration of 600nM and 200nM, DNA or nuclesomal DNA (CpG 
sites) for Dnmt3a and Dnmt3b2 at 600nM and 100nM respectively, BSA at 0.2µg/µl and SAM 
(Sigma A7007, 10mM) at 250µM. 
The reaction was mixed well and incubated for 1 hour at 37°C. Another 250µM SAM was 
added following incubation for 1-1,5 hours. This step was repeated twice. The reaction was 
heat-inactivated at 65°C for 20min. 40µl of the reaction were directly subjected to bisulfite 
conversion. 
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E.2.13.3 Bisulfite conversion with Epitect Kit (Qiagen) 
40µl of the DNA methylation reaction was processed with the Epitect bisulfite conversion kit 
(Qiagen) with the following exceptions. The last 60°C incubation step was prolonged from 2h 
55min to 6 hours. After DNA workup, the two DNA eluates were combined following PCR 
amplification of bisulfite converted DNA. 
 
E.2.13.4 PCR amplification of bisulfite converted DNA 
After bisulfite treatment of DNA, the upper and lower strand are no longer complementary to 
one another and thus can be individually analyzed. 
The upper (+) and the lower strand (-) were PCR amplified with primer pairs MF81/82 and 
MF112/113 respectively. The PCR reaction was performed as described for colony PCR 
(E.2.2.5) except that 8µl of the bisulfite converted DNA were used as template, the annealing 
temperature was at 56°C and 40 amplification cycles were applied. 
 
E.2.13.5 TA-Cloning of PCR fragments and sequencing 
PCR fragments (3µl) were cloned into the pGEM-T-EASY vector (Promega) according to the 
manufacturer’s instructions.  
E.2.13.6 Analysis of bisulfite converted DNA 
Analysis of bisulfite converted DNA was done with BiQ ANALYZER software (http://biq-
analyzer.bioinf.mpi-inf.mpg.de/) that had been provided by C. Bock (Bock et al. 2005). 
Sequencing files in txt or fasta format are uploaded into the program following a ClustalW 
alignment against the non-bisulfite treated DNA of the same strand. The program guides 
through multiple steps of quality assurance, checking for right orientation, sufficient bisulfite 
conversion rate (90% is the default cut-off) and identical sequences. Each step can be 
corrected manually, giving the possibility to account for CpA and CpT methylation that is 
normally evaluated as incomplete bisulfite conversion by the program. The results are 
presented in a single HTML documentation file. The raw data is presented as both, “derived 
methylation data” in which the CpG site number with the corresponding methylation status is 
given (1= meC; 0= C, X= non CpG or ambiguous position) and as “results in machine 
readable format” in which the position of the CpG site (distance between CpG and CpG = 
number of bp+2) and the respective methylation status is shown. Both data can be copied 
and pasted as unicode format into an Exel spreadsheet and subsequent statistical analysis 
be performed. 
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E.2.14 MALDI – Matrix Assisted Laser Desorption Ionization 
E.2.14.1 Sample preparation for protein identification by MALDI-MS analysis 
Proteins to be identified were separated via gel electrophoresis and subsequently sent to 
MALDI-MS identification either to the Zentrallabor für Proteinanalytik, LMU München, or to 
the Prof. Dr. R. Deutzmann, University of Regensburg. There, proteins were subjected to 
tryptic digestion and analyzed via MALDI-MS.  
20µl of previously prepared SDS gel electrophoresis samples were loaded on 4 -12% 
NuPage gradient gels and run in MOPS running buffer containing antioxidants for 1.5 hours 
at 200V and 50mA. The gel was stained with Simple Stain (Invitrogen) according to 
instructions given and protein bands unique for “specific” beads cut out and sent for MALDI 
analysis. 
 
E.2.14.2 MALDI analysis following immunoprecipitation 
For MALDI analysis Dnmt1 was immunoprecipitated with 50µl proteinG sepharose cross-
linked with anti Dnmt1 antibody 2C1 (E.2.12.2) from 9mg placenta nuclear extract (E.2.9.1), 
4,5mg Hela S3 nuclear extract (E.2.9.2) and 2mg MNase released Hela S3 nuclear extract 
E.2.9.3). Prior to immunoprecipitation the extracts were precleared with 50µl proteiG 
sepharose for 2 hours at 4°C. Immunoprecipitation was carried out in 1x PBS supplemented 
with protease inhibitors for 2h at 4°C. Beads were washed 3 times with 1x PBS with 10min 
incubation in-between following addition of 40µl HU buffer and boiling 10min at 65°C. 
Proteins bands of interest were treated as described above.  
 
E.2.14.3 MALDI analysis using iTRAQ labeling 
Immunoprecipitation was performed as described (E.2.14.2) and bound proteins were eluted 
from the ‘beads’ with 100µl 100mM glycine pH 3.0 (5min incubation) by acidic denaturation. 
The samples were neutralized with 1/th volume of 500mM Tris pH 8.0, 1.5M NaCl and 
methanol/chloroform precipitation of proteins performed as described in the following: 
Methanol/-Chloroform precipitation 
Up to 200µl of protein sample can be processed in a 2ml reaction tube. 
400µl of methanol is added to 100µl of protein sample and mixed well by vortexing. 
Additional 100µl of chloroform are added and once again mixed. For phase separation 300µl 
of water are added to the sample and mixed vigorously. After incubation on ice for 5min, the 
sample is centrifuged (5min, 4°C, 130000g) following removal of the upper phase while 
keeping the interphase with precipitated proteins. 300µl of methanol is added and again 
incubated on ice for 5min following centrifugation. The supernatant is removed, the protein 
pellet dried in a vacuum pump and stored until use at -20°C. 
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iTRAQ labeling 
Lyophilized protein samples were resuspended in 20 µl dissolution buffer and reduced with 
5mM Tris-(2-carboxyethyl) phosphine at 60°C for 1 h. Cysteins were blocked with 10mM 
methyl methanethiosulfonate (MMTS) at room temperature for 10 min as described 
previously (Ross et al. 2004; Chen and Andrews 2009). After tryptic digestion (3µg pure 
trypsin) for 20 h at 37°C, 70 µl ethanol was added to the needed vials of iTRAQTM reagents. 
Tryptic peptides of the ‘specific’ and ‘control’ immunoprecipitations were incubated with 
different combinations of the four iTRAQTM reagents for 2h at room temperature. The two 
labeling reactions were combined and lyophilized.  
Separation of peptides by liquid chromatography (LC): 
The combined differently labeled peptides were dissolved in 40ul 0.1% TFA for 2h at ambient 
temperature following centrifugation (@10min, 13,000g). The supernatant was recovered, 
10ul loaded on a C18-Pep-Mep reversed phase column (75um i.D. x 15cm) and peptides 
separated with the nano-flow HPLC-system (Dionex) applying a linear gradient of 5% to 95% 
of buffer B (80% acetone-nitril, 0.05% TFA) for 135 min. Fractions were collected every 20s 
for 127min, automatically mixed with 5 volumes of CHCA-matrix (2mg/ml in 70% aceton-
nitrile, 0.1% TFA) and spotted on a MALDI-target by the probot-system (Dionex). 
MALDI-MS/MS Analysis: 
Spotted fractions were analyzed with a MALDI-TOF/TOF-system of the 4700 series (Applied 
Biosystems). The Cal 4700 standard peptide mixture was used routinely for calibration. For 
ionization the laser intensity was adjusted from sample to sample and usually 1000 shots in 
MS-mode and 2500 shots in MSMS-Mode were applied. The MS spectrum was recorded 
and subsequently the six most intense peaks per spot were further fragmented yielding the 
respective MSMS spectra. In order to avoid peptides derived from IgG-molecules or trypsin, 
prominent peptide-masses of these molecules were placed on an eclusion list. 
Database-search and data-evaluation: 
The measured m/z ratios were assigned to the peptide and the respective protein by 
MASCOT database search in the human database. Only non-redundant peptides with a C.I. 
> 95% were included in the analysis. The peak area for the iTRAQ reporter ions were 
interpreted, corrected by the GPS-Explorer software and the raw dataset exported to 
Microsoft Excel. The average of all peptides of a given protein were calculated and outliers 
were deleted by manual evaluation. The ratios of the iTRAQ reporter-ion derived from the 
‘specific’ IP over iTRAQ reporter-ions derived from ‘control’ IP were established. 
 
E.2.15 CHIP- chromatin immunoprecipiation 
Chromatin immunoprecipitation (CHIP) is a widely applied technique to show localization of 
factors on DNA at certain genomic loci. Proteins are formaldehyde cross-linked either directly 
to the DNA or via interaction partners. After solubilization and fractionation of the chromatin 
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POI’s can be immunoprecipitated via a target specific antibody together with the associated 
chromatin. After protein digest and reversal of the formaldehyde cross-link the co-
immunoprecipitated DNA can be purified. In the case of known targets the DNA can be 
directly analyzed in qPCR or if no target gene is known, be amplified for Micro-Array analysis 
which is referred to as CHIP-on-CHIP. 
The following protocols for CHIP were adapted from protocols kindly provided by Dr. A. 
Rascle and Dr. A. Németh. 
 
E.2.15.1 CHIP buffers, chemicals and enzymes 
If not stated differently, all solution were prepared with milliQ water and filtered through a 
0,22µm filter. In addition, SDS(+), Triton and IP buffer were supplemented with protease 
inhibitors (10ug/ml Aprotinin, 10ug/ml Leupeptin, 0.5mM PMSF) prior to use. 
Filter tips and 1,5ml reaction cups were from Sarstedt (Biosphere, DNAse and RNAse free). 
If not stated differently all solutions were filtered (0,022µm) and stored at room temperature. 
 
SDS(+) Buffer *: 100mM NaCl 5M: 5ml 
 50mM Tris pH 8.0 1M: 12.5ml 
 5mM EDTA 0.5M: 2.5ml 
 0.5% SDS 20%: 6.25ml 
 250ml  
 
SDS(-) Buffer *:  Same as SDS(+) without SDS – used on cells 
not FA cross-linked when testing antibodies: cell pellet is resuspended in SDS(-) Buffer first, 
then SDS is added to a final concentration of 0.5%. 
 
Triton Dilution Buffer *: 100mM NaCl 5M: 5ml 
 100mM Tris pH 8.0 1M: 25ml 
 5mM EDTA 0.5M: 2.5ml 
 5% Triton X-100 20%:
 62.5ml 
 250ml  
 
IP Buffer *: 1 volume SDS(+) Buffer + 0.5 volume Triton 
Dilution Buffer 
 Add protease inhibitors prior to use 
 
Eltuion Buffer : 1% SDS, 0.1M NaHCO3 (always prepare fresh 
from stock components; 20% SDS, 1M NaHCO3) 
 
150mM Wash Buffer : 150mM NaCl 5M: 15ml 
 20mM Tris pH 8.0 1M: 10ml 
 5mM EDTA 0.5M: 5ml 
MATERIALS AND METHODS 
143 
 1% Triton X-100 20%: 25ml 
 0.2% SDS 20%: 5ml 
 500ml 
 
500mM Wash Buffer : 500mM NaCl 5M: 50ml 
 20mM Tris pH 8.0 1M: 10ml 
 5mM EDTA 0.5M: 5ml 
 1% Triton X-100 20%: 25ml 
 0.2% SDS 20%: 5ml 
 500ml 
 
LiCl Wash Buffer : 0.5% (w/v) Deoxycholic acid 10%: 25ml 
 1mM EDTA 0.5M: 1ml 
 250mM LiCl 2M: 62.5ml 
 0.5% (v/v) NP-40 10%: 25ml 
 10mM Tris pH 8.0 1M: 5ml 
 500ml  
 
TE Buffer: 10mM Tris, pH 8.0 
 1mM EDTA 
 50ml  
 
Glycogen (Roche #901-393; 20mg/ml; -20˚C) 
Proteinase K (SIGMA P-6556; 20mg/ml stock in H2O; -20˚C) 
RNAseA (Invitrogen, 20mg/ml, from Mini-prep kits, stored at room temperature) 
ProteinG sepharose (GE Healthcare, from E. Kremmer):  
ProteinG sepharose stored in 20% ethanol at 4°C is washed twice with 1x PBS and three 
times with IP buffer). Usually 300 to 400µl proteinG beads are resuspended in 1000µl IP 
buffer supplemented with 500µg/ml BSA (Fatty Acid free SIGMA A-7511; 25mg/ml stock in 
H2O) and 500µg/ml Salmon Sperm DNA (Gibco 15632-011) and incubated on wheel for a 
few hours and stored at 4˚C. 
 
E.2.15.2 CHIP antibodies 
The following antibodies were used for chromatin immunoprecipitation. 
Table 10  Antibodies for chromatin immunoprecipitation 
 
antibody source species amount 
anti Dnmt1 
2G3-1, 2E8-1, 
2C1, 2C12 
E. Kremmer, Helmoltz 
Gesellschaft rat monoclonal, TCS 
1:1:1:1 mixture, 
1300µl/60µl slurry proteinG 
sepharose as titrated 
anti H3 abcam ab 1791 rabbit polyclonal 5µg 
anti HAUSP/ 
USP7 Bethyl laboratories rabbit polyclonal 10µg 
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ICBP90/NP95 
BD Transduction 
laboratories 612264 mouse monoclonal, IgG2a 5µg 
anti ICBP90 
C.Bonner, references 
(Hopfner et al. 
2000),(Hopfner et al. 
2001)  
mouse monoclonal 5µg 
anti Sp1 Upstate 07-645 rabbit polyclonal 10µg 
Anti RNAPII 
CTD 8WG16 
(non-Ph-CTD) 
D. Eick; (Thompson et al. 
1989; Xie et al. 2006) mouse monolconal, TCS 
1000µl / 60µl slurry protein 
G sepharose, as titrated 
IgG rat normal sc-2026 rat polyclonal 4µg 
IgG rabbit 
normal sc-2027 rabbit polyclonal 4µg 
 
E.2.15.3 Formaldehyde cross-link of mammalian cells 
Mammalian cells of interest (E.1.11) were grown in their respective medium on 15cm tissue 
culture plates to a confluency of 60-80%. Prior to fixation, cells from o 15cm plate were 
detached with Trypsin/EDTA treatment and the cell number determined.  
The other culture dishes were subsequently subjected to the formaldehyde cross-link 
procedure. Tissue culture plates were put on a shaking platform and fixation started with the 
addition of formaldehyde solution (SIGMA F1635) to a final concentration of 1% (550µl of 
37% solution to 20ml medium). Fixation was carried out for 10-20min at room temperature 
and stopped with the addition of 800µl 3.25M glycine (125mM final concentration) following 
5min incubation. Cells were then washed twice with 10ml ice-cold 1xPBS, harvested, 
adjusted to 2x107cells/ml with 1xPBS and 1ml aliquots snap frozen in liquid nitrogen and 
stored at -80°C.  
 
E.2.15.4 Cell lysis and chromatin isolation 
Cell pellets of 2x107 cells were properly resuspended in 1ml SDS(+) buffer (including 
protease inhibitors). Samples were cooled on ice.  
Sonication was performed with 7 cycles of 20 bursts (50% output control, 20% intensity 
output (position 3)) with 30sec cooling in-between. 
After sonication, ½ volume of Triton Dilution buffer was added and the sample stored on ice 
until all cell pellets had been worked up. Cell debris was removed by centrifugation (5min, 
16000g, 4°C) and the supernatant used for subsequent immnoprecipitations.  
E.2.15.5 Chromatin Immunoprecipitation 
The efficiency of the immunoprecipitation reaction depends on multiple factors: the amount of 
one’s protein of interest (POI) in the cell, the quality of the specific antibody in 
immunoprecipitation, buffer conditions and the amount of antibody used per IP reaction. For 
optimal results these parameters should be verified in pilot experiments. 
Initially, the immunoprecipitation setup was used for 3.3x106 cells, but was then applied on 
2x107 cells. 
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Preclearing of the whole cell lysate (E.2.15.4) was performed with 60µl slurry of preblocked 
proteinG sepharose/2x107 cells (E.2.15.1) for 1h at 4°C. After centrifugation (5min, 500g, 
4°C) the supernatant, which was then referred to as Input lysate, was used for specific 
immunoprecipitation. 2x 50µl were kept for the Input (total) control and stored on ice until the 
DNA workup (see below). The precleared lysate, although not recommended, can be frozen 
on dry ice an stored up to several weeks at -80°C. 
Immunoprecipitation was carried out with 1.35ml lysate/IP corresponding to approximately 
2x107 cells/IP (27x of input). The primary antibody was added following incubation for 1.5h. 
60µl slurry of preblocked proteinG sepharose was dispensed per IP using a cut tip and 
subsequently incubated for another 2.5h. A no antibody control (IgG or protein A alone) was 
included. 
When working with an antibody tissue culture supernatant (TCS) the preblocked proteinG 
sepharose was incubated for at least 2 hours with an adequate amount of TCS with 10% IP 
buffer and afterwards washed twice with IP buffer. The input lysate was then directly 
incubated with the antibody coupled proteinG beads. 
 
The Immuno-complexes bound to proteinG sepharose were washed with volumes of 1ml 
according to the procedure outlined below to remove unspecific protein and DNA 
interactions. Washing steps were carried out at 4°C. 
 
 2x IP Buffer  - short 
 2x 150mM NaCl Wash Buffer -short 
 2x 500mM NaCl Wash Buffer – 5min on wheel 
4˚C  
 2x LiCl Wash Buffer – 5min on wheel 4˚C  
 2x TE – short (buffer and washing at RT) 
 
Elution of chromatin immuno-complexes from proteinG sepharose was performed in two 
steps at 37°C for 15min at 800rpm. The first elution was done with 230µl of elution buffer and 
the second elution with 200µl elution buffer. 200µl were withdrawn after each step, combined 
and transferred into a 500µl PCR reaction cup for the DNA work-up (see below) 
The input DNA was filled up to 400µl with elution buffer and treated in parallel with the IP 
samples.  
 
E.2.15.6 Reverse cross-link and purification of DNA 
2µl of RNAse (20mg/ml) were added to Input, IP, DNA and pellet samples and incubated for 
2 hours at 37°C. 5µl of proteinaseK (20mg/ml) were added following incubation for 4 hours at 
42°C. Reversal of cross-link was performed at 65°C for 8 hours. For convenience these 
steps were carried our overnight in the Perkin Elmer PCR machine. 
DNA purification was done as described in the following: 
400µl sample together with 50µl water and 100µl 2M LiCl are transferred into a 1.5 ml 
reaction cup. 500µl of Phenol/Chloroform/Isoamylalcohol (25/24/1, pH 8.0, Roth) are added 
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and the mixture is vortexed for 1min. After centrifugation (5min, 13000g, RT) 500µl of the 
upper aqueous phase are transferred into a new reaction cup, 2µl glycogen (20mg/ml) and 
1ml ethanol are added. Ethanol precipitation is performed for 1h at -20°C, following 
centrifugation (30min, 13000g, 4°C) and washing with 1ml of 70% ethanol. The white pellet is 
dried for 30min at 37°C and dissolved in 40µl of TE buffer. 
The DNA is diluted to 200µl with milliQ water and stored at-20°C. 
4µl are used for each qPCR reaction. 
 
E.2.16 Quantitative REAL-TIME PCR (qPCR) 
E.2.16.1 qPCR - principles and theory 
In general, the polymerase chain reaction (PCR) is a method to amplify a DNA segment of 
choice in vitro with appropriate oligonucleotides. A target double-stranded (ds) DNA is 
incubated with a heat resistant DNA polymerase (Taq, isolated form the bacteria Thermus 
aquaticus) desoxynucleotides and a vast surplus of oligonucleotides complementary to the 
sense and anti-sense strand of the region on interest to be amplified. During the course of 
multiple rounds of denaturation, primer annealing and DNA polymerization the target DNA 
fragment bordered by the specific primers is amplified. 
With every cycle of new synthesis and denaturation the amount of the target DNA segment is 
doubled. Thus, the PCR reaction leads to an exponential amplification, since the newly 
synthesized DNA provide for an additional template. 
Quantitative REAL-TIME PCR (in the following referred to as qPCR) is a very sensitive 
method that not only detects extremely low amounts of synthesized dsDNA, but also allows 
to record the kinetic course of the reaction and thus to determine the amount of DNA at the 
onset of the reaction. 
The initial amplification reaction is described as follows: 
 
where Z(n) is the amount of target DNA after amplification with the cycle number n. Z(0) is 
the initial amount of DNA at the beginning of the reaction. The basis of the exponential 
function, is referred to as amplification value Av with a maximum value of 2 if the reaction 
runs with reaction efficiency E of 1.0 thus 100%. From the formula above, it is evident that 
little variations in the reaction’s efficiency lead to drastic differences in the amount of product. 
The efficiency of the reaction is primarily dependent on the optimization of the PCR reaction 
and can vary substantially according to reaction conditions and the quality of the 
oligonucleotides. 
 
Figure 63  Sheme of a typical qPCR cycle 
Shematic view of a typical qPCR cycle comprising a 90°C 
denaturation step, an annealing step (indicated annealing 
temparature of 58°C) and an elongation step at 72°C. At the 
end of the elongation step the fluorescence signal (grey 
bubble), which is directly proportional to the amount of 
dsDNA in the reaction tube, is recorded. 
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At the end of the reaction, when the activity of the Taq polymerase decreases and PCR 
components become limiting, the amount of product reaches a constant value – the plateau 
of the reaction. The kinetic of the reaction is determined through the change in the intensity 
of the fluorescence signal which is recorded at the end of each elongation cycle. 
 
In our laboratory the detection of dsDNA is performed with the SYBR Green reagent 
(Roche), that after intercalation into ds DNA excerts characteristic excitation and emission 
spectra at 509 and 526nm respectively. The measured fluorescence signal is directly 
proportional to the amount of dsDNA in the reaction tube. Hence, a clear disadvantage of this 
method is that also potential primer dimers or unspecific reaction products contribute to the 
fluorescence signal and thus taint the quantitative analysis. A melt curve analysis provided 
by the qPCR cycler (Corbett Reseach, RG300), verifies the purity of the reaction product. 
 
Figure 64  qPCR - melt curve analysis 
Melt curve analysis at the end of a qPCR run. The 
temperature is raised in 0.5°C increments from 
60°C to 95°C and the fluorescence signal is 
recorded. As can be seen in the diagram only one 
specific product was amplified. 
 
 
E.2.16.2 Absolute, relative and comparative quantitation 
The basis of quantitation is the ct-value (cycle threshold) that is defined as the intersection 
between an amplification curve and a threshold line. The threshold must be set in the linear 
phase of the amplification plot – where the logarithm of the fluorescence signal is plotted 
against the cycle number (Figure 65). 
Absolute quantitation 
Absolute quantitation is only possible if a standard curve of one’s target DNA with one 
specific primer set is generated. Therefore a dilution series of known concentration is 
amplified and the respective ct-values of the DNA samples are plotted against the logarithm 
of the respective concentration. When analyzing an unknown sample with the same primer 
pair, the concentration can be read out from the standard curve with the determined ct-value.  
Relative quantitation 
Very often a relative increase or decrease in comparison to a defined sample is of interest. 
For example in CHIP analysis the ratio of a certain target DNA immunoprecipitated with a 
specific antibody versus the IgG control is the readout of enrichment. In this case the same 
primer pair with the same amplification efficiency (E.2.16.3) is used for both samples. Thus, 
either assuming an amplification value of 2.0 or having determined the exact primer 
efficiency for the specific primer pair, one can calculate a relative concentration for both 
samples with the following formula: 
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where Cr is the relative concentration, Av the amplification value and ct the cycle threshold 
value. The ratio of the calculated concentrations gives the degree of enrichment. 
Comparative quantitation 
The comparative analysis mode of the RotorGene software calculates in principle a relative 
concentration of all samples analyzed as described above. But instead of assuming an 
optimal amplification value, the software determines from the exponential phase of each 
qPCR reaction a respective amplification value that is set as basis for the formula above. For 
optimal primer pairs the amplification value is virtually the same for high and low DNA 
concentrations (see primer efficiency) and thus allows the same calculations as mentioned 
above. Interestingly, the amplification values were always 10-15% lower than the 
amplification values determined manually (E.2.16.3). Of course, this can have a profound 
effect on the data, for my example in CHIP analysis it could lead to a less significant 
enrichment of a certain target DNA versus IgG control. 
 
 
Figure 65  Exponential and logarithmic amplification curve 
A.) Exponential amplification curve of a sample in duplicate. The norm –fluorescence is blotted against the cycle 
number. The threshold line is indicated. B.) Logarithmic plot of the amplification curve (A). The threshold line was 
placed in the linear phase of the reaction - assuming an optimal qPCR condition. 
E.2.16.3 Primer efficiency 
For optimal and reliable results it is crucial that the PCR reaction works equally well for 
samples with a high and a low DNA content. Also for comparison of different genomic loci it 
is indispensible that the amplification efficiency E of a PCR reaction using SYBR Green lies 
at least between 90% and 110% better between 95% and 105%.  
In order to determine the amplification efficiency of a given primer pair, five 1:5 dilutions of 
target DNA (sonified HCT-116 genomic DNA, E.2.16.7) were prepared and a standard curve 
as described under absolute quantitation was generated.  
From the linear slope of the graph (calculated by the RotorGene software) the amplification 
value Av and the reaction efficiency E are calculated according to the following formulas: 
 
where m is the slope of the standard curve. 
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Figure 66  DNA dilution series and standard curve analysis 
A.) Amplification curves of five samples in triplicate in 1:5 dilution steps plotted in logarithmic scale. B.) Standard 
curve as given by the RotorGene Software. The ct values are plotted against the logarithm of the concentration. 
The slope M and the efficiency E is given in graph as well as R2 which is a statistical parameter indicating the 
correlation of two values. A R2 value >0.99 provides good confidence in correlating two values. 
 
Table 11  Amplification value and primer efficiency 
 
Gene primer pair Amplification value Av 
Efficiency E (%) 
HoxA7 MC15/16 2,088 104,40% 
HoxA7 MC17/18 2,108 105,40% 
HoxA7 MC113/114 2,004 100,20% 
HoxA7 MC117/118 1,924 96,10% 
HoxA7 MC121/122 1,995 99,80% 
WNT1 MC23/24 1,82 91,40% 
WNT1 MC135/136 2,014 100,70% 
WNT1 MC99/100 2,05 102,60% 
WNT1 MC127/128 1,936 96,80% 
WNT1 MC129/130 2,12 106,00% 
IGFBP3 MC39/40 2,01 100,50% 
IGFBP3 MC41/42 2,009 100,40% 
IGFBP3 MC107/108 2,033 101,70% 
IGFBP3 MC109/110 1,979 98,90% 
POLR2A MC101/102 1,994 99,70% 
 
E.2.16.4 qPCR reaction setup 
qPCR reaction setup: 
 µl/ reaction 
master mix (MM) 9.67 
HotStar Taq Qiagen 5u/ul 0.08 
[1:400 000] SG stock (SYBR Green) 0.25 
primer 1 [10uM] 0.40 
primer 2 [10uM] 0.40 
water 5.2 
total 16.0 
Master-Mix (MM) 
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 µl/ reaction 
Qiagen 10xPCR buffer 2.0 
MgCl2 Qiagen 25mM 0.8 
25mM dNTPs 0.16 
Water 6.71 
total 9.67 
 
4µl of DNA-sample are added to each qPCR reaction (total volume 20µl). In the total reaction 
MgCl2, oligonucleotides and dNTP’s are at a final concentration of 2.5mM, 0.2µM and 200µM 
respectively. The SYBR Green concentration for optimal detection had been titrated 
empirically. The qPCR reaction was performed in the RotorGene RG300 machine from 
Corbett Research. SYBR Green was excited in the FAM/SYBR channel at 470nm and the 
fluorescence detected at 510nm. 
 
A three – step PCR program was used: 
cycle step temperature time number of cycles 
initial denaturation 95 15min 1 
denaturation 95 15sec 
annealing 58 20sec 
extension 72 30sec 
40 
Melt curve 60-95 0.5°C/5sec   
 
E.2.16.5 qPCR oligonucleotides and gene targets 
qPCR primer were designed using the freely available perlprimer software 
(http://perlprimer.sourceforge.net/, (Marshall 2004)) with the following modulation. 
The primer annealing temperature Tm was set to 65-68°C with a temperature difference of 1-
2°C. The amplicon length was chosen between 50 and 150bp. The primer length was set to 
20-28 nucleotides. The primer pairs with the lowest ∆G- value for full dimers and if possible 
with a C or G at their 3’end were chosen.  
Binding of oligonucleotides to unique genomic loci was verified using the UCSC Genome 
Browser which was also chosen for the retrieval of genomic sequences. 
 
Table 12  qPCR primers for CHIP analyis 
 
Name Target gene Sequence 
MC15 HoxA7 TGAGGTCGGGTTTATGGTGTG 
MC16 HoxA7 AACCCTTCCCCTAAACGCC 
MC17 HoxA7 CCTGGACCCTCTGAAAGTGATG 
MC18 HoxA7 CACCATAAACCCGACCTCACA 
MC23 WNT1 CCAGGGTTGTTAAAGCCAGACT 
MC24 WNT1 CAGTTGCGGCGACTTTGG 
MC39 IGFBP3 GGCTCCCTGAGACCCAAATG 
MC40 IGFBP3 CGCTCCGCATTCGTGTGTA 
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MC41 IGFBP3 CACTCCACCCCCACAAACTC 
MC42 IGFBP3 CTTCGGTGACCAACAGAGGAC 
MC99 WNT1 GTCCTCCTAAGTCCCTTCCTATTCTC 
MC100 WNT1 CCCAACCTCATTTCCACATCATCAC 
MC101 POLR2A TTTGCTGAAGATGAAACCGTTGTCC 
MC102 POLR2A CTTTAATCCCACCGCCTCTCCT 
MC107 IGFBP3 GGAGACAAGGTATGTGGGCTGTG 
MC108 IGFBP3 CAGCACTGATGGAAGGATGAACTC 
MC109 IGFBP3 TCAGAGACTCGAGCACAGCA 
MC110 IGFBP3 CAACACAGCCGCCTAAGTCAC 
MC113 HoxA7 CTGCCCTGAGAATGTGCTGAG 
MC114 HoxA7 GTGCCAAGCCAGAGAAGGAG 
MC117 HoxA7 TTTATGAGTTGTTCGGCCCTTCCA 
MC118 HoxA7 GTTCATGTTCACGGTTCTCATCCAC 
MC121 HoxA7 ATTTGAGCCTCTTGCCCTTCC 
MC122 HoxA7 CTCCGCCAATCTCAGCAGTC 
MC127 WNT1 TCTCTTCCCACCTCTGCTTGAC 
MC128 WNT1 CCTTTATCCCTTATGAGTTTCTTCCCAC 
MC129 WNT1 TGCCATGTGACGAAGAAAGAGCC 
MC130 WNT1 AAGTTGCTGGGAGGTGGGAG 
MC135 WNT1 GGATTTCCCTGACCACAGCC 
MC136 WNT1 GAGATGCTTAACCGCCCAGGA 
 
Table 13  Genes of interest in CHIP analysis 
 
Gene Region 
Primer 
pair comment 
HoxA7 chr7:27,164,029-27,164,237 MC15/16 
Dnmt1 CHIP, Region E, (Wu et al. 
2008) 
HoxA7 chr7:27,164,029-27,164,237 MC17/18  
WNT1 chr12:47,658,373-47,658,671 MC23/24 Dnmt1 CHIP, (Viré et al. 2005) 
IGFBP3 chr7:45,927,409-45,927,917 MC39/40 MSP analysis by R. Kappler 
IGFBP3 chr7:45,927,409-45,927,917 MC41/42  
POLR2A chr17:7,323,162-7,363,161 MC101/102 Serves as a reference gene 
 
E.2.16.6 qPCR evaluation of CHIP samples 
DNA from CHIP samples was purified as described in E.2.15.6 and 4µl taken per qPCR 
reaction. All samples were analyzed in triplicate. For the primer pairs of the genomic regions 
of interest the primer efficiency was determined (E.2.16.3) and each sample analyzed as 
described for relative quantitation (E.2.16.2). In order to provide for statistical analysis of the 
qPCR reaction, each “specific” CHIP sample was divided by all three IgG control reactions 
yielding 9 “specific” CHIP sample/ IgG ratios. From these data average value and standard 
deviation was calculated. For good qPCR samples the deviation from the average ct – value 
of the triplicate reaction was usually < 0.3, for low DNA content < 0.5. Due to the fact that the 
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DNA content of IgG control samples was at the edge of the detection limit, outliers with 
deviations > 0.5 were dismissed from the evaluation.  
For the evaluation of three biological replicas, an average value and the respective standard 
deviation were derived from all ratios determined. This includes also results from two 
different primer pairs specific for the same region of interest, as given for example by 
MC15/16 and MC17/18 for the HoxA7 locus, as long as primer efficiencies are almost equal 
(average +/- 5%). 
In publications it is often found that the specific enrichment of a DNA sample versus IgG 
control is plotted as percentage of the Input sample. Typical CHIP efficiencies for abundant 
DNA binding proteins and good antibodies are in the range of 1-10% of the Input sample. For 
histone H3 (RB gene promoter, HoxA7) and RNA PolymeraseII (POLR2A locus) efficiencies 
of 5%-7% and 9% respectively could be observed.  
The enrichment of the POI’s Dnmt1, ICBP90 and USP7 was reproducible in the range of 
0.05% - 0.1% with 2x107 cells/ IP reaction. Initially the amount of antibody necessary for 
almost full depletion of the target protein from a WCE of a given cell number was titrated for 
all proteins under investigation. This was done during the establishment of the CHIP 
procedure for whole cell extracts of 3.3x106 cells from the LS174T cell line. When changing 
to the HCT-116 cell line, the amount of cells used/ IP reaction was raised to 2x107 cells 
(factor of 6) but the amount of antibody only increased by a factor of 2. This could in part 
account for the low CHIP efficiency. Therefore in the evaluation the specific enrichment was 
not plotted as percentage of the Input. 
 
E.2.16.7 Isolation of genomic DNA for qPCR analysis 
In order to validate oligonucleotides designed for the amplification of target regions of interest 
in qPCR, genomic DNA from the cell lines of interest was isolated.  
Cell lines of choice were grown on 15cm plates to confluency (usually 2-4 15cm plates). The 
medium was withdrawn and 6ml of lysis buffer (50mM Tris, pH 8.0, 20mM EDTA, 1% SDS) 
added. Cells were lysed immediately and RNAseA digest performed with 25µl (20mg/ml) for 
2h at 37°C. 
After addition of 25µl of ProteinaseK (10mg/ml, Sigma) tissue culture plates were incubated 
at 37°C overnight. The highly viscous solution was vortexed for 5-10min and 3-5 bursts of 
sonication applied in order to shear the genomic DNA. The DNA was precipitated with the 
addition of 0.5V of 7.5 ammoniumacetate and 2V of 100% ice-cold ethanol following 
centrifugation (30min, 4°C, 20,000g). After washing with 70% ethanol the DNA was dried (but 
avoid complete drying) and dissolved in 2-4ml of warmed milliQ water. Complete dissolving 
was achieved through incubation at 45°C in a thermo shaker.  
If the DNA solution was still viscous, 2-3 bursts with the Branson Digital Sonifier (10-20% 
output, 2sec bursts) were applied. Approximately, 700-900µg of genomic DNA with an 
average size of 10-20kb were recovered from one 15 cm tissue culture plate.  
Typically, 20ng of isolated DNA was used per qPCR reaction. For the determination of the 
primer efficiency in qPCR, genomic DNA was further sheared to 500 to 1000bp. 
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